<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d9" for="edge" attr.name="context" attr.type="string" />
  <key id="d8" for="edge" attr.name="type" attr.type="string" />
  <key id="d7" for="node" attr.name="canonical_name" attr.type="string" />
  <key id="d6" for="node" attr.name="name" attr.type="string" />
  <key id="d5" for="node" attr.name="entity_type" attr.type="string" />
  <key id="d4" for="node" attr.name="paper_id" attr.type="string" />
  <key id="d3" for="node" attr.name="statement" attr.type="string" />
  <key id="d2" for="node" attr.name="year" attr.type="long" />
  <key id="d1" for="node" attr.name="content" attr.type="string" />
  <key id="d0" for="node" attr.name="type" attr.type="string" />
  <graph edgedefault="directed">
    <node id="PDF_59_2021">
      <data key="d0">Paper</data>
      <data key="d1">Here is the full text from the scientific PDF, extracted for you in English:

Resource
Cell
Integrated analysis of multimodal single-cell data
Graphical abstract
Single-cell multimodal
Weighted nearest neighbors Multimodal reference atlas
data technologies
CITE-seq
AAAA
AAAA
AAAA
AAAA
Surface protein Gene expression
10x multiome, SHARE-seq
AAAA
WAAAA
AAAA
AAAA
Open chromatin Gene expression
ASAP-seq
Surface protein Open chromatin
RNA
+
Protein
Modality weights
יוויייייי
UMAP 2
WNN
scRNA query ma</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_59_2021_Method_8555089686631967267">
      <data key="d0">Method</data>
      <data key="d1">"weighted-nearest neighbor” analysis, an unsupervised framework to learn the relative utility of each data type in each cell, enabling an integrative analysis of multiple modalities.</data>
      <data key="d3">"weighted-nearest neighbor” analysis, an unsupervised framework to learn the relative utility of each data type in each cell, enabling an integrative analysis of multiple modalities.</data>
      <data key="d4">PDF_59_2021</data>
    </node>
    <node id="PDF_59_2021_Result_-396664699954888416">
      <data key="d0">Result</data>
      <data key="d1">Multimodal analysis substantially improves our ability to resolve cell states, allowing us to identify and validate previously unreported lymphoid subpopulations.</data>
      <data key="d3">Multimodal analysis substantially improves our ability to resolve cell states, allowing us to identify and validate previously unreported lymphoid subpopulations.</data>
      <data key="d4">PDF_59_2021</data>
    </node>
    <node id="PDF_59_2021_Result_6868027964320193478">
      <data key="d0">Result</data>
      <data key="d1">WNN analysis exhibited superior or equivalent performance to alternative approaches for each of the 25 proteins, as well as the RNA transcriptome</data>
      <data key="d3">WNN analysis exhibited superior or equivalent performance to alternative approaches for each of the 25 proteins, as well as the RNA transcriptome</data>
      <data key="d4">PDF_59_2021</data>
    </node>
    <node id="Gene_RNA">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RNA</data>
      <data key="d7">RNA</data>
    </node>
    <node id="PDF_59_2021_Result_7083814114640163605">
      <data key="d0">Result</data>
      <data key="d1">WNN analysis identified a novel population of Basal cells that exhibits distinct chromatin accessibility profiles, but does not exhibit unique transcriptomic characteristics</data>
      <data key="d3">WNN analysis identified a novel population of Basal cells that exhibits distinct chromatin accessibility profiles, but does not exhibit unique transcriptomic characteristics</data>
      <data key="d4">PDF_59_2021</data>
    </node>
    <node id="PDF_59_2021_Conclusion_-3231416748386769626">
      <data key="d0">Conclusion</data>
      <data key="d1">WNN analysis is capable of sensitively and robustly characterizing populations that cannot be identified by a single modality, exhibits best-in-class performance, and can be flexibly applied to multiple data types for integrative and multimodal analysis.</data>
      <data key="d3">WNN analysis is capable of sensitively and robustly characterizing populations that cannot be identified by a single modality, exhibits best-in-class performance, and can be flexibly applied to multiple data types for integrative and multimodal analysis.</data>
      <data key="d4">PDF_59_2021</data>
    </node>
    <node id="PDF_47_2015">
      <data key="d0">Paper</data>
      <data key="d1">INTRODUCTION

Different types of virus-like particles (VLPs) can be produced
using virus capsid protein, which self-assembles to form VLPs.
The VLPs are devoid of any genetic material, and they provide
useful information for viral infection mechanisms and also serve
as a very effective tool for vaccination.1,2 There are many types
of capsid proteins, but here, the primary focus was on lipid
layer-surrounded VLPs, because the lipid surface can be used to
display proteins for functionalization wit</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_47_2015_Hypothesis_-2067254802045177128">
      <data key="d0">Hypothesis</data>
      <data key="d1">the dual use of the nanobiomaterial chimeric VLPs as a platform for vaccination against influenza A virus</data>
      <data key="d3">the dual use of the nanobiomaterial chimeric VLPs as a platform for vaccination against influenza A virus</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="Disease_INFLUENZA VIRUS">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">INFLUENZA VIRUS</data>
      <data key="d7">Influenza virus</data>
    </node>
    <node id="Protein_M1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">M1</data>
      <data key="d7">M1</data>
    </node>
    <node id="Gene_GAG">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GAG</data>
      <data key="d7">Gag</data>
    </node>
    <node id="PDF_47_2015_Method_2971991304512974076">
      <data key="d0">Method</data>
      <data key="d1">chimeric VLPs were prepared using gag and M1 capsid proteins</data>
      <data key="d3">chimeric VLPs were prepared using gag and M1 capsid proteins</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="PDF_47_2015_Method_6986028135312992208">
      <data key="d0">Method</data>
      <data key="d1">Chimeric VLPs were expressed in silkworms, and larval hemolymph was collected, which was used for purification using DDDDK-tagged protein purification gel.</data>
      <data key="d3">Chimeric VLPs were expressed in silkworms, and larval hemolymph was collected, which was used for purification using DDDDK-tagged protein purification gel.</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="PDF_47_2015_Method_1237512635389314286">
      <data key="d0">Method</data>
      <data key="d1">LS174T cells when treated with chimeric VLPs packaged with calcein-AM showed fluorescence</data>
      <data key="d3">LS174T cells when treated with chimeric VLPs packaged with calcein-AM showed fluorescence</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="PDF_47_2015_Method_6906002643227996844">
      <data key="d0">Method</data>
      <data key="d1">Large spheroids were treated with 100 µg of chimeric VLPs packaged with similar amounts of calcein-AM</data>
      <data key="d3">Large spheroids were treated with 100 µg of chimeric VLPs packaged with similar amounts of calcein-AM</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="PDF_47_2015_Method_-3607690434020706431">
      <data key="d0">Method</data>
      <data key="d1">chimeric VLPs with doxorubicin a known effective chemotherapeutic reagent that intercalates DNA.</data>
      <data key="d3">chimeric VLPs with doxorubicin a known effective chemotherapeutic reagent that intercalates DNA.</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="Gene_DNA">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DNA</data>
      <data key="d7">DNA</data>
    </node>
    <node id="Compound_DOXORUBICIN">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">DOXORUBICIN</data>
      <data key="d7">Doxorubicin</data>
    </node>
    <node id="PDF_47_2015_Result_-8141722876521394081">
      <data key="d0">Result</data>
      <data key="d1">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
      <data key="d3">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="PDF_47_2015_Conclusion_-7873761754406593097">
      <data key="d0">Conclusion</data>
      <data key="d1">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
      <data key="d3">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
      <data key="d4">PDF_47_2015</data>
    </node>
    <node id="PDF_18_2013">
      <data key="d0">Paper</data>
      <data key="d1">npg
2013 Nature America, Inc. All rights reserved.
COMMENTARY
OPEN
The Genotype-Tissue Expression (GTEX)
project
The GTEx Consortium*
Genome-wide association studies have identified thousands of loci for common diseases, but, for the majority
of these, the mechanisms underlying disease susceptibility remain unknown. Most associated variants are not
correlated with protein-coding changes, suggesting that polymorphisms in regulatory regions probably contribute to
many disease phenotypes. Here we d</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_18_2013_Hypothesis_9145217608372488246">
      <data key="d0">Hypothesis</data>
      <data key="d1">polymorphisms in regulatory regions probably contribute to many disease phenotypes</data>
      <data key="d3">polymorphisms in regulatory regions probably contribute to many disease phenotypes</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="Disease_DISEASE">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">DISEASE</data>
      <data key="d7">Disease</data>
    </node>
    <node id="PDF_18_2013_Method_3355561105809089282">
      <data key="d0">Method</data>
      <data key="d1">Expression quantitative trait locus (eQTL) mapping</data>
      <data key="d3">Expression quantitative trait locus (eQTL) mapping</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_18_2013_Method_-7322543800572006856">
      <data key="d0">Method</data>
      <data key="d1">massively parallel sequencing of RNA</data>
      <data key="d3">massively parallel sequencing of RNA</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_18_2013_Method_-7411871501972655322">
      <data key="d0">Method</data>
      <data key="d1">DNA genotyping using the Illumina HumanOmni5M-Quad BeadChip</data>
      <data key="d3">DNA genotyping using the Illumina HumanOmni5M-Quad BeadChip</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_18_2013_Method_-2795797867525489279">
      <data key="d0">Method</data>
      <data key="d1">RNA sequencing (RNA-seq) using a 76-base, paired-end Illumina TruSeq RNA protocol</data>
      <data key="d3">RNA sequencing (RNA-seq) using a 76-base, paired-end Illumina TruSeq RNA protocol</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_18_2013_Result_1244115097555209734">
      <data key="d0">Result</data>
      <data key="d1">eQTLs are common in humans</data>
      <data key="d3">eQTLs are common in humans</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_18_2013_Result_-3083704486613450933">
      <data key="d0">Result</data>
      <data key="d1">Genetic variation can also influence gene expression through alterations in splicing, noncoding RNA expression and RNA stability</data>
      <data key="d3">Genetic variation can also influence gene expression through alterations in splicing, noncoding RNA expression and RNA stability</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="Gene_GENE">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GENE</data>
      <data key="d7">Gene</data>
    </node>
    <node id="PDF_18_2013_Conclusion_8957017362153238353">
      <data key="d0">Conclusion</data>
      <data key="d1">A large-scale GTEx resource will be a powerful tool in unraveling the complex patterns of genetic variation and gene regulation across diverse human tissue types</data>
      <data key="d3">A large-scale GTEx resource will be a powerful tool in unraveling the complex patterns of genetic variation and gene regulation across diverse human tissue types</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_18_2013_Conclusion_-618019860618239858">
      <data key="d0">Conclusion</data>
      <data key="d1">The GTEx project will aid in the interpretation of GWAS findings for translational research by providing data and resources on eQTLs in a wide range of tissues of relevance to many diseases</data>
      <data key="d3">The GTEx project will aid in the interpretation of GWAS findings for translational research by providing data and resources on eQTLs in a wide range of tissues of relevance to many diseases</data>
      <data key="d4">PDF_18_2013</data>
    </node>
    <node id="PDF_43_2015">
      <data key="d0">Paper</data>
      <data key="d1">Article
Cell
Regulated Formation of an Amyloid-like
Translational Repressor Governs Gametogenesis
Graphical Abstract
Starvation
Meiosis
nucleus
Meiosis II
Authors
Rim4 amyloid-like aggregates
repress translation of bound mRNA
5'UTR
RRM
RRM
RRM
RRM
AAAAAA
AAAAAA
AAAAAA
AAAAAA
Aggreates are cleared at MI-MII transition
activating mRNA translation
5'UTR
AAAAAA
AAAAAA
AAAAAA
Luke E. Berchowitz, Greg Kabachinski,
Margaret R. Walker, Wendy V. Gilbert,
....
Thomas U. Schwartz, Angelika Amon
Corresponde</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_43_2015_Result_1232533132656410363">
      <data key="d0">Result</data>
      <data key="d1">Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein.</data>
      <data key="d3">Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="Protein_RIM4">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">RIM4</data>
      <data key="d7">Rim4</data>
    </node>
    <node id="PDF_43_2015_Result_6295905729555225160">
      <data key="d0">Result</data>
      <data key="d1">Rim4 aggregation is a developmentally regulated process; starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation.</data>
      <data key="d3">Rim4 aggregation is a developmentally regulated process; starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_43_2015_Result_-5005069938393570841">
      <data key="d0">Result</data>
      <data key="d1">At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence.</data>
      <data key="d3">At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_43_2015_Result_-8351889389887584085">
      <data key="d0">Result</data>
      <data key="d1">Rim4 binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
      <data key="d3">Rim4 binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="Gene_CLB3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CLB3</data>
      <data key="d7">CLB3</data>
    </node>
    <node id="PDF_43_2015_Result_-1285961404983887914">
      <data key="d0">Result</data>
      <data key="d1">Rim4 forms fibrillar helical structures.</data>
      <data key="d3">Rim4 forms fibrillar helical structures.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_43_2015_Result_-2613529904302867661">
      <data key="d0">Result</data>
      <data key="d1">Rim4 fibers are composed of ẞ sheets.</data>
      <data key="d3">Rim4 fibers are composed of ẞ sheets.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_43_2015_Result_4886046759576315579">
      <data key="d0">Result</data>
      <data key="d1">Rim4 structures within the cell are largely static.</data>
      <data key="d3">Rim4 structures within the cell are largely static.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_43_2015_Result_-5040507421319311137">
      <data key="d0">Result</data>
      <data key="d1">Rim44204C was not cleared from cells efficiently compared to Rim4-EGFP. The mutant protein persisted in cells well beyond exit from meiosis I.</data>
      <data key="d3">Rim44204C was not cleared from cells efficiently compared to Rim4-EGFP. The mutant protein persisted in cells well beyond exit from meiosis I.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_43_2015_Conclusion_2995070332061102522">
      <data key="d0">Conclusion</data>
      <data key="d1">Regulated formation of amyloid-like aggregates establishes and upholds gametogenesis.</data>
      <data key="d3">Regulated formation of amyloid-like aggregates establishes and upholds gametogenesis.</data>
      <data key="d4">PDF_43_2015</data>
    </node>
    <node id="PDF_46_2010">
      <data key="d0">Paper</data>
      <data key="d1">Pumilio 2 controls translation by competing with eIF4E
for 7-methyl guanosine cap recognition
QUIPING CAO, KIRAN PADMANABHAN,¹ and JOEL D. RICHTER
Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA
ABSTRACT
Pumilio 2 (Pum2) interacts with the 3' UTR-containing pumilio binding element (PBE) of RINGO/SPY mRNA to repress
translation in Xenopus oocytes. Here, we show that Pum2 also binds directly to the 5' 7mG cap structure; in so doing, it</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_46_2010_Hypothesis_-3405269730038062220">
      <data key="d0">Hypothesis</data>
      <data key="d1">Vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
      <data key="d3">Vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
      <data key="d4">PDF_46_2010</data>
    </node>
    <node id="Protein_PUMILIO">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PUMILIO</data>
      <data key="d7">Pumilio</data>
    </node>
    <node id="Protein_EIF4E">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">EIF4E</data>
      <data key="d7">eIF4E</data>
    </node>
    <node id="PDF_46_2010_Method_13251123843783398">
      <data key="d0">Method</data>
      <data key="d1">Using deletion analysis, we have mapped the cap interaction domain of Pum2 to the amino terminus of the protein and identified a conserved tryptophan residue that mediates this specific interaction.</data>
      <data key="d3">Using deletion analysis, we have mapped the cap interaction domain of Pum2 to the amino terminus of the protein and identified a conserved tryptophan residue that mediates this specific interaction.</data>
      <data key="d4">PDF_46_2010</data>
    </node>
    <node id="Protein_PUM2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PUM2</data>
      <data key="d7">Pum2</data>
    </node>
    <node id="PDF_46_2010_Result_-2080384439553327116">
      <data key="d0">Result</data>
      <data key="d1">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
      <data key="d3">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
      <data key="d4">PDF_46_2010</data>
    </node>
    <node id="PDF_46_2010_Result_3576297978772130101">
      <data key="d0">Result</data>
      <data key="d1">Reporter mRNA-based assays demonstrate that Pum2 requires the conserved tryptophan to repress translation in injected Xenopus oocytes.</data>
      <data key="d3">Reporter mRNA-based assays demonstrate that Pum2 requires the conserved tryptophan to repress translation in injected Xenopus oocytes.</data>
      <data key="d4">PDF_46_2010</data>
    </node>
    <node id="PDF_46_2010_Conclusion_1116816789150258791">
      <data key="d0">Conclusion</data>
      <data key="d1">Pum2 represses translation by a novel mechanism.</data>
      <data key="d3">Pum2 represses translation by a novel mechanism.</data>
      <data key="d4">PDF_46_2010</data>
    </node>
    <node id="PDF_46_2010_Conclusion_6644930847896084558">
      <data key="d0">Conclusion</data>
      <data key="d1">Pum2 combines two binding specificities, with the cap and the 3' UTR PBE, to repress translation.</data>
      <data key="d3">Pum2 combines two binding specificities, with the cap and the 3' UTR PBE, to repress translation.</data>
      <data key="d4">PDF_46_2010</data>
    </node>
    <node id="PDF_04_2013">
      <data key="d0">Paper</data>
      <data key="d1">Here is the extracted text from the scientific PDF you provided. 

**Genesis and Regulatory Wiring of Retroelement-Derived
Domesticated Genes: A Phylogenomic Perspective**

Janez Kokošar and Dušan Kordiš*
Department of Molecular and Biomedical Sciences, Josef Stefan Institute, Ljubljana, Slovenia
*Corresponding author: E-mail: dusan.kordis@ijs.si.
Associate editor: Jianzhi Zhang

**Abstract**
Molecular domestications of transposable elements have occurred repeatedly during the evolution of eukar</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_04_2013_Hypothesis_-1004234798704718426">
      <data key="d0">Hypothesis</data>
      <data key="d1">RDDGs originated from retroelement remains</data>
      <data key="d3">RDDGs originated from retroelement remains</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Method_-5853943805316702823">
      <data key="d0">Method</data>
      <data key="d1">phylogenomic analysis, using whole-genome information from more than 90 chordate genomes</data>
      <data key="d3">phylogenomic analysis, using whole-genome information from more than 90 chordate genomes</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Method_-513096850265994287">
      <data key="d0">Method</data>
      <data key="d1">comparative genomic and phylogenomic analyses</data>
      <data key="d3">comparative genomic and phylogenomic analyses</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Method_8289517316011524710">
      <data key="d0">Method</data>
      <data key="d1">Bayesian phylogenetics and conserved synteny</data>
      <data key="d3">Bayesian phylogenetics and conserved synteny</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Result_-2978051934439163862">
      <data key="d0">Result</data>
      <data key="d1">major diversification has occurred in the ancestor of placental mammals</data>
      <data key="d3">major diversification has occurred in the ancestor of placental mammals</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Result_-1004234798704718426">
      <data key="d0">Result</data>
      <data key="d1">RDDGs originated from retroelement remains</data>
      <data key="d3">RDDGs originated from retroelement remains</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Result_-2176971479370297039">
      <data key="d0">Result</data>
      <data key="d1">the major diversification inside the DGs occurred in the ancestor of placental mammals</data>
      <data key="d3">the major diversification inside the DGs occurred in the ancestor of placental mammals</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Result_-574567070756559876">
      <data key="d0">Result</data>
      <data key="d1">RDDGs originated from Metaviridae remains</data>
      <data key="d3">RDDGs originated from Metaviridae remains</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Result_7891659851682385134">
      <data key="d0">Result</data>
      <data key="d1">burst of RDDG origination took place in the ancestor of placentals</data>
      <data key="d3">burst of RDDG origination took place in the ancestor of placentals</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Result_6996102153578627956">
      <data key="d0">Result</data>
      <data key="d1">chromosomal gene movements of RDDGs were highly dynamic only in the ancestor of placental mammals</data>
      <data key="d3">chromosomal gene movements of RDDGs were highly dynamic only in the ancestor of placental mammals</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Conclusion_-8703100330869748797">
      <data key="d0">Conclusion</data>
      <data key="d1">RDDGs have been crucially involved in, or even promoted development of, phenotypic novelties such as placenta and neocortex</data>
      <data key="d3">RDDGs have been crucially involved in, or even promoted development of, phenotypic novelties such as placenta and neocortex</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_04_2013_Conclusion_-2706192554863336224">
      <data key="d0">Conclusion</data>
      <data key="d1">the emergence of the orthologous RDDG families in placental mammals is most probably connected to the origin of their innovations and adaptations, such as placenta and newly evolved brain functions</data>
      <data key="d3">the emergence of the orthologous RDDG families in placental mammals is most probably connected to the origin of their innovations and adaptations, such as placenta and newly evolved brain functions</data>
      <data key="d4">PDF_04_2013</data>
    </node>
    <node id="PDF_44_2021">
      <data key="d0">Paper</data>
      <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Nature. Author manuscript; available in PMC 2022 January 01.
Published in final edited form as:
Nature. 2021 July ; 595(7866): 303-308. doi:10.1038/s41586-021-03633-w.
NORAD-induced PUMILIO phase separation is required for
genome stability
Mahmoud M. Elguindy1,2, Joshua T. Mendell1,3,4,5,*
1Department of Molecular Biology, University of Texas Southwestern Medical C</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_44_2021_Hypothesis_-6356674699053909287">
      <data key="d0">Hypothesis</data>
      <data key="d1">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
      <data key="d3">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="Gene_NORAD">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NORAD</data>
      <data key="d7">NORAD</data>
    </node>
    <node id="PDF_44_2021_Method_693890980709095830">
      <data key="d0">Method</data>
      <data key="d1">using CRISPR interference (CRISPRi)</data>
      <data key="d3">using CRISPR interference (CRISPRi)</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="PDF_44_2021_Method_1967647359851464652">
      <data key="d0">Method</data>
      <data key="d1">RNA-seq</data>
      <data key="d3">RNA-seq</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="PDF_44_2021_Result_-2718178320447919999">
      <data key="d0">Result</data>
      <data key="d1">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
      <data key="d3">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="PDF_44_2021_Result_-6694412374928544773">
      <data key="d0">Result</data>
      <data key="d1">NORAD depletion in parental, circPRE)-, or low-valency circPRE1-2-expressing cells resulted in a significant increase in chromosome segregation defects.</data>
      <data key="d3">NORAD depletion in parental, circPRE)-, or low-valency circPRE1-2-expressing cells resulted in a significant increase in chromosome segregation defects.</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="PDF_44_2021_Result_2739798725196345567">
      <data key="d0">Result</data>
      <data key="d1">Expression of PUM condensate-inducing circPRE4 or circPRE8, at levels that supplied comparable or fewer total PREs per cell than the low-valency constructs, suppressed aberrant chromosome segregation.</data>
      <data key="d3">Expression of PUM condensate-inducing circPRE4 or circPRE8, at levels that supplied comparable or fewer total PREs per cell than the low-valency constructs, suppressed aberrant chromosome segregation.</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="PDF_44_2021_Conclusion_3631881401228220472">
      <data key="d0">Conclusion</data>
      <data key="d1">NORAD is able to out-compete thousands of other transcripts to bind and regulate the activity of PUM proteins by nucleating the formation of liquid-like cytoplasmic RNP condensates, termed NP bodies.</data>
      <data key="d3">NORAD is able to out-compete thousands of other transcripts to bind and regulate the activity of PUM proteins by nucleating the formation of liquid-like cytoplasmic RNP condensates, termed NP bodies.</data>
      <data key="d4">PDF_44_2021</data>
    </node>
    <node id="PDF_13_2018">
      <data key="d0">Paper</data>
      <data key="d1">Cell Stem Cell
Resource
Single-Cell RNA Sequencing Analysis Reveals
Sequential Cell Fate Transition during Human
Spermatogenesis
Mei Wang, 1,8,9 Xixi Liu, 2,5,9 Gang Chang, 3,9 Yidong Chen, 2,5,7,9 Geng An, 4,9 Liying Yan, 2,5 Shuai Gao, 2,5 Yanwen Xu, 1,8
Yueli Cui, 2,5 Ji Dong, 2,5 Yuhan Chen, 1,8 Xiaoying Fan, 2,5 Yuqiong Hu, 2,5,7 Ke Song, 1,8 Xiaohui Zhu, 2,5 Yun Gao, 2,5
Zhaokai Yao, 1,8 Shuhui Bian, 2,5,7 Yu Hou, 2,5 Jiahao Lu, 1,8 Rui Wang, 2,5 Yong Fan, 4 Ying Lian, 2,5 Wenhao Tang, 2,5</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_13_2018_Result_6760138119466857430">
      <data key="d0">Result</data>
      <data key="d1">Single-cell RNA sequencing (scRNA-seq) analysis identified sequential and stepwise development of three spermatogonia subtypes, seven spermatocyte subtypes, and four spermatid subtypes.</data>
      <data key="d3">Single-cell RNA sequencing (scRNA-seq) analysis identified sequential and stepwise development of three spermatogonia subtypes, seven spermatocyte subtypes, and four spermatid subtypes.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="PDF_13_2018_Result_-8392518174099388496">
      <data key="d0">Result</data>
      <data key="d1">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
      <data key="d3">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="Gene_HMGA1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HMGA1</data>
      <data key="d7">HMGA1</data>
    </node>
    <node id="Gene_PIWIL4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PIWIL4</data>
      <data key="d7">PIWIL4</data>
    </node>
    <node id="Gene_TEX29">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TEX29</data>
      <data key="d7">TEX29</data>
    </node>
    <node id="Gene_SCML1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SCML1</data>
      <data key="d7">SCML1</data>
    </node>
    <node id="Gene_CCDC112">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CCDC112</data>
      <data key="d7">CCDC112</data>
    </node>
    <node id="PDF_13_2018_Result_1353884620932293391">
      <data key="d0">Result</data>
      <data key="d1">Altered gene expression patterns were identified in the testicular somatic cells of one NOA patient via scRNA-seq analysis.</data>
      <data key="d3">Altered gene expression patterns were identified in the testicular somatic cells of one NOA patient via scRNA-seq analysis.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="Disease_NOA">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">NOA</data>
      <data key="d7">NOA</data>
    </node>
    <node id="PDF_13_2018_Method_5436116581824974414">
      <data key="d0">Method</data>
      <data key="d1">scRNA sequencing of 2,854 individual testicular cells from donors with normal spermatogenesis and 174 testicular cells from one donor diagnosed as having nonobstructive azoospermia (NOA) using a modified scRNA-seq method.</data>
      <data key="d3">scRNA sequencing of 2,854 individual testicular cells from donors with normal spermatogenesis and 174 testicular cells from one donor diagnosed as having nonobstructive azoospermia (NOA) using a modified scRNA-seq method.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="PDF_13_2018_Result_7075937358766314031">
      <data key="d0">Result</data>
      <data key="d1">GFRA1 and RET were highly enriched in cluster 1, which was associated with self-renewal of spermatogonia via the RET pathway.</data>
      <data key="d3">GFRA1 and RET were highly enriched in cluster 1, which was associated with self-renewal of spermatogonia via the RET pathway.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="Gene_GFRA1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GFRA1</data>
      <data key="d7">GFRA1</data>
    </node>
    <node id="Gene_RET">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RET</data>
      <data key="d7">RET</data>
    </node>
    <node id="PDF_13_2018_Result_-3821930742129508863">
      <data key="d0">Result</data>
      <data key="d1">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1.</data>
      <data key="d3">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="Gene_FGFR3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FGFR3</data>
      <data key="d7">FGFR3</data>
    </node>
    <node id="Gene_BMPR1B">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">BMPR1B</data>
      <data key="d7">BMPR1B</data>
    </node>
    <node id="PDF_13_2018_Result_6190377741352676371">
      <data key="d0">Result</data>
      <data key="d1">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells.</data>
      <data key="d3">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="Gene_DMRT1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DMRT1</data>
      <data key="d7">DMRT1</data>
    </node>
    <node id="Gene_UTF1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UTF1</data>
      <data key="d7">UTF1</data>
    </node>
    <node id="PDF_13_2018_Result_-3542001147096938638">
      <data key="d0">Result</data>
      <data key="d1">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs.</data>
      <data key="d3">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="PDF_13_2018_Result_-1582368244051296899">
      <data key="d0">Result</data>
      <data key="d1">FGF and BMP pathways might participate in maintaining the self-renewal of human SSCs.</data>
      <data key="d3">FGF and BMP pathways might participate in maintaining the self-renewal of human SSCs.</data>
      <data key="d4">PDF_13_2018</data>
    </node>
    <node id="PDF_35_2018">
      <data key="d0">Paper</data>
      <data key="d1">Focus Article
Regulation of germ cell
development by intercellular
signaling in the mammalian
ovarian follicle
Hugh J. Clarke *
Prior to ovulation, the mammalian oocyte undergoes a process of differentiation
within the ovarian follicle that confers on it the ability to give rise to an embryo.
Differentiation comprises two phases-growth, during which the oocyte
increases more than 100-fold in volume as it accumulates macromolecules and
organelles that will sustain early embryogenesis; and meiotic</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_35_2018_Hypothesis_1471499653583860445">
      <data key="d0">Hypothesis</data>
      <data key="d1">TZPs may represent sites of attachment that exist between the oocyte and adjacent granulosa cells before the zona pellucida becomes assembled around the oocyte.</data>
      <data key="d3">TZPs may represent sites of attachment that exist between the oocyte and adjacent granulosa cells before the zona pellucida becomes assembled around the oocyte.</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="PDF_35_2018_Method_-7853830282551524773">
      <data key="d0">Method</data>
      <data key="d1">using Cre-lox strategy, enabling genes to be modified in specific cells at specific stages of differentiation</data>
      <data key="d3">using Cre-lox strategy, enabling genes to be modified in specific cells at specific stages of differentiation</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="PDF_35_2018_Result_-1222015465563957096">
      <data key="d0">Result</data>
      <data key="d1">deletion of Ptk2 reduces the number of TZPs by about one-third</data>
      <data key="d3">deletion of Ptk2 reduces the number of TZPs by about one-third</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="Gene_PTK2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PTK2</data>
      <data key="d7">PTK2</data>
    </node>
    <node id="PDF_35_2018_Result_3646420711576390928">
      <data key="d0">Result</data>
      <data key="d1">Activating PI3-kinase signaling within the oocyte is sufficient to initiate its growth</data>
      <data key="d3">Activating PI3-kinase signaling within the oocyte is sufficient to initiate its growth</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="PDF_35_2018_Result_-6142646404841884170">
      <data key="d0">Result</data>
      <data key="d1">KITL produced by the granulosa cells in the primordial follicle triggers growth of the enclosed oocyte.</data>
      <data key="d3">KITL produced by the granulosa cells in the primordial follicle triggers growth of the enclosed oocyte.</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="Gene_KITL">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">KITL</data>
      <data key="d7">KITL</data>
    </node>
    <node id="PDF_35_2018_Result_-4381403732090175772">
      <data key="d0">Result</data>
      <data key="d1">Signals from the granulosa cells play an essential role not only in initiating oocyte growth but also in sustaining it</data>
      <data key="d3">Signals from the granulosa cells play an essential role not only in initiating oocyte growth but also in sustaining it</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="PDF_35_2018_Result_-4626389359787746016">
      <data key="d0">Result</data>
      <data key="d1">gap junctional communication mediated through GJA1 between the granulosa cells is required for normal oocyte development</data>
      <data key="d3">gap junctional communication mediated through GJA1 between the granulosa cells is required for normal oocyte development</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="Gene_GJA1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GJA1</data>
      <data key="d7">GJA1</data>
    </node>
    <node id="PDF_35_2018_Result_-4895343190942377132">
      <data key="d0">Result</data>
      <data key="d1">GJA4 is essential in oocytes but not in granulosa cells for gap junctional coupling between the two cell types and for normal oocyte development.</data>
      <data key="d3">GJA4 is essential in oocytes but not in granulosa cells for gap junctional coupling between the two cell types and for normal oocyte development.</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="Gene_GJA4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GJA4</data>
      <data key="d7">GJA4</data>
    </node>
    <node id="PDF_35_2018_Result_-4532093255262841035">
      <data key="d0">Result</data>
      <data key="d1">granulosa cells provide a function via gap junctions that enables the oocyte to regulate its pH in response to environmental stress</data>
      <data key="d3">granulosa cells provide a function via gap junctions that enables the oocyte to regulate its pH in response to environmental stress</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="PDF_35_2018_Result_7953584757813559338">
      <data key="d0">Result</data>
      <data key="d1">GDF9 and bone morphogenetic protein (BMP) 15 regulate differentiation of the somatic compartment of the follicle</data>
      <data key="d3">GDF9 and bone morphogenetic protein (BMP) 15 regulate differentiation of the somatic compartment of the follicle</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="Protein_GDF9">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">GDF9</data>
      <data key="d7">GDF9</data>
    </node>
    <node id="Protein_BMP15">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">BMP15</data>
      <data key="d7">BMP15</data>
    </node>
    <node id="PDF_35_2018_Conclusion_2113275934678562524">
      <data key="d0">Conclusion</data>
      <data key="d1">oocyte differentiation depends on continuous signaling interactions with the somatic cells of the follicle</data>
      <data key="d3">oocyte differentiation depends on continuous signaling interactions with the somatic cells of the follicle</data>
      <data key="d4">PDF_35_2018</data>
    </node>
    <node id="PDF_53_2019">
      <data key="d0">Paper</data>
      <data key="d1">Negative-Stain Transmission Electron
Microscopy of Molecular Complexes for
Image Analysis by 2D Class Averaging
John R. Gallagher,¹ Alexander J. Kim,¹ Neetu M. Gulati,¹
and Audray K. Harris1,2
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland
2Corresponding author: harrisau@mail.nih.gov
Negative-stain transmission electron microscopy (EM) is a technique that has
provided nanometer resolution images of macro</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_53_2019_Method_-1219795650780411187">
      <data key="d0">Method</data>
      <data key="d1">Negative-stain transmission electron microscopy (EM) is a technique that has provided nanometer resolution images of macromolecules for about 60 years.</data>
      <data key="d3">Negative-stain transmission electron microscopy (EM) is a technique that has provided nanometer resolution images of macromolecules for about 60 years.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_53_2019_Method_4902097279125757331">
      <data key="d0">Method</data>
      <data key="d1">Using uranyl acetate stained molecular complexes of influenza hemagglutinin bound to Fab 441D6, we describe a simple and efficient means to collect several hundred micrographs with SerialEM.</data>
      <data key="d3">Using uranyl acetate stained molecular complexes of influenza hemagglutinin bound to Fab 441D6, we describe a simple and efficient means to collect several hundred micrographs with SerialEM.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="Protein_HEMAGGLUTININ">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">HEMAGGLUTININ</data>
      <data key="d7">Hemagglutinin</data>
    </node>
    <node id="PDF_53_2019_Method_8956086421417944838">
      <data key="d0">Method</data>
      <data key="d1">Using RELION, we illustrate how tens of thousands of complexes can be auto-picked and classified to accurately describe the domain level topology of this unconventional hemagglutinin head-domain epitope.</data>
      <data key="d3">Using RELION, we illustrate how tens of thousands of complexes can be auto-picked and classified to accurately describe the domain level topology of this unconventional hemagglutinin head-domain epitope.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_53_2019_Result_4407109962732350617">
      <data key="d0">Result</data>
      <data key="d1">By comparing to the cryo-EM density map of the same complex, we show that questions about epitope mapping and conformational heterogeneity can readily be answered by this negative-stain method.</data>
      <data key="d3">By comparing to the cryo-EM density map of the same complex, we show that questions about epitope mapping and conformational heterogeneity can readily be answered by this negative-stain method.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_53_2019_Method_-5397861566614506470">
      <data key="d0">Method</data>
      <data key="d1">This article aims to depict the workflow moving from particles in buffer to a large number of electron micrographs, and then analyzing these micrographs by 2D class averaging.</data>
      <data key="d3">This article aims to depict the workflow moving from particles in buffer to a large number of electron micrographs, and then analyzing these micrographs by 2D class averaging.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_53_2019_Method_4042852740830363960">
      <data key="d0">Method</data>
      <data key="d1">As an example for this article, we use the molecular complex of the antibody fragment antigen-binding (Fab) 441D6 in complex with influenza hemagglutinin (HA) A/New York/653/1996.</data>
      <data key="d3">As an example for this article, we use the molecular complex of the antibody fragment antigen-binding (Fab) 441D6 in complex with influenza hemagglutinin (HA) A/New York/653/1996.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_53_2019_Result_5879963537206037678">
      <data key="d0">Result</data>
      <data key="d1">The epitope of the 441D6 antibody targets the immunodominant head region of influenza hemagglutinin, yet 441D6 is unique in that it has broad activity against viruses spanning 90 years of evolution by the H1 subtype of influenza.</data>
      <data key="d3">The epitope of the 441D6 antibody targets the immunodominant head region of influenza hemagglutinin, yet 441D6 is unique in that it has broad activity against viruses spanning 90 years of evolution by the H1 subtype of influenza.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_53_2019_Result_-1173615124721186537">
      <data key="d0">Result</data>
      <data key="d1">The HA ectodomain in this complex is just 10 nm tall, but the 3 Fabs bound to HA add substantial information to the images that aid in particle alignment during 2D classification.</data>
      <data key="d3">The HA ectodomain in this complex is just 10 nm tall, but the 3 Fabs bound to HA add substantial information to the images that aid in particle alignment during 2D classification.</data>
      <data key="d4">PDF_53_2019</data>
    </node>
    <node id="PDF_21_2018">
      <data key="d0">Paper</data>
      <data key="d1">i An update to this article is included at the end
Article
Cell
The Neuronal Gene Arc Encodes a Repurposed
Retrotransposon Gag Protein that Mediates
Intercellular RNA Transfer
Graphical Abstract
Donor Neuron
mRNAs are released
in recipient neurons
mRNAs are
encapsulated by Arc
mRNAs travel
neuron-to-neuron in
ACBARS
Authors
Elissa D. Pastuzyn, Cameron E. Day,
....
Rachel B. Kearns, John A.G. Briggs,
Cédric Feschotte, Jason D. Shepherd
Correspondence
jason.shepherd@neuro.utah.edu
In Brief
The neu</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_21_2018_Hypothesis_-6711494172673707469">
      <data key="d0">Hypothesis</data>
      <data key="d1">Arc might bind and encapsulate RNA.</data>
      <data key="d3">Arc might bind and encapsulate RNA.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="Gene_ARC">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ARC</data>
      <data key="d7">ARC</data>
    </node>
    <node id="Compound_RNA">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">RNA</data>
      <data key="d7">RNA</data>
    </node>
    <node id="PDF_21_2018_Method_-4435858006020023394">
      <data key="d0">Method</data>
      <data key="d1">qRT-PCR was used to determine levels of Arc mRNA and a highly abundant bacterial mRNA, asnA.</data>
      <data key="d3">qRT-PCR was used to determine levels of Arc mRNA and a highly abundant bacterial mRNA, asnA.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="Compound_MRNA">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">MRNA</data>
      <data key="d7">mRNA</data>
    </node>
    <node id="PDF_21_2018_Result_5862787048161013709">
      <data key="d0">Result</data>
      <data key="d1">Arc mRNA levels were ~10-fold higher than asnA in prArc capsids.</data>
      <data key="d3">Arc mRNA levels were ~10-fold higher than asnA in prArc capsids.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_-2561575624741178409">
      <data key="d0">Result</data>
      <data key="d1">RNase did not degrade Arc or asnA mRNA, but significantly degraded exogenous free GFP mRNA, indicating that Arc and asnA mRNA were protected from RNase degradation.</data>
      <data key="d3">RNase did not degrade Arc or asnA mRNA, but significantly degraded exogenous free GFP mRNA, indicating that Arc and asnA mRNA were protected from RNase degradation.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="Gene_GFP">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GFP</data>
      <data key="d7">GFP</data>
    </node>
    <node id="PDF_21_2018_Result_8271825533067228110">
      <data key="d0">Result</data>
      <data key="d1">Arc mRNA was found to selectively immunoprecipitate (IP) with Arc protein.</data>
      <data key="d3">Arc mRNA was found to selectively immunoprecipitate (IP) with Arc protein.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_5479638528315697116">
      <data key="d0">Result</data>
      <data key="d1">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
      <data key="d3">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_-2650723884943910926">
      <data key="d0">Result</data>
      <data key="d1">Proper Arc capsid assembly may be required for Arc release via EVs.</data>
      <data key="d3">Proper Arc capsid assembly may be required for Arc release via EVs.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_-31356167626557605">
      <data key="d0">Result</data>
      <data key="d1">Arc protein and RNA were protected or bound in a complex within EVs.</data>
      <data key="d3">Arc protein and RNA were protected or bound in a complex within EVs.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_-5819687445513004650">
      <data key="d0">Result</data>
      <data key="d1">Arc is present in a subpopulation of EVs.</data>
      <data key="d3">Arc is present in a subpopulation of EVs.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_2373320235939752663">
      <data key="d0">Result</data>
      <data key="d1">KCI treatment, which increases neuronal activity, resulted in significantly more Arc released into the media.</data>
      <data key="d3">KCI treatment, which increases neuronal activity, resulted in significantly more Arc released into the media.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_-6856516339722873094">
      <data key="d0">Result</data>
      <data key="d1">Uptake of Arc protein and mRNA was endocytosis-dependent.</data>
      <data key="d3">Uptake of Arc protein and mRNA was endocytosis-dependent.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_5366497761396605588">
      <data key="d0">Result</data>
      <data key="d1">Arc EVs released from HEK cells are capable of transferring highly abundant mRNAs cell-to-cell.</data>
      <data key="d3">Arc EVs released from HEK cells are capable of transferring highly abundant mRNAs cell-to-cell.</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_21_2018_Result_5709093982205541626">
      <data key="d0">Result</data>
      <data key="d1">Arc KO neurons incubated with WT EVs showed a clear increase in dendritic Arc levels, while KO neurons incubated with EVs derived from KO cells exhibited no increase in dendritic Arc levels</data>
      <data key="d3">Arc KO neurons incubated with WT EVs showed a clear increase in dendritic Arc levels, while KO neurons incubated with EVs derived from KO cells exhibited no increase in dendritic Arc levels</data>
      <data key="d4">PDF_21_2018</data>
    </node>
    <node id="PDF_15_2018">
      <data key="d0">Paper</data>
      <data key="d1">Cell Reports
DAZL Regulates Germ Cell Survival through a
Network of PolyA-Proximal mRNA Interactions
Graphical Abstract
Dazl
Wild Type
-GUU-AAAAA-
Dazl
GUU
Germ cell survival
Dazl-/-
-GUU-AAAAA
Germ cell loss
~GUU
AAAAAAA
-GUU-AAAAAAA
Dazl
-AAAAAAA
GUU-AAAAAAA
Dazl
-GUU-AAAAAAA
AAAAAAA
_ GUU-AAAAAAA
AAAAAAA
GUUGUUAAAAAAA
GUJAAAAAAA
Authors
Article
Leah L. Zagore, Thomas J. Sweet,
Molly M. Hannigan, ..., Maria Hatzoglou,
Chaolin Zhang, Donny D. Licatalosi
Correspondence
ddl33@case.edu
In Brief
Co</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_15_2018_Hypothesis_1007946484764416786">
      <data key="d0">Hypothesis</data>
      <data key="d1">DAZL regulates germ cell survival through mRNA interactions.</data>
      <data key="d3">DAZL regulates germ cell survival through mRNA interactions.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="Protein_DAZL">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">DAZL</data>
      <data key="d7">DAZL</data>
    </node>
    <node id="Process_GERM CELL">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">GERM CELL</data>
      <data key="d7">Germ cell</data>
    </node>
    <node id="PDF_15_2018_Method_-2517075424149377844">
      <data key="d0">Method</data>
      <data key="d1">Transcriptome-wide DAZL-RNA interactions were mapped in vivo.</data>
      <data key="d3">Transcriptome-wide DAZL-RNA interactions were mapped in vivo.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Method_5718292584660158798">
      <data key="d0">Method</data>
      <data key="d1">Fluorescence-activated cell sorting and RNA-seq were used to identify mRNAs sensitive to DAZL deletion in male germ cells.</data>
      <data key="d3">Fluorescence-activated cell sorting and RNA-seq were used to identify mRNAs sensitive to DAZL deletion in male germ cells.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-7590350723895944720">
      <data key="d0">Result</data>
      <data key="d1">DAZL binds thousands of mRNAs via polyA-proximal 3' UTR interactions.</data>
      <data key="d3">DAZL binds thousands of mRNAs via polyA-proximal 3' UTR interactions.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-2390999112066596134">
      <data key="d0">Result</data>
      <data key="d1">DAZL post-transcriptionally controls a subset of its mRNA targets critical for germ cell proliferation and survival.</data>
      <data key="d3">DAZL post-transcriptionally controls a subset of its mRNA targets critical for germ cell proliferation and survival.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-8304336012457207293">
      <data key="d0">Result</data>
      <data key="d1">PolyA sequences have key roles in specifying DAZL-RNA interactions.</data>
      <data key="d3">PolyA sequences have key roles in specifying DAZL-RNA interactions.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Conclusion_-9175436270815840847">
      <data key="d0">Conclusion</data>
      <data key="d1">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
      <data key="d3">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-7180594045898953281">
      <data key="d0">Result</data>
      <data key="d1">DAZL directly and reproducibly binds distinct sites in &gt;3,900 transcripts in adult testis.</data>
      <data key="d3">DAZL directly and reproducibly binds distinct sites in &gt;3,900 transcripts in adult testis.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_2996698402664526239">
      <data key="d0">Result</data>
      <data key="d1">DAZL predominantly binds GUU-rich sequences in vivo.</data>
      <data key="d3">DAZL predominantly binds GUU-rich sequences in vivo.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-1997307962784977924">
      <data key="d0">Result</data>
      <data key="d1">The majority of DAZL BR3 sites mapped to 3' UTRs of protein-coding genes.</data>
      <data key="d3">The majority of DAZL BR3 sites mapped to 3' UTRs of protein-coding genes.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-226380008784307942">
      <data key="d0">Result</data>
      <data key="d1">DAZL preferentially binds GUU sites in close proximity to polyA sequences.</data>
      <data key="d3">DAZL preferentially binds GUU sites in close proximity to polyA sequences.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-8336969885079060192">
      <data key="d0">Result</data>
      <data key="d1">DAZL directly enhances steady-state mRNA levels of a subset of in vivo targets.</data>
      <data key="d3">DAZL directly enhances steady-state mRNA levels of a subset of in vivo targets.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="PDF_15_2018_Result_-6850924898633484190">
      <data key="d0">Result</data>
      <data key="d1">reduced levels of DDX4 and SYCP3 proteins previously observed in Dazl KO germ cells by IF and attributed to reduced translation are associated with significant reductions in their corresponding mRNAs.</data>
      <data key="d3">reduced levels of DDX4 and SYCP3 proteins previously observed in Dazl KO germ cells by IF and attributed to reduced translation are associated with significant reductions in their corresponding mRNAs.</data>
      <data key="d4">PDF_15_2018</data>
    </node>
    <node id="Protein_DDX4">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">DDX4</data>
      <data key="d7">DDX4</data>
    </node>
    <node id="Protein_SYCP3">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SYCP3</data>
      <data key="d7">SYCP3</data>
    </node>
    <node id="Gene_DAZL">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DAZL</data>
      <data key="d7">DAZL</data>
    </node>
    <node id="PDF_48_2024">
      <data key="d0">Paper</data>
      <data key="d1">PNAS
RESEARCH ARTICLE
BIOCHEMISTRY
OPEN ACCESS
Check for
updates
Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral
capsids that can be engineered for mRNA delivery
Victoria Madigan a,b,c,d,e,1, Yugang Zhanga,b,c,d,e,1, Rumya Raghavana,b,c,d,e, 1, Max E. Wilkinsona,b,c,d,e, Guilhem Faurea,b,c,d,e, Elena Puccioa,b,c,d,e,
Michael Segela,b,c,d,e, Blake Lasha,b,c,d,e, Rhiannon K. Macraea,b,c,d,e, and Feng Zhanga,b,c,d,e,2 D
Edited by Christine Seidman, Harvard Medical School, Boston, MA; rec</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_48_2024_Hypothesis_3273825756331219900">
      <data key="d0">Hypothesis</data>
      <data key="d1">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
      <data key="d3">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="Protein_PNMA2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA2</data>
      <data key="d7">PNMA2</data>
    </node>
    <node id="PDF_48_2024_Method_-1338264431741246350">
      <data key="d0">Method</data>
      <data key="d1">cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2</data>
      <data key="d3">cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Method_5955775648555630888">
      <data key="d0">Method</data>
      <data key="d1">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
      <data key="d3">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Method_-5447054642637606006">
      <data key="d0">Method</data>
      <data key="d1">We used cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2 expressed in E. coli at 3.1 Å resolution</data>
      <data key="d3">We used cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2 expressed in E. coli at 3.1 Å resolution</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_-5065714469652562922">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 forms icosahedral capsids efficiently but does not naturally encapsidate nucleic acids</data>
      <data key="d3">PNMA2 forms icosahedral capsids efficiently but does not naturally encapsidate nucleic acids</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_9174890333036180457">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 Is Secreted by Human Cells as a Non-enveloped Capsid</data>
      <data key="d3">PNMA2 Is Secreted by Human Cells as a Non-enveloped Capsid</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_-5182484237894007855">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 capsids are secreted from human cells without encapsidated RNA</data>
      <data key="d3">PNMA2 capsids are secreted from human cells without encapsidated RNA</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_6917212919736409197">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 purified from Escherichia coli readily assembles into capsid structures</data>
      <data key="d3">PNMA2 purified from Escherichia coli readily assembles into capsid structures</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_3560183569788301579">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 does not package its own mRNA</data>
      <data key="d3">PNMA2 does not package its own mRNA</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_6591773665246235238">
      <data key="d0">Result</data>
      <data key="d1">the interior of the capsid is rich in acidic residues</data>
      <data key="d3">the interior of the capsid is rich in acidic residues</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_2221211531204752477">
      <data key="d0">Result</data>
      <data key="d1">the interior of the capsid is therefore predicted to have a negative charge, likely accounting for the capsid's lack of RNA cargo</data>
      <data key="d3">the interior of the capsid is therefore predicted to have a negative charge, likely accounting for the capsid's lack of RNA cargo</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_-292792670483097922">
      <data key="d0">Result</data>
      <data key="d1">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
      <data key="d3">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_5112885719545256709">
      <data key="d0">Result</data>
      <data key="d1">LAH4 treatment of ePNMA2 before addition to cells increased the cytosolic localization of ePNMA2</data>
      <data key="d3">LAH4 treatment of ePNMA2 before addition to cells increased the cytosolic localization of ePNMA2</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Result_6830106072038905142">
      <data key="d0">Result</data>
      <data key="d1">ePNMA2(Cre) induced higher levels of GFP reporter expression relative to an equivalent amount of undigested and unpackaged RNA</data>
      <data key="d3">ePNMA2(Cre) induced higher levels of GFP reporter expression relative to an equivalent amount of undigested and unpackaged RNA</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Conclusion_-3138037747815046499">
      <data key="d0">Conclusion</data>
      <data key="d1">demonstrating the potential for engineered endogenous capsids as a nucleic acid therapy delivery modality</data>
      <data key="d3">demonstrating the potential for engineered endogenous capsids as a nucleic acid therapy delivery modality</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_48_2024_Conclusion_-3012642342870324051">
      <data key="d0">Conclusion</data>
      <data key="d1">PNMA2 naturally forms capsids in human cells</data>
      <data key="d3">PNMA2 naturally forms capsids in human cells</data>
      <data key="d4">PDF_48_2024</data>
    </node>
    <node id="PDF_54_2017">
      <data key="d0">Paper</data>
      <data key="d1">1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
Results
79
80
81
12,17.
Formally, structure determination by cryo-EM is an optimization problem and may be described
in a Bayesian likelihood framework12,17.
N
K
arg max log p (V.1....KX1...N)
V1...K
= arg max
V1...K
K
log p(xii) Vi)di + log p(V...k)
(1)
i=1
j=1
82
83
84
85
</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_54_2017_Method_7688401019906258025">
      <data key="d0">Method</data>
      <data key="d1">stochastic gradient descent (SGD) and branch and bound maximum likelihood optimization algorithms permit the major steps in cryo-EM structure determination to be performed in hours or minutes on an inexpensive desktop computer</data>
      <data key="d3">stochastic gradient descent (SGD) and branch and bound maximum likelihood optimization algorithms permit the major steps in cryo-EM structure determination to be performed in hours or minutes on an inexpensive desktop computer</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Method_-8451411964774970506">
      <data key="d0">Method</data>
      <data key="d1">SGD with Bayesian marginalization allows ab initio 3-D classification, enabling automated analysis and discovery of unexpected structures without bias from a reference map.</data>
      <data key="d3">SGD with Bayesian marginalization allows ab initio 3-D classification, enabling automated analysis and discovery of unexpected structures without bias from a reference map.</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Method_4197064974108894589">
      <data key="d0">Method</data>
      <data key="d1">We use a stochastic gradient descent (SGD) optimization scheme to quickly identify one or several low-resolution 3-D structures that are consistent with a set of observed images.</data>
      <data key="d3">We use a stochastic gradient descent (SGD) optimization scheme to quickly identify one or several low-resolution 3-D structures that are consistent with a set of observed images.</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Result_1955790977945443604">
      <data key="d0">Result</data>
      <data key="d1">With 35,645 TRPV1 particle images SGD optimization resulted in a low-resolution 3-D map in 75 minutes from random initialization</data>
      <data key="d3">With 35,645 TRPV1 particle images SGD optimization resulted in a low-resolution 3-D map in 75 minutes from random initialization</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="Gene_TRPV1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TRPV1</data>
      <data key="d7">TRPV1</data>
    </node>
    <node id="PDF_54_2017_Result_2303491669298692077">
      <data key="d0">Result</data>
      <data key="d1">When applied to a dataset of conformationally heterogeneous Thermus thermophilus V/A-ATPase particle images, the algorithm was able to discern three different conformational states for the enzyme, again from random initializations.</data>
      <data key="d3">When applied to a dataset of conformationally heterogeneous Thermus thermophilus V/A-ATPase particle images, the algorithm was able to discern three different conformational states for the enzyme, again from random initializations.</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="Protein_THERMUS THERMOPHILUS V/A-ATPASE">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">THERMUS THERMOPHILUS V/A-ATPASE</data>
      <data key="d7">Thermus thermophilus V/A-ATPase</data>
    </node>
    <node id="PDF_54_2017_Method_8797155108939160349">
      <data key="d0">Method</data>
      <data key="d1">We implemented the branch and bound approach and applied it to high-resolution structure determination from several published datasets: the 20S proteasome from Thermoplasma acidophilum, the 80S ribosome from Plasmodium falciparum, amphipol-solubilized rat TRPV1, as well as the T. thermophilus V/A-ATPase .</data>
      <data key="d3">We implemented the branch and bound approach and applied it to high-resolution structure determination from several published datasets: the 20S proteasome from Thermoplasma acidophilum, the 80S ribosome from Plasmodium falciparum, amphipol-solubilized rat TRPV1, as well as the T. thermophilus V/A-ATPase .</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Result_3145381923885660515">
      <data key="d0">Result</data>
      <data key="d1">Applied to 35,645 TRPV1 particle images, branch and bound orientation determination produced a 3.3 Å resolution map in 66 minutes with C4 symmetry enforced using a gold-standard refinement procedure, the FSC=0.143 resolution criterion, and correction for effects of masking on the FSC by high-resolution noise substitution</data>
      <data key="d3">Applied to 35,645 TRPV1 particle images, branch and bound orientation determination produced a 3.3 Å resolution map in 66 minutes with C4 symmetry enforced using a gold-standard refinement procedure, the FSC=0.143 resolution criterion, and correction for effects of masking on the FSC by high-resolution noise substitution</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Result_7490295063878879849">
      <data key="d0">Result</data>
      <data key="d1">With T. thermophilus V/A-ATPase particle images sorted into three classes by SGD, the branch and bound search produced maps of all three states in a total of 2.4 hours</data>
      <data key="d3">With T. thermophilus V/A-ATPase particle images sorted into three classes by SGD, the branch and bound search produced maps of all three states in a total of 2.4 hours</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Result_1273554299323043190">
      <data key="d0">Result</data>
      <data key="d1">Following SGD ab initio structure determination, the application of the branch and bound method allowed high-resolution refinement of the 80S ribosome to 3.2 Å resolution, equivalent to the published resolution, in 2.2 hours</data>
      <data key="d3">Following SGD ab initio structure determination, the application of the branch and bound method allowed high-resolution refinement of the 80S ribosome to 3.2 Å resolution, equivalent to the published resolution, in 2.2 hours</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Result_4224012381800641735">
      <data key="d0">Result</data>
      <data key="d1">Similarly, the 20S proteasome structure was refined to 2.8 Å with D7 symmetry enforced, matching the published sub-3 Å resolution from the dataset but in only 70 minutes.</data>
      <data key="d3">Similarly, the 20S proteasome structure was refined to 2.8 Å with D7 symmetry enforced, matching the published sub-3 Å resolution from the dataset but in only 70 minutes.</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_54_2017_Conclusion_2631602889920519487">
      <data key="d0">Conclusion</data>
      <data key="d1">Combination of the SGD approach and branch and bound refinement provides a complete framework for rapid ab initio calculation of multiple high-resolution maps from a heterogeneous dataset on inexpensive computer hardware.</data>
      <data key="d3">Combination of the SGD approach and branch and bound refinement provides a complete framework for rapid ab initio calculation of multiple high-resolution maps from a heterogeneous dataset on inexpensive computer hardware.</data>
      <data key="d4">PDF_54_2017</data>
    </node>
    <node id="PDF_56_2013">
      <data key="d0">Paper</data>
      <data key="d1">Published online 4 April 2013
Nucleic Acids Research, 2013, Vol. 41, No. 10 e108
doi:10.1093/nar/gkt214
The Subread aligner: fast, accurate and scalable
read mapping by seed-and-vote
Yang Liao1,2, Gordon K. Smyth1,3 and Wei Shi1,2,*
'Division of Bioinformatics, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville,
Victoria 3052, Australia, 2Department of Computing and Information Systems, The University of Melbourne,
Parkville, Victoria 3010, Australia and Departme</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_56_2013_Method_-7544974436239366695">
      <data key="d0">Method</data>
      <data key="d1">The article proposes a new multi-seed strategy, called seed-and-vote, for mapping reads to a reference genome.</data>
      <data key="d3">The article proposes a new multi-seed strategy, called seed-and-vote, for mapping reads to a reference genome.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Method_-6249181255683326149">
      <data key="d0">Method</data>
      <data key="d1">The new strategy chooses the mapped genomic location for the read directly from the seeds.</data>
      <data key="d3">The new strategy chooses the mapped genomic location for the read directly from the seeds.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Method_-3175201880659129245">
      <data key="d0">Method</data>
      <data key="d1">It uses a relatively large number of short seeds (called subreads) extracted from each read and allows all the seeds to vote on the optimal location.</data>
      <data key="d3">It uses a relatively large number of short seeds (called subreads) extracted from each read and allows all the seeds to vote on the optimal location.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Method_6682932568176380007">
      <data key="d0">Method</data>
      <data key="d1">Conventional alignment algorithms are then used to fill in detailed mismatch and indel information between the subreads that make up the winning voting block.</data>
      <data key="d3">Conventional alignment algorithms are then used to fill in detailed mismatch and indel information between the subreads that make up the winning voting block.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Method_-2653877741772185867">
      <data key="d0">Method</data>
      <data key="d1">The strategy extends easily to find exon junctions, by locating reads that contain sets of subreads mapping to different exons of the same gene.</data>
      <data key="d3">The strategy extends easily to find exon junctions, by locating reads that contain sets of subreads mapping to different exons of the same gene.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Result_6375044658037731477">
      <data key="d0">Result</data>
      <data key="d1">In extensive testing, the strategy proves to be not only fast but more than competitive with existing aligners in terms of sensitivity and accuracy.</data>
      <data key="d3">In extensive testing, the strategy proves to be not only fast but more than competitive with existing aligners in terms of sensitivity and accuracy.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Result_1917330146686069319">
      <data key="d0">Result</data>
      <data key="d1">Insertions and deletions are genomic variants that have been linked to the onset and progression of a number of diseases.</data>
      <data key="d3">Insertions and deletions are genomic variants that have been linked to the onset and progression of a number of diseases.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Result_-8371129532705357537">
      <data key="d0">Result</data>
      <data key="d1">A 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
      <data key="d3">A 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="Gene_CASPASE-8">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CASPASE-8</data>
      <data key="d7">Caspase-8</data>
    </node>
    <node id="Disease_CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">CANCER</data>
      <data key="d7">Cancer</data>
    </node>
    <node id="PDF_56_2013_Result_-4197258645961450816">
      <data key="d0">Result</data>
      <data key="d1">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
      <data key="d3">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="Gene_NCX1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NCX1</data>
      <data key="d7">Ncx1</data>
    </node>
    <node id="Disease_ALZHEIMER'S DISEASE">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">ALZHEIMER'S DISEASE</data>
      <data key="d7">Alzheimer's disease</data>
    </node>
    <node id="PDF_56_2013_Method_5416173883783034744">
      <data key="d0">Method</data>
      <data key="d1">Our Subread software finds indels rapidly anywhere in the read, mainly leveraging the fact that indels can be restricted to very small regions bounded by flanking local alignments.</data>
      <data key="d3">Our Subread software finds indels rapidly anywhere in the read, mainly leveraging the fact that indels can be restricted to very small regions bounded by flanking local alignments.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_56_2013_Method_-4908543325136705783">
      <data key="d0">Method</data>
      <data key="d1">Subjunc is a specialized version of our subread software that performs complete alignment of RNA-seq reads including detection of exon-exon junctions.</data>
      <data key="d3">Subjunc is a specialized version of our subread software that performs complete alignment of RNA-seq reads including detection of exon-exon junctions.</data>
      <data key="d4">PDF_56_2013</data>
    </node>
    <node id="PDF_58_2023">
      <data key="d0">Paper</data>
      <data key="d1">Here is the full text of the article extracted from the PDF:

Article
THE
EMBO
SOURCE
DATA
TRANSPARENT
PROCESS
OPEN
ACCESS
JOURNAL
Assembly and function of the amyloid-like
translational repressor Rim4 is coupled with
nutrient conditions
ID
Diana SM Ottoz¹, Lauren C Tang², Annie E Dyatel¹, Marko Jovanovic² &amp; Luke E Berchowitz 1,3,* D
Abstract
Amyloid-like protein assemblies have been associated with toxic
phenotypes because of their repetitive and stable structure. How-
ever, evidence that cells</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_58_2023_Hypothesis_4007391546585230220">
      <data key="d0">Hypothesis</data>
      <data key="d1">We propose that Rim4 assembly, triggered by its IDR, stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
      <data key="d3">We propose that Rim4 assembly, triggered by its IDR, stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Result_4022060413640833732">
      <data key="d0">Result</data>
      <data key="d1">Assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression.</data>
      <data key="d3">Assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Result_3964162956670131810">
      <data key="d0">Result</data>
      <data key="d1">Rim4 represses translation when it binds the transcripts at their 5' end, while it does not have any effect when it binds their 3' end.</data>
      <data key="d3">Rim4 represses translation when it binds the transcripts at their 5' end, while it does not have any effect when it binds their 3' end.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Result_-6742168171520011431">
      <data key="d0">Result</data>
      <data key="d1">Rim4 assembly depends exclusively on its intrinsically disordered region (IDR), which contains the regulatory elements to control this process.</data>
      <data key="d3">Rim4 assembly depends exclusively on its intrinsically disordered region (IDR), which contains the regulatory elements to control this process.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Result_-5517693063529632874">
      <data key="d0">Result</data>
      <data key="d1">Assembly is prevented by protein kinase A (PKA) which promotes growth and suppresses meiotic entry.</data>
      <data key="d3">Assembly is prevented by protein kinase A (PKA) which promotes growth and suppresses meiotic entry.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="Protein_PKA">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PKA</data>
      <data key="d7">PKA</data>
    </node>
    <node id="PDF_58_2023_Result_-2624458770473747325">
      <data key="d0">Result</data>
      <data key="d1">The presence of a non-fermentable carbon source combined with the absence of a fermentable one is the prime nutrient stimulus for Rim4 assembly.</data>
      <data key="d3">The presence of a non-fermentable carbon source combined with the absence of a fermentable one is the prime nutrient stimulus for Rim4 assembly.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Result_-2258982936542749936">
      <data key="d0">Result</data>
      <data key="d1">The PKA signaling pathway transduces the carbon source input into Rim4 assembly. Moreover, prevention of assembly in starvation also prevents translational repression.</data>
      <data key="d3">The PKA signaling pathway transduces the carbon source input into Rim4 assembly. Moreover, prevention of assembly in starvation also prevents translational repression.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Result_859948616927543380">
      <data key="d0">Result</data>
      <data key="d1">Rim4 is phosphorylated by PKA and that this phosphorylation negatively correlates with assembly.</data>
      <data key="d3">Rim4 is phosphorylated by PKA and that this phosphorylation negatively correlates with assembly.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_58_2023_Conclusion_-5717137549867826958">
      <data key="d0">Conclusion</data>
      <data key="d1">Rim4 assemblies prevent translation because they bind the 5' region of a transcript, likely making the start codon invisible to ribosomes.</data>
      <data key="d3">Rim4 assemblies prevent translation because they bind the 5' region of a transcript, likely making the start codon invisible to ribosomes.</data>
      <data key="d4">PDF_58_2023</data>
    </node>
    <node id="PDF_45_2016">
      <data key="d0">Paper</data>
      <data key="d1">Here is the full text from the scientific PDF provided:

© 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 1271-1282 doi:10.1242/jcs.179218
The Company of
Biologists
TOOLS AND TECHNIQUES
DAZL and CPEB1 regulate mRNA translation synergistically
during oocyte maturation
Joao P. Sousa Martins 1,2,3, Xueqing Liu1,2,3, Ashwini Oke1,3,4, Ripla Arora1,2,3, Federica Franciosi 1,2,3,5,
Stephan Viville6,7, Diana J. Laird1,2,3, Jennifer C. Fung1,3,4 and Marco Conti 1,</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_45_2016_Hypothesis_-6101710439350279351">
      <data key="d0">Hypothesis</data>
      <data key="d1">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
      <data key="d3">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="Protein_CPEB1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CPEB1</data>
      <data key="d7">CPEB1</data>
    </node>
    <node id="PDF_45_2016_Method_7250690860974551574">
      <data key="d0">Method</data>
      <data key="d1">RiboTag RNA immunoprecipitation (RIP) was used to discover a synergy between CPEB1 and DAZL as translation regulators.</data>
      <data key="d3">RiboTag RNA immunoprecipitation (RIP) was used to discover a synergy between CPEB1 and DAZL as translation regulators.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Method_-1748601871715343443">
      <data key="d0">Method</data>
      <data key="d1">Morpholino oligonucleotide (MO) knockdown was used to evaluate the consequence of depleting RBPs on ribosome loading.</data>
      <data key="d3">Morpholino oligonucleotide (MO) knockdown was used to evaluate the consequence of depleting RBPs on ribosome loading.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Method_-4938452527471818004">
      <data key="d0">Method</data>
      <data key="d1">RNA immunoprecipitation was performed with CPEB1-specific antibodies.</data>
      <data key="d3">RNA immunoprecipitation was performed with CPEB1-specific antibodies.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Method_-4152828870250651972">
      <data key="d0">Method</data>
      <data key="d1">Site-directed mutagenesis of the Tex19.1 3' UTR was used to investigate DAZL element cooperation.</data>
      <data key="d3">Site-directed mutagenesis of the Tex19.1 3' UTR was used to investigate DAZL element cooperation.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="Gene_TEX19.1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TEX19.1</data>
      <data key="d7">Tex19.1</data>
    </node>
    <node id="PDF_45_2016_Result_2404442980995303048">
      <data key="d0">Result</data>
      <data key="d1">Ribosome loading is induced in a DAZL- and CPEB1-dependent manner.</data>
      <data key="d3">Ribosome loading is induced in a DAZL- and CPEB1-dependent manner.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Result_-2644096955943264538">
      <data key="d0">Result</data>
      <data key="d1">DAZL and cytoplasmic polyadenylation elements (CPEs) synergize in the translation pattern of maternal mRNAs.</data>
      <data key="d3">DAZL and cytoplasmic polyadenylation elements (CPEs) synergize in the translation pattern of maternal mRNAs.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Result_-4701501202074256566">
      <data key="d0">Result</data>
      <data key="d1">Knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII.</data>
      <data key="d3">Knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Result_4639059725475883834">
      <data key="d0">Result</data>
      <data key="d1">Depletion in DAZL resulted in an almost complete block of progression into MII.</data>
      <data key="d3">Depletion in DAZL resulted in an almost complete block of progression into MII.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Result_5155631779279264016">
      <data key="d0">Result</data>
      <data key="d1">Mutation of the CPE significantly decreased translation of the reporter.</data>
      <data key="d3">Mutation of the CPE significantly decreased translation of the reporter.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Result_3921908020221437532">
      <data key="d0">Result</data>
      <data key="d1">The three identified DAZL elements are functional in that they are bound by DAZL and contribute to the overall rate of translation.</data>
      <data key="d3">The three identified DAZL elements are functional in that they are bound by DAZL and contribute to the overall rate of translation.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_45_2016_Conclusion_-4496265613559077990">
      <data key="d0">Conclusion</data>
      <data key="d1">The number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
      <data key="d3">The number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
      <data key="d4">PDF_45_2016</data>
    </node>
    <node id="PDF_42_2001">
      <data key="d0">Paper</data>
      <data key="d1">THE JOURNAL OF BIOLOGICAL CHEMISTRY
© 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Vol. 276, No. 4, Issue of January 26, pp. 2802-2807, 2001
Printed in U.S.A.

MAP-1, a Novel Proapoptotic Protein Containing a BH3-like Motif
That Associates with Bax through Its Bcl-2 Homology Domains*

Kuan Onn Tan, Karen Mei Ling Tan, Shing-Leng Chan, Karen S. Y. Yee, Maja Bévort,
Khay Chun Ang, and Victor C. Yu‡

From the Institute of Molecular and Cell Biology, 30 Medical Dr., Sing</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_42_2001_Hypothesis_-7026073560641975375">
      <data key="d0">Hypothesis</data>
      <data key="d1">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
      <data key="d3">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="Protein_MAP-1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MAP-1</data>
      <data key="d7">MAP-1</data>
    </node>
    <node id="Process_APOPTOSIS">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">APOPTOSIS</data>
      <data key="d7">Apoptosis</data>
    </node>
    <node id="Protein_BAX">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">BAX</data>
      <data key="d7">Bax</data>
    </node>
    <node id="PDF_42_2001_Method_-1419310273261393209">
      <data key="d0">Method</data>
      <data key="d1">Yeast two-hybrid screen was performed to identify Bax-associating proteins.</data>
      <data key="d3">Yeast two-hybrid screen was performed to identify Bax-associating proteins.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="PDF_42_2001_Result_-4452401184474898440">
      <data key="d0">Result</data>
      <data key="d1">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
      <data key="d3">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="Protein_BCL-2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">BCL-2</data>
      <data key="d7">Bcl-2</data>
    </node>
    <node id="Protein_BCL-XL">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">BCL-XL</data>
      <data key="d7">Bcl-XL</data>
    </node>
    <node id="PDF_42_2001_Result_3177950791281978896">
      <data key="d0">Result</data>
      <data key="d1">The BH3-like domain in MAP-1 appeared to be required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
      <data key="d3">The BH3-like domain in MAP-1 appeared to be required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="PDF_42_2001_Result_-4997145210810257954">
      <data key="d0">Result</data>
      <data key="d1">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
      <data key="d3">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="PDF_42_2001_Result_5221699065262225750">
      <data key="d0">Result</data>
      <data key="d1">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
      <data key="d3">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="PDF_42_2001_Conclusion_4445681050503740959">
      <data key="d0">Conclusion</data>
      <data key="d1">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
      <data key="d3">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
      <data key="d4">PDF_42_2001</data>
    </node>
    <node id="PDF_17_2020">
      <data key="d0">Paper</data>
      <data key="d1">nature
COMMUNICATIONS

ARTICLE
Check for updates
https://doi.org/10.1038/s41467-020-15209-9 OPEN

The RNA-binding protein DAZL functions as
repressor and activator of mRNA translation during
oocyte maturation

Cai-Rong Yang 1,2,3, Gabriel Rajkovic1,2,3, Enrico Maria Daldello 1,2,3, Xuan G. Luong1,2,3, Jing Chen1,2,3 &amp;
Marco Conti 1,2,3

Deleted in azoospermia-like (DAZL) is an RNA-binding protein critical for gamete develop-
ment. In full-grown oocytes, the DAZL protein increases 4-fold during r</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_17_2020_Hypothesis_2284572265749887740">
      <data key="d0">Hypothesis</data>
      <data key="d1">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
      <data key="d3">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Method_-8850148362164679445">
      <data key="d0">Method</data>
      <data key="d1">RiboTag IP/qPCR</data>
      <data key="d3">RiboTag IP/qPCR</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Method_2642830594039964302">
      <data key="d0">Method</data>
      <data key="d1">DAZL RIP-Chip dataset</data>
      <data key="d3">DAZL RIP-Chip dataset</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-5959770185381564212">
      <data key="d0">Result</data>
      <data key="d1">DAZL protein is detectable in full-grown GV-arrested oocytes with protein levels increasing up to MII.</data>
      <data key="d3">DAZL protein is detectable in full-grown GV-arrested oocytes with protein levels increasing up to MII.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_2075076618419982025">
      <data key="d0">Result</data>
      <data key="d1">Blockage of Dazl mRNA translation markedly reduces the endogenous DAZL protein expression.</data>
      <data key="d3">Blockage of Dazl mRNA translation markedly reduces the endogenous DAZL protein expression.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-7173593530584593532">
      <data key="d0">Result</data>
      <data key="d1">DAZL depletion disrupts oocyte maturation to MII</data>
      <data key="d3">DAZL depletion disrupts oocyte maturation to MII</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-6536138405992685902">
      <data key="d0">Result</data>
      <data key="d1">DAZL depletion causes increases and decreases in translational efficiency of a wide range of transcripts expressed in the oocyte.</data>
      <data key="d3">DAZL depletion causes increases and decreases in translational efficiency of a wide range of transcripts expressed in the oocyte.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_245597328199661046">
      <data key="d0">Result</data>
      <data key="d1">Ribosome loading onto Tex19.1 mRNA is decreased after injection of DAZL-MO at the MI stage.</data>
      <data key="d3">Ribosome loading onto Tex19.1 mRNA is decreased after injection of DAZL-MO at the MI stage.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-965682607400442980">
      <data key="d0">Result</data>
      <data key="d1">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
      <data key="d3">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="Gene_CCNB1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CCNB1</data>
      <data key="d7">CCNB1</data>
    </node>
    <node id="PDF_17_2020_Result_1437644137961784082">
      <data key="d0">Result</data>
      <data key="d1">DAZL depletion disrupts DAZL target loading onto ribosomes with high selectivity.</data>
      <data key="d3">DAZL depletion disrupts DAZL target loading onto ribosomes with high selectivity.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-8993382840130368184">
      <data key="d0">Result</data>
      <data key="d1">Decrease in ribosome loading onto a group of transcripts after DAZL depletion.</data>
      <data key="d3">Decrease in ribosome loading onto a group of transcripts after DAZL depletion.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-1014845171459318107">
      <data key="d0">Result</data>
      <data key="d1">Translation increases for a group of transcripts after DAZL removal.</data>
      <data key="d3">Translation increases for a group of transcripts after DAZL removal.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-1636690093800803172">
      <data key="d0">Result</data>
      <data key="d1">DAZL functions as a translational activator and a translational repressor during the GV-to-MI transition.</data>
      <data key="d3">DAZL functions as a translational activator and a translational repressor during the GV-to-MI transition.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Result_-8566290086651872475">
      <data key="d0">Result</data>
      <data key="d1">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
      <data key="d3">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="Gene_AKAP10">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">AKAP10</data>
      <data key="d7">Akap10</data>
    </node>
    <node id="Gene_CENPE">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CENPE</data>
      <data key="d7">Cenpe</data>
    </node>
    <node id="Gene_NSF">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NSF</data>
      <data key="d7">Nsf</data>
    </node>
    <node id="Gene_YWHAZ">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">YWHAZ</data>
      <data key="d7">Ywhaz</data>
    </node>
    <node id="Gene_NIN">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NIN</data>
      <data key="d7">Nin</data>
    </node>
    <node id="Gene_YTHDF3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">YTHDF3</data>
      <data key="d7">YTHDF3</data>
    </node>
    <node id="PDF_17_2020_Conclusion_5498347170205855405">
      <data key="d0">Conclusion</data>
      <data key="d1">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
      <data key="d3">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_17_2020_Conclusion_-7127879931028460419">
      <data key="d0">Conclusion</data>
      <data key="d1">DAZL may play a dual function (both translational activator and repressor) during oocyte maturation.</data>
      <data key="d3">DAZL may play a dual function (both translational activator and repressor) during oocyte maturation.</data>
      <data key="d4">PDF_17_2020</data>
    </node>
    <node id="PDF_24_2019">
      <data key="d0">Paper</data>
      <data key="d1">Structure of the Ty3/Gypsy retrotransposon capsid
and the evolution of retroviruses
Svetlana O. Dodonovaa,b, Simone Prinza,¹, Virginia Bilanchone, Suzanne Sandmeyer, and John A. G. Briggsa,d,2

@Structural and Computational Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany; Department of Molecular Biology, Max
Planck Institute for Biophysical Chemistry, 37077 Gottingen, Germany; Department of Biological Chemistry, University of California, Irvine, CA 92697;
and Struc</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_24_2019_Hypothesis_-5270005329799762989">
      <data key="d0">Hypothesis</data>
      <data key="d1">assembly via a structurally distinct immature capsid is a later retroviral adaptation, while the structure of mature assembled capsids is conserved between LTR retrotransposons and retroviruses.</data>
      <data key="d3">assembly via a structurally distinct immature capsid is a later retroviral adaptation, while the structure of mature assembled capsids is conserved between LTR retrotransposons and retroviruses.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Method_-8841708259132838578">
      <data key="d0">Method</data>
      <data key="d1">electron tomography (ET) of immature and mature Ty3 particles within cells</data>
      <data key="d3">electron tomography (ET) of immature and mature Ty3 particles within cells</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="Gene_TY3/GYPSY">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TY3/GYPSY</data>
      <data key="d7">Ty3/Gypsy</data>
    </node>
    <node id="PDF_24_2019_Method_5684873237306666875">
      <data key="d0">Method</data>
      <data key="d1">cryo-ET and cryo-electron microscopy of purified, immature Ty3 particles</data>
      <data key="d3">cryo-ET and cryo-electron microscopy of purified, immature Ty3 particles</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Method_-7029910440999784406">
      <data key="d0">Method</data>
      <data key="d1">3D and 2D cryo-electron microscopy (cryo-EM)</data>
      <data key="d3">3D and 2D cryo-electron microscopy (cryo-EM)</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Result_-9206730576478353418">
      <data key="d0">Result</data>
      <data key="d1">Ty3 particles do not change size or shape upon maturation.</data>
      <data key="d3">Ty3 particles do not change size or shape upon maturation.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Result_5977352559163050716">
      <data key="d0">Result</data>
      <data key="d1">Ty3 capsid revealed an irregular fullerene geometry previously described for mature retrovirus core particles and a tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid that is conserved with mature HIV-1.</data>
      <data key="d3">Ty3 capsid revealed an irregular fullerene geometry previously described for mature retrovirus core particles and a tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid that is conserved with mature HIV-1.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="Gene_HIV-1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HIV-1</data>
      <data key="d7">HIV-1</data>
    </node>
    <node id="Protein_CA">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CA</data>
      <data key="d7">CA</data>
    </node>
    <node id="PDF_24_2019_Result_-4131538449364110313">
      <data key="d0">Result</data>
      <data key="d1">The particles we observed in cells expressing PR- Ty3, in which Gag3 is uncleaved, exhibited exclusively the morphology of the first type, confirming that this represents the immature form.</data>
      <data key="d3">The particles we observed in cells expressing PR- Ty3, in which Gag3 is uncleaved, exhibited exclusively the morphology of the first type, confirming that this represents the immature form.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="Protein_GAG3">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">GAG3</data>
      <data key="d7">Gag3</data>
    </node>
    <node id="PDF_24_2019_Result_3613349482426608506">
      <data key="d0">Result</data>
      <data key="d1">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
      <data key="d3">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="Protein_PGR">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PGR</data>
      <data key="d7">PGR</data>
    </node>
    <node id="Protein_NC">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">NC</data>
      <data key="d7">NC</data>
    </node>
    <node id="PDF_24_2019_Result_-2185178392975473183">
      <data key="d0">Result</data>
      <data key="d1">Complete closed structures always contained 12 pentamers, consistent with the requirements of fullerene geometry.</data>
      <data key="d3">Complete closed structures always contained 12 pentamers, consistent with the requirements of fullerene geometry.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Result_4712298205867309804">
      <data key="d0">Result</data>
      <data key="d1">39 of the 42 complete Ty3 particles were T = 9 icosahedra, where two nearest pentamers in the lattice are always separated by two hexamers sitting along one vector</data>
      <data key="d3">39 of the 42 complete Ty3 particles were T = 9 icosahedra, where two nearest pentamers in the lattice are always separated by two hexamers sitting along one vector</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Result_2103985303404241334">
      <data key="d0">Result</data>
      <data key="d1">Ty3 particles have a radius to the center of the CA layer of ~24 nm. The location of pentamers confirmed the T = 9 symmetry identified by cryo-ET and subtomogram averaging.</data>
      <data key="d3">Ty3 particles have a radius to the center of the CA layer of ~24 nm. The location of pentamers confirmed the T = 9 symmetry identified by cryo-ET and subtomogram averaging.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Result_-4154989696111793623">
      <data key="d0">Result</data>
      <data key="d1">the Ty3 CA-NTD is a bundle of four a-helices, while CA-CTD consists of five a-helices</data>
      <data key="d3">the Ty3 CA-NTD is a bundle of four a-helices, while CA-CTD consists of five a-helices</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Result_2218025804671713400">
      <data key="d0">Result</data>
      <data key="d1">the protruding capsomers of the Ty3 capsid are formed by the CA-NTD, while the inner layer, linking the capsomers together, is formed by the CA-CTD.</data>
      <data key="d3">the protruding capsomers of the Ty3 capsid are formed by the CA-NTD, while the inner layer, linking the capsomers together, is formed by the CA-CTD.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_24_2019_Conclusion_-4262552190683583444">
      <data key="d0">Conclusion</data>
      <data key="d1">The findings provide a structural basis for studying retrotransposon capsids, including those domesticated in higher organisms.</data>
      <data key="d3">The findings provide a structural basis for studying retrotransposon capsids, including those domesticated in higher organisms.</data>
      <data key="d4">PDF_24_2019</data>
    </node>
    <node id="PDF_51_2019">
      <data key="d0">Paper</data>
      <data key="d1">Check for
updates
Chapter 17
Visualization and Functional Analysis of Spindle Actin
and Chromosome Segregation in Mammalian Oocytes
Binyam Mogessie
Abstract
Chromosome segregation is conserved throughout eukaryotes. In most systems, it is solely driven by a
spindle machinery that is assembled from microtubules. We have recently discovered that actin filaments
that are embedded inside meiotic spindles (spindle actin) are needed for accurate chromosome segregation
in mammalian oocytes. To understa</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_51_2019_Hypothesis_8115540044170500196">
      <data key="d0">Hypothesis</data>
      <data key="d1">actin filaments that are embedded inside meiotic spindles (spindle actin) are needed for accurate chromosome segregation in mammalian oocytes.</data>
      <data key="d3">actin filaments that are embedded inside meiotic spindles (spindle actin) are needed for accurate chromosome segregation in mammalian oocytes.</data>
      <data key="d4">PDF_51_2019</data>
    </node>
    <node id="Protein_ACTIN">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ACTIN</data>
      <data key="d7">Actin</data>
    </node>
    <node id="Gene_CHROMOSOME">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CHROMOSOME</data>
      <data key="d7">Chromosome</data>
    </node>
    <node id="PDF_51_2019_Method_-5735195520754807737">
      <data key="d0">Method</data>
      <data key="d1">high-resolution and super-resolution live and immunofluorescence microscopy assays</data>
      <data key="d3">high-resolution and super-resolution live and immunofluorescence microscopy assays</data>
      <data key="d4">PDF_51_2019</data>
    </node>
    <node id="PDF_51_2019_Result_2712254139860532268">
      <data key="d0">Result</data>
      <data key="d1">the actin cytoskeleton plays a vital role inside the meiotic spindle—actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
      <data key="d3">the actin cytoskeleton plays a vital role inside the meiotic spindle—actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
      <data key="d4">PDF_51_2019</data>
    </node>
    <node id="Protein_MICROTUBULES">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MICROTUBULES</data>
      <data key="d7">Microtubules</data>
    </node>
    <node id="PDF_51_2019_Conclusion_6582000612346819448">
      <data key="d0">Conclusion</data>
      <data key="d1">This finding constitutes an important safety mechanism in mammalian meiosis that prevents aneuploidy in oocytes and eggs.</data>
      <data key="d3">This finding constitutes an important safety mechanism in mammalian meiosis that prevents aneuploidy in oocytes and eggs.</data>
      <data key="d4">PDF_51_2019</data>
    </node>
    <node id="PDF_31_2019">
      <data key="d0">Paper</data>
      <data key="d1">ARTICLE
Leveraging Polygenic Functional Enrichment
to Improve GWAS Power
Gleb Kichaev, 1,* Gaurav Bhatia,2 Po-Ru Loh, 2,3 Steven Gazal, 2,3 Kathryn Burch,¹ Malika K. Freund, 4
Armin Schoech,2,3 Bogdan Pasaniuc, 1,4,5,7 and Alkes L. Price2,3,6,7,*
Functional genomics data has the potential to increase GWAS power by identifying SNPs that have a higher prior probability of associ-
ation. Here, we introduce a method that leverages polygenic functional enrichment to incorporate coding, conserved, reg</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_31_2019_Hypothesis_-1505715401570687279">
      <data key="d0">Hypothesis</data>
      <data key="d1">incorporating functional information into association analyses has the potential to increase GWAS power</data>
      <data key="d3">incorporating functional information into association analyses has the potential to increase GWAS power</data>
      <data key="d4">PDF_31_2019</data>
    </node>
    <node id="PDF_31_2019_Method_-709854425819029840">
      <data key="d0">Method</data>
      <data key="d1">uses polygenic modeling to weight SNPs according to how well they tag functional categories that are enriched for heritability</data>
      <data key="d3">uses polygenic modeling to weight SNPs according to how well they tag functional categories that are enriched for heritability</data>
      <data key="d4">PDF_31_2019</data>
    </node>
    <node id="Gene_SNP">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SNP</data>
      <data key="d7">SNP</data>
    </node>
    <node id="PDF_31_2019_Method_6647634106377694263">
      <data key="d0">Method</data>
      <data key="d1">stratified LD score regression to compute the expected x2 statistic of each SNP based on the functional annotations that it tags</data>
      <data key="d3">stratified LD score regression to compute the expected x2 statistic of each SNP based on the functional annotations that it tags</data>
      <data key="d4">PDF_31_2019</data>
    </node>
    <node id="PDF_31_2019_Method_7702720213570326580">
      <data key="d0">Method</data>
      <data key="d1">stratify SNPs into bins of expected x² and estimate the proportion of null (π0) and alternative (1) SNPs within each bin using the Storey π0 estimator to obtain bin-specific weights</data>
      <data key="d3">stratify SNPs into bins of expected x² and estimate the proportion of null (π0) and alternative (1) SNPs within each bin using the Storey π0 estimator to obtain bin-specific weights</data>
      <data key="d4">PDF_31_2019</data>
    </node>
    <node id="PDF_31_2019_Result_-338647571991638286">
      <data key="d0">Result</data>
      <data key="d1">FINDOR was well calibrated, producing a similar number of false-positive (independent, genome-wide significant) associations at null loci as the unweighted approach</data>
      <data key="d3">FINDOR was well calibrated, producing a similar number of false-positive (independent, genome-wide significant) associations at null loci as the unweighted approach</data>
      <data key="d4">PDF_31_2019</data>
    </node>
    <node id="PDF_31_2019_Conclusion_-5067430079113536512">
      <data key="d0">Conclusion</data>
      <data key="d1">leveraging functional enrichment using our method robustly increases GWAS power</data>
      <data key="d3">leveraging functional enrichment using our method robustly increases GWAS power</data>
      <data key="d4">PDF_31_2019</data>
    </node>
    <node id="PDF_27_2021">
      <data key="d0">Paper</data>
      <data key="d1">Published online 12 October 2020
Nucleic Acids Research, 2021, Vol. 49, Database issue D1311-D1320
doi: 10.1093/nar/gkaa840
Open Targets Genetics: systematic identification of
trait-associated genes using large-scale genetics and
functional genomics
Maya Ghoussaini¹,2, Edward Mountjoy1,2, Miguel Carmona 2,3, Gareth Peat2,3,
Ellen M. Schmidt1,2, Andrew Hercules2,3, Luca Fumis2,3, Alfredo Miranda2,3,
Denise Carvalho-Silva2,3, Annalisa Buniello 2,3, Tony Burdett 2,3, James Hayhurst2,3,
Jarrod Baker</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_27_2021_Method_5185360021543371970">
      <data key="d0">Method</data>
      <data key="d1">integrates human GWAS and functional genomics data including gene expression, protein abundance, chromatin interaction and conformation data from a wide range of cell types and tissues</data>
      <data key="d3">integrates human GWAS and functional genomics data including gene expression, protein abundance, chromatin interaction and conformation data from a wide range of cell types and tissues</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_-184328622009993282">
      <data key="d0">Method</data>
      <data key="d1">systematic statistical fine-mapping across thousands of trait-associated loci to resolve association signals</data>
      <data key="d3">systematic statistical fine-mapping across thousands of trait-associated loci to resolve association signals</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_-5336804443890382792">
      <data key="d0">Method</data>
      <data key="d1">cross-trait/disease disease colocalisation analysis and disease-molecular trait colocalisation analysis across 92 tissues and cell types</data>
      <data key="d3">cross-trait/disease disease colocalisation analysis and disease-molecular trait colocalisation analysis across 92 tissues and cell types</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_568344526147719102">
      <data key="d0">Method</data>
      <data key="d1">linking each variant to its likely target gene(s), using a single evidence score aggregating across a range of functional genomics datasets (disease agnostic)</data>
      <data key="d3">linking each variant to its likely target gene(s), using a single evidence score aggregating across a range of functional genomics datasets (disease agnostic)</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_2198496925447455445">
      <data key="d0">Method</data>
      <data key="d1">prediction of the likely causal gene(s) for all GWAS-associated loci using a machine learning model combining genetics and functional genomics information in a single ‘locus to gene’ (L2G) score</data>
      <data key="d3">prediction of the likely causal gene(s) for all GWAS-associated loci using a machine learning model combining genetics and functional genomics information in a single ‘locus to gene’ (L2G) score</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_5181139286335260250">
      <data key="d0">Method</data>
      <data key="d1">Phenome Wide Association Study (PheWAS) analysis across a wide range of diseases and traits</data>
      <data key="d3">Phenome Wide Association Study (PheWAS) analysis across a wide range of diseases and traits</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_4676797937516684910">
      <data key="d0">Method</data>
      <data key="d1">enriched trait––gene evidence with orthogonal evidence including clinical trials that might support therapeutic hypothesis by linking with the Open Targets Platform</data>
      <data key="d3">enriched trait––gene evidence with orthogonal evidence including clinical trials that might support therapeutic hypothesis by linking with the Open Targets Platform</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_4766238233594093224">
      <data key="d0">Method</data>
      <data key="d1">identification of novel targets for drug discovery and drug repurposing</data>
      <data key="d3">identification of novel targets for drug discovery and drug repurposing</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_7791584285453694810">
      <data key="d0">Method</data>
      <data key="d1">Retrieving, processing, analysing and presenting the large amount of biological data in the Genetics Portal introduces some challenges</data>
      <data key="d3">Retrieving, processing, analysing and presenting the large amount of biological data in the Genetics Portal introduces some challenges</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_-1893416914845820382">
      <data key="d0">Method</data>
      <data key="d1">we use GCTA-COJO to identify independent signals, and then perform per-signal conditional analysis adjusting for other independent signals in a ±2 Mb region from the lead variant</data>
      <data key="d3">we use GCTA-COJO to identify independent signals, and then perform per-signal conditional analysis adjusting for other independent signals in a ±2 Mb region from the lead variant</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_-6312226490387712209">
      <data key="d0">Method</data>
      <data key="d1">fine-mapping using the Approximate Bayes Factor approach is performed</data>
      <data key="d3">fine-mapping using the Approximate Bayes Factor approach is performed</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_5428752849094157889">
      <data key="d0">Method</data>
      <data key="d1">we use the PICS method with an LD reference from the most closely matched 1000 genomes project superpopulation</data>
      <data key="d3">we use the PICS method with an LD reference from the most closely matched 1000 genomes project superpopulation</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_-4927905169314473897">
      <data key="d0">Method</data>
      <data key="d1">disease-agnostic Variant to Gene (V2G) analysis pipeline which provides a single aggregated score for each variant-gene prediction. This analysis combines four different data types; molecular phenotype quantitative trait loci datasets (eQTLs and pQTLs), chromatin interaction and conformation datasets, in silico functional predictions (using the Variant Effect Predictor or VEP score), and distance from the canonical transcript start site</data>
      <data key="d3">disease-agnostic Variant to Gene (V2G) analysis pipeline which provides a single aggregated score for each variant-gene prediction. This analysis combines four different data types; molecular phenotype quantitative trait loci datasets (eQTLs and pQTLs), chromatin interaction and conformation datasets, in silico functional predictions (using the Variant Effect Predictor or VEP score), and distance from the canonical transcript start site</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Method_-8431858731903342285">
      <data key="d0">Method</data>
      <data key="d1">disease-specific gene prioritisation approach (Locus to Gene score, L2G) to prioritise genes at all trait-associated loci using a machine learning model. For this, we integrate fine-mapping credible set analysis across all 133,441 loci with functional genomics data (including pathogenicity prediction, colocalisation with molecular quantitative trait loci, genomic distance and chromatin interaction data) to generate L2G predictive features. We then train a supervised model using over 400 gold-standard positive GWAS loci for which we are confident of the gene implicated</data>
      <data key="d3">disease-specific gene prioritisation approach (Locus to Gene score, L2G) to prioritise genes at all trait-associated loci using a machine learning model. For this, we integrate fine-mapping credible set analysis across all 133,441 loci with functional genomics data (including pathogenicity prediction, colocalisation with molecular quantitative trait loci, genomic distance and chromatin interaction data) to generate L2G predictive features. We then train a supervised model using over 400 gold-standard positive GWAS loci for which we are confident of the gene implicated</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_27_2021_Conclusion_3957623437691924036">
      <data key="d0">Conclusion</data>
      <data key="d1">The Open Targets Genetics Portal addresses these challenges and provides the results in a unique open platform which can be queried programmatically or via an informative user interface. This enables users to address a wide range of research questions, and provides underlying evidence to aid drug discovery.</data>
      <data key="d3">The Open Targets Genetics Portal addresses these challenges and provides the results in a unique open platform which can be queried programmatically or via an informative user interface. This enables users to address a wide range of research questions, and provides underlying evidence to aid drug discovery.</data>
      <data key="d4">PDF_27_2021</data>
    </node>
    <node id="PDF_23_2024">
      <data key="d0">Paper</data>
      <data key="d1">Article
Cell
PNMA2 forms immunogenic non-enveloped virus-
like capsids associated with paraneoplastic
neurological syndrome
Junjie Xu, 1 Simon Erlendsson, 2,3 Manvendra Singh, 4 G. Aaron Holling, 5 Matthew Regier, 1 Iosune Ibiricu, 1 Jenifer Einstein, 1
Michael P. Hantak, 1 Gregory S. Day, 7 Amanda L. Piquet, 8 Tammy L. Smith, 7 Stacey L. Clardy, 9 Alexandra M. Whiteley, 5
Cédric Feschotte, 4 John A.G. Briggs, 2,6 and Jason D. Shepherd 1,10,11,*
1Department of Neurobiology, University of Utah, S</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_23_2024_Hypothesis_4467084021045422591">
      <data key="d0">Hypothesis</data>
      <data key="d1">Aberrant PNMA2 capsids released outside the central nervous system may cause autoantibody generation.</data>
      <data key="d3">Aberrant PNMA2 capsids released outside the central nervous system may cause autoantibody generation.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Method_4671185371064331777">
      <data key="d0">Method</data>
      <data key="d1">Mice were injected with recombinant PNMA2 capsids to induce autoantibodies.</data>
      <data key="d3">Mice were injected with recombinant PNMA2 capsids to induce autoantibodies.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Method_-3379669466993812965">
      <data key="d0">Method</data>
      <data key="d1">Cryoelectron microscopy (cryo-EM) was used to determine atomic resolution structures of PNMA2 capsids and design PNMA2 mutants.</data>
      <data key="d3">Cryoelectron microscopy (cryo-EM) was used to determine atomic resolution structures of PNMA2 capsids and design PNMA2 mutants.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Method_-8141248330658761304">
      <data key="d0">Method</data>
      <data key="d1">ELISA was used to measure autoantibodies binding to PNMA2 capsids.</data>
      <data key="d3">ELISA was used to measure autoantibodies binding to PNMA2 capsids.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Method_8941480093709857562">
      <data key="d0">Method</data>
      <data key="d1">Size-exclusion chromatography was used to analyze the formation of PNMA2 capsids.</data>
      <data key="d3">Size-exclusion chromatography was used to analyze the formation of PNMA2 capsids.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Method_2187362492794927034">
      <data key="d0">Method</data>
      <data key="d1">Iodixanol gradient ultracentrifugation was used to separate proteins by density and size to determine if PNMA2 is released in EVs.</data>
      <data key="d3">Iodixanol gradient ultracentrifugation was used to separate proteins by density and size to determine if PNMA2 is released in EVs.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Method_-8413006734587928990">
      <data key="d0">Method</data>
      <data key="d1">Proteinase K protection assay was performed to determine whether released PNMA2 protein is enveloped by a membrane.</data>
      <data key="d3">Proteinase K protection assay was performed to determine whether released PNMA2 protein is enveloped by a membrane.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_-5486377703570402137">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 proteins self-assemble into T = 1 icosahedral virus-like capsids.</data>
      <data key="d3">PNMA2 proteins self-assemble into T = 1 icosahedral virus-like capsids.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_8651207074546910418">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 is released from cells as non-enveloped capsids.</data>
      <data key="d3">PNMA2 is released from cells as non-enveloped capsids.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_-3634584178799983258">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 capsids induce autoantibody production.</data>
      <data key="d3">PNMA2 capsids induce autoantibody production.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_-1701831125906101092">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease preferentially bind to exterior surface spike epitopes of PNMA2 capsids.</data>
      <data key="d3">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease preferentially bind to exterior surface spike epitopes of PNMA2 capsids.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_-3445624113107174785">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 capsids are capable of inducing maturation of dendritic cells in vitro.</data>
      <data key="d3">PNMA2 capsids are capable of inducing maturation of dendritic cells in vitro.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_-6065715060686981222">
      <data key="d0">Result</data>
      <data key="d1">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
      <data key="d3">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Conclusion_-6011584818940328899">
      <data key="d0">Conclusion</data>
      <data key="d1">PNMA2 is a Gag-like protein that forms endogenous virus-like capsids that are released without a membrane and can trigger a robust immune response when ectopically expressed outside the CNS, which results in neurological deficits.</data>
      <data key="d3">PNMA2 is a Gag-like protein that forms endogenous virus-like capsids that are released without a membrane and can trigger a robust immune response when ectopically expressed outside the CNS, which results in neurological deficits.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Conclusion_-2703974928012477476">
      <data key="d0">Conclusion</data>
      <data key="d1">The virus-like properties of PNMA2 protein may underlie some of the neurological symptoms associated with anti-Ma2 paraneoplastic disease.</data>
      <data key="d3">The virus-like properties of PNMA2 protein may underlie some of the neurological symptoms associated with anti-Ma2 paraneoplastic disease.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_-2528330424662017208">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 mRNA is expressed in excitatory and inhibitory neurons.</data>
      <data key="d3">PNMA2 mRNA is expressed in excitatory and inhibitory neurons.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="Gene_PNMA2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA2</data>
      <data key="d7">PNMA2</data>
    </node>
    <node id="PDF_23_2024_Result_-8493437373168743840">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 is highly and almost exclusively expressed in human brain tissue samples.</data>
      <data key="d3">PNMA2 is highly and almost exclusively expressed in human brain tissue samples.</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="PDF_23_2024_Result_5631681551773626603">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 protein was isolated in early fractions that are also enriched with canonical EV proteins such as the ESCRT protein ALIX</data>
      <data key="d3">PNMA2 protein was isolated in early fractions that are also enriched with canonical EV proteins such as the ESCRT protein ALIX</data>
      <data key="d4">PDF_23_2024</data>
    </node>
    <node id="Protein_ALIX">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ALIX</data>
      <data key="d7">ALIX</data>
    </node>
    <node id="PDF_22_2021">
      <data key="d0">Paper</data>
      <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Science. Author manuscript; available in PMC 2022 February 20.
Published in final edited form as:
Science. 2021 August 20; 373(6557): 882–889. doi:10.1126/science.abg6155.
Mammalian retrovirus-like protein PEG10 packages its own
mRNA and can be pseudotyped for mRNA delivery
Michael Segel 1,2,3,4,5, Blake Lash1,2,3,4,5, Jingwei Song1,2,3,4,5, Alim Ladha1,2,3,4,5, Ca</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_22_2021_Hypothesis_6193989128551963948">
      <data key="d0">Hypothesis</data>
      <data key="d1">Additional retroelement-derived proteins encoded in the mammalian genome transfer specific nucleic acids, providing a potentially programmable mechanism for intercellular communication.</data>
      <data key="d3">Additional retroelement-derived proteins encoded in the mammalian genome transfer specific nucleic acids, providing a potentially programmable mechanism for intercellular communication.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Method_-66702390253835033">
      <data key="d0">Method</data>
      <data key="d1">We searched the human and mouse genomes for gag homologs.</data>
      <data key="d3">We searched the human and mouse genomes for gag homologs.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Method_-8638589072930922688">
      <data key="d0">Method</data>
      <data key="d1">CRISPR activation to induce expression of endogenous genes in mouse N2a cells.</data>
      <data key="d3">CRISPR activation to induce expression of endogenous genes in mouse N2a cells.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="Process_N2A CELLS">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">N2A CELLS</data>
      <data key="d7">N2a cells</data>
    </node>
    <node id="PDF_22_2021_Result_-5669282480205138710">
      <data key="d0">Result</data>
      <data key="d1">MmPeg10 transcriptional activation led to accumulation of significant amounts of full length MmPeg10 mRNA transcripts in the VLP fraction</data>
      <data key="d3">MmPeg10 transcriptional activation led to accumulation of significant amounts of full length MmPeg10 mRNA transcripts in the VLP fraction</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="Gene_PEG10">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PEG10</data>
      <data key="d7">PEG10</data>
    </node>
    <node id="PDF_22_2021_Result_6697060852037958138">
      <data key="d0">Result</data>
      <data key="d1">PEG10 contains two putative nucleic acid binding domains, namely the NC and RT, which are released from the polypeptide upon PEG10 self processing.</data>
      <data key="d3">PEG10 contains two putative nucleic acid binding domains, namely the NC and RT, which are released from the polypeptide upon PEG10 self processing.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="Protein_PEG10">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PEG10</data>
      <data key="d7">PEG10</data>
    </node>
    <node id="PDF_22_2021_Result_8451587848992825607">
      <data key="d0">Result</data>
      <data key="d1">mRNA export depends on the MmPEG10 NC, as loss of the nucleic acid-binding zinc finger CCHC motif (residues 416-429) from the MmPEG10 NC substantially reduced export of its mRNA</data>
      <data key="d3">mRNA export depends on the MmPEG10 NC, as loss of the nucleic acid-binding zinc finger CCHC motif (residues 416-429) from the MmPEG10 NC substantially reduced export of its mRNA</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Result_-8620483130168636363">
      <data key="d0">Result</data>
      <data key="d1">MmPEG10 strongly bound a number of mRNAs in N2a cells including its own mRNA</data>
      <data key="d3">MmPEG10 strongly bound a number of mRNAs in N2a cells including its own mRNA</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Result_-1419816334220739220">
      <data key="d0">Result</data>
      <data key="d1">The mRNAs of 49 genes downregulated in the brain upon MmPeg10 knockout are bound to MmPEG10 in the age-matched mouse brain, suggesting that one of the functions of MmPEG10 is to bind and stabilize mRNAs with fundamental roles in neurodevelopment.</data>
      <data key="d3">The mRNAs of 49 genes downregulated in the brain upon MmPeg10 knockout are bound to MmPEG10 in the age-matched mouse brain, suggesting that one of the functions of MmPEG10 is to bind and stabilize mRNAs with fundamental roles in neurodevelopment.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Method_-3586676997868765252">
      <data key="d0">Method</data>
      <data key="d1">UTR grafting approach has been demonstrated for the Ty3 retroelement and darc1</data>
      <data key="d3">UTR grafting approach has been demonstrated for the Ty3 retroelement and darc1</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Result_6335271355366042181">
      <data key="d0">Result</data>
      <data key="d1">Addition of the Peg10UTRs enables functional intercellular transfer of an mRNA via VLPs and that these VLPs require a fusogenic protein for cell entry.</data>
      <data key="d3">Addition of the Peg10UTRs enables functional intercellular transfer of an mRNA via VLPs and that these VLPs require a fusogenic protein for cell entry.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_22_2021_Result_2635079953497084240">
      <data key="d0">Result</data>
      <data key="d1">SEND was able to functionally transfer SpCas9, leading to ~60% indels in recipient cells</data>
      <data key="d3">SEND was able to functionally transfer SpCas9, leading to ~60% indels in recipient cells</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="Protein_CAS9">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CAS9</data>
      <data key="d7">Cas9</data>
    </node>
    <node id="PDF_22_2021_Conclusion_7691408861461016036">
      <data key="d0">Conclusion</data>
      <data key="d1">As a modular, fully endogenous system, SEND has the potential to be extended into a minimally immunogenic delivery platform that can be repeatedly dosed, greatly expanding the applications for nucleic acid therapy.</data>
      <data key="d3">As a modular, fully endogenous system, SEND has the potential to be extended into a minimally immunogenic delivery platform that can be repeatedly dosed, greatly expanding the applications for nucleic acid therapy.</data>
      <data key="d4">PDF_22_2021</data>
    </node>
    <node id="PDF_16_2017">
      <data key="d0">Paper</data>
      <data key="d1">Here is the extracted text from the scientific PDF you provided:

Molecular Human Reproduction, Vol.23, No.3 pp. 177-186, 2017
Advanced Access publication on February 18, 2017 doi:10.1093/molehr/gax004

molecular
human
reproduction

ORIGINAL ARTICLE

RNA immunoprecipitation identifies
novel targets of DAZL in human
foetal ovary

Roseanne Rosario*, *, Richard W.P. Smith', Ian R. Adams²,
and Richard A. Anderson'

'MRC Centre for Reproductive Health, Queens Medical Research Institute, University of</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_16_2017_Hypothesis_-93077183457633057">
      <data key="d0">Hypothesis</data>
      <data key="d1">Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary?</data>
      <data key="d3">Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary?</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="PDF_16_2017_Method_-7105474563644511331">
      <data key="d0">Method</data>
      <data key="d1">We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue (17 weeks of gestation, obtained after elective termination of pregnancy) to identify novel DAZL targets involved in meiosis (n = 3 biological replicates).</data>
      <data key="d3">We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue (17 weeks of gestation, obtained after elective termination of pregnancy) to identify novel DAZL targets involved in meiosis (n = 3 biological replicates).</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="PDF_16_2017_Method_6083705114603944930">
      <data key="d0">Method</data>
      <data key="d1">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
      <data key="d3">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="Protein_SMCIB">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SMCIB</data>
      <data key="d7">SMCIB</data>
    </node>
    <node id="PDF_16_2017_Method_-6046330054613322383">
      <data key="d0">Method</data>
      <data key="d1">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
      <data key="d3">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="Protein_SYCP1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SYCP1</data>
      <data key="d7">SYCP1</data>
    </node>
    <node id="Protein_TEX11">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TEX11</data>
      <data key="d7">TEX11</data>
    </node>
    <node id="PDF_16_2017_Result_-4507820774077407011">
      <data key="d0">Result</data>
      <data key="d1">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
      <data key="d3">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="Gene_RAD21">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RAD21</data>
      <data key="d7">RAD21</data>
    </node>
    <node id="Gene_MAD2L1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MAD2L1</data>
      <data key="d7">MAD2L1</data>
    </node>
    <node id="Gene_TRIP13">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TRIP13</data>
      <data key="d7">TRIP13</data>
    </node>
    <node id="Gene_HORMADI">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HORMADI</data>
      <data key="d7">HORMADI</data>
    </node>
    <node id="Gene_RAD18">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RAD18</data>
      <data key="d7">RAD18</data>
    </node>
    <node id="Gene_RAD51">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RAD51</data>
      <data key="d7">RAD51</data>
    </node>
    <node id="PDF_16_2017_Result_3043543269034543926">
      <data key="d0">Result</data>
      <data key="d1">We demonstrated that the translation of novel targets SYCPI (P = 0.004), TEXII (P = 0.004) and SMCIB (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
      <data key="d3">We demonstrated that the translation of novel targets SYCPI (P = 0.004), TEXII (P = 0.004) and SMCIB (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="PDF_16_2017_Conclusion_-1693031729440580785">
      <data key="d0">Conclusion</data>
      <data key="d1">SYCPI (synaptonemal complex protein-1), TEXII (testis expressed 11) and SMCIB (structural maintenance of chromosomes IB) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.</data>
      <data key="d3">SYCPI (synaptonemal complex protein-1), TEXII (testis expressed 11) and SMCIB (structural maintenance of chromosomes IB) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="PDF_16_2017_Conclusion_7572226408189671675">
      <data key="d0">Conclusion</data>
      <data key="d1">These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
      <data key="d3">These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
      <data key="d4">PDF_16_2017</data>
    </node>
    <node id="PDF_30_2021">
      <data key="d0">Paper</data>
      <data key="d1">Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
LTH &amp; HUMAN SERVICES-US,
HHS Public Access
Author manuscript
Nat Genet. Author manuscript; available in PMC 2022 January 05.
Published in final edited form as:
Nat Genet. 2021 August; 53(8): 1260–1269. doi:10.1038/s41588-021-00892-1.
Whole-exome imputation within UK Biobank powers rare coding
variant association and fine-mapping analyses
Alison R. Barton1,2,3,*, Maxwell A. Sherman1,2,4, Ronen E. Mukamel1,2, Po-Ru Loh1,2,*
1D</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_30_2021_Hypothesis_2160001289349944145">
      <data key="d0">Hypothesis</data>
      <data key="d1">We reasoned that although exome sequencing of ~10% of the UKB cohort provided insufficient power to directly assess the effects of ultra-rare variants (which have &lt;10 carriers in N~50,000 sequenced participants), we could leverage the extensive haplotype sharing within the UKB cohort to accurately impute these variants into up to ~100 carriers in the full cohort, thereby powering association analysis.</data>
      <data key="d3">We reasoned that although exome sequencing of ~10% of the UKB cohort provided insufficient power to directly assess the effects of ultra-rare variants (which have &lt;10 carriers in N~50,000 sequenced participants), we could leverage the extensive haplotype sharing within the UKB cohort to accurately impute these variants into up to ~100 carriers in the full cohort, thereby powering association analysis.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Method_-4320380909749958002">
      <data key="d0">Method</data>
      <data key="d1">We leveraged whole-exome sequencing of 49,960 UKB participants together with SNP-array genotyping in the full cohort to impute exome-wide variants into all UKB participants</data>
      <data key="d3">We leveraged whole-exome sequencing of 49,960 UKB participants together with SNP-array genotyping in the full cohort to impute exome-wide variants into all UKB participants</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Method_-7985357732871102285">
      <data key="d0">Method</data>
      <data key="d1">We tested the imputed variants for association with 54 heritable quantitative traits by running linear mixed model association analysis on N=459,259 participants of European ancestry using BOLT-LMM</data>
      <data key="d3">We tested the imputed variants for association with 54 heritable quantitative traits by running linear mixed model association analysis on N=459,259 participants of European ancestry using BOLT-LMM</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Method_-5705176645279342252">
      <data key="d0">Method</data>
      <data key="d1">filtering pipeline that combined variant annotation filters (to increase the prior on causality) with statistical fine-mapping</data>
      <data key="d3">filtering pipeline that combined variant annotation filters (to increase the prior on causality) with statistical fine-mapping</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Result_-8635379153542959884">
      <data key="d0">Result</data>
      <data key="d1">Association and fine-mapping analyses of 54 quantitative traits identified 1,189 significant associations (P&lt;5 x 10−8) involving 675 distinct rare protein-altering variants (MAF&lt;0.01) that passed stringent filters for likely causality.</data>
      <data key="d3">Association and fine-mapping analyses of 54 quantitative traits identified 1,189 significant associations (P&lt;5 x 10−8) involving 675 distinct rare protein-altering variants (MAF&lt;0.01) that passed stringent filters for likely causality.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Result_-7595614694216120791">
      <data key="d0">Result</data>
      <data key="d1">Across all traits, 49% of associations (578/1,189) occurred in genes with two or more hits; follow-up analyses of these genes identified allelic series containing up to 45 distinct likely-causal variants.</data>
      <data key="d3">Across all traits, 49% of associations (578/1,189) occurred in genes with two or more hits; follow-up analyses of these genes identified allelic series containing up to 45 distinct likely-causal variants.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Result_-7208524670598810401">
      <data key="d0">Result</data>
      <data key="d1">At NPR2, which encodes a natriuretic peptide receptor involved in bone growth regulation, 11 rare coding variants independently associated with height.</data>
      <data key="d3">At NPR2, which encodes a natriuretic peptide receptor involved in bone growth regulation, 11 rare coding variants independently associated with height.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="Gene_NPR2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NPR2</data>
      <data key="d7">NPR2</data>
    </node>
    <node id="PDF_30_2021_Result_-4071101592301487076">
      <data key="d0">Result</data>
      <data key="d1">APOC3 exhibited the widest variety of likely-causal associations, with the splice donor variant rs138326449 associating with 13 distinct traits including lipid levels, white blood cell and red blood cell traits, and kidney biomarkers.</data>
      <data key="d3">APOC3 exhibited the widest variety of likely-causal associations, with the splice donor variant rs138326449 associating with 13 distinct traits including lipid levels, white blood cell and red blood cell traits, and kidney biomarkers.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="Gene_APOC3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">APOC3</data>
      <data key="d7">APOC3</data>
    </node>
    <node id="PDF_30_2021_Result_-294535297058227258">
      <data key="d0">Result</data>
      <data key="d1">In PDE3B, the stop gain variant rs150090666 associated likely-causally with 10 distinct traits, including expected associations with waist-hip-ratio and lipid measurements, but also associations with red blood cell traits, SHBG levels, and height.</data>
      <data key="d3">In PDE3B, the stop gain variant rs150090666 associated likely-causally with 10 distinct traits, including expected associations with waist-hip-ratio and lipid measurements, but also associations with red blood cell traits, SHBG levels, and height.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="Gene_PDE3B">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PDE3B</data>
      <data key="d7">PDE3B</data>
    </node>
    <node id="PDF_30_2021_Result_6142259157110338341">
      <data key="d0">Result</data>
      <data key="d1">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion</data>
      <data key="d3">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="Gene_MC4R">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MC4R</data>
      <data key="d7">MC4R</data>
    </node>
    <node id="PDF_30_2021_Conclusion_-4318441215335671446">
      <data key="d0">Conclusion</data>
      <data key="d1">Our results demonstrate the utility of within-cohort imputation in population-scale GWAS cohorts, provide a catalog of likely-causal, large-effect coding variant associations, and foreshadow the insights that will be revealed as genetic biobank studies continue to grow.</data>
      <data key="d3">Our results demonstrate the utility of within-cohort imputation in population-scale GWAS cohorts, provide a catalog of likely-causal, large-effect coding variant associations, and foreshadow the insights that will be revealed as genetic biobank studies continue to grow.</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_30_2021_Conclusion_5730400630930705530">
      <data key="d0">Conclusion</data>
      <data key="d1">Among gene-trait pairs implicated by our single-variant association tests, 32% were not detected by burden analysis, indicating that single-variant analysis can often be more powerful than gene-based tests for discovering novel loci associated with complex traits</data>
      <data key="d3">Among gene-trait pairs implicated by our single-variant association tests, 32% were not detected by burden analysis, indicating that single-variant analysis can often be more powerful than gene-based tests for discovering novel loci associated with complex traits</data>
      <data key="d4">PDF_30_2021</data>
    </node>
    <node id="PDF_57_2014">
      <data key="d0">Paper</data>
      <data key="d1">Love et al. Genome Biology (2014) 15:550
Page 1 of 21
Genome Biology
Open Access
METHOD
Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2
Michael I Love 1,2,3, Wolfgang Huber² and Simon Anders2*
Abstract
In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read
counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate
numbers, discreteness, large dynamic range</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_57_2014_Method_-5536773674226873468">
      <data key="d0">Method</data>
      <data key="d1">DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.</data>
      <data key="d3">DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_928844818076935177">
      <data key="d0">Method</data>
      <data key="d1">We present DESeq2, a successor to our DESeq method [4]. DESeq2 integrates methodological advances with several novel features to facilitate a more quantitative analysis of comparative RNA-seq data using shrinkage estimators for dispersion and fold change.</data>
      <data key="d3">We present DESeq2, a successor to our DESeq method [4]. DESeq2 integrates methodological advances with several novel features to facilitate a more quantitative analysis of comparative RNA-seq data using shrinkage estimators for dispersion and fold change.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_6627841982578422952">
      <data key="d0">Method</data>
      <data key="d1">We model read counts Kij as following a negative binomial distribution (sometimes also called a gamma-Poisson distribution) with mean µij and dispersion ai.</data>
      <data key="d3">We model read counts Kij as following a negative binomial distribution (sometimes also called a gamma-Poisson distribution) with mean µij and dispersion ai.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_281207146266776335">
      <data key="d0">Method</data>
      <data key="d1">To estimate these size factors, the DESeq2 package offers the median-of-ratios method already used in DESeq [4].</data>
      <data key="d3">To estimate these size factors, the DESeq2 package offers the median-of-ratios method already used in DESeq [4].</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_3049487649392500733">
      <data key="d0">Method</data>
      <data key="d1">In DESeq2, we assume that genes of similar average expression strength have similar dispersion.</data>
      <data key="d3">In DESeq2, we assume that genes of similar average expression strength have similar dispersion.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-4138664636761175751">
      <data key="d0">Method</data>
      <data key="d1">DESeq2 estimates the width of the prior distribution from the data and therefore automatically controls the amount of shrinkage based on the observed properties of the data.</data>
      <data key="d3">DESeq2 estimates the width of the prior distribution from the data and therefore automatically controls the amount of shrinkage based on the observed properties of the data.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-8973457162758577703">
      <data key="d0">Method</data>
      <data key="d1">DESeq2 handles these cases by using the gene-wise estimate instead of the shrunken estimate when the former is more than 2 residual standard deviations above the curve.</data>
      <data key="d3">DESeq2 handles these cases by using the gene-wise estimate instead of the shrunken estimate when the former is more than 2 residual standard deviations above the curve.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-1107127596074901886">
      <data key="d0">Method</data>
      <data key="d1">DESeq2 overcomes this issue by shrinking LFC estimates toward zero in a manner such that shrinkage is stronger when the available information for a gene is low, which may be because counts are low, dispersion is high or there are few degrees of freedom.</data>
      <data key="d3">DESeq2 overcomes this issue by shrinking LFC estimates toward zero in a manner such that shrinkage is stronger when the available information for a gene is low, which may be because counts are low, dispersion is high or there are few degrees of freedom.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_7490987086473275578">
      <data key="d0">Method</data>
      <data key="d1">The resulting MAP LFCs are biased toward zero in a manner that removes the problem of exaggerated LFCs for low counts.</data>
      <data key="d3">The resulting MAP LFCs are biased toward zero in a manner that removes the problem of exaggerated LFCs for low counts.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_7686857928769654649">
      <data key="d0">Method</data>
      <data key="d1">For significance testing, DESeq2 uses a Wald test: the shrunken estimate of LFC is divided by its standard error, resulting in a z-statistic, which is compared to a standard normal distribution.</data>
      <data key="d3">For significance testing, DESeq2 uses a Wald test: the shrunken estimate of LFC is divided by its standard error, resulting in a z-statistic, which is compared to a standard normal distribution.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_2176240826659309713">
      <data key="d0">Method</data>
      <data key="d1">DESeq2 by default will choose a threshold that maximizes the number of genes found at a user-specified target FDR.</data>
      <data key="d3">DESeq2 by default will choose a threshold that maximizes the number of genes found at a user-specified target FDR.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_2054776320862152537">
      <data key="d0">Method</data>
      <data key="d1">For such analyses, DESeq2 offers a test of the composite null hypothesis |ẞir| ≥ 0, which will report genes as significant for which there is evidence that their LFC is weaker than 0.</data>
      <data key="d3">For such analyses, DESeq2 offers a test of the composite null hypothesis |ẞir| ≥ 0, which will report genes as significant for which there is evidence that their LFC is weaker than 0.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-2628623931096176784">
      <data key="d0">Method</data>
      <data key="d1">DESeq2 flags, for each gene, those samples that have a Cook's distance greater than the 0.99 quantile of the F(p, m - p) distribution, where p is the number of model parameters including the intercept, and m is the number of samples.</data>
      <data key="d3">DESeq2 flags, for each gene, those samples that have a Cook's distance greater than the 0.99 quantile of the F(p, m - p) distribution, where p is the number of model parameters including the intercept, and m is the number of samples.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_5722336715795250337">
      <data key="d0">Method</data>
      <data key="d1">By default, outliers in conditions with six or fewer replicates cause the whole gene to be flagged and removed from subsequent analysis, including P value adjustment for multiple testing.</data>
      <data key="d3">By default, outliers in conditions with six or fewer replicates cause the whole gene to be flagged and removed from subsequent analysis, including P value adjustment for multiple testing.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-3926302964775411936">
      <data key="d0">Method</data>
      <data key="d1">DESeq2 replaces the outlier counts with an imputed value, namely the trimmed mean over all samples, scaled by the size factor, and then re-estimates the dispersion, LFCs and P values for these genes.</data>
      <data key="d3">DESeq2 replaces the outlier counts with an imputed value, namely the trimmed mean over all samples, scaled by the size factor, and then re-estimates the dispersion, LFCs and P values for these genes.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-4313129312883767923">
      <data key="d0">Method</data>
      <data key="d1">Therefore, we use the shrinkage approach of DESeq2 to implement a regularized logarithm transformation (rlog), which behaves similarly to a log2 transformation for genes with high counts, while shrinking together the values for different samples for genes with low counts.</data>
      <data key="d3">Therefore, we use the shrinkage approach of DESeq2 to implement a regularized logarithm transformation (rlog), which behaves similarly to a log2 transformation for genes with high counts, while shrinking together the values for different samples for genes with low counts.</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_57_2014_Method_-7148381996951902563">
      <data key="d0">Method</data>
      <data key="d1">The rlog transformation is calculated by fitting for each gene a GLM with a baseline expression (i.e., intercept only) and, computing for each sample, shrunken LFCs with respect to the baseline, using the same empirical Bayes procedure as before (Methods).</data>
      <data key="d3">The rlog transformation is calculated by fitting for each gene a GLM with a baseline expression (i.e., intercept only) and, computing for each sample, shrunken LFCs with respect to the baseline, using the same empirical Bayes procedure as before (Methods).</data>
      <data key="d4">PDF_57_2014</data>
    </node>
    <node id="PDF_55_2023">
      <data key="d0">Paper</data>
      <data key="d1">Here's the full English text extracted from the scientific PDF:

**ARTICLE**

**Riel and Sgn1 form an RNA-binding complex that enforces the meiotic entry cell fate decision**

Alec Gaspary¹, Raphaelle Laureau, Annie Dyatel¹, Gizem Dursuk¹, Yael Simon, and Luke E. Berchowitz¹,2

¹Department of Genetics and Development, Hammer Health Sciences Center, Columbia University Irving Medical Center, New York, NY, USA; ²Taub Institute for Research on Alzheimer's and the Aging Brain, New York, NY, USA.

Co</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_55_2023_Hypothesis_2414538738140634289">
      <data key="d0">Hypothesis</data>
      <data key="d1">We hypothesized that there may be unknown yeast RBPs that are inessential for vegetative growth but critical for meiosis.</data>
      <data key="d3">We hypothesized that there may be unknown yeast RBPs that are inessential for vegetative growth but critical for meiosis.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Method_-4679836695388845332">
      <data key="d0">Method</data>
      <data key="d1">We performed a systematic screen in the efficient sporulation strain SK1 to identify RBPs that are important for meiotic entry in S. cerevisiae.</data>
      <data key="d3">We performed a systematic screen in the efficient sporulation strain SK1 to identify RBPs that are important for meiotic entry in S. cerevisiae.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Result_-969201998017372530">
      <data key="d0">Result</data>
      <data key="d1">The most severe entry mutant we observed was riel∆, which showed ~15% of cells entering meiotic prophase at 6 h.</data>
      <data key="d3">The most severe entry mutant we observed was riel∆, which showed ~15% of cells entering meiotic prophase at 6 h.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="Gene_RTL9">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL9</data>
      <data key="d7">RTL9</data>
    </node>
    <node id="PDF_55_2023_Result_-7406233373455181378">
      <data key="d0">Result</data>
      <data key="d1">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
      <data key="d3">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="Protein_IME1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">IME1</data>
      <data key="d7">IME1</data>
    </node>
    <node id="Protein_IME2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">IME2</data>
      <data key="d7">Ime2</data>
    </node>
    <node id="Protein_IME4">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">IME4</data>
      <data key="d7">Ime4</data>
    </node>
    <node id="PDF_55_2023_Result_-1103732407464580779">
      <data key="d0">Result</data>
      <data key="d1">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
      <data key="d3">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="Protein_RTL9">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">RTL9</data>
      <data key="d7">RTL9</data>
    </node>
    <node id="Gene_IME1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">IME1</data>
      <data key="d7">IME1</data>
    </node>
    <node id="PDF_55_2023_Result_7862179539634199818">
      <data key="d0">Result</data>
      <data key="d1">We observed increased abundance of Riel in actively translating fractions (i.e., ribosomes and polysomes) in the crosslinked samples throughout pre-meiotic S-phase.</data>
      <data key="d3">We observed increased abundance of Riel in actively translating fractions (i.e., ribosomes and polysomes) in the crosslinked samples throughout pre-meiotic S-phase.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Result_7737093034733274042">
      <data key="d0">Result</data>
      <data key="d1">We found that the presence or absence of Riel did not affect poly(A) tail length of IMEI.</data>
      <data key="d3">We found that the presence or absence of Riel did not affect poly(A) tail length of IMEI.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Result_5963463901830595246">
      <data key="d0">Result</data>
      <data key="d1">The most highly enriched protein was another RNA-binding protein Sgnl which harbors significant similarity to the translation initiation factor eIF4B.</data>
      <data key="d3">The most highly enriched protein was another RNA-binding protein Sgnl which harbors significant similarity to the translation initiation factor eIF4B.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="Protein_SGN1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SGN1</data>
      <data key="d7">SGN1</data>
    </node>
    <node id="PDF_55_2023_Result_-3397886118733152105">
      <data key="d0">Result</data>
      <data key="d1">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot.</data>
      <data key="d3">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Result_7535285844095637219">
      <data key="d0">Result</data>
      <data key="d1">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels.</data>
      <data key="d3">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="Gene_SGN1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SGN1</data>
      <data key="d7">SGN1</data>
    </node>
    <node id="PDF_55_2023_Result_8086110237662957897">
      <data key="d0">Result</data>
      <data key="d1">We found that Sgnl binds IME1 mRNA compared with the BSA control.</data>
      <data key="d3">We found that Sgnl binds IME1 mRNA compared with the BSA control.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Result_3050807498403910935">
      <data key="d0">Result</data>
      <data key="d1">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
      <data key="d3">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Result_-3298673367396207587">
      <data key="d0">Result</data>
      <data key="d1">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type.</data>
      <data key="d3">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_55_2023_Conclusion_-1110881446195742522">
      <data key="d0">Conclusion</data>
      <data key="d1">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
      <data key="d3">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
      <data key="d4">PDF_55_2023</data>
    </node>
    <node id="PDF_06_2021">
      <data key="d0">Paper</data>
      <data key="d1">Here is the complete text from the scientific PDF, as requested.

Developmental Cell
Article
Meiotic Cells Counteract Programmed
Retrotransposon Activation via RNA-Binding
Translational Repressor Assemblies
Raphaelle Laureau, 1 Annie Dyatel,¹ Gizem Dursuk, 1 Samantha Brown,¹ Hannah Adeoye, 1 Jia-Xing Yue, 2
Matteo De Chiara, Anthony Harris, Elçin Ünal, 3 Gianni Liti, 2 lan R. Adams, and Luke E. Berchowitz1,5,*
1Department of Genetics and Development, Hammer Health Sciences Center, Columbia Unive</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_06_2021_Result_8382118199712686593">
      <data key="d0">Result</data>
      <data key="d1">The transcriptional activation of Ty3/Gypsy retrotransposons and host defense are controlled by master meiotic regulators.</data>
      <data key="d3">The transcriptional activation of Ty3/Gypsy retrotransposons and host defense are controlled by master meiotic regulators.</data>
      <data key="d4">PDF_06_2021</data>
    </node>
    <node id="PDF_06_2021_Result_-3259732354378302525">
      <data key="d0">Result</data>
      <data key="d1">budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
      <data key="d3">budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
      <data key="d4">PDF_06_2021</data>
    </node>
    <node id="Protein_NDT80">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">NDT80</data>
      <data key="d7">Ndt80</data>
    </node>
    <node id="PDF_06_2021_Result_6013483683489674608">
      <data key="d0">Result</data>
      <data key="d1">yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
      <data key="d3">yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
      <data key="d4">PDF_06_2021</data>
    </node>
    <node id="PDF_06_2021_Result_-6752065244819639597">
      <data key="d0">Result</data>
      <data key="d1">mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
      <data key="d3">mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
      <data key="d4">PDF_06_2021</data>
    </node>
    <node id="Protein_STRA8">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">STRA8</data>
      <data key="d7">Stra8</data>
    </node>
    <node id="Protein_MYBL1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MYBL1</data>
      <data key="d7">Mybl1</data>
    </node>
    <node id="PDF_39_2016">
      <data key="d0">Paper</data>
      <data key="d1">Here is the full text, as requested:

Article
Cell Reports
MOAP-1 Mediates Fas-Induced Apoptosis in Liver by
Facilitating tBid Recruitment to Mitochondria
Chong Teik Tan, Qi-Ling Zhou,
+ Fas activation
X MOAP-1 Knockout
Intact mitochondria
Survival
Yu-Chin Su, ..., Kanaga Sabapathy,
Chun-Dong Yu, Victor C. Yu
Correspondence
phayuv@nus.edu.sg
In Brief
Activation of Fas apoptotic signaling
triggers acute liver injury. Tan et al. show
that deletion of the MOAP-1 gene
protects mice from this injury.</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_39_2016_Result_-859609404261212333">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1-deficient mice are resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
      <data key="d3">MOAP-1-deficient mice are resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_MOAP-1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MOAP-1</data>
      <data key="d7">MOAP-1</data>
    </node>
    <node id="Protein_FAS">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">FAS</data>
      <data key="d7">Fas</data>
    </node>
    <node id="PDF_39_2016_Result_-622129940698925204">
      <data key="d0">Result</data>
      <data key="d1">In the absence of MOAP-1, mitochondrial accumulation of tBid is markedly impaired.</data>
      <data key="d3">In the absence of MOAP-1, mitochondrial accumulation of tBid is markedly impaired.</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_TBID">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TBID</data>
      <data key="d7">tBid</data>
    </node>
    <node id="PDF_39_2016_Result_1141399373227490210">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 binds to MTCH2, and this interaction appears necessary for MTCH2 to engage tBid.</data>
      <data key="d3">MOAP-1 binds to MTCH2, and this interaction appears necessary for MTCH2 to engage tBid.</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_MTCH2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MTCH2</data>
      <data key="d7">MTCH2</data>
    </node>
    <node id="PDF_39_2016_Result_4026234273222297620">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 is required to mediate Fas apoptotic signaling in liver</data>
      <data key="d3">MOAP-1 is required to mediate Fas apoptotic signaling in liver</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_6195547222244729274">
      <data key="d0">Result</data>
      <data key="d1">Loss of MOAP-1 protects mice from Fas-induced liver injury and lethality</data>
      <data key="d3">Loss of MOAP-1 protects mice from Fas-induced liver injury and lethality</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_-5010782213656739121">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 is required for efficient tBid recruitment to mitochondria</data>
      <data key="d3">MOAP-1 is required for efficient tBid recruitment to mitochondria</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_-3097834726290967901">
      <data key="d0">Result</data>
      <data key="d1">Binding of MOAP-1 to MTCH2 engages the receptor function of MTCH2 for tBid</data>
      <data key="d3">Binding of MOAP-1 to MTCH2 engages the receptor function of MTCH2 for tBid</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_8930972293622260889">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 KO MEFs also demonstrated resistance to apoptosis induced by overexpression of Bax or tBid.</data>
      <data key="d3">MOAP-1 KO MEFs also demonstrated resistance to apoptosis induced by overexpression of Bax or tBid.</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_3312376890371302347">
      <data key="d0">Result</data>
      <data key="d1">isolated mitochondria prepared from the MOAP-1 KO liver were markedly resistant to the cytochrome c releasing effect of recombinant Bax and tBid</data>
      <data key="d3">isolated mitochondria prepared from the MOAP-1 KO liver were markedly resistant to the cytochrome c releasing effect of recombinant Bax and tBid</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_CYTOCHROME C">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CYTOCHROME C</data>
      <data key="d7">Cytochrome c</data>
    </node>
    <node id="PDF_39_2016_Result_-5542923386328879516">
      <data key="d0">Result</data>
      <data key="d1">caspase-8 activation remained unaffected, while activation of caspase-3 and caspase-7 was significantly impaired</data>
      <data key="d3">caspase-8 activation remained unaffected, while activation of caspase-3 and caspase-7 was significantly impaired</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_CASPASE-8">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CASPASE-8</data>
      <data key="d7">Caspase-8</data>
    </node>
    <node id="Protein_CASPASE-3">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CASPASE-3</data>
      <data key="d7">Caspase-3</data>
    </node>
    <node id="Protein_CASPASE-7">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CASPASE-7</data>
      <data key="d7">Caspase-7</data>
    </node>
    <node id="PDF_39_2016_Result_-4940940051045183701">
      <data key="d0">Result</data>
      <data key="d1">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
      <data key="d3">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_CASPASE-9">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CASPASE-9</data>
      <data key="d7">Caspase-9</data>
    </node>
    <node id="Protein_SMAC">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SMAC</data>
      <data key="d7">Smac</data>
    </node>
    <node id="Protein_AIF">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">AIF</data>
      <data key="d7">AIF</data>
    </node>
    <node id="Protein_BAK">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">BAK</data>
      <data key="d7">Bak</data>
    </node>
    <node id="PDF_39_2016_Result_-2977154365048100006">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 KO hepatocytes treated with increasing concentrations of recombinant Flag-tagged soluble Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor by aggregation, exhibited significant reduction in cell death and caspase-3 activation</data>
      <data key="d3">MOAP-1 KO hepatocytes treated with increasing concentrations of recombinant Flag-tagged soluble Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor by aggregation, exhibited significant reduction in cell death and caspase-3 activation</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="Protein_FASL">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">FASL</data>
      <data key="d7">FasL</data>
    </node>
    <node id="PDF_39_2016_Result_-287882437199433340">
      <data key="d0">Result</data>
      <data key="d1">mitochondrial accumulation of tBid was markedly hindered in the absence of MOAP-1</data>
      <data key="d3">mitochondrial accumulation of tBid was markedly hindered in the absence of MOAP-1</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_4381616005818362437">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 associates with MTCH2 and Fas Activation Promotes Their Interaction</data>
      <data key="d3">MOAP-1 associates with MTCH2 and Fas Activation Promotes Their Interaction</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_39_2016_Result_-1699613784156464021">
      <data key="d0">Result</data>
      <data key="d1">Interaction of MOAP-1 with MTCH2 Is Necessary for Mediating the Mitochondrial Receptor Function of MTCH2 for tBid</data>
      <data key="d3">Interaction of MOAP-1 with MTCH2 Is Necessary for Mediating the Mitochondrial Receptor Function of MTCH2 for tBid</data>
      <data key="d4">PDF_39_2016</data>
    </node>
    <node id="PDF_02_2017">
      <data key="d0">Paper</data>
      <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Trends Genet. Author manuscript; available in PMC 2018 November 01.
Published in final edited form as:
Trends Genet. 2017 November ; 33(11): 817–831. doi:10.1016/j.tig.2017.07.011.
Transposable element domestication as an adaptation to
evolutionary conflicts
Diwash Jangam¹, Cédric Feschotte2,3, and Esther Betrán¹
1Department of Biology, University of Texas at Arlin</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_02_2017_Hypothesis_-1505558058449884577">
      <data key="d0">Hypothesis</data>
      <data key="d1">TE domestication might be the sole, inevitable evolutionary resolution in certain conflicting situations</data>
      <data key="d3">TE domestication might be the sole, inevitable evolutionary resolution in certain conflicting situations</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="PDF_02_2017_Result_-4918474746629675554">
      <data key="d0">Result</data>
      <data key="d1">The catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib</data>
      <data key="d3">The catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_RAG1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">RAG1</data>
      <data key="d7">RAG1</data>
    </node>
    <node id="Gene_TRANSIB">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TRANSIB</data>
      <data key="d7">Transib</data>
    </node>
    <node id="PDF_02_2017_Result_2263818987114240670">
      <data key="d0">Result</data>
      <data key="d1">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
      <data key="d3">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_RAG2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">RAG2</data>
      <data key="d7">RAG2</data>
    </node>
    <node id="PDF_02_2017_Result_-6247892651716705642">
      <data key="d0">Result</data>
      <data key="d1">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
      <data key="d3">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_CAS1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CAS1</data>
      <data key="d7">Cas1</data>
    </node>
    <node id="Gene_CASPOSONS">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CASPOSONS</data>
      <data key="d7">Casposons</data>
    </node>
    <node id="PDF_02_2017_Result_-7098461936421922945">
      <data key="d0">Result</data>
      <data key="d1">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
      <data key="d3">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_TNPB">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TNPB</data>
      <data key="d7">TNPB</data>
    </node>
    <node id="PDF_02_2017_Result_3556966989706529864">
      <data key="d0">Result</data>
      <data key="d1">Several proteins derived from the Envelope (Env) gene of endogenous retroviruses are known to aid in the protection of the host cell by restricting infection of related retroviruses</data>
      <data key="d3">Several proteins derived from the Envelope (Env) gene of endogenous retroviruses are known to aid in the protection of the host cell by restricting infection of related retroviruses</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Gene_ENV">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ENV</data>
      <data key="d7">Env</data>
    </node>
    <node id="PDF_02_2017_Result_879410794103001418">
      <data key="d0">Result</data>
      <data key="d1">A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
      <data key="d3">A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Gene_FV1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FV1</data>
      <data key="d7">Fv1</data>
    </node>
    <node id="Gene_ERV-L">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ERV-L</data>
      <data key="d7">ERV-L</data>
    </node>
    <node id="PDF_02_2017_Result_-2443396244489801236">
      <data key="d0">Result</data>
      <data key="d1">In the fission yeast Schizosaccharomyces pombe, three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements</data>
      <data key="d3">In the fission yeast Schizosaccharomyces pombe, three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_ABP1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ABP1</data>
      <data key="d7">Abp1</data>
    </node>
    <node id="Protein_CBH1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CBH1</data>
      <data key="d7">Cbh1</data>
    </node>
    <node id="Protein_CBH2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CBH2</data>
      <data key="d7">Cbh2</data>
    </node>
    <node id="Gene_TF2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TF2</data>
      <data key="d7">Tf2</data>
    </node>
    <node id="PDF_02_2017_Result_-731319792273618549">
      <data key="d0">Result</data>
      <data key="d1">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms and partake in an epigenetic silencing pathway that transcriptionally represses a broad array of TEs</data>
      <data key="d3">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms and partake in an epigenetic silencing pathway that transcriptionally represses a broad array of TEs</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Gene_MAIL1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MAIL1</data>
      <data key="d7">MAIL1</data>
    </node>
    <node id="Gene_MAIN">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MAIN</data>
      <data key="d7">MAIN</data>
    </node>
    <node id="PDF_02_2017_Result_2718246493069241434">
      <data key="d0">Result</data>
      <data key="d1">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway and directly derives from a PIF-like transposase</data>
      <data key="d3">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway and directly derives from a PIF-like transposase</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_ALP1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ALP1</data>
      <data key="d7">ALP1</data>
    </node>
    <node id="Gene_PIF">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PIF</data>
      <data key="d7">PIF</data>
    </node>
    <node id="PDF_02_2017_Result_-6753965463531387508">
      <data key="d0">Result</data>
      <data key="d1">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s)</data>
      <data key="d3">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s)</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_L1TD1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">L1TD1</data>
      <data key="d7">L1TD1</data>
    </node>
    <node id="Gene_LINE-1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">LINE-1</data>
      <data key="d7">LINE-1</data>
    </node>
    <node id="PDF_02_2017_Result_-1014798711374166906">
      <data key="d0">Result</data>
      <data key="d1">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
      <data key="d3">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_PIGGYMAC">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PIGGYMAC</data>
      <data key="d7">PiggyMac</data>
    </node>
    <node id="Gene_PGM">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PGM</data>
      <data key="d7">Pgm</data>
    </node>
    <node id="Protein_TPB2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TPB2</data>
      <data key="d7">TPB2</data>
    </node>
    <node id="Protein_TPB1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TPB1</data>
      <data key="d7">TPB1</data>
    </node>
    <node id="Protein_TBP6">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TBP6</data>
      <data key="d7">TBP6</data>
    </node>
    <node id="Protein_LIA5">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">LIA5</data>
      <data key="d7">Lia5</data>
    </node>
    <node id="PDF_02_2017_Result_-7631635505600857314">
      <data key="d0">Result</data>
      <data key="d1">the prp8 protein, which is an integral component of the spliceosomal complex, displays significant sequence similarity with reverse transcriptases and as such has been proposed to derive from an anciently domesticated retroelement</data>
      <data key="d3">the prp8 protein, which is an integral component of the spliceosomal complex, displays significant sequence similarity with reverse transcriptases and as such has been proposed to derive from an anciently domesticated retroelement</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_PRP8">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PRP8</data>
      <data key="d7">prp8</data>
    </node>
    <node id="PDF_02_2017_Result_-5670819990802419644">
      <data key="d0">Result</data>
      <data key="d1">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
      <data key="d3">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
      <data key="d4">PDF_02_2017</data>
    </node>
    <node id="Protein_SYNCYTIN">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SYNCYTIN</data>
      <data key="d7">SYNCYTIN</data>
    </node>
    <node id="PDF_19_2024">
      <data key="d0">Paper</data>
      <data key="d1">nature aging
a
Resource
https://doi.org/10.1038/s43587-023-00552-5
A single-cell atlas of the aging mouse ovary
Received: 12 May 2023
Accepted: 1 December 2023
Published online: 10 January 2024
Check for updates
José V. V. Isola¹8, Sarah R. Ocañas 2,3,4,5,8, Chase R. Hubbart¹, Sunghwan Ko2,3,
Samim Ali Mondal¹, Jessica D. Hense 1,6, Hannah N. C. Carter,
Augusto Schneider, Susan Kovats, José Alberola-Ila,
Willard M. Freeman 2,5 &amp; Michael B. Stout 1,5
Ovarian aging leads to diminished fertility, d</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_19_2024_Result_-2246670777324478465">
      <data key="d0">Result</data>
      <data key="d1">Single-cell RNA sequencing on ovarian tissue from young (3-month-old) and reproductively aged (9-month-old) mice revealed a doubling of immune cells in the aged ovary, with lymphocyte proportions increasing the most, which was confirmed by flow cytometry.</data>
      <data key="d3">Single-cell RNA sequencing on ovarian tissue from young (3-month-old) and reproductively aged (9-month-old) mice revealed a doubling of immune cells in the aged ovary, with lymphocyte proportions increasing the most, which was confirmed by flow cytometry.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_4392848714266283568">
      <data key="d0">Result</data>
      <data key="d1">Age-related downregulation of collagenase pathways in stromal fibroblasts, which corresponds to rises in ovarian fibrosis.</data>
      <data key="d3">Age-related downregulation of collagenase pathways in stromal fibroblasts, which corresponds to rises in ovarian fibrosis.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_3293424466776908951">
      <data key="d0">Result</data>
      <data key="d1">Follicular cells displayed stress-response, immunogenic and fibrotic signaling pathway inductions with aging.</data>
      <data key="d3">Follicular cells displayed stress-response, immunogenic and fibrotic signaling pathway inductions with aging.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_-5852185682534259895">
      <data key="d0">Result</data>
      <data key="d1">The percentage of GCs was lower in 9-month-old ovaries.</data>
      <data key="d3">The percentage of GCs was lower in 9-month-old ovaries.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_-7671793743846407121">
      <data key="d0">Result</data>
      <data key="d1">The most marked change in ovarian cellularity with advancing age was the greater than twofold increase in immune cells.</data>
      <data key="d3">The most marked change in ovarian cellularity with advancing age was the greater than twofold increase in immune cells.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_1695621361997568259">
      <data key="d0">Result</data>
      <data key="d1">Cell types showing the greatest increase with age were lymphoid, including B cells, conventional T cells and innate-like T cells.</data>
      <data key="d3">Cell types showing the greatest increase with age were lymphoid, including B cells, conventional T cells and innate-like T cells.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_-7276153623578830034">
      <data key="d0">Result</data>
      <data key="d1">The percentage of CD4+ T cells was also increased within the aged ovary.</data>
      <data key="d3">The percentage of CD4+ T cells was also increased within the aged ovary.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_19_2024_Result_-8996690323318280995">
      <data key="d0">Result</data>
      <data key="d1">Monocytes that express CD300e, which negatively regulates T cell activation, were identified only in the aged ovaries.</data>
      <data key="d3">Monocytes that express CD300e, which negatively regulates T cell activation, were identified only in the aged ovaries.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="Gene_CD300E">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CD300E</data>
      <data key="d7">CD300e</data>
    </node>
    <node id="PDF_19_2024_Result_-7691746358260924415">
      <data key="d0">Result</data>
      <data key="d1">Observed a higher percentage and number of CD90+ cells (T cells and innate lymphoid cells) in aged ovaries, which aligns with the scRNA-seq findings.</data>
      <data key="d3">Observed a higher percentage and number of CD90+ cells (T cells and innate lymphoid cells) in aged ovaries, which aligns with the scRNA-seq findings.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="Gene_CD90">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CD90</data>
      <data key="d7">CD90</data>
    </node>
    <node id="PDF_19_2024_Result_1481681276088822288">
      <data key="d0">Result</data>
      <data key="d1">Observed an increase in the percentage of CD8+ T cells, 'double-negative αẞ T cells' (DNs), MAIT cells, NKT cells and y8Ts and a decrease in CD4+ αẞ T cells and innate lymphoid cells in aged ovaries.</data>
      <data key="d3">Observed an increase in the percentage of CD8+ T cells, 'double-negative αẞ T cells' (DNs), MAIT cells, NKT cells and y8Ts and a decrease in CD4+ αẞ T cells and innate lymphoid cells in aged ovaries.</data>
      <data key="d4">PDF_19_2024</data>
    </node>
    <node id="PDF_49_2017">
      <data key="d0">Paper</data>
      <data key="d1">QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly,
extensible, open-source solution for digital pathology and whole slide image analysis. In addition to
offering a comprehensive panel of tumor identification and high-throughput biomarker evaluation
tools, QuPath provides researchers with powerful batch-processing and scripting functionality, and an
extensible platform with which to develop and share new algorithms to analyze complex tissue images.
Fur</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_49_2017_Result_1583259639433620737">
      <data key="d0">Result</data>
      <data key="d1">A statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8 (log-rank test, p-values 0.006 and 0.007 respectively; Fig. 2a,b).</data>
      <data key="d3">A statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8 (log-rank test, p-values 0.006 and 0.007 respectively; Fig. 2a,b).</data>
      <data key="d4">PDF_49_2017</data>
    </node>
    <node id="Protein_CD3">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CD3</data>
      <data key="d7">CD3</data>
    </node>
    <node id="Protein_CD8">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CD8</data>
      <data key="d7">CD8</data>
    </node>
    <node id="PDF_49_2017_Result_-2238772983670542827">
      <data key="d0">Result</data>
      <data key="d1">Aberrant p53 expression (diffuse intense or completely absent immunoreactivity) is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression (p=0.003 extreme negative/positive vs. intermediate; Fig. 2c).</data>
      <data key="d3">Aberrant p53 expression (diffuse intense or completely absent immunoreactivity) is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression (p=0.003 extreme negative/positive vs. intermediate; Fig. 2c).</data>
      <data key="d4">PDF_49_2017</data>
    </node>
    <node id="Protein_TP53">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TP53</data>
      <data key="d7">TP53</data>
    </node>
    <node id="Gene_TP53">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TP53</data>
      <data key="d7">TP53</data>
    </node>
    <node id="PDF_49_2017_Result_-2305178240930469589">
      <data key="d0">Result</data>
      <data key="d1">Higher PD-L1 expression to be significantly associated with improved disease-specific survival in unadjusted analysis (p=0.004, Fig. 2d).</data>
      <data key="d3">Higher PD-L1 expression to be significantly associated with improved disease-specific survival in unadjusted analysis (p=0.004, Fig. 2d).</data>
      <data key="d4">PDF_49_2017</data>
    </node>
    <node id="Protein_PD-L1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PD-L1</data>
      <data key="d7">PD-L1</data>
    </node>
    <node id="PDF_49_2017_Result_-7341262223599777269">
      <data key="d0">Result</data>
      <data key="d1">Lower disease-specific survival among patients with a high tumor stromal percentage in unadjusted analysis (p = 0.013; Fig. 2e).</data>
      <data key="d3">Lower disease-specific survival among patients with a high tumor stromal percentage in unadjusted analysis (p = 0.013; Fig. 2e).</data>
      <data key="d4">PDF_49_2017</data>
    </node>
    <node id="PDF_29_2021">
      <data key="d0">Paper</data>
      <data key="d1">LTH &amp; HUMAN SERVICES-US,
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
HHS Public Access
Author manuscript
Nat Genet. Author manuscript; available in PMC 2021 July 18.
Published in final edited form as:
Nat Genet. 2021 February ; 53(2): 185–194. doi:10.1038/s41588-020-00757-z.
Genetics of 35 blood and urine biomarkers in the UK Biobank
Nasa Sinnott- Armstrong1,2,3,*,†, Yosuke Tanigawa4,*,+, David Amar4,5, Nina Mars2, Christian
Benner2, Matthew Aguirre, Guhan Ram Venkata</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_29_2021_Result_-6668271628605658249">
      <data key="d0">Result</data>
      <data key="d1">We identify 1,857 loci associated with at least one trait, containing 3,374 fine-mapped associations, and additional sets of large-effect (&gt; 0.1 sd) protein-altering, HLA, and copy-number variant associations.</data>
      <data key="d3">We identify 1,857 loci associated with at least one trait, containing 3,374 fine-mapped associations, and additional sets of large-effect (&gt; 0.1 sd) protein-altering, HLA, and copy-number variant associations.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="PDF_29_2021_Result_-8618075455610814167">
      <data key="d0">Result</data>
      <data key="d1">Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke.</data>
      <data key="d3">Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Compound_URATE">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">URATE</data>
      <data key="d7">Urate</data>
    </node>
    <node id="Disease_GOUT">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">GOUT</data>
      <data key="d7">Gout</data>
    </node>
    <node id="Protein_CYSTATIN C">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CYSTATIN C</data>
      <data key="d7">Cystatin C</data>
    </node>
    <node id="Disease_STROKE">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">STROKE</data>
      <data key="d7">Stroke</data>
    </node>
    <node id="PDF_29_2021_Result_-101941758172532081">
      <data key="d0">Result</data>
      <data key="d1">develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset relative to single-disease PRSs.</data>
      <data key="d3">develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset relative to single-disease PRSs.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Disease_CHRONIC KIDNEY DISEASE">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">CHRONIC KIDNEY DISEASE</data>
      <data key="d7">Chronic kidney disease</data>
    </node>
    <node id="Disease_TYPE 2 DIABETES">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">TYPE 2 DIABETES</data>
      <data key="d7">Type 2 diabetes</data>
    </node>
    <node id="Disease_ALCOHOLIC CIRRHOSIS">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">ALCOHOLIC CIRRHOSIS</data>
      <data key="d7">Alcoholic cirrhosis</data>
    </node>
    <node id="PDF_29_2021_Result_1248226264167135126">
      <data key="d0">Result</data>
      <data key="d1">We found 58 associations across 28 biomarker traits and allelotypes (Supplementary Table 9).</data>
      <data key="d3">We found 58 associations across 28 biomarker traits and allelotypes (Supplementary Table 9).</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="PDF_29_2021_Result_-1863785578001539891">
      <data key="d0">Result</data>
      <data key="d1">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
      <data key="d3">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Gene_TGFB1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TGFB1</data>
      <data key="d7">TGFB1</data>
    </node>
    <node id="Gene_AXL">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">AXL</data>
      <data key="d7">AXL</data>
    </node>
    <node id="Gene_PFN1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PFN1</data>
      <data key="d7">PFN1</data>
    </node>
    <node id="Gene_GYPC">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GYPC</data>
      <data key="d7">GYPC</data>
    </node>
    <node id="Gene_IL6R">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">IL6R</data>
      <data key="d7">IL6R</data>
    </node>
    <node id="Gene_VEGFA">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">VEGFA</data>
      <data key="d7">VEGFA</data>
    </node>
    <node id="Gene_HFE">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HFE</data>
      <data key="d7">HFE</data>
    </node>
    <node id="Disease_HEMOCHROMATOSIS">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">HEMOCHROMATOSIS</data>
      <data key="d7">Hemochromatosis</data>
    </node>
    <node id="Gene_CD33">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CD33</data>
      <data key="d7">CD33</data>
    </node>
    <node id="Gene_CD36">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CD36</data>
      <data key="d7">CD36</data>
    </node>
    <node id="PDF_29_2021_Result_-789076811375776843">
      <data key="d0">Result</data>
      <data key="d1">We find several heterozygous deletion events, and single-nucleotide variants that we fine-mapped to two main signals: a missense variant in SLCO1B1 (rs34671512, marginal beta = -0.11 sd, p = 1.25 × 10–95) and a non-coding association in an intron of SLCO1B3 (rs11045598, marginal beta = 0.076 sd, p = 1.31 × 10-139).</data>
      <data key="d3">We find several heterozygous deletion events, and single-nucleotide variants that we fine-mapped to two main signals: a missense variant in SLCO1B1 (rs34671512, marginal beta = -0.11 sd, p = 1.25 × 10–95) and a non-coding association in an intron of SLCO1B3 (rs11045598, marginal beta = 0.076 sd, p = 1.31 × 10-139).</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Gene_SLCO1B1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SLCO1B1</data>
      <data key="d7">SLCO1B1</data>
    </node>
    <node id="Gene_SLCO1B3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SLCO1B3</data>
      <data key="d7">SLCO1B3</data>
    </node>
    <node id="PDF_29_2021_Result_-8472704266374613823">
      <data key="d0">Result</data>
      <data key="d1">we discovered two independent fine-mapped variants, rs114303452 (a missense variant with MAF = 1%) and rs59950280 (a non-coding variant with MAF = 34%). These two variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium (Figure 3d). In addition, rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor.</data>
      <data key="d3">we discovered two independent fine-mapped variants, rs114303452 (a missense variant with MAF = 1%) and rs59950280 (a non-coding variant with MAF = 34%). These two variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium (Figure 3d). In addition, rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Protein_IGF-1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">IGF-1</data>
      <data key="d7">IGF-1</data>
    </node>
    <node id="Gene_HGFAC">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HGFAC</data>
      <data key="d7">HGFAC</data>
    </node>
    <node id="Protein_HEPATOCYTE GROWTH FACTOR">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">HEPATOCYTE GROWTH FACTOR</data>
      <data key="d7">Hepatocyte growth factor</data>
    </node>
    <node id="PDF_29_2021_Result_6532212628664238437">
      <data key="d0">Result</data>
      <data key="d1">We found genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports53–54, of ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)55–57, as well as an increasing effect of alanine aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)58,59.</data>
      <data key="d3">We found genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports53–54, of ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)55–57, as well as an increasing effect of alanine aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)58,59.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Protein_SHBG">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SHBG</data>
      <data key="d7">SHBG</data>
    </node>
    <node id="Disease_DIABETES">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">DIABETES</data>
      <data key="d7">Diabetes</data>
    </node>
    <node id="Protein_APOA">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">APOA</data>
      <data key="d7">ApoA</data>
    </node>
    <node id="Protein_ALANINE AMINOTRANSFERASE">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ALANINE AMINOTRANSFERASE</data>
      <data key="d7">Alanine aminotransferase</data>
    </node>
    <node id="PDF_29_2021_Result_236672704149590749">
      <data key="d0">Result</data>
      <data key="d1">There was a consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)60,61.</data>
      <data key="d3">There was a consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)60,61.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="PDF_29_2021_Result_4612942148811822835">
      <data key="d0">Result</data>
      <data key="d1">Finally, both HDL and ApoA were associated with increased risk of age-related macular degeneration62, as was cystatin C63–65.</data>
      <data key="d3">Finally, both HDL and ApoA were associated with increased risk of age-related macular degeneration62, as was cystatin C63–65.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Protein_HDL">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">HDL</data>
      <data key="d7">HDL</data>
    </node>
    <node id="Disease_AGE-RELATED MACULAR DEGENERATION">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">AGE-RELATED MACULAR DEGENERATION</data>
      <data key="d7">Age-related macular degeneration</data>
    </node>
    <node id="PDF_29_2021_Result_-2120443794230431094">
      <data key="d0">Result</data>
      <data key="d1">We estimated a causal protective effect of testosterone on inflammatory bowel disease (0.70 OR/SD, FDR-adjusted p = 3.86×10−3)66,67, and a protective effect of urate on breast cancer risk (0.87 OR/SD, FDR-adjusted p = 0.033)68.</data>
      <data key="d3">We estimated a causal protective effect of testosterone on inflammatory bowel disease (0.70 OR/SD, FDR-adjusted p = 3.86×10−3)66,67, and a protective effect of urate on breast cancer risk (0.87 OR/SD, FDR-adjusted p = 0.033)68.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="Compound_TESTOSTERONE">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">TESTOSTERONE</data>
      <data key="d7">Testosterone</data>
    </node>
    <node id="Disease_INFLAMMATORY BOWEL DISEASE">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">INFLAMMATORY BOWEL DISEASE</data>
      <data key="d7">Inflammatory bowel disease</data>
    </node>
    <node id="Disease_BREAST CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">BREAST CANCER</data>
      <data key="d7">Breast cancer</data>
    </node>
    <node id="PDF_29_2021_Hypothesis_-8359145954004597191">
      <data key="d0">Hypothesis</data>
      <data key="d1">We hypothesized that the 35 biomarker PRSs may improve the prediction of higher-level traits and diseases in combination with the PRS for the trait or disease itself.</data>
      <data key="d3">We hypothesized that the 35 biomarker PRSs may improve the prediction of higher-level traits and diseases in combination with the PRS for the trait or disease itself.</data>
      <data key="d4">PDF_29_2021</data>
    </node>
    <node id="PDF_25_2015">
      <data key="d0">Paper</data>
      <data key="d1">Journal of Virological Methods 225 (2015) 59-63
Contents lists available at ScienceDirect
Journal of Virological Methods
journal homepage: www.elsevier.com/locate/jviromet
Journal of
Virological
Methods
ELSEVIER
Protocol
A protocol for the gentle purification of virus-like
particles produced in plants
Hadrien Peyret*
Department of Biological Chemistry, John Innes Centre, Norwich, UK
CrossMark
Article history:
Received 25 February 2015
Received in revised form 1 September 2015
Accepted 13 Septemb</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_25_2015_Method_-2036723048305678366">
      <data key="d0">Method</data>
      <data key="d1">The method presented here is based on ultracentrifugation and density gradients, with no pelleting or precipitation step.</data>
      <data key="d3">The method presented here is based on ultracentrifugation and density gradients, with no pelleting or precipitation step.</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="PDF_25_2015_Method_-5430434396878724885">
      <data key="d0">Method</data>
      <data key="d1">A protocol for the gentle purification of virus-like particles (VLPs) that have been produced in plants.</data>
      <data key="d3">A protocol for the gentle purification of virus-like particles (VLPs) that have been produced in plants.</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="Process_VIRUS-LIKE PARTICLE">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">VIRUS-LIKE PARTICLE</data>
      <data key="d7">Virus-like particle</data>
    </node>
    <node id="PDF_25_2015_Result_1420458054246977434">
      <data key="d0">Result</data>
      <data key="d1">Blended leaf material forms a thick slurry which is significantly more fluid after filtration over Miracloth.</data>
      <data key="d3">Blended leaf material forms a thick slurry which is significantly more fluid after filtration over Miracloth.</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="PDF_25_2015_Result_-1862653331997825808">
      <data key="d0">Result</data>
      <data key="d1">The double sucrose cushion will always result in a green band of dense impurities forming at the interface between the 25% and 70% sucrose layers</data>
      <data key="d3">The double sucrose cushion will always result in a green band of dense impurities forming at the interface between the 25% and 70% sucrose layers</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="Compound_SUCROSE">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">SUCROSE</data>
      <data key="d7">Sucrose</data>
    </node>
    <node id="PDF_25_2015_Result_-1370368055683610152">
      <data key="d0">Result</data>
      <data key="d1">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
      <data key="d3">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="PDF_25_2015_Result_-477183488283338742">
      <data key="d0">Result</data>
      <data key="d1">the concentrate can be centrifuged to remove some of these impurities, but the Nycodenz gradient will separate them from the VLPs much more efficiently.</data>
      <data key="d3">the concentrate can be centrifuged to remove some of these impurities, but the Nycodenz gradient will separate them from the VLPs much more efficiently.</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="Compound_NYCODENZ">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">NYCODENZ</data>
      <data key="d7">Nycodenz</data>
    </node>
    <node id="PDF_25_2015_Result_-2720929313772291954">
      <data key="d0">Result</data>
      <data key="d1">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
      <data key="d3">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="PDF_25_2015_Conclusion_223876976186484895">
      <data key="d0">Conclusion</data>
      <data key="d1">The protocol described here is suitable for determining whether VLPs are formed after recombinant protein expression in plants.</data>
      <data key="d3">The protocol described here is suitable for determining whether VLPs are formed after recombinant protein expression in plants.</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="PDF_25_2015_Conclusion_424253452703904926">
      <data key="d0">Conclusion</data>
      <data key="d1">This protocol is therefore a powerful tool for testing whether a gene construct directs the formation of VLPs in plants</data>
      <data key="d3">This protocol is therefore a powerful tool for testing whether a gene construct directs the formation of VLPs in plants</data>
      <data key="d4">PDF_25_2015</data>
    </node>
    <node id="PDF_09_2017">
      <data key="d0">Paper</data>
      <data key="d1">www.impactjournals.com/oncotarget/
Oncotarget, 2017, Vol. 8, (No. 57), pp: 96809-96825
Research Paper
Pnma5 is essential to the progression of meiosis in mouse
oocytes through a chain of phosphorylation
Xiao-Lan Zhang¹,*, Peng Liu1*, Zhi-Xia Yang¹*, Jing-Jing Zhao³, Lei-Lei Gao¹, Bo
Yuan, Li-Ya Shi¹, Chun-Xiang Zhou¹, Hai-Feng Qiao5, Ya-Hong Liu, Xiao-Yan
Ying, Jun-Qiang Zhang², Xiu-Feng Ling² and Dong Zhang¹
1State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Ji</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_09_2017_Hypothesis_1393163785014218773">
      <data key="d0">Hypothesis</data>
      <data key="d1">Pnma5 might play important roles in meiosis.</data>
      <data key="d3">Pnma5 might play important roles in meiosis.</data>
      <data key="d4">PDF_09_2017</data>
    </node>
    <node id="Protein_PNMA5">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA5</data>
      <data key="d7">PNMA5</data>
    </node>
    <node id="Process_MEIOSIS">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">MEIOSIS</data>
      <data key="d7">Meiosis</data>
    </node>
    <node id="PDF_09_2017_Result_-5221559463308174901">
      <data key="d0">Result</data>
      <data key="d1">loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
      <data key="d3">loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
      <data key="d4">PDF_09_2017</data>
    </node>
    <node id="PDF_09_2017_Result_-6606755681523707516">
      <data key="d0">Result</data>
      <data key="d1">Pnma5 knockdown caused significantly lower fertilization</data>
      <data key="d3">Pnma5 knockdown caused significantly lower fertilization</data>
      <data key="d4">PDF_09_2017</data>
    </node>
    <node id="PDF_09_2017_Result_7708946650816017519">
      <data key="d0">Result</data>
      <data key="d1">Pnma5 knockdown was found to significantly decrease the stability of spindle microtubules and altered F-actin organization within actin cap regions, cause significantly abnormal mitochondria aggregation and lower ATP concentration</data>
      <data key="d3">Pnma5 knockdown was found to significantly decrease the stability of spindle microtubules and altered F-actin organization within actin cap regions, cause significantly abnormal mitochondria aggregation and lower ATP concentration</data>
      <data key="d4">PDF_09_2017</data>
    </node>
    <node id="PDF_09_2017_Result_2749814980667974658">
      <data key="d0">Result</data>
      <data key="d1">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
      <data key="d3">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
      <data key="d4">PDF_09_2017</data>
    </node>
    <node id="Protein_AKT1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">AKT1</data>
      <data key="d7">AKT1</data>
    </node>
    <node id="Protein_GSK3B">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">GSK3B</data>
      <data key="d7">GSK3B</data>
    </node>
    <node id="Gene_SRC">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SRC</data>
      <data key="d7">Src</data>
    </node>
    <node id="Protein_ERK1/2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ERK1/2</data>
      <data key="d7">ERK1/2</data>
    </node>
    <node id="PDF_09_2017_Conclusion_2201721553397396131">
      <data key="d0">Conclusion</data>
      <data key="d1">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
      <data key="d3">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
      <data key="d4">PDF_09_2017</data>
    </node>
    <node id="PDF_08_2021">
      <data key="d0">Paper</data>
      <data key="d1">Check for updates
Therapeutic Advances in Neurological Disorders
Autoimmune Neurology Special Collection
Review
Paraneoplastic neurological syndromes:
clinical presentations and management
Michelle F. Devine, Naga Kothapalli, Mahmoud Elkhooly and Divyanshu Dubey D
Abstract: We provide an overview of the varied presentations of paraneoplastic neurological
syndromes. We also review the onconeural antibodies and their particular oncological and
neurological associations. Recognition of these syndro</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_08_2021_Result_-7806054370102963390">
      <data key="d0">Result</data>
      <data key="d1">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
      <data key="d3">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_ANNA-1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ANNA-1</data>
      <data key="d7">ANNA-1</data>
    </node>
    <node id="Gene_HU">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HU</data>
      <data key="d7">Hu</data>
    </node>
    <node id="PDF_08_2021_Result_825622307980447196">
      <data key="d0">Result</data>
      <data key="d1">The most common clinical syndrome associated with PCA-1 IgG is paraneoplastic cerebellar degeneration (PCD).</data>
      <data key="d3">The most common clinical syndrome associated with PCA-1 IgG is paraneoplastic cerebellar degeneration (PCD).</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_PCA-1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PCA-1</data>
      <data key="d7">PCA-1</data>
    </node>
    <node id="PDF_08_2021_Result_3339080492896259986">
      <data key="d0">Result</data>
      <data key="d1">CRMP5 IgG has been described in association with paraneoplastic peripheral neuropathy, cranial neuropathy, gastroparesis, encephalitis, cerebellar ataxia, myelopathy, and chorea.</data>
      <data key="d3">CRMP5 IgG has been described in association with paraneoplastic peripheral neuropathy, cranial neuropathy, gastroparesis, encephalitis, cerebellar ataxia, myelopathy, and chorea.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_CRMP5">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CRMP5</data>
      <data key="d7">CRMP5</data>
    </node>
    <node id="PDF_08_2021_Result_7269316006305881669">
      <data key="d0">Result</data>
      <data key="d1">Paraneoplastic limbic and/or diencephalic encephalitis is the typical clinical phenotype associated with Ma2 IgG.</data>
      <data key="d3">Paraneoplastic limbic and/or diencephalic encephalitis is the typical clinical phenotype associated with Ma2 IgG.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_MA2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MA2</data>
      <data key="d7">Ma2</data>
    </node>
    <node id="PDF_08_2021_Result_3414348154684077920">
      <data key="d0">Result</data>
      <data key="d1">Amphiphysin IgG was initially described in women with paraneoplastic stiff person syndrome and breast cancer.</data>
      <data key="d3">Amphiphysin IgG was initially described in women with paraneoplastic stiff person syndrome and breast cancer.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_AMPHIPHYSIN">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">AMPHIPHYSIN</data>
      <data key="d7">Amphiphysin</data>
    </node>
    <node id="PDF_08_2021_Result_8722671742599844941">
      <data key="d0">Result</data>
      <data key="d1">SOX1 antibodies have been described in association with PNS and small-cell cancer, especially Lambert-Eaton myasthenic syndrome (LEMS).</data>
      <data key="d3">SOX1 antibodies have been described in association with PNS and small-cell cancer, especially Lambert-Eaton myasthenic syndrome (LEMS).</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_SOX1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SOX1</data>
      <data key="d7">SOX1</data>
    </node>
    <node id="PDF_08_2021_Result_6825218308017713514">
      <data key="d0">Result</data>
      <data key="d1">KLHL11 is a novel onconeural antibody associated with rhombencephalitis phenotype (brainstem and/or cerebellar involvement) and a few cases of limbic encephalitis with or without rhombencephalitis.</data>
      <data key="d3">KLHL11 is a novel onconeural antibody associated with rhombencephalitis phenotype (brainstem and/or cerebellar involvement) and a few cases of limbic encephalitis with or without rhombencephalitis.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_KLHL11">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">KLHL11</data>
      <data key="d7">KLHL11</data>
    </node>
    <node id="PDF_08_2021_Result_-8953127831898435091">
      <data key="d0">Result</data>
      <data key="d1">PDE10A IgG was recently described among seven patients with PNS, with movement disorders as the predominant presentation.</data>
      <data key="d3">PDE10A IgG was recently described among seven patients with PNS, with movement disorders as the predominant presentation.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_PDE10A">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PDE10A</data>
      <data key="d7">PDE10A</data>
    </node>
    <node id="PDF_08_2021_Result_-5825267102230932480">
      <data key="d0">Result</data>
      <data key="d1">GABA-B-R encephalitis commonly presents with refractory non-convulsive status epilepticus and/or limbic encephalitis.</data>
      <data key="d3">GABA-B-R encephalitis commonly presents with refractory non-convulsive status epilepticus and/or limbic encephalitis.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_GABA-B-R">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">GABA-B-R</data>
      <data key="d7">GABA-B-R</data>
    </node>
    <node id="PDF_08_2021_Result_2162731638846710996">
      <data key="d0">Result</data>
      <data key="d1">mGlur5 autoantibodies have been described in association with Ophelia syndrome which presents with encephalopathy, mood disturbances, and seizures.</data>
      <data key="d3">mGlur5 autoantibodies have been described in association with Ophelia syndrome which presents with encephalopathy, mood disturbances, and seizures.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_MGLUR5">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MGLUR5</data>
      <data key="d7">mGlur5</data>
    </node>
    <node id="PDF_08_2021_Result_-1517347387119099141">
      <data key="d0">Result</data>
      <data key="d1">Limbic encephalitis is a common neurological presentation for AMPA-R IgG-seropositive cases, though phenotypic variability ranges from minimal symptoms to fulminant panencephalitis.</data>
      <data key="d3">Limbic encephalitis is a common neurological presentation for AMPA-R IgG-seropositive cases, though phenotypic variability ranges from minimal symptoms to fulminant panencephalitis.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_AMPA-R">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">AMPA-R</data>
      <data key="d7">AMPA-R</data>
    </node>
    <node id="PDF_08_2021_Result_-38064801075553443">
      <data key="d0">Result</data>
      <data key="d1">NMDA-R encephalitis can be associated with a neoplasm in 20-40% of cases.</data>
      <data key="d3">NMDA-R encephalitis can be associated with a neoplasm in 20-40% of cases.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_NMDA-R">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">NMDA-R</data>
      <data key="d7">NMDA-R</data>
    </node>
    <node id="PDF_08_2021_Result_8950524083492213155">
      <data key="d0">Result</data>
      <data key="d1">CASPR2-IgG is associated with thymomas in about 20% of cases, though other tumors have been reported rarely (melanomas).</data>
      <data key="d3">CASPR2-IgG is associated with thymomas in about 20% of cases, though other tumors have been reported rarely (melanomas).</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_CASPR2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CASPR2</data>
      <data key="d7">CASPR2</data>
    </node>
    <node id="PDF_08_2021_Result_1766543395992789895">
      <data key="d0">Result</data>
      <data key="d1">LGI1-IgG is associated with thymoma in about 5-15% of cases; rare cases of squamous cell lung cancer have also been reported.</data>
      <data key="d3">LGI1-IgG is associated with thymoma in about 5-15% of cases; rare cases of squamous cell lung cancer have also been reported.</data>
      <data key="d4">PDF_08_2021</data>
    </node>
    <node id="Protein_LGI1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">LGI1</data>
      <data key="d7">LGI1</data>
    </node>
    <node id="PDF_41_2007">
      <data key="d0">Paper</data>
      <data key="d1">Inhibition of ubiquitin-mediated degradation
of MOAP-1 by apoptotic stimuli promotes
Bax function in mitochondria
Nai Yang Fu, Sunil K. Sukumaran, and Victor C. Yu*
Institute of Molecular and Cell Biology, 61 Biopolis Drive (Proteos), Singapore 138673
Edited by Xiaodong Wang, University of Texas Southwestern Medical Center,
The multidomain proapoptotic protein Bax of the Bcl-2 family is a
central regulator for controlling the release of apoptogenic factors
from mitochondria. Recent evidence sugg</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_41_2007_Hypothesis_-689113054231307486">
      <data key="d0">Hypothesis</data>
      <data key="d1">Apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
      <data key="d3">Apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Method_5338535536287173866">
      <data key="d0">Method</data>
      <data key="d1">Using a combined immunoprecipitation (IP)/Western blot analysis</data>
      <data key="d3">Using a combined immunoprecipitation (IP)/Western blot analysis</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Method_1032877104525586277">
      <data key="d0">Method</data>
      <data key="d1">real-time PCR</data>
      <data key="d3">real-time PCR</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Method_8309077585871600362">
      <data key="d0">Method</data>
      <data key="d1">pulse-chase analysis</data>
      <data key="d3">pulse-chase analysis</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Method_7431052621562894497">
      <data key="d0">Method</data>
      <data key="d1">RNAi knockdown</data>
      <data key="d3">RNAi knockdown</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Result_9034946831122568883">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 protein levels were rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
      <data key="d3">MOAP-1 protein levels were rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="Protein_TRAIL">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TRAIL</data>
      <data key="d7">TRAIL</data>
    </node>
    <node id="PDF_41_2007_Result_-8785409896595452916">
      <data key="d0">Result</data>
      <data key="d1">the up-regulation of MOAP-1 by DNA-damaging stimuli involves a p53-independent mechanism.</data>
      <data key="d3">the up-regulation of MOAP-1 by DNA-damaging stimuli involves a p53-independent mechanism.</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Result_1496278862152900520">
      <data key="d0">Result</data>
      <data key="d1">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
      <data key="d3">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="Compound_ETOP">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">ETOP</data>
      <data key="d7">ETOP</data>
    </node>
    <node id="PDF_41_2007_Result_3164139135748833122">
      <data key="d0">Result</data>
      <data key="d1">Polyubiquitinated forms of myc-tagged MOAP-1 were readily observed in the transfected cells in the presence of MG132</data>
      <data key="d3">Polyubiquitinated forms of myc-tagged MOAP-1 were readily observed in the transfected cells in the presence of MG132</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="Compound_MG132">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">MG132</data>
      <data key="d7">MG132</data>
    </node>
    <node id="PDF_41_2007_Result_7124440656041761807">
      <data key="d0">Result</data>
      <data key="d1">Higher levels of MOAP-1 promote TRAIL-induced Bax activation.</data>
      <data key="d3">Higher levels of MOAP-1 promote TRAIL-induced Bax activation.</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Result_240844253262632726">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid-mediated Cyto c release</data>
      <data key="d3">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid-mediated Cyto c release</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_41_2007_Conclusion_-2415286575872238197">
      <data key="d0">Conclusion</data>
      <data key="d1">protein stabilization, possibly by inhibition of its degradation, is likely to be a predominant mechanism underlying the up-regulation of MOAP-1 induced by apoptotic stimuli.</data>
      <data key="d3">protein stabilization, possibly by inhibition of its degradation, is likely to be a predominant mechanism underlying the up-regulation of MOAP-1 induced by apoptotic stimuli.</data>
      <data key="d4">PDF_41_2007</data>
    </node>
    <node id="PDF_60_2012">
      <data key="d0">Paper</data>
      <data key="d1">Here is the complete extracted text from the scientific PDF, with all content in English:

**The Journal of Neuroscience, May 9, 2012 32(19):6525-6541.6525**

**Behavioral/Systems/Cognitive**

**Reduced Excitatory Neurotransmission and Mild Autism-Relevant Phenotypes in Adolescent Shank3 Null Mutant Mice**

Mu Yang,¹ Ozlem Bozdagi, Maria Luisa Scattoni,¹ Markus Wöhr,¹ Florence I. Roullet,¹ Adam M. Katz,¹
Danielle N. Abrams,¹ David Kalikhman,¹ Harrison Simon,¹ Leuk Woldeyohannes,¹ James Y. Zhang,</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_60_2012_Result_-6325789410598421256">
      <data key="d0">Result</data>
      <data key="d1">Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice.</data>
      <data key="d3">Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice.</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="Gene_SHANK3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SHANK3</data>
      <data key="d7">Shank3</data>
    </node>
    <node id="PDF_60_2012_Result_7573320034497081939">
      <data key="d0">Result</data>
      <data key="d1">Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task.</data>
      <data key="d3">Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task.</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Result_4221648513671489682">
      <data key="d0">Result</data>
      <data key="d1">Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants.</data>
      <data key="d3">Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants.</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Result_-1118987072125800902">
      <data key="d0">Result</data>
      <data key="d1">Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses.</data>
      <data key="d3">Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses.</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Method_-628012974630234620">
      <data key="d0">Method</data>
      <data key="d1">Mice with mutations in the gene coding for the Shank3 protein were generated at the Mount Sinai School of Medicine as previously described (Bozdagi et al., 2010).</data>
      <data key="d3">Mice with mutations in the gene coding for the Shank3 protein were generated at the Mount Sinai School of Medicine as previously described (Bozdagi et al., 2010).</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Method_2027951336582469118">
      <data key="d0">Method</data>
      <data key="d1">Acute hippocampal slices were prepared from 4- to 6-week-old homozygous, heterozygous, and wild-type littermate mice.</data>
      <data key="d3">Acute hippocampal slices were prepared from 4- to 6-week-old homozygous, heterozygous, and wild-type littermate mice.</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Method_-1581565459935259450">
      <data key="d0">Method</data>
      <data key="d1">Field EPSPs (fEPSPs) were recorded from stratum radiatum in CA1, evoked by stimulation of the Schaffer collaterals every 30 s with 100 μs pulses.</data>
      <data key="d3">Field EPSPs (fEPSPs) were recorded from stratum radiatum in CA1, evoked by stimulation of the Schaffer collaterals every 30 s with 100 μs pulses.</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Method_6756882782261408350">
      <data key="d0">Method</data>
      <data key="d1">LTP was induced with TBS (10 theta bursts of four pulses at 100 Hz, with an interval of 200 ms).</data>
      <data key="d3">LTP was induced with TBS (10 theta bursts of four pulses at 100 Hz, with an interval of 200 ms).</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_60_2012_Method_7392739741379220742">
      <data key="d0">Method</data>
      <data key="d1">Long-term depression (LTD) was induced by a low-frequency stimulation protocol (900 pulses at 1 Hz for 15 min, or by paired-pulse low-frequency stimulation (1 Hz for 15 min; 50 ms interstimulus interval).</data>
      <data key="d3">Long-term depression (LTD) was induced by a low-frequency stimulation protocol (900 pulses at 1 Hz for 15 min, or by paired-pulse low-frequency stimulation (1 Hz for 15 min; 50 ms interstimulus interval).</data>
      <data key="d4">PDF_60_2012</data>
    </node>
    <node id="PDF_11_2021">
      <data key="d0">Paper</data>
      <data key="d1">Received: 31 December 2020 Revised: 18 March 2021 Accepted: 13 April 2021
DOI: 10.1111/jcmm.16594
ORIGINAL ARTICLE
Check for updates
WILEY
Single-cell transcriptome analysis of human oocyte ageing
Lihua Yuan 1,2 | Ping Yin² | Hua Yan² | Xiufang Zhong2 | Chunxia Ren² | Kai Li² |
Boon Chin Heng³ | Wuwen Zhang2 | Guoqing Tong2
3
1Shuguang Clinical Medical College,
Shanghai University of Traditional Chinese
Medicine, Shanghai, China
2Center of Reproductive Medicine,
Shuguang Hospital Affiliated to S</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_11_2021_Result_-5378304781096126423">
      <data key="d0">Result</data>
      <data key="d1">481 differentially expressed genes (DEGs) were identified, including 322 upregulated genes enriched in transcription, ubiquitination, epigenetic regulation, and cellular processes, and 159 downregulated genes enriched in ubiquitination, cell cycle, signalling pathway, and DNA repair.</data>
      <data key="d3">481 differentially expressed genes (DEGs) were identified, including 322 upregulated genes enriched in transcription, ubiquitination, epigenetic regulation, and cellular processes, and 159 downregulated genes enriched in ubiquitination, cell cycle, signalling pathway, and DNA repair.</data>
      <data key="d4">PDF_11_2021</data>
    </node>
    <node id="PDF_11_2021_Result_-5129435826745893698">
      <data key="d0">Result</data>
      <data key="d1">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
      <data key="d3">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
      <data key="d4">PDF_11_2021</data>
    </node>
    <node id="Gene_UBE2C">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBE2C</data>
      <data key="d7">UBE2C</data>
    </node>
    <node id="Gene_UBC">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBC</data>
      <data key="d7">UBC</data>
    </node>
    <node id="Gene_CDC34">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CDC34</data>
      <data key="d7">CDC34</data>
    </node>
    <node id="Gene_UBR1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBR1</data>
      <data key="d7">UBR1</data>
    </node>
    <node id="Gene_KIF11">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">KIF11</data>
      <data key="d7">KIF11</data>
    </node>
    <node id="Gene_ASF1B">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ASF1B</data>
      <data key="d7">ASF1B</data>
    </node>
    <node id="Gene_PRC1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PRC1</data>
      <data key="d7">PRC1</data>
    </node>
    <node id="Gene_ESPL1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ESPL1</data>
      <data key="d7">ESPL1</data>
    </node>
    <node id="Gene_GTSE1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GTSE1</data>
      <data key="d7">GTSE1</data>
    </node>
    <node id="Gene_EXO1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">EXO1</data>
      <data key="d7">EXO1</data>
    </node>
    <node id="Gene_UBA1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBA1</data>
      <data key="d7">UBA1</data>
    </node>
    <node id="Gene_KIF4A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">KIF4A</data>
      <data key="d7">KIF4A</data>
    </node>
    <node id="Gene_UBA52">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBA52</data>
      <data key="d7">UBA52</data>
    </node>
    <node id="Gene_UBE2V2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBE2V2</data>
      <data key="d7">UBE2V2</data>
    </node>
    <node id="Gene_SKP1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SKP1</data>
      <data key="d7">SKP1</data>
    </node>
    <node id="PDF_11_2021_Result_4041609895537003458">
      <data key="d0">Result</data>
      <data key="d1">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
      <data key="d3">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
      <data key="d4">PDF_11_2021</data>
    </node>
    <node id="Process_UBIQUITINATION">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">UBIQUITINATION</data>
      <data key="d7">Ubiquitination</data>
    </node>
    <node id="Process_CELL CYCLE">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">CELL CYCLE</data>
      <data key="d7">Cell cycle</data>
    </node>
    <node id="PDF_11_2021_Conclusion_7055719392448873627">
      <data key="d0">Conclusion</data>
      <data key="d1">UBE2C may play a crucial role in human oocyte ageing.</data>
      <data key="d3">UBE2C may play a crucial role in human oocyte ageing.</data>
      <data key="d4">PDF_11_2021</data>
    </node>
    <node id="PDF_11_2021_Method_-524147421028985117">
      <data key="d0">Method</data>
      <data key="d1">single-cell RNA sequencing from MII human oocytes donated by patients undergoing intracytoplasmic sperm injection.</data>
      <data key="d3">single-cell RNA sequencing from MII human oocytes donated by patients undergoing intracytoplasmic sperm injection.</data>
      <data key="d4">PDF_11_2021</data>
    </node>
    <node id="PDF_50_2022">
      <data key="d0">Paper</data>
      <data key="d1">Here is the complete text from the scientific PDF, as requested:

© 2022. Published by The Company of Biologists Ltd | Journal of Cell Science (2022) 135, jcs259807. doi:10.1242/jcs.259807
The Company of
Biologists
RESEARCH ARTICLE
The prophase oocyte nucleus is a homeostatic G-actin buffer
Kathleen Scheffler¹,*, Federica Giannini¹,*, Tom Lemonnier¹,* and Binyam Mogessie1,2,‡
ABSTRACT
Formation of healthy mammalian eggs from oocytes requires
specialised F-actin structures. F-actin disruption pro</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_50_2022_Result_-8438249765820968018">
      <data key="d0">Result</data>
      <data key="d1">Mammalian oocyte nuclei contain prominent F-actin structures</data>
      <data key="d3">Mammalian oocyte nuclei contain prominent F-actin structures</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Result_-9067956160207902124">
      <data key="d0">Result</data>
      <data key="d1">nuclear F-actin structures are a common feature of healthy, non-manipulated mammalian oocytes</data>
      <data key="d3">nuclear F-actin structures are a common feature of healthy, non-manipulated mammalian oocytes</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="Process_OOCYTE">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">OOCYTE</data>
      <data key="d7">Oocyte</data>
    </node>
    <node id="PDF_50_2022_Result_1689558169658718004">
      <data key="d0">Result</data>
      <data key="d1">Cytoplasmic F-actin disruption induces excessive nuclear F-actin assembly</data>
      <data key="d3">Cytoplasmic F-actin disruption induces excessive nuclear F-actin assembly</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="Compound_CYTOCHALASIN D">
      <data key="d0">Entity</data>
      <data key="d5">Compound</data>
      <data key="d6">CYTOCHALASIN D</data>
      <data key="d7">Cytochalasin D</data>
    </node>
    <node id="PDF_50_2022_Result_-6654145113654609864">
      <data key="d0">Result</data>
      <data key="d1">Excess G-actin causes uncontrolled cytoplasmic and nuclear F-actin assembly</data>
      <data key="d3">Excess G-actin causes uncontrolled cytoplasmic and nuclear F-actin assembly</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Result_3173920965600668476">
      <data key="d0">Result</data>
      <data key="d1">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
      <data key="d3">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Result_-1945302862363437988">
      <data key="d0">Result</data>
      <data key="d1">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
      <data key="d3">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Method_-8785663842181427493">
      <data key="d0">Method</data>
      <data key="d1">cytoskeletal disruption tools with nuclear import inhibition and high-resolution microscopy assays</data>
      <data key="d3">cytoskeletal disruption tools with nuclear import inhibition and high-resolution microscopy assays</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Method_-8645387118691467615">
      <data key="d0">Method</data>
      <data key="d1">fluorescent phalloidin</data>
      <data key="d3">fluorescent phalloidin</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Method_8827718208517569856">
      <data key="d0">Method</data>
      <data key="d1">super-resolution live imaging of nuclear F-actin using fluorescence-labelled actin nanobody</data>
      <data key="d3">super-resolution live imaging of nuclear F-actin using fluorescence-labelled actin nanobody</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Method_-2027175557915624560">
      <data key="d0">Method</data>
      <data key="d1">targeting F-tractin and the calponin homology domain of utrophin to the nucleus</data>
      <data key="d3">targeting F-tractin and the calponin homology domain of utrophin to the nucleus</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="Protein_UTROPHIN">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">UTROPHIN</data>
      <data key="d7">Utrophin</data>
    </node>
    <node id="PDF_50_2022_Method_-4237319117149186885">
      <data key="d0">Method</data>
      <data key="d1">disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment</data>
      <data key="d3">disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Method_3956828076427853317">
      <data key="d0">Method</data>
      <data key="d1">blocking nuclear import by using a combination of Importazole and Ivermectin</data>
      <data key="d3">blocking nuclear import by using a combination of Importazole and Ivermectin</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_50_2022_Method_2914987445334635170">
      <data key="d0">Method</data>
      <data key="d1">visualising chromatin by staining with 5-SiR-Hoechst</data>
      <data key="d3">visualising chromatin by staining with 5-SiR-Hoechst</data>
      <data key="d4">PDF_50_2022</data>
    </node>
    <node id="PDF_20_2018">
      <data key="d0">Paper</data>
      <data key="d1">Cell
Article
Retrovirus-like Gag Protein Arc1 Binds RNA and
Traffics across Synaptic Boutons
James Ashley, Benjamin Cordy,
NMJ
Diandra Lucia, Lee G. Fradkin,
Vivian Budnik, Travis Thomson
extracellular
vesicle
multivesicular
body
dArc1 capsid
Correspondence
vivian.budnik@umassmed.edu (V.B.),
travis.thomson@umassmed.edu (T.T.)
immature
synaptic bouton
postsynaptic maturation
synaptic
vesicle
In Brief
darc1 RNA
The neuronal protein Arc is evolutionarily
related to retrotransposon Gag proteins
and </data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_20_2018_Hypothesis_-2277325410450353680">
      <data key="d0">Hypothesis</data>
      <data key="d1">dArc1 influences synaptic plasticity by utilizing a retroviral-like mechanism for transport between synaptic partners in Drosophila.</data>
      <data key="d3">dArc1 influences synaptic plasticity by utilizing a retroviral-like mechanism for transport between synaptic partners in Drosophila.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="Protein_DARC1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">DARC1</data>
      <data key="d7">dArc1</data>
    </node>
    <node id="PDF_20_2018_Method_-1656248677016132372">
      <data key="d0">Method</data>
      <data key="d1">Downregulation of darc1 in motorneurons using Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
      <data key="d3">Downregulation of darc1 in motorneurons using Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="Gene_DARC1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DARC1</data>
      <data key="d7">dArc1</data>
    </node>
    <node id="PDF_20_2018_Method_-5344327631043359523">
      <data key="d0">Method</data>
      <data key="d1">Blocking EV release from presynaptic boutons using Rab11 dominant-negative (Rab11-DN) specifically in neurons.</data>
      <data key="d3">Blocking EV release from presynaptic boutons using Rab11 dominant-negative (Rab11-DN) specifically in neurons.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Method_480367400685621251">
      <data key="d0">Method</data>
      <data key="d1">Expression of a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
      <data key="d3">Expression of a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Method_-6882647881110000094">
      <data key="d0">Method</data>
      <data key="d1">Expression of darc1-3'UTR alone in neurons fused to GFP.</data>
      <data key="d3">Expression of darc1-3'UTR alone in neurons fused to GFP.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="Protein_GFP">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">GFP</data>
      <data key="d7">GFP</data>
    </node>
    <node id="PDF_20_2018_Method_-644288147001791370">
      <data key="d0">Method</data>
      <data key="d1">Mass-spectrometry-based proteomic analysis of the S2 cell EV fraction.</data>
      <data key="d3">Mass-spectrometry-based proteomic analysis of the S2 cell EV fraction.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_-2797600141949413289">
      <data key="d0">Result</data>
      <data key="d1">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
      <data key="d3">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_-5204513441619088489">
      <data key="d0">Result</data>
      <data key="d1">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in dArc1 protein immunoreactive signal, both in pre- and postsynaptic compartments.</data>
      <data key="d3">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in dArc1 protein immunoreactive signal, both in pre- and postsynaptic compartments.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_-6715708487462895540">
      <data key="d0">Result</data>
      <data key="d1">Expressing dArc1-RNAi with a muscle Gal4 driver, C57-Gal4, did not affect dArc1 RNA nor dArc1 protein levels.</data>
      <data key="d3">Expressing dArc1-RNAi with a muscle Gal4 driver, C57-Gal4, did not affect dArc1 RNA nor dArc1 protein levels.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_7537782149737195130">
      <data key="d0">Result</data>
      <data key="d1">Expression of Rab11 dominant-negative (Rab11-DN) resulted in a highly significant reduction in darc1 RNA and protein in the postsynaptic region.</data>
      <data key="d3">Expression of Rab11 dominant-negative (Rab11-DN) resulted in a highly significant reduction in darc1 RNA and protein in the postsynaptic region.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_-6403490340212377427">
      <data key="d0">Result</data>
      <data key="d1">Expression of Rab11DN in neurons, we observed a decrease in dArc1 levels in both the pre- and postsynaptic compartments.</data>
      <data key="d3">Expression of Rab11DN in neurons, we observed a decrease in dArc1 levels in both the pre- and postsynaptic compartments.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_3083881529455983430">
      <data key="d0">Result</data>
      <data key="d1">The ratio of postsynaptic dArc1 levels relative to presynaptic levels was significantly decreased upon expressing Rab11DN in neurons.</data>
      <data key="d3">The ratio of postsynaptic dArc1 levels relative to presynaptic levels was significantly decreased upon expressing Rab11DN in neurons.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_7408676244789082373">
      <data key="d0">Result</data>
      <data key="d1">Expression of a dArc1 transgene composed of the darc1 ORF, plus the UTR, resulted in the presence of dArc1, not only in presynaptic boutons, but also at the postsynaptic region.</data>
      <data key="d3">Expression of a dArc1 transgene composed of the darc1 ORF, plus the UTR, resulted in the presence of dArc1, not only in presynaptic boutons, but also at the postsynaptic region.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_1163457062016506767">
      <data key="d0">Result</data>
      <data key="d1">Expressing a dArc1 transgene lacking the 3' UTR resulted in accumulation of the dArc1 signal in presynaptic terminals, but virtually no signal was observed at the postsynaptic region.</data>
      <data key="d3">Expressing a dArc1 transgene lacking the 3' UTR resulted in accumulation of the dArc1 signal in presynaptic terminals, but virtually no signal was observed at the postsynaptic region.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_-5762510954293473928">
      <data key="d0">Result</data>
      <data key="d1">Expression of darc1-3'UTR-GFP resulted in the presence of GFP signal in the muscle.</data>
      <data key="d3">Expression of darc1-3'UTR-GFP resulted in the presence of GFP signal in the muscle.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Result_-7911249017561744152">
      <data key="d0">Result</data>
      <data key="d1">Copia mRNA was highly enriched in S2 EVs.</data>
      <data key="d3">Copia mRNA was highly enriched in S2 EVs.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_20_2018_Conclusion_-8716216063639187595">
      <data key="d0">Conclusion</data>
      <data key="d1">darc1 mRNA can be transferred from neurons to postsynaptic muscles in a manner dependent on its 3' UTR.</data>
      <data key="d3">darc1 mRNA can be transferred from neurons to postsynaptic muscles in a manner dependent on its 3' UTR.</data>
      <data key="d4">PDF_20_2018</data>
    </node>
    <node id="PDF_14_2024">
      <data key="d0">Paper</data>
      <data key="d1">nature aging
Resource
a
https://doi.org/10.1038/s43587-024-00762-5
Molecular and genetic insights into
human ovarian aging from single-nuclei
multi-omics analyses
Received: 9 April 2024
Accepted: 25 October 2024
Published online: 22 November 2024
Chen Jin 1,13 Xizhe Wang1,13, Jiping Yang1,13, Seungsoo Kim¹,
Adam D. Hudgins¹, Amir Gamliel², Mingzhuo Pei¹, Daniela Contreras¹,
Melody Devos¹, Qinghua Guo¹, Jan Vijg³, Marco Conti 4,5,6,
Jan Hoeijmakers 7,8,9, Judith Campisi 10,11, Rogerio Lobo¹, Zev </data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_14_2024_Result_698617080513532731">
      <data key="d0">Result</data>
      <data key="d1">Our analyses reveal coordinated changes in transcriptomes and chromatin accessibilities across cell types in the ovary during aging, notably mTOR signaling being a prominent ovary-specific aging pathway.</data>
      <data key="d3">Our analyses reveal coordinated changes in transcriptomes and chromatin accessibilities across cell types in the ovary during aging, notably mTOR signaling being a prominent ovary-specific aging pathway.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="Protein_MTOR">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">MTOR</data>
      <data key="d7">mTOR</data>
    </node>
    <node id="PDF_14_2024_Result_-988406403681697774">
      <data key="d0">Result</data>
      <data key="d1">Cell-type-specific regulatory networks reveal enhanced activity of the transcription factor CEBPD across cell types in the aged ovary.</data>
      <data key="d3">Cell-type-specific regulatory networks reveal enhanced activity of the transcription factor CEBPD across cell types in the aged ovary.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="Gene_CEBPD">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CEBPD</data>
      <data key="d7">CEBPD</data>
    </node>
    <node id="PDF_14_2024_Result_9206975857790275680">
      <data key="d0">Result</data>
      <data key="d1">Integration of our multi-omics data with genetic variants associated with age at natural menopause demonstrates a global impact of functional variants on gene regulatory networks across ovarian cell types.</data>
      <data key="d3">Integration of our multi-omics data with genetic variants associated with age at natural menopause demonstrates a global impact of functional variants on gene regulatory networks across ovarian cell types.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_-4327315747016988718">
      <data key="d0">Result</data>
      <data key="d1">We found significant changes in several cell types during aging. The abundance of granulosa and theca cells, critical components of ovarian follicles, was significantly decreased in aged compared to young ovaries.</data>
      <data key="d3">We found significant changes in several cell types during aging. The abundance of granulosa and theca cells, critical components of ovarian follicles, was significantly decreased in aged compared to young ovaries.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_-8568622846752454557">
      <data key="d0">Result</data>
      <data key="d1">Blood vessel and lymphatic endothelial cells also markedly decreased in proportion in aged ovaries.</data>
      <data key="d3">Blood vessel and lymphatic endothelial cells also markedly decreased in proportion in aged ovaries.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_7866887381660180214">
      <data key="d0">Result</data>
      <data key="d1">Aged epithelial cells exhibited significantly elevated expression of cell-cycle-associated genes, whereas aged granulosa cells, theca cells and endothelial cells showed increased expression of apoptosis-associated genes and/or decreased expression of cell-cycle-associated genes compared to young counterparts</data>
      <data key="d3">Aged epithelial cells exhibited significantly elevated expression of cell-cycle-associated genes, whereas aged granulosa cells, theca cells and endothelial cells showed increased expression of apoptosis-associated genes and/or decreased expression of cell-cycle-associated genes compared to young counterparts</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_1807411026894976387">
      <data key="d0">Result</data>
      <data key="d1">We identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes (Fig. 2c). Among 'common DEGs' differentially expressed in at least four cell types, 218 were upregulated and 182 were downregulated in aged ovaries (Extended Data Fig. 3d). Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
      <data key="d3">We identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes (Fig. 2c). Among 'common DEGs' differentially expressed in at least four cell types, 218 were upregulated and 182 were downregulated in aged ovaries (Extended Data Fig. 3d). Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="Gene_RICTOR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RICTOR</data>
      <data key="d7">RICTOR</data>
    </node>
    <node id="Gene_IGF1R">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">IGF1R</data>
      <data key="d7">IGF1R</data>
    </node>
    <node id="Gene_MAP3K5">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MAP3K5</data>
      <data key="d7">MAP3K5</data>
    </node>
    <node id="Gene_APOE">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">APOE</data>
      <data key="d7">APOE</data>
    </node>
    <node id="PDF_14_2024_Result_8551616417210739611">
      <data key="d0">Result</data>
      <data key="d1">Gene expression in histone modification, cellular senescence and nutrient-sensing signaling pathways, including mTOR and insulin pathways, increased in aged ovaries across cell types.</data>
      <data key="d3">Gene expression in histone modification, cellular senescence and nutrient-sensing signaling pathways, including mTOR and insulin pathways, increased in aged ovaries across cell types.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_-2280256764557005638">
      <data key="d0">Result</data>
      <data key="d1">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
      <data key="d3">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="Gene_MT-ATP6">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MT-ATP6</data>
      <data key="d7">MT-ATP6</data>
    </node>
    <node id="PDF_14_2024_Result_-8640295239952696749">
      <data key="d0">Result</data>
      <data key="d1">Notably, mTOR signaling emerged as an ovary-specific aging-prevalent pathway (Fig. 2j), highlighting its unique and central role in ovarian aging.</data>
      <data key="d3">Notably, mTOR signaling emerged as an ovary-specific aging-prevalent pathway (Fig. 2j), highlighting its unique and central role in ovarian aging.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_-9187319836934874983">
      <data key="d0">Result</data>
      <data key="d1">GO analysis indicated that those genes were predominantly enriched in cytoplasmic translation (Extended Data Fig. 6k), a process centrally regulated by mTOR signaling.</data>
      <data key="d3">GO analysis indicated that those genes were predominantly enriched in cytoplasmic translation (Extended Data Fig. 6k), a process centrally regulated by mTOR signaling.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Result_-8703015156211998918">
      <data key="d0">Result</data>
      <data key="d1">Few ovarian cells expressed CDKN2A (-0.43%), whereas a higher proportion expressed CDKNIA in young (~9.49%) and aged (-15.56%) ovaries (Extended Data Fig. 7a,b). We found significant increases in CDKN1A+ cells with age in several cell types (Fig. 3a). Using in situ hybridization, we observed approximately threefold increases in both the proportion of CDKN1A+ cells and CDKN1A expression in aged ovaries</data>
      <data key="d3">Few ovarian cells expressed CDKN2A (-0.43%), whereas a higher proportion expressed CDKNIA in young (~9.49%) and aged (-15.56%) ovaries (Extended Data Fig. 7a,b). We found significant increases in CDKN1A+ cells with age in several cell types (Fig. 3a). Using in situ hybridization, we observed approximately threefold increases in both the proportion of CDKN1A+ cells and CDKN1A expression in aged ovaries</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="Gene_CDKN2A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CDKN2A</data>
      <data key="d7">CDKN2A</data>
    </node>
    <node id="Gene_CDKN1A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CDKN1A</data>
      <data key="d7">CDKN1A</data>
    </node>
    <node id="PDF_14_2024_Method_-4468557934955342655">
      <data key="d0">Method</data>
      <data key="d1">We performed single-nuclei RNA sequencing (snRNA-seq) and single-nuclei assay for transposase-accessible chromatin using sequencing (snATAC-seq) on the same flash-frozen human ovarian tissues from young (n = 4; ages 23-29 years) and reproductively aged (n = 4; ages 49-54 years) donors, all displaying normal ovarian histology</data>
      <data key="d3">We performed single-nuclei RNA sequencing (snRNA-seq) and single-nuclei assay for transposase-accessible chromatin using sequencing (snATAC-seq) on the same flash-frozen human ovarian tissues from young (n = 4; ages 23-29 years) and reproductively aged (n = 4; ages 49-54 years) donors, all displaying normal ovarian histology</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_14_2024_Conclusion_8678426044594854731">
      <data key="d0">Conclusion</data>
      <data key="d1">In conclusion, our comprehensive analysis reveals the distinct and accelerated nature of ovarian aging, characterized by high transcriptomic coordination and distinct pathway activity changes. Notably, we identify mTOR signaling as a unique factor in ovarian aging, offering potential insights into sex-specific longevity responses.</data>
      <data key="d3">In conclusion, our comprehensive analysis reveals the distinct and accelerated nature of ovarian aging, characterized by high transcriptomic coordination and distinct pathway activity changes. Notably, we identify mTOR signaling as a unique factor in ovarian aging, offering potential insights into sex-specific longevity responses.</data>
      <data key="d4">PDF_14_2024</data>
    </node>
    <node id="PDF_36_2014">
      <data key="d0">Paper</data>
      <data key="d1">INTRODUCTION
It is known that mammalian oocytes spontaneously resume meiosis once extracted from
their follicular environment and are placed in in vitro culture [1]. Despite 35 years of in vitro
fertilization research we still have a limited understanding of the involved processes. In all
mammalian species, in vitro maturation (IVM) of fully-grown oocytes from small follicles
translates into lower embryonic developmental rates compared to in vivo matured counterparts
[2,3]. Human oocytes matured</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_36_2014_Hypothesis_-4581629201792558485">
      <data key="d0">Hypothesis</data>
      <data key="d1">We hypothesized that the cumulus cells transfer mRNAs benefitting oocyte maturation in an orchestrated fashion.</data>
      <data key="d3">We hypothesized that the cumulus cells transfer mRNAs benefitting oocyte maturation in an orchestrated fashion.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Method_-6235652054259386671">
      <data key="d0">Method</data>
      <data key="d1">Oocytes were exposed to [H]-uridine during the first three hours of maturation.</data>
      <data key="d3">Oocytes were exposed to [H]-uridine during the first three hours of maturation.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Method_8353492016227027839">
      <data key="d0">Method</data>
      <data key="d1">RNA-seq libraries preparation and sequencing</data>
      <data key="d3">RNA-seq libraries preparation and sequencing</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Method_-1186184607536260342">
      <data key="d0">Method</data>
      <data key="d1">Sequences were then aligned to the UMD3.1 assembly of the bovine genome using TopHat2 software.</data>
      <data key="d3">Sequences were then aligned to the UMD3.1 assembly of the bovine genome using TopHat2 software.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_701997354051037417">
      <data key="d0">Result</data>
      <data key="d1">Abundant silver deposition was observed in the transcriptionally active nucleus of the cumulus cells, and also within other regions of their cytoplasm including the TZP.</data>
      <data key="d3">Abundant silver deposition was observed in the transcriptionally active nucleus of the cumulus cells, and also within other regions of their cytoplasm including the TZP.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_5618481464386920812">
      <data key="d0">Result</data>
      <data key="d1">Regional analysis of images for silver grain deposition demonstrated a significantly higher localization of signal in the cumulus cells and in TZPs compared to the values obtained in the entire zona pellucida and in the ooplasm.</data>
      <data key="d3">Regional analysis of images for silver grain deposition demonstrated a significantly higher localization of signal in the cumulus cells and in TZPs compared to the values obtained in the entire zona pellucida and in the ooplasm.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_-4290939226307115869">
      <data key="d0">Result</data>
      <data key="d1">Evidence of active transfer of RNA from the cumulus cells to the oocyte was found by comparing signal distribution of labeled nascent RNA within a fully enclosed oocyte to the signal detected in a partially denuded oocyte.</data>
      <data key="d3">Evidence of active transfer of RNA from the cumulus cells to the oocyte was found by comparing signal distribution of labeled nascent RNA within a fully enclosed oocyte to the signal detected in a partially denuded oocyte.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_2825853247146102558">
      <data key="d0">Result</data>
      <data key="d1">None of the cumulus enclosed oocytes showed any trend in regional signal difference whereas of the 11 partially denuded oocytes evaluated, 8 demonstrated a significantly higher RNA signal in the regions of ooplasm proximal to the cumulus cells compared to their distal regions (p &lt; 0.05).</data>
      <data key="d3">None of the cumulus enclosed oocytes showed any trend in regional signal difference whereas of the 11 partially denuded oocytes evaluated, 8 demonstrated a significantly higher RNA signal in the regions of ooplasm proximal to the cumulus cells compared to their distal regions (p &lt; 0.05).</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_8661057302304770805">
      <data key="d0">Result</data>
      <data key="d1">total RNA staining in living COCs was carried out using confocal live-cell imaging and revealed the displacement of RNA granules in TZPs</data>
      <data key="d3">total RNA staining in living COCs was carried out using confocal live-cell imaging and revealed the displacement of RNA granules in TZPs</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_840697272430828145">
      <data key="d0">Result</data>
      <data key="d1">Comparing this list to those found associated with the polyribosomes, 1,226 transcripts intersected.</data>
      <data key="d3">Comparing this list to those found associated with the polyribosomes, 1,226 transcripts intersected.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_-1672728848851353053">
      <data key="d0">Result</data>
      <data key="d1">Gene list analysis showed enrichment for biological processes such as transcript regulation, protein localization, protein transport, and RNA processing</data>
      <data key="d3">Gene list analysis showed enrichment for biological processes such as transcript regulation, protein localization, protein transport, and RNA processing</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_6027862475993588056">
      <data key="d0">Result</data>
      <data key="d1">A second more stringent analysis was done limiting the first list to include only transcripts from the ones identified in the TZPs following a pulse labeling of de novo transcription representing transcripts synthesized in the cumulus cells and sent to the TZPs.</data>
      <data key="d3">A second more stringent analysis was done limiting the first list to include only transcripts from the ones identified in the TZPs following a pulse labeling of de novo transcription representing transcripts synthesized in the cumulus cells and sent to the TZPs.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_-1777460526827516678">
      <data key="d0">Result</data>
      <data key="d1">The genelist was reduced to 63 transcripts that was analyzed and showed enrichment for actin and cytoskeleton related biological processes</data>
      <data key="d3">The genelist was reduced to 63 transcripts that was analyzed and showed enrichment for actin and cytoskeleton related biological processes</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Result_6629279409665764727">
      <data key="d0">Result</data>
      <data key="d1">Oocytes demonstrated an increasing number of RNA bearing TZPs over time, significantly increasing between 0 h, 2 h and 4 h post slaughter and appearing to plateau by 6 h</data>
      <data key="d3">Oocytes demonstrated an increasing number of RNA bearing TZPs over time, significantly increasing between 0 h, 2 h and 4 h post slaughter and appearing to plateau by 6 h</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_36_2014_Conclusion_-2309782612301189427">
      <data key="d0">Conclusion</data>
      <data key="d1">The presented results highlight the additional contribution of the cumulus cells to the oocyte in the form of large cargo transfer. We focused on RNA transfer from the cumulus cells, and its importance for gamete maturation.</data>
      <data key="d3">The presented results highlight the additional contribution of the cumulus cells to the oocyte in the form of large cargo transfer. We focused on RNA transfer from the cumulus cells, and its importance for gamete maturation.</data>
      <data key="d4">PDF_36_2014</data>
    </node>
    <node id="PDF_26_2021">
      <data key="d0">Paper</data>
      <data key="d1">Europe PMC Funders Group
Author Manuscript
Nat Genet. Author manuscript; available in PMC 2022 April 28.
Published in final edited form as:
Nat Genet. 2021 November 01; 53(11): 1527–1533. doi:10.1038/s41588-021-00945-5.
An open approach to systematically prioritize causal variants
and genes at all published human GWAS trait-associated loci
Edward Mountjoy1,2, Ellen M. Schmidt1,2, Miguel Carmona2,3, Jeremy
Schwartzentruber 1,2,3, Gareth Peat2,3, Alfredo Miranda2,3, Luca Fumis2,3, James
Hayhurst2,</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_26_2021_Hypothesis_-2141755271873352750">
      <data key="d0">Hypothesis</data>
      <data key="d1">There is a need for a comprehensive, unbiased, scalable and reproducible approach that leverages all the publicly available data and knowledge to assign genes systematically to published loci across the entire range of phenotypes and diseases.</data>
      <data key="d3">There is a need for a comprehensive, unbiased, scalable and reproducible approach that leverages all the publicly available data and knowledge to assign genes systematically to published loci across the entire range of phenotypes and diseases.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Method_4203238487998385059">
      <data key="d0">Method</data>
      <data key="d1">We integrate information from GWAS, expression and protein quantitative trait loci (eQTL and pQTL) and epigenomics data (e.g. promoter capture Hi-C, DNase hypersensitivity sites).</data>
      <data key="d3">We integrate information from GWAS, expression and protein quantitative trait loci (eQTL and pQTL) and epigenomics data (e.g. promoter capture Hi-C, DNase hypersensitivity sites).</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Method_8826136706996301483">
      <data key="d0">Method</data>
      <data key="d1">We developed a machine learning model trained on a set of 445 curated gold-standard GWAS loci for which we have moderate or strong confidence in the functionally implicated gene.</data>
      <data key="d3">We developed a machine learning model trained on a set of 445 curated gold-standard GWAS loci for which we have moderate or strong confidence in the functionally implicated gene.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Method_3553343200590021148">
      <data key="d0">Method</data>
      <data key="d1">The model integrates the fine-mapping with the functional genomics data, gene distance, and in silico functional predictions to link each locus to its target gene(s).</data>
      <data key="d3">The model integrates the fine-mapping with the functional genomics data, gene distance, and in silico functional predictions to link each locus to its target gene(s).</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Result_2965268241399295019">
      <data key="d0">Result</data>
      <data key="d1">We detected a total of 133,441 sentinel variants, with 53% of these being shared by more than one study (70,860 distinct sentinel variants).</data>
      <data key="d3">We detected a total of 133,441 sentinel variants, with 53% of these being shared by more than one study (70,860 distinct sentinel variants).</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Result_6705156232853208908">
      <data key="d0">Result</data>
      <data key="d1">Single-variant credible sets were 8.5 times more likely to have a moderate or high impact on protein-coding transcripts as predicted by the Ensembl variant effect predictor (VEP)25 compared to variants in credible sets with 2 or more variants (OR = 8.51, P&lt;2.2 × 10-16, Fisher's exact test).</data>
      <data key="d3">Single-variant credible sets were 8.5 times more likely to have a moderate or high impact on protein-coding transcripts as predicted by the Ensembl variant effect predictor (VEP)25 compared to variants in credible sets with 2 or more variants (OR = 8.51, P&lt;2.2 × 10-16, Fisher's exact test).</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Result_7465759539642683672">
      <data key="d0">Result</data>
      <data key="d1">We identified 2,284 single coding variants linking 378 genes to 303 traits.</data>
      <data key="d3">We identified 2,284 single coding variants linking 378 genes to 303 traits.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Result_2283355659124299239">
      <data key="d0">Result</data>
      <data key="d1">missense variant rs35383942, associated with breast cancer20,26, which is a predicted deleterious missense variant (Arg28Gln, CADD = 24.3) in PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3). PHLDA3 is the direct target of TP53 and acts as a tumor suppressor gene through inhibition of AKT1, an oncogene that plays a pivotal role in cell proliferation and survival27.</data>
      <data key="d3">missense variant rs35383942, associated with breast cancer20,26, which is a predicted deleterious missense variant (Arg28Gln, CADD = 24.3) in PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3). PHLDA3 is the direct target of TP53 and acts as a tumor suppressor gene through inhibition of AKT1, an oncogene that plays a pivotal role in cell proliferation and survival27.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="Gene_PHLDA3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PHLDA3</data>
      <data key="d7">PHLDA3</data>
    </node>
    <node id="Gene_AKT1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">AKT1</data>
      <data key="d7">AKT1</data>
    </node>
    <node id="PDF_26_2021_Result_-5112193740278983862">
      <data key="d0">Result</data>
      <data key="d1">GWAS-molecular QTL loci were tested if there was at least 1 variant overlapping in their 95% credible sets, suggesting prior evidence for colocalization</data>
      <data key="d3">GWAS-molecular QTL loci were tested if there was at least 1 variant overlapping in their 95% credible sets, suggesting prior evidence for colocalization</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Result_-1895649761733174660">
      <data key="d0">Result</data>
      <data key="d1">One example is a locus on chromosome 6 that colocalizes with asthma (6_90220794_T_C) and Crohn's disease (6_90263440_C_A), suggesting that the two diseases may share common genetic etiology at this locus.</data>
      <data key="d3">One example is a locus on chromosome 6 that colocalizes with asthma (6_90220794_T_C) and Crohn's disease (6_90263440_C_A), suggesting that the two diseases may share common genetic etiology at this locus.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="Disease_ASTHMA">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">ASTHMA</data>
      <data key="d7">asthma</data>
    </node>
    <node id="Disease_CROHN'S DISEASE">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">CROHN'S DISEASE</data>
      <data key="d7">Crohn's disease</data>
    </node>
    <node id="PDF_26_2021_Result_4625010045828912386">
      <data key="d0">Result</data>
      <data key="d1">missense variant rs34324219 is causal of changes in TCNI RNA and protein expression in whole blood16,18 and also colocalizes (H4 &gt; 0.99) with pernicious anemia, a disorder in which too few red blood cells are produced due to vitamin B12 deficiency. TCNI encodes the protein haptocorrin (also known as Transcobalamin-1), which binds vitamin B12 and is involved in its uptake30.</data>
      <data key="d3">missense variant rs34324219 is causal of changes in TCNI RNA and protein expression in whole blood16,18 and also colocalizes (H4 &gt; 0.99) with pernicious anemia, a disorder in which too few red blood cells are produced due to vitamin B12 deficiency. TCNI encodes the protein haptocorrin (also known as Transcobalamin-1), which binds vitamin B12 and is involved in its uptake30.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="Gene_TCNI">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TCNI</data>
      <data key="d7">TCNI</data>
    </node>
    <node id="Disease_PERNICIOUS ANEMIA">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">PERNICIOUS ANEMIA</data>
      <data key="d7">pernicious anemia</data>
    </node>
    <node id="PDF_26_2021_Result_8225931682651769769">
      <data key="d0">Result</data>
      <data key="d1">splice region variant rs1893592 causes increased expression of UBASH3A in most GTEx tissues, including thyroid. This signal colocalizes (H4 &gt; 0.87) with self-reported treatment using the thyroid hormone sodium levothyroxine.</data>
      <data key="d3">splice region variant rs1893592 causes increased expression of UBASH3A in most GTEx tissues, including thyroid. This signal colocalizes (H4 &gt; 0.87) with self-reported treatment using the thyroid hormone sodium levothyroxine.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="Gene_UBASH3A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">UBASH3A</data>
      <data key="d7">UBASH3A</data>
    </node>
    <node id="PDF_26_2021_Result_-3702318993863419222">
      <data key="d0">Result</data>
      <data key="d1">the synonymous variant rs2228079 is the only credibly causal variant for an eQTL associated with altered ADORA1 expression in whole blood (eQTLGen) and colocalizes with asthma in UK Biobank (H4 &gt; 0.99). ADORA1 encodes a type of adenosine receptor, a class of proteins targeted by an approved drug (Theophylline) for the treatment of asthma.</data>
      <data key="d3">the synonymous variant rs2228079 is the only credibly causal variant for an eQTL associated with altered ADORA1 expression in whole blood (eQTLGen) and colocalizes with asthma in UK Biobank (H4 &gt; 0.99). ADORA1 encodes a type of adenosine receptor, a class of proteins targeted by an approved drug (Theophylline) for the treatment of asthma.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="Gene_ADORA1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ADORA1</data>
      <data key="d7">ADORA1</data>
    </node>
    <node id="PDF_26_2021_Result_1567204159337948278">
      <data key="d0">Result</data>
      <data key="d1">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease32. ADAM15, a disintegrin and metalloproteinase, is strongly upregulated in colon tissues from inflammatory bowel disease patients compared to healthy controls and plays a role in leukocyte trans-migration across epithelial and endothelial barriers as well as the differentiation of regenerative colonic mucosa33.</data>
      <data key="d3">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease32. ADAM15, a disintegrin and metalloproteinase, is strongly upregulated in colon tissues from inflammatory bowel disease patients compared to healthy controls and plays a role in leukocyte trans-migration across epithelial and endothelial barriers as well as the differentiation of regenerative colonic mucosa33.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="Gene_ADAM15">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ADAM15</data>
      <data key="d7">ADAM15</data>
    </node>
    <node id="PDF_26_2021_Result_3416407546144195946">
      <data key="d0">Result</data>
      <data key="d1">Genes prioritized by the model were enriched with OR 7.4, 8.5 and 8.1 (95% CI: (5.7, 9.4), (6.3, 11.3), (5.7, 11.5)) across clinical trial phases ≥2, ≥3 and 4, respectively (Supplementary Table 15).</data>
      <data key="d3">Genes prioritized by the model were enriched with OR 7.4, 8.5 and 8.1 (95% CI: (5.7, 9.4), (6.3, 11.3), (5.7, 11.5)) across clinical trial phases ≥2, ≥3 and 4, respectively (Supplementary Table 15).</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_26_2021_Conclusion_-2741862318158167987">
      <data key="d0">Conclusion</data>
      <data key="d1">The top genes prioritized by the L2G score recover known relationships, including disease-gene pairs with approved drugs, as well as novel disease-drug target associations that suggest potential novel therapeutic targets to pursue.</data>
      <data key="d3">The top genes prioritized by the L2G score recover known relationships, including disease-gene pairs with approved drugs, as well as novel disease-drug target associations that suggest potential novel therapeutic targets to pursue.</data>
      <data key="d4">PDF_26_2021</data>
    </node>
    <node id="PDF_12_2018">
      <data key="d0">Paper</data>
      <data key="d1">Resource
Molecular Cell
Transcriptome Landscape of Human
Folliculogenesis Reveals Oocyte and Granulosa Cell
Interactions
Graphical Abstract
Oocyte
Granulosa cells
Human Ovary Follicle RNA-Seq &amp; Data processing
Primordial Primary Secondary Antral Preovulatory NOTCH3
GJC1
GJA3
GJA1
GJA5
JAG2
KIT
GDF9
KITLG
BMPR2
Interaction
Dynamic gene expression
IGF2, GNRHR2
IGF2R, PRKCA, GFRA1, TSC1
NTRK2, PTEN
mTOR, Neurotrophin
Insulin, GnRH Pathway
Primordial follicle
Primary follicle
Highlights
• RNA-seq of</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_12_2018_Result_7486583060309970973">
      <data key="d0">Result</data>
      <data key="d1">RNA-seq of oocytes and granulosa cells mapped transcriptome and signature genes.</data>
      <data key="d3">RNA-seq of oocytes and granulosa cells mapped transcriptome and signature genes.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_8933350561417510806">
      <data key="d0">Result</data>
      <data key="d1">KEGG/GSEA analysis uncovered pathways involved in primordial follicle activation.</data>
      <data key="d3">KEGG/GSEA analysis uncovered pathways involved in primordial follicle activation.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_-6140916622838638125">
      <data key="d0">Result</data>
      <data key="d1">Oocyte-granulosa cell interactions exhibit stage- and species-specific patterns.</data>
      <data key="d3">Oocyte-granulosa cell interactions exhibit stage- and species-specific patterns.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_-4703424313083051490">
      <data key="d0">Result</data>
      <data key="d1">RNA-seq analysis identified candidate secretory biomarkers of ovarian reserve.</data>
      <data key="d3">RNA-seq analysis identified candidate secretory biomarkers of ovarian reserve.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Method_-2021815697879481789">
      <data key="d0">Method</data>
      <data key="d1">single-cell RNA-seq analysis was used to investigate the transcriptomic profiles from both the oocyte and somatic follicular compartments during folliculogenesis.</data>
      <data key="d3">single-cell RNA-seq analysis was used to investigate the transcriptomic profiles from both the oocyte and somatic follicular compartments during folliculogenesis.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_-2939370240858087120">
      <data key="d0">Result</data>
      <data key="d1">Unique features in transcriptional machinery, transcription factor networks, and reciprocal interactions in human oocytes and GCs that displayed developmental-stage-specific expression patterns were revealed using RNA sequencing (RNA-seq) analysis of human oocytes and corresponding granulosa cells (GCs) spanning five follicular stages.</data>
      <data key="d3">Unique features in transcriptional machinery, transcription factor networks, and reciprocal interactions in human oocytes and GCs that displayed developmental-stage-specific expression patterns were revealed using RNA sequencing (RNA-seq) analysis of human oocytes and corresponding granulosa cells (GCs) spanning five follicular stages.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_-788479294020660724">
      <data key="d0">Result</data>
      <data key="d1">Specific gene signatures of two cell types in particular developmental stage that may reflect developmental competency and ovarian reserve were identified.</data>
      <data key="d3">Specific gene signatures of two cell types in particular developmental stage that may reflect developmental competency and ovarian reserve were identified.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_-3702855254991307585">
      <data key="d0">Result</data>
      <data key="d1">Key pathways that may concert germline-somatic interactions and drive the transition of primordial-to-primary follicle, which represents follicle activation were uncovered.</data>
      <data key="d3">Key pathways that may concert germline-somatic interactions and drive the transition of primordial-to-primary follicle, which represents follicle activation were uncovered.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_12_2018_Result_-3203383090689864948">
      <data key="d0">Result</data>
      <data key="d1">The expression levels of ZP2, ZP3, and ZP4 remained stable across all stages.</data>
      <data key="d3">The expression levels of ZP2, ZP3, and ZP4 remained stable across all stages.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_ZP2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZP2</data>
      <data key="d7">ZP2</data>
    </node>
    <node id="Gene_ZP3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZP3</data>
      <data key="d7">ZP3</data>
    </node>
    <node id="Gene_ZP4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZP4</data>
      <data key="d7">ZP4</data>
    </node>
    <node id="PDF_12_2018_Result_-6971313324989892593">
      <data key="d0">Result</data>
      <data key="d1">NANOG and POU5F1 were under-expressed in most stages in oocytes.</data>
      <data key="d3">NANOG and POU5F1 were under-expressed in most stages in oocytes.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_NANOG">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NANOG</data>
      <data key="d7">NANOG</data>
    </node>
    <node id="Gene_POU5F1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">POU5F1</data>
      <data key="d7">POU5F1</data>
    </node>
    <node id="PDF_12_2018_Result_-81438276525384463">
      <data key="d0">Result</data>
      <data key="d1">DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation.</data>
      <data key="d3">DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_DNMT1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DNMT1</data>
      <data key="d7">DNMT1</data>
    </node>
    <node id="Gene_DNMT3A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DNMT3A</data>
      <data key="d7">DNMT3A</data>
    </node>
    <node id="Gene_DNMT3B">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">DNMT3B</data>
      <data key="d7">DNMT3B</data>
    </node>
    <node id="PDF_12_2018_Result_-7407277092437647686">
      <data key="d0">Result</data>
      <data key="d1">ten-eleven translocation (TET) family genes were under-expressed in oocytes at all stages of follicular development</data>
      <data key="d3">ten-eleven translocation (TET) family genes were under-expressed in oocytes at all stages of follicular development</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_TET">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TET</data>
      <data key="d7">TET</data>
    </node>
    <node id="PDF_12_2018_Result_944240677981491619">
      <data key="d0">Result</data>
      <data key="d1">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregulated in the antral follicles, with a peak expression level in the pre-ovulatory follicles.</data>
      <data key="d3">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregulated in the antral follicles, with a peak expression level in the pre-ovulatory follicles.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_CYP11A1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP11A1</data>
      <data key="d7">CYP11A1</data>
    </node>
    <node id="Gene_CYP19A1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP19A1</data>
      <data key="d7">CYP19A1</data>
    </node>
    <node id="Gene_HSD17B1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HSD17B1</data>
      <data key="d7">HSD17B1</data>
    </node>
    <node id="Gene_HSD3B2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">HSD3B2</data>
      <data key="d7">HSD3B2</data>
    </node>
    <node id="PDF_12_2018_Result_-2160727510158328070">
      <data key="d0">Result</data>
      <data key="d1">NR5A1, a key regulator of the steroidogenic enzyme-encoding genes exhibited an upregulation with the progression of follicular growth.</data>
      <data key="d3">NR5A1, a key regulator of the steroidogenic enzyme-encoding genes exhibited an upregulation with the progression of follicular growth.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_NR5A1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NR5A1</data>
      <data key="d7">NR5A1</data>
    </node>
    <node id="PDF_12_2018_Result_-6172522668642341516">
      <data key="d0">Result</data>
      <data key="d1">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
      <data key="d3">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_AR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">AR</data>
      <data key="d7">AR</data>
    </node>
    <node id="Gene_ESR1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ESR1</data>
      <data key="d7">ESR1</data>
    </node>
    <node id="Gene_ESR2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ESR2</data>
      <data key="d7">ESR2</data>
    </node>
    <node id="Gene_PGR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PGR</data>
      <data key="d7">PGR</data>
    </node>
    <node id="PDF_12_2018_Result_-4039650709046783173">
      <data key="d0">Result</data>
      <data key="d1">The distinct stage-specific expression patterns of NTF4 and LCP2 in oocytes were further confirmed by the IHC staining, showing that these genes were preferentially expressed in the oocyte of antral stage.</data>
      <data key="d3">The distinct stage-specific expression patterns of NTF4 and LCP2 in oocytes were further confirmed by the IHC staining, showing that these genes were preferentially expressed in the oocyte of antral stage.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="Gene_NTF4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NTF4</data>
      <data key="d7">NTF4</data>
    </node>
    <node id="Gene_LCP2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">LCP2</data>
      <data key="d7">LCP2</data>
    </node>
    <node id="PDF_12_2018_Result_-5315904747595834147">
      <data key="d0">Result</data>
      <data key="d1">NTF4 was proposed to facilitate follicular development by inducing FSH receptor (Fshr) in mouse.</data>
      <data key="d3">NTF4 was proposed to facilitate follicular development by inducing FSH receptor (Fshr) in mouse.</data>
      <data key="d4">PDF_12_2018</data>
    </node>
    <node id="PDF_10_2013">
      <data key="d0">Paper</data>
      <data key="d1">Cell Reports
Resource
Cellular Source and Mechanisms
of High Transcriptome Complexity
in the Mammalian Testis
Magali Soumillon,1,2,9,10,* Anamaria Necsulea, 1,2,11 Manuela Weier,¹ David Brawand, 1,2 Xiaolan Zhang, Hongcang Gu, 3
Pauline Barthès, 4 Maria Kokkinaki, 5 Serge Nef, Andreas Gnirke, Martin Dym,5 Bernard de Massy, 4
Tarjei S. Mikkelsen, 3,7,8 and Henrik Kaessmann1,2,*
1Center for Integrative Genomics, University of Lausanne
2Swiss Institute of Bioinformatics
Génopode, CH-1015, Lausanne,</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_10_2013_Result_-1885943170887345517">
      <data key="d0">Result</data>
      <data key="d1">Transcription of the genome is substantially more widespread in the testis than in other organs across representative mammals.</data>
      <data key="d3">Transcription of the genome is substantially more widespread in the testis than in other organs across representative mammals.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="Process_TESTIS">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">TESTIS</data>
      <data key="d7">Testis</data>
    </node>
    <node id="PDF_10_2013_Result_7725767464489587165">
      <data key="d0">Result</data>
      <data key="d1">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
      <data key="d3">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="Process_SPERMATOCYTES">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">SPERMATOCYTES</data>
      <data key="d7">Spermatocytes</data>
    </node>
    <node id="Process_SPERMATID">
      <data key="d0">Entity</data>
      <data key="d5">Process</data>
      <data key="d6">SPERMATID</data>
      <data key="d7">Spermatid</data>
    </node>
    <node id="PDF_10_2013_Result_-4192911723484206628">
      <data key="d0">Result</data>
      <data key="d1">The widespread transcriptional activity in spermatocytes and spermatids encompasses protein-coding and long noncoding RNA genes but also poorly conserved intergenic sequences.</data>
      <data key="d3">The widespread transcriptional activity in spermatocytes and spermatids encompasses protein-coding and long noncoding RNA genes but also poorly conserved intergenic sequences.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_-8153798442757081942">
      <data key="d0">Result</data>
      <data key="d1">Transcription of duplicated genes is facilitated in spermatocytes and spermatids.</data>
      <data key="d3">Transcription of duplicated genes is facilitated in spermatocytes and spermatids.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_-8494411155176871299">
      <data key="d0">Result</data>
      <data key="d1">Retrocopies with truncated open reading frames are transcribed at significantly higher levels in spermatids than in the other tissues.</data>
      <data key="d3">Retrocopies with truncated open reading frames are transcribed at significantly higher levels in spermatids than in the other tissues.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_-255612553421251552">
      <data key="d0">Result</data>
      <data key="d1">Functional retrocopies show a striking upregulation in both spermatids and spermatocytes.</data>
      <data key="d3">Functional retrocopies show a striking upregulation in both spermatids and spermatocytes.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_-6139091716181816132">
      <data key="d0">Result</data>
      <data key="d1">Analyses revealed reduced expression levels of protein-coding genes on the X chromosome in spermatocytes and spermatids, consistent with the action of meiotic sex chromosome inactivation (MSCI).</data>
      <data key="d3">Analyses revealed reduced expression levels of protein-coding genes on the X chromosome in spermatocytes and spermatids, consistent with the action of meiotic sex chromosome inactivation (MSCI).</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_-7874717298818535336">
      <data key="d0">Result</data>
      <data key="d1">Spermatid-specific genes are highly enriched among recent X-linked genes.</data>
      <data key="d3">Spermatid-specific genes are highly enriched among recent X-linked genes.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_-4414499184920452212">
      <data key="d0">Result</data>
      <data key="d1">Transcribed intergenic sequences tend to be closer to the 3' end of genes in somatic tissues than in testis and meiotic/postmeiotic germ cells.</data>
      <data key="d3">Transcribed intergenic sequences tend to be closer to the 3' end of genes in somatic tissues than in testis and meiotic/postmeiotic germ cells.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_5215376643377076169">
      <data key="d0">Result</data>
      <data key="d1">Potentially functional IncRNAs, retrogenes, and pseudogenes also show significantly lower promoter CpG methylation levels in the germline (in particular in spermatids) than in brain and liver</data>
      <data key="d3">Potentially functional IncRNAs, retrogenes, and pseudogenes also show significantly lower promoter CpG methylation levels in the germline (in particular in spermatids) than in brain and liver</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Result_4759294671080592958">
      <data key="d0">Result</data>
      <data key="d1">High Levels of H3K4me2 Suggest an Overall Open Chromatin State in Spermatocytes and Spermatids</data>
      <data key="d3">High Levels of H3K4me2 Suggest an Overall Open Chromatin State in Spermatocytes and Spermatids</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Conclusion_-3876279374405834021">
      <data key="d0">Conclusion</data>
      <data key="d1">Promiscuous transcriptional activity in the testis is common to amniotes.</data>
      <data key="d3">Promiscuous transcriptional activity in the testis is common to amniotes.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_10_2013_Conclusion_1181494436016370092">
      <data key="d0">Conclusion</data>
      <data key="d1">High transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
      <data key="d3">High transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
      <data key="d4">PDF_10_2013</data>
    </node>
    <node id="PDF_52_2013">
      <data key="d0">Paper</data>
      <data key="d1">SHORT COMMUNICATION
Proteins
STRUCTURE FUNCTION BIOINFORMATICS
Optimized E. coli expression strain LOBSTR
eliminates common contaminants from
His-tag purification
Kasper R. Andersen, Nina C. Leksa, and Thomas U. Schwartz*
Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139
ABSTRACT
His-tag affinity purification is one of the most commonly used methods to purify recombinant proteins expressed in E. coli.
One drawback of using the H</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_52_2013_Hypothesis_-5734895547226781640">
      <data key="d0">Hypothesis</data>
      <data key="d1">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering.</data>
      <data key="d3">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="Protein_E. COLI">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">E. COLI</data>
      <data key="d7">E. coli</data>
    </node>
    <node id="Protein_ARNA">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ARNA</data>
      <data key="d7">ArnA</data>
    </node>
    <node id="Protein_SLYD">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SLYD</data>
      <data key="d7">SlyD</data>
    </node>
    <node id="PDF_52_2013_Method_6159908519209120681">
      <data key="d0">Method</data>
      <data key="d1">Wild-type arnA was PCR amplified from E. coli genomic DNA with Ndel and Xhol restriction site overhangs on the 5' and 3' ends, respectively, using primers 1F and 1R, and cloned into the bacterial expression vector pColaDuet.</data>
      <data key="d3">Wild-type arnA was PCR amplified from E. coli genomic DNA with Ndel and Xhol restriction site overhangs on the 5' and 3' ends, respectively, using primers 1F and 1R, and cloned into the bacterial expression vector pColaDuet.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="Gene_ARNA">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ARNA</data>
      <data key="d7">ArnA</data>
    </node>
    <node id="PDF_52_2013_Method_-1679159450622589730">
      <data key="d0">Method</data>
      <data key="d1">Two serine point mutations were introduced at site 1 (H359S and H361S) using primers 2F and 2R. Two additional serine point mutations were introduced at site 2 (H592S and H593S) using primers 3F and 3R to generate the final arnA mutant containing a total of four histidine to serine mutations.</data>
      <data key="d3">Two serine point mutations were introduced at site 1 (H359S and H361S) using primers 2F and 2R. Two additional serine point mutations were introduced at site 2 (H592S and H593S) using primers 3F and 3R to generate the final arnA mutant containing a total of four histidine to serine mutations.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Method_4914478715813577696">
      <data key="d0">Method</data>
      <data key="d1">For the modification in slyD, the arnA mutant strain was transformed with a PCR product (generated using primers 5F and 5R) containing a selectable marker flanked by homologous overhangs that, after recombination, result in the elimination of the 46-residue C-terminal, histidine-rich segment of SlyD.</data>
      <data key="d3">For the modification in slyD, the arnA mutant strain was transformed with a PCR product (generated using primers 5F and 5R) containing a selectable marker flanked by homologous overhangs that, after recombination, result in the elimination of the 46-residue C-terminal, histidine-rich segment of SlyD.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="Gene_SLYD">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SLYD</data>
      <data key="d7">SlyD</data>
    </node>
    <node id="PDF_52_2013_Method_-5706840038920429083">
      <data key="d0">Method</data>
      <data key="d1">The binding affinity of wild-type and mutant ArnA were assessed by immobilizing purified protein onto a 1 ml His-Trap FF column (GE Healthcare) equilibrated in 50 mM potassium phosphate pH 8.0, 300 mM NaCl, and 5 mM beta-mercaptoethanol. Protein was eluted with a linear gradient of 0-150 mM imidazole. The imidazole concentration at the elution peak of each protein was recorded and compared.</data>
      <data key="d3">The binding affinity of wild-type and mutant ArnA were assessed by immobilizing purified protein onto a 1 ml His-Trap FF column (GE Healthcare) equilibrated in 50 mM potassium phosphate pH 8.0, 300 mM NaCl, and 5 mM beta-mercaptoethanol. Protein was eluted with a linear gradient of 0-150 mM imidazole. The imidazole concentration at the elution peak of each protein was recorded and compared.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Method_6168529183989123255">
      <data key="d0">Method</data>
      <data key="d1">To test protein purification, BL21(DE3) and LOBSTR cultures were started at 37°C in LB medium supplemented with 0.4% (w/v) glucose and appropriate antibiotic selection. At OD600 ~0.7, cultures were shifted to 18°C and induced with 0.2 mM IPTG ~20 min later.</data>
      <data key="d3">To test protein purification, BL21(DE3) and LOBSTR cultures were started at 37°C in LB medium supplemented with 0.4% (w/v) glucose and appropriate antibiotic selection. At OD600 ~0.7, cultures were shifted to 18°C and induced with 0.2 mM IPTG ~20 min later.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Result_4850446997388966157">
      <data key="d0">Result</data>
      <data key="d1">Wild-type ArnA eluted at a concentration of ~60 mM imidazole, while mutant ArnA showed significantly weaker binding affinity, eluting at ~30 mM imidazole (Supporting Information Fig. S3).</data>
      <data key="d3">Wild-type ArnA eluted at a concentration of ~60 mM imidazole, while mutant ArnA showed significantly weaker binding affinity, eluting at ~30 mM imidazole (Supporting Information Fig. S3).</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Result_2225262699681295805">
      <data key="d0">Result</data>
      <data key="d1">No significant difference in growth rate at any of the induction temperatures was observed between LOBSTR and BL21(DE3), and the final OD600 of the cultures after overnight induction were very similar (Fig. 1).</data>
      <data key="d3">No significant difference in growth rate at any of the induction temperatures was observed between LOBSTR and BL21(DE3), and the final OD600 of the cultures after overnight induction were very similar (Fig. 1).</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Result_-8681156170595938174">
      <data key="d0">Result</data>
      <data key="d1">In the BL21(DE3) strain background, high levels of contamination by both ArnA and SlyD can be seen in the elutions (Fig. 2).</data>
      <data key="d3">In the BL21(DE3) strain background, high levels of contamination by both ArnA and SlyD can be seen in the elutions (Fig. 2).</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Conclusion_8110779714584621644">
      <data key="d0">Conclusion</data>
      <data key="d1">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
      <data key="d3">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_52_2013_Conclusion_-8661795774046833844">
      <data key="d0">Conclusion</data>
      <data key="d1">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
      <data key="d3">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
      <data key="d4">PDF_52_2013</data>
    </node>
    <node id="PDF_38_2024">
      <data key="d0">Paper</data>
      <data key="d1">bioRxiv preprint doi: https://doi.org/10.1101/2024.03.11.584343; this version posted March 13, 2024. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is
made available under aCC-BY-NC-ND 4.0 International license.
1 Rejuvenation of aged oocyte through exposure to young follicular microenvironment
2
3
4
5
HaiYang Wang¹*, Zhongwei Huang2,3,4, Yaelim Lee¹, XinJie Song¹, X</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_38_2024_Hypothesis_-223572616346477788">
      <data key="d0">Hypothesis</data>
      <data key="d1">Follicular somatic cell aging compromises the quality and developmental competence of oocytes</data>
      <data key="d3">Follicular somatic cell aging compromises the quality and developmental competence of oocytes</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Method_-4401955429965563503">
      <data key="d0">Method</data>
      <data key="d1">transplanted young oocytes into aged r-follicles (the resulting RCFs are designated YA) or young r-follicles (YY) as a control</data>
      <data key="d3">transplanted young oocytes into aged r-follicles (the resulting RCFs are designated YA) or young r-follicles (YY) as a control</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_4306185755151122737">
      <data key="d0">Result</data>
      <data key="d1">Culturing in aged r-follicles significantly reduced the meiotic maturation of young oocytes</data>
      <data key="d3">Culturing in aged r-follicles significantly reduced the meiotic maturation of young oocytes</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_4378009987062824907">
      <data key="d0">Result</data>
      <data key="d1">increased incidence of aberrant meiotic spindle and/or misaligned chromosomes in oocytes from YA RCFs compared to those from YY RCFs or unperturbed (not subjected to RCF manipulation) young follicles (Y)</data>
      <data key="d3">increased incidence of aberrant meiotic spindle and/or misaligned chromosomes in oocytes from YA RCFs compared to those from YY RCFs or unperturbed (not subjected to RCF manipulation) young follicles (Y)</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_3224092205729395042">
      <data key="d0">Result</data>
      <data key="d1">YA RCFs-derived oocytes manifested elevated ROS and declined mitochondrial AΨm compared to those from Y or from YY RCFs</data>
      <data key="d3">YA RCFs-derived oocytes manifested elevated ROS and declined mitochondrial AΨm compared to those from Y or from YY RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_-489932016778249674">
      <data key="d0">Result</data>
      <data key="d1">oocytes from YA RCFs exhibited reduced frequency of blastocyst formation compared to those from Y or YY RCFs, indicating an impaired developmental potential of those young oocytes exposed to an aged follicular environment</data>
      <data key="d3">oocytes from YA RCFs exhibited reduced frequency of blastocyst formation compared to those from Y or YY RCFs, indicating an impaired developmental potential of those young oocytes exposed to an aged follicular environment</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Hypothesis_-8517930215337802133">
      <data key="d0">Hypothesis</data>
      <data key="d1">exposure to the young follicular environment could reduce defects of aged oocytes</data>
      <data key="d3">exposure to the young follicular environment could reduce defects of aged oocytes</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Method_4376635027615082468">
      <data key="d0">Method</data>
      <data key="d1">transplanting them into young r-follicles (AY) or, as a direct control, aged r-follicles (AA)</data>
      <data key="d3">transplanting them into young r-follicles (AY) or, as a direct control, aged r-follicles (AA)</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_7299610866587252928">
      <data key="d0">Result</data>
      <data key="d1">Culturing in young r-follicles significantly reduced the death rate and restored meiotic maturation of aged oocytes to a level similar to young oocytes YY RCFs</data>
      <data key="d3">Culturing in young r-follicles significantly reduced the death rate and restored meiotic maturation of aged oocytes to a level similar to young oocytes YY RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_6561237049069652966">
      <data key="d0">Result</data>
      <data key="d1">the occurrence of aberrant spindle and chromosome misalignment were significantly reduced in oocytes from AY, compared to AA, RCFs</data>
      <data key="d3">the occurrence of aberrant spindle and chromosome misalignment were significantly reduced in oocytes from AY, compared to AA, RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_8073478051405116997">
      <data key="d0">Result</data>
      <data key="d1">AY RCFs significantly improved the rate of blastocyst formation of aged oocytes</data>
      <data key="d3">AY RCFs significantly improved the rate of blastocyst formation of aged oocytes</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_-6518587417760608308">
      <data key="d0">Result</data>
      <data key="d1">The size and total cell number of blastocysts developed from AY RCFs were also significantly increased compared to those from AA RCFs</data>
      <data key="d3">The size and total cell number of blastocysts developed from AY RCFs were also significantly increased compared to those from AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_4162469824736645289">
      <data key="d0">Result</data>
      <data key="d1">oocytes from AY RCFs produced a significantly higher (~3.5x higher) rate of live birth than those from AA RCFs or aged intact follicles (A)</data>
      <data key="d3">oocytes from AY RCFs produced a significantly higher (~3.5x higher) rate of live birth than those from AA RCFs or aged intact follicles (A)</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Conclusion_-7381205409386493005">
      <data key="d0">Conclusion</data>
      <data key="d1">the young follicular environment can partially restore the quality and developmental competence of aged oocytes</data>
      <data key="d3">the young follicular environment can partially restore the quality and developmental competence of aged oocytes</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Hypothesis_5889087032916649007">
      <data key="d0">Hypothesis</data>
      <data key="d1">the improved oocyte quality in AY RCFs may be associated with improved TZP formation</data>
      <data key="d3">the improved oocyte quality in AY RCFs may be associated with improved TZP formation</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Method_-462396753919817674">
      <data key="d0">Method</data>
      <data key="d1">Examined gap junctional communication between the oocyte and granulosa cells by implanting a unlabeled, wild-type oocyte into r-follicles pre-incubated with Calcein AM, a gap-junction-permeable fluorescent dye</data>
      <data key="d3">Examined gap junctional communication between the oocyte and granulosa cells by implanting a unlabeled, wild-type oocyte into r-follicles pre-incubated with Calcein AM, a gap-junction-permeable fluorescent dye</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_7449037887177630701">
      <data key="d0">Result</data>
      <data key="d1">AY RCFs formed a greater number of TZPs per unit length of the oocyte periphery than AA RCFs or aged intact follicles (A)</data>
      <data key="d3">AY RCFs formed a greater number of TZPs per unit length of the oocyte periphery than AA RCFs or aged intact follicles (A)</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_2955274227378749766">
      <data key="d0">Result</data>
      <data key="d1">the metabolic profile of oocytes from AY RCFs partially separated from that of oocytes from AA RCFs, suggesting metabolic remodelling of aged oocytes by the young r-follicles</data>
      <data key="d3">the metabolic profile of oocytes from AY RCFs partially separated from that of oocytes from AA RCFs, suggesting metabolic remodelling of aged oocytes by the young r-follicles</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_-6339374513486062175">
      <data key="d0">Result</data>
      <data key="d1">the transcriptomic landscape of aged oocytes from AY RCF resembled more closely that of young oocytes from YY RCFs than that of aged oocytes from AA RCFs</data>
      <data key="d3">the transcriptomic landscape of aged oocytes from AY RCF resembled more closely that of young oocytes from YY RCFs than that of aged oocytes from AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_895454001165733164">
      <data key="d0">Result</data>
      <data key="d1">the AY RCFs potentially restored several affected pathways in aged oocytes, such as the estrogen signalling, Ras signalling, and nucleotide excision repair</data>
      <data key="d3">the AY RCFs potentially restored several affected pathways in aged oocytes, such as the estrogen signalling, Ras signalling, and nucleotide excision repair</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_-308545013131585826">
      <data key="d0">Result</data>
      <data key="d1">ATP production was largely restored in oocytes from AY RCFs</data>
      <data key="d3">ATP production was largely restored in oocytes from AY RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_1768535996649763872">
      <data key="d0">Result</data>
      <data key="d1">Mitochondria in oocytes from AY RCFS exhibited more uniform cytoplasmic distribution, reassembly that in YY oocytes, than in oocytes from AA RCFs</data>
      <data key="d3">Mitochondria in oocytes from AY RCFS exhibited more uniform cytoplasmic distribution, reassembly that in YY oocytes, than in oocytes from AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_6375873074088976139">
      <data key="d0">Result</data>
      <data key="d1">culturing within young r-follicles largely restored mitochondrial membrane potential in aged oocytes</data>
      <data key="d3">culturing within young r-follicles largely restored mitochondrial membrane potential in aged oocytes</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_4966564730208617556">
      <data key="d0">Result</data>
      <data key="d1">Oocytes from AY RCFs exhibited lower mitochondrial and cellular ROS than aged oocytes from AA RCFs</data>
      <data key="d3">Oocytes from AY RCFs exhibited lower mitochondrial and cellular ROS than aged oocytes from AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_6458589539598536726">
      <data key="d0">Result</data>
      <data key="d1">oocytes from AY RCFs exhibited a reduced rate of chromosomal abnormalities compared to oocytes from AA RCFs</data>
      <data key="d3">oocytes from AY RCFs exhibited a reduced rate of chromosomal abnormalities compared to oocytes from AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_2095598226064636887">
      <data key="d0">Result</data>
      <data key="d1">the level of chromosomal Rec8 in oocytes from AY RCFs was significantly higher than that in AA RCFs</data>
      <data key="d3">the level of chromosomal Rec8 in oocytes from AY RCFs was significantly higher than that in AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="Gene_REC8">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">REC8</data>
      <data key="d7">Rec8</data>
    </node>
    <node id="PDF_38_2024_Result_6383333419769449458">
      <data key="d0">Result</data>
      <data key="d1">oocytes from AY exhibited shorter distances between sister kinetochores than oocytes from AA RCFS</data>
      <data key="d3">oocytes from AY exhibited shorter distances between sister kinetochores than oocytes from AA RCFS</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_38_2024_Result_-4299649364787469483">
      <data key="d0">Result</data>
      <data key="d1">the incidence of lagging chromosomes during the anaphase of meiosis I was significantly lower in oocytes from AY RCFs than AA RCFs</data>
      <data key="d3">the incidence of lagging chromosomes during the anaphase of meiosis I was significantly lower in oocytes from AY RCFs than AA RCFs</data>
      <data key="d4">PDF_38_2024</data>
    </node>
    <node id="PDF_01_2012">
      <data key="d0">Paper</data>
      <data key="d1">frontiers in
MICROBIOLOGY
REVIEW ARTICLE
published: 27 July 2012
doi: 10.3389/fmicb.2012.00262
The role of genes domesticated from LTR retrotransposons
and retroviruses in mammals
Tomoko Kaneko-Ishino1* and Fumitoshi Ishino2
1 School of Health Sciences, Tokai University, Isehara, Kanagawa, Japan
2 Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
Edited by:
Yukihito Ishizaka, National Center for
Global Health and Medicine, Japan
Reviewed by:
Matthew Lorincz, Universit</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_01_2012_Result_2142836395188910664">
      <data key="d0">Result</data>
      <data key="d1">PEG10 and PEG11/RTL1 play essential but different roles in placental development.</data>
      <data key="d3">PEG10 and PEG11/RTL1 play essential but different roles in placental development.</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_RTL1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL1</data>
      <data key="d7">RTL1</data>
    </node>
    <node id="PDF_01_2012_Result_-7678692972089207567">
      <data key="d0">Result</data>
      <data key="d1">PEG10 is conserved in both the marsupials and the eutherians, while PEG11/RTL1 is a eutherian-specific gene.</data>
      <data key="d3">PEG10 is conserved in both the marsupials and the eutherians, while PEG11/RTL1 is a eutherian-specific gene.</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Conclusion_329299745985449097">
      <data key="d0">Conclusion</data>
      <data key="d1">domesticated genes were deeply involved in the evolution of mammals via the establishment of the viviparous reproduction system</data>
      <data key="d3">domesticated genes were deeply involved in the evolution of mammals via the establishment of the viviparous reproduction system</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Result_6157335559941784404">
      <data key="d0">Result</data>
      <data key="d1">Human SYNCYTIN (ERVWE1) mediates placental cytotrophoblast fusion so as to produce syncytiotrophoblast cells in human placental morphogenesis</data>
      <data key="d3">Human SYNCYTIN (ERVWE1) mediates placental cytotrophoblast fusion so as to produce syncytiotrophoblast cells in human placental morphogenesis</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_SYNCYTIN">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SYNCYTIN</data>
      <data key="d7">SYNCYTIN</data>
    </node>
    <node id="PDF_01_2012_Result_-1393423759134320958">
      <data key="d0">Result</data>
      <data key="d1">mouse SyncytinA and B have been to be essential placental genes using knockout mice</data>
      <data key="d3">mouse SyncytinA and B have been to be essential placental genes using knockout mice</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_SYNCYTIN-A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SYNCYTIN-A</data>
      <data key="d7">Syncytin-A</data>
    </node>
    <node id="Gene_SYNCYTINB">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SYNCYTINB</data>
      <data key="d7">SyncytinB</data>
    </node>
    <node id="PDF_01_2012_Result_7593594633745370916">
      <data key="d0">Result</data>
      <data key="d1">PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
      <data key="d3">PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Result_-3921433967535018377">
      <data key="d0">Result</data>
      <data key="d1">Mouse Peg10 and Peg11/Rtl1 are the major genes responsible for the lethal phenotypes observed in these imprinted regions, respectively</data>
      <data key="d3">Mouse Peg10 and Peg11/Rtl1 are the major genes responsible for the lethal phenotypes observed in these imprinted regions, respectively</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Result_2019707484135489002">
      <data key="d0">Result</data>
      <data key="d1">Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
      <data key="d3">Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Result_-2067314764590101881">
      <data key="d0">Result</data>
      <data key="d1">PEG10 is highly expressed in a great majority of hepatocellular carcinomas and confers oncogenic activity.</data>
      <data key="d3">PEG10 is highly expressed in a great majority of hepatocellular carcinomas and confers oncogenic activity.</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Result_-7322599711768990899">
      <data key="d0">Result</data>
      <data key="d1">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis. Overexpression of PEG10 decreased the cell death mediated by SIAH1, suggesting that PEG10 has a growth promoting function related to apoptosis in somatic cells</data>
      <data key="d3">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis. Overexpression of PEG10 decreased the cell death mediated by SIAH1, suggesting that PEG10 has a growth promoting function related to apoptosis in somatic cells</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Protein_SIAH1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SIAH1</data>
      <data key="d7">SIAH1</data>
    </node>
    <node id="PDF_01_2012_Result_9148938541017551914">
      <data key="d0">Result</data>
      <data key="d1">loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14)</data>
      <data key="d3">loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14)</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Result_-172222816078977826">
      <data key="d0">Result</data>
      <data key="d1">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
      <data key="d3">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_PNMA4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA4</data>
      <data key="d7">PNMA4</data>
    </node>
    <node id="PDF_01_2012_Result_7867362277137198711">
      <data key="d0">Result</data>
      <data key="d1">PNMA10 to be a candidate gene for X-linked mental retardation (XLMR) in humans</data>
      <data key="d3">PNMA10 to be a candidate gene for X-linked mental retardation (XLMR) in humans</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_PNMA10">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA10</data>
      <data key="d7">PNMA10</data>
    </node>
    <node id="Disease_X-LINKED MENTAL RETARDATION">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">X-LINKED MENTAL RETARDATION</data>
      <data key="d7">X-linked mental retardation</data>
    </node>
    <node id="PDF_01_2012_Result_455890509852084009">
      <data key="d0">Result</data>
      <data key="d1">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome</data>
      <data key="d3">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_PNMA14/CCDC8">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA14/CCDC8</data>
      <data key="d7">Pnma14/CCDC8</data>
    </node>
    <node id="Disease_3-M SYNDROME">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">3-M SYNDROME</data>
      <data key="d7">3-M syndrome</data>
    </node>
    <node id="PDF_01_2012_Result_6870654001407870672">
      <data key="d0">Result</data>
      <data key="d1">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
      <data key="d3">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_FILAGGRIN">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FILAGGRIN</data>
      <data key="d7">Filaggrin</data>
    </node>
    <node id="Disease_ATOPIC DERMATITIS">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">ATOPIC DERMATITIS</data>
      <data key="d7">Atopic dermatitis</data>
    </node>
    <node id="PDF_01_2012_Result_-1528068561029024688">
      <data key="d0">Result</data>
      <data key="d1">Aberrant SASPase expression in transgenic mice reportedly leads to impaired skin regeneration and skin remodeling after cutaneous injury or chemically induced hyperplasia</data>
      <data key="d3">Aberrant SASPase expression in transgenic mice reportedly leads to impaired skin regeneration and skin remodeling after cutaneous injury or chemically induced hyperplasia</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Protein_SASPASE">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SASPASE</data>
      <data key="d7">SASPase</data>
    </node>
    <node id="PDF_01_2012_Result_4512747853279298078">
      <data key="d0">Result</data>
      <data key="d1">loss of PEG3 expression is reportedly observed in gliomas</data>
      <data key="d3">loss of PEG3 expression is reportedly observed in gliomas</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="Gene_PEG3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PEG3</data>
      <data key="d7">PEG3</data>
    </node>
    <node id="Disease_GLIOMA">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">GLIOMA</data>
      <data key="d7">Glioma</data>
    </node>
    <node id="PDF_01_2012_Result_5174667025981830920">
      <data key="d0">Result</data>
      <data key="d1">PEG3 was reported to be essential for maternal nursing behavior as well as promoting embryonic growth</data>
      <data key="d3">PEG3 was reported to be essential for maternal nursing behavior as well as promoting embryonic growth</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Method_8728923512696910364">
      <data key="d0">Method</data>
      <data key="d1">using knockout mice, we demonstrated that Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
      <data key="d3">using knockout mice, we demonstrated that Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_01_2012_Method_-5642058330234326169">
      <data key="d0">Method</data>
      <data key="d1">Combined with definitive genetic studies using knockout mice, PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
      <data key="d3">Combined with definitive genetic studies using knockout mice, PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
      <data key="d4">PDF_01_2012</data>
    </node>
    <node id="PDF_32_2020">
      <data key="d0">Paper</data>
      <data key="d1">nature
COMMUNICATIONS
ARTICLE
Check for updates
https://doi.org/10.1038/s41467-020-14451-5
OPEN
Genomic analysis of male puberty timing highlights
shared genetic basis with hair colour and lifespan
Ben Hollis 1,107, Felix R. Day 1,107, Alexander S. Busch 1,2,3, Deborah J. Thompson 4,
Ana Luiza G. Soares 5,6, Paul R.H.J. Timmers 6,7, Alex Kwong 5,8,9,10, Doug F. Easton 4,
Peter K. Joshi 6,7, Nicholas J. Timpson 5, The PRACTICAL Consortium*, 23andMe Research Team*,
Ken K. Ong
1,11,107✉ &amp; John R.B.</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_32_2020_Result_-7190858703012765987">
      <data key="d0">Result</data>
      <data key="d1">We find moderately strong genomic correlation in puberty timing between sexes (rg = 0.68) and identify 76 independent signals for male puberty timing.</data>
      <data key="d3">We find moderately strong genomic correlation in puberty timing between sexes (rg = 0.68) and identify 76 independent signals for male puberty timing.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_2195511883558240892">
      <data key="d0">Result</data>
      <data key="d1">Implicated mechanisms include an unexpected link between puberty timing and natural hair colour, possibly reflecting common effects of pituitary hormones on puberty and pigmentation.</data>
      <data key="d3">Implicated mechanisms include an unexpected link between puberty timing and natural hair colour, possibly reflecting common effects of pituitary hormones on puberty and pigmentation.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_-9015728083642480272">
      <data key="d0">Result</data>
      <data key="d1">Earlier male puberty timing is genetically correlated with several adverse health outcomes and Mendelian randomization analyses show a genetic association between male puberty timing and shorter lifespan.</data>
      <data key="d3">Earlier male puberty timing is genetically correlated with several adverse health outcomes and Mendelian randomization analyses show a genetic association between male puberty timing and shorter lifespan.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_-600778431407090884">
      <data key="d0">Result</data>
      <data key="d1">We defined two dichotomous facial hair variables in UKBB men: (1) relatively early onset (N = 13,226) vs. average onset (N=161,175); and (2) relatively late onset (N=26,066) vs. average onset.</data>
      <data key="d3">We defined two dichotomous facial hair variables in UKBB men: (1) relatively early onset (N = 13,226) vs. average onset (N=161,175); and (2) relatively late onset (N=26,066) vs. average onset.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_-3950286069808651736">
      <data key="d0">Result</data>
      <data key="d1">In this combined MTAG dataset, we identified 7,897 variants associated with male puberty timing at the genome-wide statistical significance threshold (GWAS-P &lt; 5 × 10−8), comprising 76 independent signals.</data>
      <data key="d3">In this combined MTAG dataset, we identified 7,897 variants associated with male puberty timing at the genome-wide statistical significance threshold (GWAS-P &lt; 5 × 10−8), comprising 76 independent signals.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_3731139472958919123">
      <data key="d0">Result</data>
      <data key="d1">The most significantly associated variant (rs11156429,GWAS-P = 3.5 × 10-52) was located in/near LIN28B</data>
      <data key="d3">The most significantly associated variant (rs11156429,GWAS-P = 3.5 × 10-52) was located in/near LIN28B</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="Gene_LIN28B">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">LIN28B</data>
      <data key="d7">LIN28B</data>
    </node>
    <node id="PDF_32_2020_Result_4215729786201325231">
      <data key="d0">Result</data>
      <data key="d1">Of these 76 signals, 29 were not in linkage disequilibrium (LD, conservatively defined as r² &gt; 0.05) with a previously reported signal for puberty timing (either AAM in women or voice breaking in men)</data>
      <data key="d3">Of these 76 signals, 29 were not in linkage disequilibrium (LD, conservatively defined as r² &gt; 0.05) with a previously reported signal for puberty timing (either AAM in women or voice breaking in men)</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_-5114934817590951090">
      <data key="d0">Result</data>
      <data key="d1">In ALSPAC boys, a polygenic risk score for later puberty timing based on 73 of the male puberty timing signals was associated with older ages at voice breaking, peak height velocity and appearance of armpit hair (Linear regression: P = 4.5 × 10-3 to P = 1.6 × 10-14), and was associated with lower likelihood of attaining various milestones of pubertal maturation at specific time-points (Pmin (pubic hair development at age 14.7 years old): = 4.6 × 10-10, univariate model r² ~ 1.5%)(Supplementary Data 3).</data>
      <data key="d3">In ALSPAC boys, a polygenic risk score for later puberty timing based on 73 of the male puberty timing signals was associated with older ages at voice breaking, peak height velocity and appearance of armpit hair (Linear regression: P = 4.5 × 10-3 to P = 1.6 × 10-14), and was associated with lower likelihood of attaining various milestones of pubertal maturation at specific time-points (Pmin (pubic hair development at age 14.7 years old): = 4.6 × 10-10, univariate model r² ~ 1.5%)(Supplementary Data 3).</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_5673621412415047231">
      <data key="d0">Result</data>
      <data key="d1">Consistent with our previous study, we observed a moderately strong genome-wide genetic correlation in pubertal timing between males and females (rg = 0.68, P = 2.6 × 10–213; based on continuous data on voice breaking and AAM in 23andMe), with similar effect estimates in both sexes for many individual variants</data>
      <data key="d3">Consistent with our previous study, we observed a moderately strong genome-wide genetic correlation in pubertal timing between males and females (rg = 0.68, P = 2.6 × 10–213; based on continuous data on voice breaking and AAM in 23andMe), with similar effect estimates in both sexes for many individual variants</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_-646070942496193452">
      <data key="d0">Result</data>
      <data key="d1">Only one signal showed significant directionally opposite effects (i.e. the allele that conferred earlier puberty timing in one sex delayed puberty in the other sex); rs6931884 at SIM1/PRDM13/MCHR2</data>
      <data key="d3">Only one signal showed significant directionally opposite effects (i.e. the allele that conferred earlier puberty timing in one sex delayed puberty in the other sex); rs6931884 at SIM1/PRDM13/MCHR2</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="Gene_SIM1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SIM1</data>
      <data key="d7">SIM1</data>
    </node>
    <node id="Gene_PRDM13">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PRDM13</data>
      <data key="d7">PRDM13</data>
    </node>
    <node id="Gene_MCHR2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MCHR2</data>
      <data key="d7">MCHR2</data>
    </node>
    <node id="PDF_32_2020_Result_5319186395597754623">
      <data key="d0">Result</data>
      <data key="d1">Two variants located near to genes that are disrupted in rare disorders of puberty 12,13 showed no effect or weaker effect in males than in females: rs184950120, 5'UTR to MKRN3 (ẞvoice-breaking 0.085 years/allele; ẞmenarche = 0.396_years/allele, Pheterogeneity = 3.6 × 10-3), and rs62342064, one of 3 AAM variants in/near TACR3 (ẞvoice-breaking = -0.017 years/allele; ẞmenarche = 0.057 years/allele, Pheterogeneity = 4.2 × 10-5).</data>
      <data key="d3">Two variants located near to genes that are disrupted in rare disorders of puberty 12,13 showed no effect or weaker effect in males than in females: rs184950120, 5'UTR to MKRN3 (ẞvoice-breaking 0.085 years/allele; ẞmenarche = 0.396_years/allele, Pheterogeneity = 3.6 × 10-3), and rs62342064, one of 3 AAM variants in/near TACR3 (ẞvoice-breaking = -0.017 years/allele; ẞmenarche = 0.057 years/allele, Pheterogeneity = 4.2 × 10-5).</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="Gene_MKRN3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MKRN3</data>
      <data key="d7">MKRN3</data>
    </node>
    <node id="Gene_TACR3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TACR3</data>
      <data key="d7">TACR3</data>
    </node>
    <node id="PDF_32_2020_Result_-2403631607639503096">
      <data key="d0">Result</data>
      <data key="d1">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism14.</data>
      <data key="d3">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism14.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="Gene_KDM4C">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">KDM4C</data>
      <data key="d7">KDM4C</data>
    </node>
    <node id="Gene_ALX4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ALX4</data>
      <data key="d7">ALX4</data>
    </node>
    <node id="Protein_FGF">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">FGF</data>
      <data key="d7">FGF</data>
    </node>
    <node id="PDF_32_2020_Result_-279265792154362175">
      <data key="d0">Result</data>
      <data key="d1">A further 10 lead variants were in strong LD (r² &gt; 0.8) with one or more non-synonymous variants, of which three have not previously been associated with puberty timing: FGF11, which encodes a FGF expressed in the developing CNS and promotes peripheral androgen receptor expression15, TFAP4, which encodes a transcription factor of the basic helix-loop-helix-zipper family16, and GCKR, which encodes a regulatory protein that inhibits glucokinase in liver and pancreatic islets and is associated with a range of cardiometabolic traits17</data>
      <data key="d3">A further 10 lead variants were in strong LD (r² &gt; 0.8) with one or more non-synonymous variants, of which three have not previously been associated with puberty timing: FGF11, which encodes a FGF expressed in the developing CNS and promotes peripheral androgen receptor expression15, TFAP4, which encodes a transcription factor of the basic helix-loop-helix-zipper family16, and GCKR, which encodes a regulatory protein that inhibits glucokinase in liver and pancreatic islets and is associated with a range of cardiometabolic traits17</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="Gene_FGF">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FGF</data>
      <data key="d7">FGF</data>
    </node>
    <node id="Gene_TFAP4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">TFAP4</data>
      <data key="d7">TFAP4</data>
    </node>
    <node id="Gene_GCKR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GCKR</data>
      <data key="d7">GCKR</data>
    </node>
    <node id="PDF_32_2020_Result_6877622394219411371">
      <data key="d0">Result</data>
      <data key="d1">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
      <data key="d3">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="Gene_SRD5A2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SRD5A2</data>
      <data key="d7">SRD5A2</data>
    </node>
    <node id="Gene_LEPR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">LEPR</data>
      <data key="d7">LEPR</data>
    </node>
    <node id="Gene_SMARCAD1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SMARCAD1</data>
      <data key="d7">SMARCAD1</data>
    </node>
    <node id="Gene_BDNF">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">BDNF</data>
      <data key="d7">BDNF</data>
    </node>
    <node id="Gene_FNDC9">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FNDC9</data>
      <data key="d7">FNDC9</data>
    </node>
    <node id="Gene_FAM118A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FAM118A</data>
      <data key="d7">FAM118A</data>
    </node>
    <node id="Gene_ZNF446">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZNF446</data>
      <data key="d7">ZNF446</data>
    </node>
    <node id="PDF_32_2020_Result_5404182611834045705">
      <data key="d0">Result</data>
      <data key="d1">Consistent with genetic analyses of AAM in females, tissues in the CNS were the most strongly enriched for genes co-located near to male puberty timing associated variants</data>
      <data key="d3">Consistent with genetic analyses of AAM in females, tissues in the CNS were the most strongly enriched for genes co-located near to male puberty timing associated variants</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_4768121198739981723">
      <data key="d0">Result</data>
      <data key="d1">Four pathways showed evidence of enrichment: histone methyltransferase complex (FDR = 0.01); regulation of transcription (FDR = 0.02)); ATP binding (FDR = 0.03); and cAMP biosynthetic process (FDR = 0.03)</data>
      <data key="d3">Four pathways showed evidence of enrichment: histone methyltransferase complex (FDR = 0.01); regulation of transcription (FDR = 0.02)); ATP binding (FDR = 0.03); and cAMP biosynthetic process (FDR = 0.03)</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_2436937814848041185">
      <data key="d0">Result</data>
      <data key="d1">Men with red, dark brown and black natural hair colours showed progressively higher odds of early puberty timing, relative to men with blond hair. Similarly, women with darker natural hair colours had earlier puberty timing relative to women with blond hair</data>
      <data key="d3">Men with red, dark brown and black natural hair colours showed progressively higher odds of early puberty timing, relative to men with blond hair. Similarly, women with darker natural hair colours had earlier puberty timing relative to women with blond hair</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_32_2020_Result_-2230303066513665884">
      <data key="d0">Result</data>
      <data key="d1">Using a two-sample Mendelian randomisation (MR) approach, we modelled 119 recently reported GWAS hair colour signals as a single instrumental variable18 on age at voice breaking (in 23andMe men). The findings infer that susceptibility to darker natural hair colour also confers earlier puberty timing in men (ẞīvw = -0.044 years per ordered category, PIVW = 7.10 × 10-3) with no evidence of heterogeneity across signals (Cochrane Q: P = 0.99) or directional pleiotropy (MR-Egger Intercept: P=0.99)</data>
      <data key="d3">Using a two-sample Mendelian randomisation (MR) approach, we modelled 119 recently reported GWAS hair colour signals as a single instrumental variable18 on age at voice breaking (in 23andMe men). The findings infer that susceptibility to darker natural hair colour also confers earlier puberty timing in men (ẞīvw = -0.044 years per ordered category, PIVW = 7.10 × 10-3) with no evidence of heterogeneity across signals (Cochrane Q: P = 0.99) or directional pleiotropy (MR-Egger Intercept: P=0.99)</data>
      <data key="d4">PDF_32_2020</data>
    </node>
    <node id="PDF_40_2006">
      <data key="d0">Paper</data>
      <data key="d1">Here is the requested text from the PDF:

The RASSF1A Tumor Suppressor Activates Bax via MOAP-1*
Received for publication, November 10, 2005 Published, JBC Papers in Press, December 12, 2005, DOI 10.1074/jbc.M512128200
Michele D. Vos, Ashraf Dallol, Kristin Eckfeld, Nadia P. C. Allen, Howard Donninger, Luke B. Hesson,
Diego Calvisi, Farida Latif¹, and Geoffrey J. Clark#2
From the Department of Cell and Cancer Biology, NCI, National Institutes of Health, Rockville, Maryland 20850-3300, the
"Depar</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_40_2006_Hypothesis_-7729659190863877600">
      <data key="d0">Hypothesis</data>
      <data key="d1">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis.</data>
      <data key="d3">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="Gene_RASSF">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RASSF</data>
      <data key="d7">RASSF</data>
    </node>
    <node id="Protein_RAS">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">RAS</data>
      <data key="d7">Ras</data>
    </node>
    <node id="PDF_40_2006_Method_-1851821532008149103">
      <data key="d0">Method</data>
      <data key="d1">Yeast two-hybrid analysis was performed using a full-length RASSF1A clone.</data>
      <data key="d3">Yeast two-hybrid analysis was performed using a full-length RASSF1A clone.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Method_7867957586338794398">
      <data key="d0">Method</data>
      <data key="d1">Co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
      <data key="d3">Co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Method_2907123142089443626">
      <data key="d0">Method</data>
      <data key="d1">We used expression vectors to generate H1299 cell lines (negative for endogenous RASSF1A expression) that stably re-express exogenous wild type or mutant RASSF1A protein at a level that is comparable with the endogenous protein levels found in the RASSF1A-positive cell H1792.</data>
      <data key="d3">We used expression vectors to generate H1299 cell lines (negative for endogenous RASSF1A expression) that stably re-express exogenous wild type or mutant RASSF1A protein at a level that is comparable with the endogenous protein levels found in the RASSF1A-positive cell H1792.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Method_6525108347789616891">
      <data key="d0">Method</data>
      <data key="d1">H1792 cells were transfected with 1-5 µg of shRNA vector and selected in puromycin. Selected cells were examined for loss of RASSF1A expression by Western analysis using a RASSF1A polyclonal antibody and by qRT-PCR.</data>
      <data key="d3">H1792 cells were transfected with 1-5 µg of shRNA vector and selected in puromycin. Selected cells were examined for loss of RASSF1A expression by Western analysis using a RASSF1A polyclonal antibody and by qRT-PCR.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-6166309786436243553">
      <data key="d0">Result</data>
      <data key="d1">RASSF1A directly binds the protein Modulator of Apoptosis-1 (MOAP-1)</data>
      <data key="d3">RASSF1A directly binds the protein Modulator of Apoptosis-1 (MOAP-1)</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-1821673362539447090">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 was determined to be a RASSF1A interaction partner in a yeast two-hybrid screen.</data>
      <data key="d3">MOAP-1 was determined to be a RASSF1A interaction partner in a yeast two-hybrid screen.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_5799130818778099298">
      <data key="d0">Result</data>
      <data key="d1">RASSF1A and MOAP-1 can interact in mammalian cells and that the interaction is enhanced in the presence of activated K-Ras.</data>
      <data key="d3">RASSF1A and MOAP-1 can interact in mammalian cells and that the interaction is enhanced in the presence of activated K-Ras.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_948731372623059496">
      <data key="d0">Result</data>
      <data key="d1">Wild type RASSF1A but not a tumor derived point mutant can activate Bax via MOAP-1.</data>
      <data key="d3">Wild type RASSF1A but not a tumor derived point mutant can activate Bax via MOAP-1.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-957024816232778490">
      <data key="d0">Result</data>
      <data key="d1">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
      <data key="d3">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_5648813083697518686">
      <data key="d0">Result</data>
      <data key="d1">The ability of K-Ras 12v to activate Bax is dependent upon RASSF1A.</data>
      <data key="d3">The ability of K-Ras 12v to activate Bax is dependent upon RASSF1A.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-1854708955097321731">
      <data key="d0">Result</data>
      <data key="d1">In the presence of RASSF1A, MOAP-1 is recruited to microtubule structures with RASSF1A.</data>
      <data key="d3">In the presence of RASSF1A, MOAP-1 is recruited to microtubule structures with RASSF1A.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-1632554297047910644">
      <data key="d0">Result</data>
      <data key="d1">The co-immunoprecipitation of RASSF1A and MOAP-1 was only readily detectable in the samples derived form the stromal tissue surrounding the tumors.</data>
      <data key="d3">The co-immunoprecipitation of RASSF1A and MOAP-1 was only readily detectable in the samples derived form the stromal tissue surrounding the tumors.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_5908750418673841027">
      <data key="d0">Result</data>
      <data key="d1">Upon the addition of activated K-Ras to the transfection, the level of MOAP-1 co-precipitation with RASSF1A increased substantially.</data>
      <data key="d3">Upon the addition of activated K-Ras to the transfection, the level of MOAP-1 co-precipitation with RASSF1A increased substantially.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-6442075429125860034">
      <data key="d0">Result</data>
      <data key="d1">The C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
      <data key="d3">The C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-7396215420825107056">
      <data key="d0">Result</data>
      <data key="d1">Activated K-Ras promoted the formation of a complex between RASSF1A and MOAP-1.</data>
      <data key="d3">Activated K-Ras promoted the formation of a complex between RASSF1A and MOAP-1.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_6250568740775828390">
      <data key="d0">Result</data>
      <data key="d1">Co-transfection of K-Ras 12v, RASSF1A, and MOAP-1 induced synergistic cell death.</data>
      <data key="d3">Co-transfection of K-Ras 12v, RASSF1A, and MOAP-1 induced synergistic cell death.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-7818253702727186456">
      <data key="d0">Result</data>
      <data key="d1">RASSF1A induces the relocalization and clustering of Bax.</data>
      <data key="d3">RASSF1A induces the relocalization and clustering of Bax.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-7616297845824850474">
      <data key="d0">Result</data>
      <data key="d1">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax, suggesting that RASSF1A activates Bax via MOAP-1.</data>
      <data key="d3">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax, suggesting that RASSF1A activates Bax via MOAP-1.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_-489717104173259498">
      <data key="d0">Result</data>
      <data key="d1">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells.</data>
      <data key="d3">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="Disease_LUNG CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">LUNG CANCER</data>
      <data key="d7">Lung cancer</data>
    </node>
    <node id="PDF_40_2006_Result_-6659723526613081581">
      <data key="d0">Result</data>
      <data key="d1">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A.</data>
      <data key="d3">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Result_6818911312146639850">
      <data key="d0">Result</data>
      <data key="d1">The cells where the expression of endogenous RASSF1A is inhibited by the shRNA construct are defective for K-Ras12v mediated Bax activation.</data>
      <data key="d3">The cells where the expression of endogenous RASSF1A is inhibited by the shRNA construct are defective for K-Ras12v mediated Bax activation.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_40_2006_Conclusion_-6905685080099351152">
      <data key="d0">Conclusion</data>
      <data key="d1">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
      <data key="d3">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
      <data key="d4">PDF_40_2006</data>
    </node>
    <node id="PDF_03_2016">
      <data key="d0">Paper</data>
      <data key="d1">REVIEW
Not so bad after all: retroviruses and long terminal repeat
retrotransposons as a source of new genes in vertebrates
M. Naville', I. A. Warren, Z. Haftek-Terreau', D. Chalopin 12, F. Brunet', P. Levin', D. Galiana and J.-N. Volff
1) Institut de Génomique Fonctionnelle de Lyon, Ecole Normale Supérieure de Lyon, CNRS UMR5242, Université Lyon I, Lyon, France and 2) Department of
Genetics, University of Georgia, Athens, GA, USA

Abstract
Viruses and transposable elements, once considered as p</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_03_2016_Conclusion_-5540540946875681424">
      <data key="d0">Conclusion</data>
      <data key="d1">Retroviruses and LTR retrotransposons have repeatedly contributed their coding sequences for the formation of new protein-coding genes in vertebrates, playing an important role in the evolution and diversification of the vertebrate lineage.</data>
      <data key="d3">Retroviruses and LTR retrotransposons have repeatedly contributed their coding sequences for the formation of new protein-coding genes in vertebrates, playing an important role in the evolution and diversification of the vertebrate lineage.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_8932776040224861331">
      <data key="d0">Result</data>
      <data key="d1">At least 85 genes derived from the gag gene of LTR retrotransposons have been identified in the human genome, belonging to diverse families with a particular involvement of Ty3/Gypsy elements.</data>
      <data key="d3">At least 85 genes derived from the gag gene of LTR retrotransposons have been identified in the human genome, belonging to diverse families with a particular involvement of Ty3/Gypsy elements.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_5008136592909895597">
      <data key="d0">Result</data>
      <data key="d1">The Mart gene family is derived from a vertebrate Ty3/Gypsy retrotransposon family called Sushi and contains at least 11 genes in placental mammals.</data>
      <data key="d3">The Mart gene family is derived from a vertebrate Ty3/Gypsy retrotransposon family called Sushi and contains at least 11 genes in placental mammals.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_-4912794319540144318">
      <data key="d0">Result</data>
      <data key="d1">Peg10 knockout mice display defects in placenta formation leading to early embryonic lethality.</data>
      <data key="d3">Peg10 knockout mice display defects in placenta formation leading to early embryonic lethality.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_8188781800364835129">
      <data key="d0">Result</data>
      <data key="d1">Modification of Peg 11/Rtl expression causes late-foetal and/or neonatal lethality in mouse and is essential for the maintenance of foetal capillaries at the foeto-maternal interface during the late-foetal stage.</data>
      <data key="d3">Modification of Peg 11/Rtl expression causes late-foetal and/or neonatal lethality in mouse and is essential for the maintenance of foetal capillaries at the foeto-maternal interface during the late-foetal stage.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_-4666806675382766829">
      <data key="d0">Result</data>
      <data key="d1">Knock-out mice for LdocI/Sirh7 show abnormal placental cell differentiation and maturation, with an overproduction of placental progesterone and placental lactogen I from trophoblast giant cells.</data>
      <data key="d3">Knock-out mice for LdocI/Sirh7 show abnormal placental cell differentiation and maturation, with an overproduction of placental progesterone and placental lactogen I from trophoblast giant cells.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_LDOCI/SIRH7">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">LDOCI/SIRH7</data>
      <data key="d7">LdocI/Sirh7</data>
    </node>
    <node id="PDF_03_2016_Result_7814833608294222903">
      <data key="d0">Result</data>
      <data key="d1">Disruption of the Zcchc16/Mart4 gene in the mouse causes abnormal behaviours related to cognition.</data>
      <data key="d3">Disruption of the Zcchc16/Mart4 gene in the mouse causes abnormal behaviours related to cognition.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_ZCCHC16/MART4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZCCHC16/MART4</data>
      <data key="d7">Zcchc16/Mart4</data>
    </node>
    <node id="PDF_03_2016_Result_-4847374812115247732">
      <data key="d0">Result</data>
      <data key="d1">Peg10 is overexpressed in human hepatocellular carcinoma and other types of tumours and might promote cancer formation through the suppression of apoptosis and the stimulation of cell proliferation.</data>
      <data key="d3">Peg10 is overexpressed in human hepatocellular carcinoma and other types of tumours and might promote cancer formation through the suppression of apoptosis and the stimulation of cell proliferation.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_6382256618424890930">
      <data key="d0">Result</data>
      <data key="d1">Overexpression of Peg11/Rtll in the liver of adult mice results in highly penetrant tumour formation, suggesting a role as a driver of hepatocarcinogenesis.</data>
      <data key="d3">Overexpression of Peg11/Rtll in the liver of adult mice results in highly penetrant tumour formation, suggesting a role as a driver of hepatocarcinogenesis.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_4354168392301783316">
      <data key="d0">Result</data>
      <data key="d1">Ldocl, considered as a tumour suppressor down-regulated in human pancreatic cancer cell lines, inhibits nuclear factor-KB activation and induces apoptosis.</data>
      <data key="d3">Ldocl, considered as a tumour suppressor down-regulated in human pancreatic cancer cell lines, inhibits nuclear factor-KB activation and induces apoptosis.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_30824326631533312">
      <data key="d0">Result</data>
      <data key="d1">The Ma/Pnma gene family originated from a Gypsy/Ty3 LTR retrotransposon, independently from the Mart gene family.</data>
      <data key="d3">The Ma/Pnma gene family originated from a Gypsy/Ty3 LTR retrotransposon, independently from the Mart gene family.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_2318753918519824998">
      <data key="d0">Result</data>
      <data key="d1">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
      <data key="d3">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_4563320361831730202">
      <data key="d0">Result</data>
      <data key="d1">Pnmal is a pro-apoptotic protein in neurons, and its overexpression may contribute to neurodegenerative disorders.</data>
      <data key="d3">Pnmal is a pro-apoptotic protein in neurons, and its overexpression may contribute to neurodegenerative disorders.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_PNMA1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA1</data>
      <data key="d7">PNMA1</data>
    </node>
    <node id="PDF_03_2016_Result_4969557758143124656">
      <data key="d0">Result</data>
      <data key="d1">Pnma10/SIZNI contributes to Bone Morphogenetic Protein (BMP)-dependent cholinergic-neuron-specific gene expression.</data>
      <data key="d3">Pnma10/SIZNI contributes to Bone Morphogenetic Protein (BMP)-dependent cholinergic-neuron-specific gene expression.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_7082405829594301175">
      <data key="d0">Result</data>
      <data key="d1">The SCAN family of transcription factors includes C2H2 zinc finger proteins with a vertebrate-specific domain called SCAN, formed through the molecular domestication of a Gmr/-like LTR retrotransposon.</data>
      <data key="d3">The SCAN family of transcription factors includes C2H2 zinc finger proteins with a vertebrate-specific domain called SCAN, formed through the molecular domestication of a Gmr/-like LTR retrotransposon.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_5091741717295391460">
      <data key="d0">Result</data>
      <data key="d1">SCAN domain transcription factors are involved in haematopoiesis, regulation of pluripotency of embryonic stem cells, control of lipid metabolism, regulation of hippocampal neuronal cholesterol biosynthesis, chondrogenesis, as well as in muscle stem cell behaviour, core body temperature, body fat and maternal behaviour.</data>
      <data key="d3">SCAN domain transcription factors are involved in haematopoiesis, regulation of pluripotency of embryonic stem cells, control of lipid metabolism, regulation of hippocampal neuronal cholesterol biosynthesis, chondrogenesis, as well as in muscle stem cell behaviour, core body temperature, body fat and maternal behaviour.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_-8730759386501864041">
      <data key="d0">Result</data>
      <data key="d1">NRIF is a mediator of neuronal apoptosis, ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation, and Mzfl is involved in the aetiology of major solid tumours.</data>
      <data key="d3">NRIF is a mediator of neuronal apoptosis, ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation, and Mzfl is involved in the aetiology of major solid tumours.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_ZNF307">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZNF307</data>
      <data key="d7">ZNF307</data>
    </node>
    <node id="Gene_MZFI">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MZFI</data>
      <data key="d7">MZFI</data>
    </node>
    <node id="PDF_03_2016_Result_1684840525726849843">
      <data key="d0">Result</data>
      <data key="d1">Fv1 protects against infection by the murine leukaemia virus and other types of retroviruses by blocking infection through interaction with the capsid protein of the restricted murine leukaemia virus.</data>
      <data key="d3">Fv1 protects against infection by the murine leukaemia virus and other types of retroviruses by blocking infection through interaction with the capsid protein of the restricted murine leukaemia virus.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_-6800160112503435970">
      <data key="d0">Result</data>
      <data key="d1">enJS56A1 and enJSRV-20 can block the replication of related exogenous retroviruses in sheep.</data>
      <data key="d3">enJS56A1 and enJSRV-20 can block the replication of related exogenous retroviruses in sheep.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_ENJS56A1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ENJS56A1</data>
      <data key="d7">enJS56A1</data>
    </node>
    <node id="Gene_ENJSRV-20">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ENJSRV-20</data>
      <data key="d7">enJSRV-20</data>
    </node>
    <node id="PDF_03_2016_Result_7772321383417943399">
      <data key="d0">Result</data>
      <data key="d1">Arc is required for learning and memory in the mammalian brain.</data>
      <data key="d3">Arc is required for learning and memory in the mammalian brain.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_503518524870890840">
      <data key="d0">Result</data>
      <data key="d1">Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor in chicken.</data>
      <data key="d3">Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor in chicken.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_ENS-1/ERNI">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ENS-1/ERNI</data>
      <data key="d7">Ens-1/Erni</data>
    </node>
    <node id="Protein_SOX2">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SOX2</data>
      <data key="d7">SOX2</data>
    </node>
    <node id="PDF_03_2016_Result_-5773482404300397553">
      <data key="d0">Result</data>
      <data key="d1">Gin-2 is present in cartilaginous and ray-finned fish, amphibians, birds and reptiles, suggesting a molecular domestication event approximately 500 MYA, while Gin-1 is more recent and has been formed independently of Gin-2 in a common ancestor of birds/reptiles and mammals.</data>
      <data key="d3">Gin-2 is present in cartilaginous and ray-finned fish, amphibians, birds and reptiles, suggesting a molecular domestication event approximately 500 MYA, while Gin-1 is more recent and has been formed independently of Gin-2 in a common ancestor of birds/reptiles and mammals.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_GIN-1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GIN-1</data>
      <data key="d7">Gin-1</data>
    </node>
    <node id="Gene_GIN-2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">GIN-2</data>
      <data key="d7">Gin-2</data>
    </node>
    <node id="PDF_03_2016_Result_7673383833239711187">
      <data key="d0">Result</data>
      <data key="d1">CGINI integrase-like domain has been inactivated by mutations but might have retained the three-dimensional folding observed in retroviral integrases, with a proposed role in the resistance to retroviruses through regulation of viral protein ubiquitination.</data>
      <data key="d3">CGINI integrase-like domain has been inactivated by mutations but might have retained the three-dimensional folding observed in retroviral integrases, with a proposed role in the resistance to retroviruses through regulation of viral protein ubiquitination.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_CGINI">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CGINI</data>
      <data key="d7">CGINI</data>
    </node>
    <node id="PDF_03_2016_Result_6686826447617577678">
      <data key="d0">Result</data>
      <data key="d1">SASPase is involved in wrinkle formation and is necessary for the maintenance of the texture and hydration of the stratum corneum in mouse.</data>
      <data key="d3">SASPase is involved in wrinkle formation and is necessary for the maintenance of the texture and hydration of the stratum corneum in mouse.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_SASPASE">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SASPASE</data>
      <data key="d7">SASPase</data>
    </node>
    <node id="PDF_03_2016_Result_-6836807137793278398">
      <data key="d0">Result</data>
      <data key="d1">NIXI binds ligand-activated/constitutively active nuclear receptors and down-regulates transcription in specific neurons of the central nervous system in the mouse.</data>
      <data key="d3">NIXI binds ligand-activated/constitutively active nuclear receptors and down-regulates transcription in specific neurons of the central nervous system in the mouse.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_NIXI">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NIXI</data>
      <data key="d7">NIXI</data>
    </node>
    <node id="PDF_03_2016_Result_498231358140566558">
      <data key="d0">Result</data>
      <data key="d1">Syncytins are involved in the formation of the placenta by promoting the fusion of trophoblast cells.</data>
      <data key="d3">Syncytins are involved in the formation of the placenta by promoting the fusion of trophoblast cells.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_4642051770203850366">
      <data key="d0">Result</data>
      <data key="d1">Syncytin-I might also be involved in osteoclast fusion and bone resorption and may also regulate neuro-inflammation in multiple sclerosis.</data>
      <data key="d3">Syncytin-I might also be involved in osteoclast fusion and bone resorption and may also regulate neuro-inflammation in multiple sclerosis.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="Gene_SYNCYTIN-I">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SYNCYTIN-I</data>
      <data key="d7">Syncytin-I</data>
    </node>
    <node id="PDF_03_2016_Result_2937187592715934021">
      <data key="d0">Result</data>
      <data key="d1">Syncytin-A knock-out mouse embryos die in utero between 11.5 and 13.5 days of gestation, demonstrating the critical function of this gene in development.</data>
      <data key="d3">Syncytin-A knock-out mouse embryos die in utero between 11.5 and 13.5 days of gestation, demonstrating the critical function of this gene in development.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_1928585347851698732">
      <data key="d0">Result</data>
      <data key="d1">Fv-4 controls the susceptibility to infection by ecotropic murine leukaemia virus, with expression of the Env protein conferring resistance to virus infection.</data>
      <data key="d3">Fv-4 controls the susceptibility to infection by ecotropic murine leukaemia virus, with expression of the Env protein conferring resistance to virus infection.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_4500971345532382777">
      <data key="d0">Result</data>
      <data key="d1">Env-derived genes that originated from endogenous avian leucosis viruses confer protection against exogenous avian leucosis viruses by blocking their entry into the cell in domestic chicken.</data>
      <data key="d3">Env-derived genes that originated from endogenous avian leucosis viruses confer protection against exogenous avian leucosis viruses by blocking their entry into the cell in domestic chicken.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_03_2016_Result_7044040300036239640">
      <data key="d0">Result</data>
      <data key="d1">One copy of an endogenous Jaagsiekte sheep retrovirus expresses an env gene that restricts infection by exogenous Jaagsiekte sheep retroviruses in domestic sheep.</data>
      <data key="d3">One copy of an endogenous Jaagsiekte sheep retrovirus expresses an env gene that restricts infection by exogenous Jaagsiekte sheep retroviruses in domestic sheep.</data>
      <data key="d4">PDF_03_2016</data>
    </node>
    <node id="PDF_05_2024">
      <data key="d0">Paper</data>
      <data key="d1">The Diverse Evolutionary Histories of Domesticated
Metaviral Capsid Genes in Mammals
William S. Henriques,¹ Janet M. Young,² Artem Nemudryi,¹ Anna Nemudraia,¹ Blake Wiedenheft,¹*
and Harmit S. Malik 2,3,*
'Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA
2Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
Howard Hughes Medical Institute, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
*Corresponding authors: E-mails: </data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_05_2024_Hypothesis_-8250621175794110137">
      <data key="d0">Hypothesis</data>
      <data key="d1">We sought a more in-depth structural and evolutionary understanding of these genes, focusing on different fates of domesticated genes.</data>
      <data key="d3">We sought a more in-depth structural and evolutionary understanding of these genes, focusing on different fates of domesticated genes.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Method_-7150736554121306358">
      <data key="d0">Method</data>
      <data key="d1">Using a complete human genome assembly and 25 additional vertebrate genomes, we re-analyzed the evolutionary trajectories and functional potential of capsid (CA) genes domesticated from Metaviridae, a lineage of retrovirus-like retrotransposons.</data>
      <data key="d3">Using a complete human genome assembly and 25 additional vertebrate genomes, we re-analyzed the evolutionary trajectories and functional potential of capsid (CA) genes domesticated from Metaviridae, a lineage of retrovirus-like retrotransposons.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Method_-9124649043959586590">
      <data key="d0">Method</data>
      <data key="d1">We built Hidden Markov Models (HMMs) guided by atomic structures and AlphaFold predictions of retroviral and retrotransposon CA domains.</data>
      <data key="d3">We built Hidden Markov Models (HMMs) guided by atomic structures and AlphaFold predictions of retroviral and retrotransposon CA domains.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Method_5349930148425524960">
      <data key="d0">Method</data>
      <data key="d1">We performed searches of 17 additional representative mammalian genomes using sensitive HMM searches as well as iterative blast searches with both nucleotide and protein queries.</data>
      <data key="d3">We performed searches of 17 additional representative mammalian genomes using sensitive HMM searches as well as iterative blast searches with both nucleotide and protein queries.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Method_-1751801214430949228">
      <data key="d0">Method</data>
      <data key="d1">We investigated the selective pressures on metaviral genes following their domestication, estimating the ratio of nonsynonymous (dN, amino acid altering) to synonymous (dS, amino acid preserving) nucleotide substitutions using the codeml algorithm from the PAML suite.</data>
      <data key="d3">We investigated the selective pressures on metaviral genes following their domestication, estimating the ratio of nonsynonymous (dN, amino acid altering) to synonymous (dS, amino acid preserving) nucleotide substitutions using the codeml algorithm from the PAML suite.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-7948630771760546879">
      <data key="d0">Result</data>
      <data key="d1">We find that at least five independent domestication events occurred from diverse Metaviridae, giving rise to three universally retained single-copy genes evolving under purifying selection and two gene families unique to placental mammals, with multiple members showing evidence of rapid evolution.</data>
      <data key="d3">We find that at least five independent domestication events occurred from diverse Metaviridae, giving rise to three universally retained single-copy genes evolving under purifying selection and two gene families unique to placental mammals, with multiple members showing evidence of rapid evolution.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_2707318849210144789">
      <data key="d0">Result</data>
      <data key="d1">In the SIRH/RTL family, we find diverse amino-terminal domains, widespread loss of protein-coding capacity in RTL10 despite its retention in several mammalian lineages, and differential utilization of an ancient programmed ribosomal frameshift in RTL3 between the domesticated CA and protease domains.</data>
      <data key="d3">In the SIRH/RTL family, we find diverse amino-terminal domains, widespread loss of protein-coding capacity in RTL10 despite its retention in several mammalian lineages, and differential utilization of an ancient programmed ribosomal frameshift in RTL3 between the domesticated CA and protease domains.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="Gene_RTL10">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL10</data>
      <data key="d7">RTL10</data>
    </node>
    <node id="Gene_RTL3">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL3</data>
      <data key="d7">RTL3</data>
    </node>
    <node id="PDF_05_2024_Result_-7812538130216445846">
      <data key="d0">Result</data>
      <data key="d1">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
      <data key="d3">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="Gene_PNMA">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA</data>
      <data key="d7">PNMA</data>
    </node>
    <node id="PDF_05_2024_Result_4622611134237590890">
      <data key="d0">Result</data>
      <data key="d1">Our analyses lead to a significant correction of previous annotations of the essential CCDC8 gene. We show that this putative RBD is also present in several extant Metaviridae, revealing a novel protein domain configuration in retrotransposons.</data>
      <data key="d3">Our analyses lead to a significant correction of previous annotations of the essential CCDC8 gene. We show that this putative RBD is also present in several extant Metaviridae, revealing a novel protein domain configuration in retrotransposons.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="Gene_CCDC8">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CCDC8</data>
      <data key="d7">CCDC8</data>
    </node>
    <node id="PDF_05_2024_Result_5465308162423806431">
      <data key="d0">Result</data>
      <data key="d1">We found that most of the approximately two dozen bona fide domesticated metaviral CA-like genes show clear signatures of purifying selection.</data>
      <data key="d3">We found that most of the approximately two dozen bona fide domesticated metaviral CA-like genes show clear signatures of purifying selection.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_7175811470587859729">
      <data key="d0">Result</data>
      <data key="d1">Other genes have undergone lineage-specific gene duplication, pseudogenization, or loss, implying lineage-specific retention or loss of functions. Most striking among these is the RTL10 gene, whose protein-coding capacity has only been retained in a subset of mammalian lineages.</data>
      <data key="d3">Other genes have undergone lineage-specific gene duplication, pseudogenization, or loss, implying lineage-specific retention or loss of functions. Most striking among these is the RTL10 gene, whose protein-coding capacity has only been retained in a subset of mammalian lineages.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-3879734245279788128">
      <data key="d0">Result</data>
      <data key="d1">For a small subset of domesticated genes, we find evidence of positive selection, indicating their involvement in ongoing genetic conflicts or acquisition of novel functions.</data>
      <data key="d3">For a small subset of domesticated genes, we find evidence of positive selection, indicating their involvement in ongoing genetic conflicts or acquisition of novel functions.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-5460684808047439665">
      <data key="d0">Result</data>
      <data key="d1">We find that the RTL3 domesticated genes encode either a CA-protease (PR) or separately retained CA and PR genes in different mammalian lineages.</data>
      <data key="d3">We find that the RTL3 domesticated genes encode either a CA-protease (PR) or separately retained CA and PR genes in different mammalian lineages.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-8768105610583255133">
      <data key="d0">Result</data>
      <data key="d1">Instead, we find that amino-terminal domains (NTD) are widely divergent between domesticated CA gene families, reflecting their domestication from at least four distinct Metaviridae families with distinct domain architectures.</data>
      <data key="d3">Instead, we find that amino-terminal domains (NTD) are widely divergent between domesticated CA gene families, reflecting their domestication from at least four distinct Metaviridae families with distinct domain architectures.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_6588235921724353107">
      <data key="d0">Result</data>
      <data key="d1">Among these divergent NTDs, we identify a novel, putative RNA-binding domain (RBD) encoded by the PNMA family, which has undergone dramatic expansion in mammalian genomes and can be retained either with or without an associated CA domain.</data>
      <data key="d3">Among these divergent NTDs, we identify a novel, putative RNA-binding domain (RBD) encoded by the PNMA family, which has undergone dramatic expansion in mammalian genomes and can be retained either with or without an associated CA domain.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_7471956634593402423">
      <data key="d0">Result</data>
      <data key="d1">Our survey found 24 of the 85 previously identified metaviral-derived CA genes.</data>
      <data key="d3">Our survey found 24 of the 85 previously identified metaviral-derived CA genes.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-8578088350903968672">
      <data key="d0">Result</data>
      <data key="d1">Of the 3,140 discrete CA-like sequences, we found only 467 CA sequences that contain both a start codon and have the potential to encode a full-length CA domain, whereas the remaining 2,673 contain premature stop codons or frameshift mutations and are unlikely to encode proteins capable of assembling into functional CAs.</data>
      <data key="d3">Of the 3,140 discrete CA-like sequences, we found only 467 CA sequences that contain both a start codon and have the potential to encode a full-length CA domain, whereas the remaining 2,673 contain premature stop codons or frameshift mutations and are unlikely to encode proteins capable of assembling into functional CAs.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_4191206903359502720">
      <data key="d0">Result</data>
      <data key="d1">Our analyses confirm that previous catalogs of intact human-domesticated metaviral CA genes were complete.</data>
      <data key="d3">Our analyses confirm that previous catalogs of intact human-domesticated metaviral CA genes were complete.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-6072086534126386161">
      <data key="d0">Result</data>
      <data key="d1">Our phylogenomic analyses confirm previous estimates of the age of these genes.</data>
      <data key="d3">Our phylogenomic analyses confirm previous estimates of the age of these genes.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-5174452707633006292">
      <data key="d0">Result</data>
      <data key="d1">Most domesticated metaviral CA genes are at least ~100 million years (My) old, with orthologs found in shared syntenic locations in diverse placental mammals but not in marsupials.</data>
      <data key="d3">Most domesticated metaviral CA genes are at least ~100 million years (My) old, with orthologs found in shared syntenic locations in diverse placental mammals but not in marsupials.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_1842399764617129692">
      <data key="d0">Result</data>
      <data key="d1">PEG10 is slightly older (at least ~160 My), with additional marsupial paralogs that have been previously described, whereas ARC is much older (at least ~350 My), with orthologs found across all tetrapods including birds, reptiles, and amphibians.</data>
      <data key="d3">PEG10 is slightly older (at least ~160 My), with additional marsupial paralogs that have been previously described, whereas ARC is much older (at least ~350 My), with orthologs found across all tetrapods including birds, reptiles, and amphibians.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-5473730651300802820">
      <data key="d0">Result</data>
      <data key="d1">We found that four orthologous groups in our trees (PNMA6E/F, ZCCHC12/18, PNMA6A/B, and RTL8A/B/C) contain more than one human gene (with orthologs present in other species), indicating that more recent lineage-specific duplication events continue to shape some branches of the gene family.</data>
      <data key="d3">We found that four orthologous groups in our trees (PNMA6E/F, ZCCHC12/18, PNMA6A/B, and RTL8A/B/C) contain more than one human gene (with orthologs present in other species), indicating that more recent lineage-specific duplication events continue to shape some branches of the gene family.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="Gene_PNMA6E/F">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA6E/F</data>
      <data key="d7">PNMA6E/F</data>
    </node>
    <node id="Gene_ZCCHC12">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">ZCCHC12</data>
      <data key="d7">ZCCHC12</data>
    </node>
    <node id="Gene_PNMA6A/B">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA6A/B</data>
      <data key="d7">PNMA6A/B</data>
    </node>
    <node id="Gene_RTL8">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL8</data>
      <data key="d7">RTL8</data>
    </node>
    <node id="PDF_05_2024_Result_-3071525508488539027">
      <data key="d0">Result</data>
      <data key="d1">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
      <data key="d3">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="Gene_RTL6">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL6</data>
      <data key="d7">RTL6</data>
    </node>
    <node id="PDF_05_2024_Result_4143400663467412926">
      <data key="d0">Result</data>
      <data key="d1">In contrast to the eight universally retained genes, we found that 11 of the domesticated full-length and fragmented CA genes that were in the common ancestor of placental mammals have since undergone gene loss or pseudogenization in one or more mammalian lineages, suggesting that their function is not universally required in mammals or is redundant with other genes.</data>
      <data key="d3">In contrast to the eight universally retained genes, we found that 11 of the domesticated full-length and fragmented CA genes that were in the common ancestor of placental mammals have since undergone gene loss or pseudogenization in one or more mammalian lineages, suggesting that their function is not universally required in mammals or is redundant with other genes.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-4329918700508903297">
      <data key="d0">Result</data>
      <data key="d1">For example, RTL10 was present in the common ancestor of placental mammals but is retained as an intact ORF in only the three out of 18 mammalian genomes we surveyed.</data>
      <data key="d3">For example, RTL10 was present in the common ancestor of placental mammals but is retained as an intact ORF in only the three out of 18 mammalian genomes we surveyed.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-4116608036523800360">
      <data key="d0">Result</data>
      <data key="d1">We find that most Metaviridae-origin CA genes evolve under overall purifying selection, with ARC showing the strongest purifying selection (dN/dS = 0.03). RTL6 also shows strong purifying selection (dN/dS = 0.04), despite its involvement in immune functions</data>
      <data key="d3">We find that most Metaviridae-origin CA genes evolve under overall purifying selection, with ARC showing the strongest purifying selection (dN/dS = 0.03). RTL6 also shows strong purifying selection (dN/dS = 0.04), despite its involvement in immune functions</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-5206290373688159206">
      <data key="d0">Result</data>
      <data key="d1">In contrast, for RTL10, we were barely able to rule out the null hypothesis of neutral evolution (dN/dS = 0.72, close to the neutral ratio of 1) using our initial sampling (n = 3 intact primate genes).</data>
      <data key="d3">In contrast, for RTL10, we were barely able to rule out the null hypothesis of neutral evolution (dN/dS = 0.72, close to the neutral ratio of 1) using our initial sampling (n = 3 intact primate genes).</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_-8212961012354758019">
      <data key="d0">Result</data>
      <data key="d1">These tests reveal that ten of these nineteen ancient metaviral genes contain a subset of sites evolving under positive selection in primates, suggesting ongoing involvement in evolutionary arms races.</data>
      <data key="d3">These tests reveal that ten of these nineteen ancient metaviral genes contain a subset of sites evolving under positive selection in primates, suggesting ongoing involvement in evolutionary arms races.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Result_9085200772706722116">
      <data key="d0">Result</data>
      <data key="d1">Our findings of positive selection are intriguing given previous studies that implicate three of the positively selected genes (CCDC8, RTL5, RTL9) in immune-related functions</data>
      <data key="d3">Our findings of positive selection are intriguing given previous studies that implicate three of the positively selected genes (CCDC8, RTL5, RTL9) in immune-related functions</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="Gene_RTL5">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">RTL5</data>
      <data key="d7">RTL5</data>
    </node>
    <node id="PDF_05_2024_Conclusion_-6337803684018119646">
      <data key="d0">Conclusion</data>
      <data key="d1">Collectively, our study reveals the divergent outcomes of multiple domestication events from diverse Metaviridae in the common ancestor of placental mammals.</data>
      <data key="d3">Collectively, our study reveals the divergent outcomes of multiple domestication events from diverse Metaviridae in the common ancestor of placental mammals.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_05_2024_Conclusion_565513982273108119">
      <data key="d0">Conclusion</data>
      <data key="d1">Our study reveals that recurrent domestication of the gag domain from structurally diverse Metaviridae gave rise to genes with distinct evolutionary trajectories and structural features in placental mammals.</data>
      <data key="d3">Our study reveals that recurrent domestication of the gag domain from structurally diverse Metaviridae gave rise to genes with distinct evolutionary trajectories and structural features in placental mammals.</data>
      <data key="d4">PDF_05_2024</data>
    </node>
    <node id="PDF_28_2020">
      <data key="d0">Paper</data>
      <data key="d1">Europe PMC Funders Group
Author Manuscript
Nat Med. Author manuscript; available in PMC 2020 August 10.
Published in final edited form as:
Nat Med. 2020 February ; 26(2): 252–258. doi:10.1038/s41591-020-0751-5.
Using human genetics to understand the disease impacts of
testosterone in men and women
Katherine S Ruth1,*, Felix R Day2,*, Jessica Tyrrell¹,*, Deborah J Thompson³,*, Andrew R
Wood¹, Anubha Mahajan, Robin N Beaumont¹, Laura Wittemans2,4, Susan Martin¹,
Alexander S. Busch2,5,6, A. Mesut E</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_28_2020_Hypothesis_-217224069592526071">
      <data key="d0">Hypothesis</data>
      <data key="d1">We hypothesize that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
      <data key="d3">We hypothesize that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Disease_METABOLIC DISEASES">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">METABOLIC DISEASES</data>
      <data key="d7">Metabolic diseases</data>
    </node>
    <node id="PDF_28_2020_Method_9082614510201131913">
      <data key="d0">Method</data>
      <data key="d1">Mendelian randomization is a genetic approach to understand the causal effects of putative risk factors on disease.</data>
      <data key="d3">Mendelian randomization is a genetic approach to understand the causal effects of putative risk factors on disease.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Method_3810455608429950939">
      <data key="d0">Method</data>
      <data key="d1">We identified genetic determinants of testosterone levels and related sex hormone traits in 425,097 UK Biobank study participants.</data>
      <data key="d3">We identified genetic determinants of testosterone levels and related sex hormone traits in 425,097 UK Biobank study participants.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-8077364468544576836">
      <data key="d0">Result</data>
      <data key="d1">The genetic determinants of testosterone levels are substantially different between sexes.</data>
      <data key="d3">The genetic determinants of testosterone levels are substantially different between sexes.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-2538667445842039420">
      <data key="d0">Result</data>
      <data key="d1">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
      <data key="d3">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Disease_POLYCYSTIC OVARY SYNDROME">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">POLYCYSTIC OVARY SYNDROME</data>
      <data key="d7">Polycystic ovary syndrome</data>
    </node>
    <node id="PDF_28_2020_Result_-2111775495626340592">
      <data key="d0">Result</data>
      <data key="d1">Higher testosterone has adverse effects on breast and endometrial cancers in women, and prostate cancer in men.</data>
      <data key="d3">Higher testosterone has adverse effects on breast and endometrial cancers in women, and prostate cancer in men.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Disease_ENDOMETRIAL CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">ENDOMETRIAL CANCER</data>
      <data key="d7">Endometrial cancer</data>
    </node>
    <node id="Disease_PROSTATE CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">PROSTATE CANCER</data>
      <data key="d7">Prostate cancer</data>
    </node>
    <node id="PDF_28_2020_Conclusion_4234703690517401030">
      <data key="d0">Conclusion</data>
      <data key="d1">Our findings provide insights into the disease impacts of testosterone and highlight the importance of sex-specific genetic analyses.</data>
      <data key="d3">Our findings provide insights into the disease impacts of testosterone and highlight the importance of sex-specific genetic analyses.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_1936239000753188640">
      <data key="d0">Result</data>
      <data key="d1">Assessment of our SHBG-associated loci in the published meta-analysis demonstrated 236/278 (85%, binomial P=6.1x10-34) of the captured male SHBG signals had consistent direction of effect (77 with P&lt;0.05), compared to 241/283 in women (85%, binomial P=4.2x10-35, 60 at P&lt;0.05).</data>
      <data key="d3">Assessment of our SHBG-associated loci in the published meta-analysis demonstrated 236/278 (85%, binomial P=6.1x10-34) of the captured male SHBG signals had consistent direction of effect (77 with P&lt;0.05), compared to 241/283 in women (85%, binomial P=4.2x10-35, 60 at P&lt;0.05).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_9153092349707605486">
      <data key="d0">Result</data>
      <data key="d1">Notably, several variants had genome-wide significant but directionally-opposing effects on testosterone in men and women, including the missense variants: rs56196860 in FKBP4 which encodes a regulator of androgen receptor transactivation activity; and rs28929474 in SERPINA 1 which encodes one of a family of proteins which are reported to regulate steroidogenesis in testicular Leydig cells.</data>
      <data key="d3">Notably, several variants had genome-wide significant but directionally-opposing effects on testosterone in men and women, including the missense variants: rs56196860 in FKBP4 which encodes a regulator of androgen receptor transactivation activity; and rs28929474 in SERPINA 1 which encodes one of a family of proteins which are reported to regulate steroidogenesis in testicular Leydig cells.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Gene_FKBP4">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FKBP4</data>
      <data key="d7">FKBP4</data>
    </node>
    <node id="Gene_SERPINA 1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">SERPINA 1</data>
      <data key="d7">SERPINA 1</data>
    </node>
    <node id="PDF_28_2020_Result_-5298048616412677613">
      <data key="d0">Result</data>
      <data key="d1">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
      <data key="d3">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Gene_CYP3A7">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP3A7</data>
      <data key="d7">CYP3A7</data>
    </node>
    <node id="Gene_CYP2D6">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP2D6</data>
      <data key="d7">CYP2D6</data>
    </node>
    <node id="Gene_CYP2C8">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP2C8</data>
      <data key="d7">CYP2C8</data>
    </node>
    <node id="Gene_CYP2C9">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP2C9</data>
      <data key="d7">CYP2C9</data>
    </node>
    <node id="Gene_CYP11B2">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP11B2</data>
      <data key="d7">CYP11B2</data>
    </node>
    <node id="Gene_POR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">POR</data>
      <data key="d7">POR</data>
    </node>
    <node id="PDF_28_2020_Result_-4740182779277302709">
      <data key="d0">Result</data>
      <data key="d1">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
      <data key="d3">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Gene_FSHB">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">FSHB</data>
      <data key="d7">FSHB</data>
    </node>
    <node id="Gene_THADA">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">THADA</data>
      <data key="d7">THADA</data>
    </node>
    <node id="Gene_CYP17A1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYP17A1</data>
      <data key="d7">CYP17A1</data>
    </node>
    <node id="Gene_CYB5A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">CYB5A</data>
      <data key="d7">CYB5A</data>
    </node>
    <node id="Gene_LHB">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">LHB</data>
      <data key="d7">LHB</data>
    </node>
    <node id="Gene_NR3C1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">NR3C1</data>
      <data key="d7">NR3C1</data>
    </node>
    <node id="Gene_PRLR">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PRLR</data>
      <data key="d7">PRLR</data>
    </node>
    <node id="PDF_28_2020_Result_2389533462319179189">
      <data key="d0">Result</data>
      <data key="d1">In contrast to testosterone traits, the genetic architecture of SHBG levels was highly concordant between men and women (rg 0.84 [0.81-0.87], P&lt;1x10-100); 315 (88%) of the 359 genome-wide significant variants in women were also at least nominally associated (P&lt;0.05) with SHBG in men (Table S4).</data>
      <data key="d3">In contrast to testosterone traits, the genetic architecture of SHBG levels was highly concordant between men and women (rg 0.84 [0.81-0.87], P&lt;1x10-100); 315 (88%) of the 359 genome-wide significant variants in women were also at least nominally associated (P&lt;0.05) with SHBG in men (Table S4).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_1088363242006174154">
      <data key="d0">Result</data>
      <data key="d1">Among men, we found partially overlapping genetic determinants between the different sex hormone traits. This was reflected by positive genetic correlations between all four sex hormone measures (Table 1, rg 0.19-0.73), with the exception of a weak negative correlation between SHBG and bioavailable testosterone (rg -0.048 (SE 0.024), P=0.04).</data>
      <data key="d3">Among men, we found partially overlapping genetic determinants between the different sex hormone traits. This was reflected by positive genetic correlations between all four sex hormone measures (Table 1, rg 0.19-0.73), with the exception of a weak negative correlation between SHBG and bioavailable testosterone (rg -0.048 (SE 0.024), P=0.04).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-3050406182926360430">
      <data key="d0">Result</data>
      <data key="d1">These clusters helped inform genetic causal inference analyses by showing primary metabolic effects of testosterone that were beneficial in men (lower fasting glucose and lower T2D risk) but harmful in women (higher PCOS risk).</data>
      <data key="d3">These clusters helped inform genetic causal inference analyses by showing primary metabolic effects of testosterone that were beneficial in men (lower fasting glucose and lower T2D risk) but harmful in women (higher PCOS risk).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-1523441685890294439">
      <data key="d0">Result</data>
      <data key="d1">Using these genetic instruments, in men and women separately, we could infer causal positive effects of testosterone levels on lean body mass and number of lifetime sexual partners.</data>
      <data key="d3">Using these genetic instruments, in men and women separately, we could infer causal positive effects of testosterone levels on lean body mass and number of lifetime sexual partners.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_3427928079360674293">
      <data key="d0">Result</data>
      <data key="d1">For T2D and related traits, the evidence of a protective effect of testosterone was most consistent when using the cluster-specific genetic instrument representing a primary (total and bioavailable) testosterone-increasing effect independent of SHBG.</data>
      <data key="d3">For T2D and related traits, the evidence of a protective effect of testosterone was most consistent when using the cluster-specific genetic instrument representing a primary (total and bioavailable) testosterone-increasing effect independent of SHBG.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_5321336177742059226">
      <data key="d0">Result</data>
      <data key="d1">Exposure to higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose: each 1-SD higher testosterone level (approximately 3.7 nmol/L) was associated with a 15% lower T2D risk in men (total testosterone odds ratio (OR): 0.85; 95% CI: 0.77, 0.95; cluster-specific testosterone OR: 0.86; 95% CI 0.76,0.98).</data>
      <data key="d3">Exposure to higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose: each 1-SD higher testosterone level (approximately 3.7 nmol/L) was associated with a 15% lower T2D risk in men (total testosterone odds ratio (OR): 0.85; 95% CI: 0.77, 0.95; cluster-specific testosterone OR: 0.86; 95% CI 0.76,0.98).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-4991677486666615413">
      <data key="d0">Result</data>
      <data key="d1">MR analyses indicated that testosterone increases prostate cancer risk in men: each 1-SD higher bioavailable testosterone level increased prostate cancer risk by 23% (OR: 1.23; 95%CI 1.13-1.33), with consistent findings across all testosterone genetic instruments (unfiltered, Steiger-filtered and cluster-filtered).</data>
      <data key="d3">MR analyses indicated that testosterone increases prostate cancer risk in men: each 1-SD higher bioavailable testosterone level increased prostate cancer risk by 23% (OR: 1.23; 95%CI 1.13-1.33), with consistent findings across all testosterone genetic instruments (unfiltered, Steiger-filtered and cluster-filtered).</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_6827959127765461573">
      <data key="d0">Result</data>
      <data key="d1">We found consistent evidence supporting a causal effect of testosterone on higher PCOS risk in women. These effects were most evident with bioavailable testosterone, with positive findings across all MR models and all instruments (unfiltered, Steiger-filtered and cluster- filtered). These effects equated to an odds ratio of 1.51 (95%CI 1.33-1.72) per 1-SD higher bioavailable testosterone.</data>
      <data key="d3">We found consistent evidence supporting a causal effect of testosterone on higher PCOS risk in women. These effects were most evident with bioavailable testosterone, with positive findings across all MR models and all instruments (unfiltered, Steiger-filtered and cluster- filtered). These effects equated to an odds ratio of 1.51 (95%CI 1.33-1.72) per 1-SD higher bioavailable testosterone.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-148982913318525410">
      <data key="d0">Result</data>
      <data key="d1">MR analyses also showed a causal effect of bioavailable testosterone on higher T2D risk and higher fasting insulin in women (using unfiltered and Steiger-filtered instruments). Risk of T2D was increased by 37% (OR: 1.37; 95% CI 1.22, 1.53) per 1-SD higher bioavailable testosterone.</data>
      <data key="d3">MR analyses also showed a causal effect of bioavailable testosterone on higher T2D risk and higher fasting insulin in women (using unfiltered and Steiger-filtered instruments). Risk of T2D was increased by 37% (OR: 1.37; 95% CI 1.22, 1.53) per 1-SD higher bioavailable testosterone.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-246187985418947255">
      <data key="d0">Result</data>
      <data key="d1">We found evidence that testosterone increased the risk of estrogen receptor (ER)+ but not ER-breast cancer, with consistent findings across all MR models and instruments.</data>
      <data key="d3">We found evidence that testosterone increased the risk of estrogen receptor (ER)+ but not ER-breast cancer, with consistent findings across all MR models and instruments.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="PDF_28_2020_Result_-2575054046163591484">
      <data key="d0">Result</data>
      <data key="d1">Furthermore, testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer, again with consistent findings across sensitivity models.</data>
      <data key="d3">Furthermore, testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer, again with consistent findings across sensitivity models.</data>
      <data key="d4">PDF_28_2020</data>
    </node>
    <node id="Disease_OVARIAN CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">OVARIAN CANCER</data>
      <data key="d7">Ovarian cancer</data>
    </node>
    <node id="PDF_07_2018_u">
      <data key="d0">Paper</data>
      <data key="d1">Accepted Manuscript
PNMA Family: Protein Interaction Network and Cell Signalling Pathways Implicated
in Cancer and Apoptosis
Siew Wai Panga, Chandrajit Lahiria, Chit Laa Pohb, Kuan Onn Tana*
Department of Biological Sciences, Research Centre for Biomedical Sciences, Sunway
University, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia
*Corresponding author
Email address: jefft@sunway.edu.my
ABSTRACT
Paraneoplastic Ma Family (PNMA) comprises a growing number of family members
which share relativ</data>
      <data key="d2">2024</data>
    </node>
    <node id="PDF_07_2018_u_Result_6967398282304042958">
      <data key="d0">Result</data>
      <data key="d1">PNMA family members share high protein sequence homology with the highest sequence homology of 84% between PNMA7A and PNMA7B.</data>
      <data key="d3">PNMA family members share high protein sequence homology with the highest sequence homology of 84% between PNMA7A and PNMA7B.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_PNMA7A">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA7A</data>
      <data key="d7">PNMA7A</data>
    </node>
    <node id="Protein_PNMA7B">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA7B</data>
      <data key="d7">PNMA7B</data>
    </node>
    <node id="PDF_07_2018_u_Result_2917739563603746068">
      <data key="d0">Result</data>
      <data key="d1">The lowest protein sequence homology of 9.5% is between PNMA7A and CCDC8.</data>
      <data key="d3">The lowest protein sequence homology of 9.5% is between PNMA7A and CCDC8.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_CCDC8">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CCDC8</data>
      <data key="d7">CCDC8</data>
    </node>
    <node id="PDF_07_2018_u_Result_430883512617757375">
      <data key="d0">Result</data>
      <data key="d1">PNMA family members share high sequence homology at the N-terminal conserved domain (NCD), except PNMA7A, and PNMA7B.</data>
      <data key="d3">PNMA family members share high sequence homology at the N-terminal conserved domain (NCD), except PNMA7A, and PNMA7B.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_3650887773818418760">
      <data key="d0">Result</data>
      <data key="d1">The other conserved domain of the PNMA family members is the central conserved domain (CCD), except PNMA8A-C, which show significant sequence divergence within this region.</data>
      <data key="d3">The other conserved domain of the PNMA family members is the central conserved domain (CCD), except PNMA8A-C, which show significant sequence divergence within this region.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_PNMA8A">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA8A</data>
      <data key="d7">PNMA8A</data>
    </node>
    <node id="PDF_07_2018_u_Result_796343488752759396">
      <data key="d0">Result</data>
      <data key="d1">Situated between NCD and CCD domains are unique protein sequence or domain (UPD) found in some members of PNMA including the BH3-like (BH3-L) domain of MOAP-1 and PNMA1.</data>
      <data key="d3">Situated between NCD and CCD domains are unique protein sequence or domain (UPD) found in some members of PNMA including the BH3-like (BH3-L) domain of MOAP-1 and PNMA1.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_PNMA1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA1</data>
      <data key="d7">PNMA1</data>
    </node>
    <node id="PDF_07_2018_u_Result_7666105977062708496">
      <data key="d0">Result</data>
      <data key="d1">a region rich in Lysine and Arginine basic residues, and designated as KRs is found in the protein sequences of all the members of PNMA family, except PNMA8B, and PNMA8C.</data>
      <data key="d3">a region rich in Lysine and Arginine basic residues, and designated as KRs is found in the protein sequences of all the members of PNMA family, except PNMA8B, and PNMA8C.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_PNMA8B">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA8B</data>
      <data key="d7">PNMA8B</data>
    </node>
    <node id="Protein_PNMA8C">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA8C</data>
      <data key="d7">PNMA8C</data>
    </node>
    <node id="PDF_07_2018_u_Result_-7658845461493436191">
      <data key="d0">Result</data>
      <data key="d1">PNMA family members share sequence homology at a poly-glutamic acid rich region (PolyE) near the C-terminus, except PNMA6F, 8A, and 8C.</data>
      <data key="d3">PNMA family members share sequence homology at a poly-glutamic acid rich region (PolyE) near the C-terminus, except PNMA6F, 8A, and 8C.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_PNMA6F">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">PNMA6F</data>
      <data key="d7">PNMA6F</data>
    </node>
    <node id="PDF_07_2018_u_Result_8573876462104716775">
      <data key="d0">Result</data>
      <data key="d1">Nuclear targeting signal of PNMA5 was identified in the VCS region of PNMA5, PNMA7A and PNMA7B</data>
      <data key="d3">Nuclear targeting signal of PNMA5 was identified in the VCS region of PNMA5, PNMA7A and PNMA7B</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-903663589177214580">
      <data key="d0">Result</data>
      <data key="d1">Functional analysis of some members of this family have identified protein domains that are required for subcellular localization, protein-protein interactions, and cell signalling events</data>
      <data key="d3">Functional analysis of some members of this family have identified protein domains that are required for subcellular localization, protein-protein interactions, and cell signalling events</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_4162666203042980428">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
      <data key="d3">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-4457804855602327466">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
      <data key="d3">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_RASSF">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">RASSF</data>
      <data key="d7">RASSF</data>
    </node>
    <node id="Protein_TNF">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">TNF</data>
      <data key="d7">TNF</data>
    </node>
    <node id="PDF_07_2018_u_Result_-603793349120865973">
      <data key="d0">Result</data>
      <data key="d1">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
      <data key="d3">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_SMAD1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">SMAD1</data>
      <data key="d7">Smad1</data>
    </node>
    <node id="Protein_BMP">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">BMP</data>
      <data key="d7">BMP</data>
    </node>
    <node id="PDF_07_2018_u_Result_-124952066393809203">
      <data key="d0">Result</data>
      <data key="d1">PNMA7A was identified as transcriptional co-activator that interacts with c-Jun and activates AP-1 and CREB signalling</data>
      <data key="d3">PNMA7A was identified as transcriptional co-activator that interacts with c-Jun and activates AP-1 and CREB signalling</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_C-JUN">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">C-JUN</data>
      <data key="d7">c-Jun</data>
    </node>
    <node id="Protein_CREB">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CREB</data>
      <data key="d7">CREB</data>
    </node>
    <node id="PDF_07_2018_u_Result_-9052016064248680024">
      <data key="d0">Result</data>
      <data key="d1">mutations of PNMA7A were found to be associated with human mental retardation</data>
      <data key="d3">mutations of PNMA7A were found to be associated with human mental retardation</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Gene_PNMA7A">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">PNMA7A</data>
      <data key="d7">PNMA7A</data>
    </node>
    <node id="Disease_MENTAL RETARDATION">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">MENTAL RETARDATION</data>
      <data key="d7">Mental retardation</data>
    </node>
    <node id="PDF_07_2018_u_Result_2619999751612699767">
      <data key="d0">Result</data>
      <data key="d1">recent studies showed that PNMA7A functions as an oncogene and the expression is elevated in thyroid cancer cells</data>
      <data key="d3">recent studies showed that PNMA7A functions as an oncogene and the expression is elevated in thyroid cancer cells</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Disease_THYROID CANCER">
      <data key="d0">Entity</data>
      <data key="d5">Disease</data>
      <data key="d6">THYROID CANCER</data>
      <data key="d7">Thyroid cancer</data>
    </node>
    <node id="PDF_07_2018_u_Result_-2751770189889020198">
      <data key="d0">Result</data>
      <data key="d1">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
      <data key="d3">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-183868857310836864">
      <data key="d0">Result</data>
      <data key="d1">OBSL-1 was found to be the common protein interacting partner of both CCDC8 and CUL7</data>
      <data key="d3">OBSL-1 was found to be the common protein interacting partner of both CCDC8 and CUL7</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_OBSL-1">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">OBSL-1</data>
      <data key="d7">OBSL-1</data>
    </node>
    <node id="Protein_CUL7">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">CUL7</data>
      <data key="d7">CUL7</data>
    </node>
    <node id="PDF_07_2018_u_Result_7617531455839023636">
      <data key="d0">Result</data>
      <data key="d1">patients with 3-M syndrome were found to exhibit growth hormone deficiency or disordered growth factor signalling</data>
      <data key="d3">patients with 3-M syndrome were found to exhibit growth hormone deficiency or disordered growth factor signalling</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_8038901095270458073">
      <data key="d0">Result</data>
      <data key="d1">CCDC8 protein level is relative low in tumour cells, and over-expression of CCDC8 in cancer cells inhibits invasiveness and metastasis of cancer cells</data>
      <data key="d3">CCDC8 protein level is relative low in tumour cells, and over-expression of CCDC8 in cancer cells inhibits invasiveness and metastasis of cancer cells</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-438750193021511875">
      <data key="d0">Result</data>
      <data key="d1">RASSF1A is a tumor suppressor and its protein expression is frequently silenced in many cancer cells through hyper-methylation of its gene promoter</data>
      <data key="d3">RASSF1A is a tumor suppressor and its protein expression is frequently silenced in many cancer cells through hyper-methylation of its gene promoter</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-8915771799138376165">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
      <data key="d3">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_596475561888453619">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 was shown to interact with RASSF1A, and TNF-R through its RASSF1A binding domain within the KRs region and poly-glutamic acid rich residues (polyE) of its C-terminus, respectively.</data>
      <data key="d3">MOAP-1 was shown to interact with RASSF1A, and TNF-R through its RASSF1A binding domain within the KRs region and poly-glutamic acid rich residues (polyE) of its C-terminus, respectively.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_7788417139704865264">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 was reported to be present in an inactive conformation through intramolecular interaction, and by interacting with RASSF1A, MOAP-1 is unfolded with its exposed BH3-like domain to interact and promote Bax activation, leading to transmigration of activated Bax to the mitochondria</data>
      <data key="d3">MOAP-1 was reported to be present in an inactive conformation through intramolecular interaction, and by interacting with RASSF1A, MOAP-1 is unfolded with its exposed BH3-like domain to interact and promote Bax activation, leading to transmigration of activated Bax to the mitochondria</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-7410083995776227336">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 was reported as MTCH2 interacting protein and plays an important role in Fas receptor mediated apoptosis signalling by promoting recruitment of tBid to the mitochondria during apoptosis</data>
      <data key="d3">MOAP-1 was reported as MTCH2 interacting protein and plays an important role in Fas receptor mediated apoptosis signalling by promoting recruitment of tBid to the mitochondria during apoptosis</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-4560048891170104957">
      <data key="d0">Result</data>
      <data key="d1">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1.</data>
      <data key="d3">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1.</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_5009335901464109085">
      <data key="d0">Result</data>
      <data key="d1">interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
      <data key="d3">interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_3323142523373010295">
      <data key="d0">Result</data>
      <data key="d1">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
      <data key="d3">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-1751590031790914324">
      <data key="d0">Result</data>
      <data key="d1">over-expressed PNMA2 failed to promote apoptotic signalling in transfected MCF-7 cells</data>
      <data key="d3">over-expressed PNMA2 failed to promote apoptotic signalling in transfected MCF-7 cells</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-8310376796190221931">
      <data key="d0">Result</data>
      <data key="d1">PNMA2 was shown to interact with both PNMA1 and MOAP-1 in co-immunoprecipitation studies, as well as functionally antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
      <data key="d3">PNMA2 was shown to interact with both PNMA1 and MOAP-1 in co-immunoprecipitation studies, as well as functionally antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-4275182837630616509">
      <data key="d0">Result</data>
      <data key="d1">transient co-expression of MOAP-1 and PNMA5 synergistically enhanced apoptotic signalling in transfected cancer cells</data>
      <data key="d3">transient co-expression of MOAP-1 and PNMA5 synergistically enhanced apoptotic signalling in transfected cancer cells</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_3231423044467125708">
      <data key="d0">Result</data>
      <data key="d1">over-expressed CCDC8 inhibited invasiveness of A549 cells while CCDC8 knock-downed cells promoted invasiveness of the cancer cells in cell migration assay</data>
      <data key="d3">over-expressed CCDC8 inhibited invasiveness of A549 cells while CCDC8 knock-downed cells promoted invasiveness of the cancer cells in cell migration assay</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_6830077210168047751">
      <data key="d0">Result</data>
      <data key="d1">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay</data>
      <data key="d3">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Protein_ZCCHC12">
      <data key="d0">Entity</data>
      <data key="d5">Protein</data>
      <data key="d6">ZCCHC12</data>
      <data key="d7">ZCCHC12</data>
    </node>
    <node id="PDF_07_2018_u_Result_-8392931956633663813">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 has a short half-life of 25 min and the stability of the protein is regulated through ubiquitin proteasome pathway in which degradation of MOAP-1 occurred at G1, and S-G2 phases of cell cycle by the APC/CCdh1 and the UBR5 ubiquitin ligases, respectively</data>
      <data key="d3">MOAP-1 has a short half-life of 25 min and the stability of the protein is regulated through ubiquitin proteasome pathway in which degradation of MOAP-1 occurred at G1, and S-G2 phases of cell cycle by the APC/CCdh1 and the UBR5 ubiquitin ligases, respectively</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-5588286335462859396">
      <data key="d0">Result</data>
      <data key="d1">Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/CCdh1-mediated ubiquitination and degradation</data>
      <data key="d3">Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/CCdh1-mediated ubiquitination and degradation</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_7535371967778245814">
      <data key="d0">Result</data>
      <data key="d1">MOAP-1 protein level was enhanced or stabilized in the cancer cells when treated with chemo-drugs or apoptosis stimuli</data>
      <data key="d3">MOAP-1 protein level was enhanced or stabilized in the cancer cells when treated with chemo-drugs or apoptosis stimuli</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_3903858293143824201">
      <data key="d0">Result</data>
      <data key="d1">miRNA-1228 negatively regulates MOAP-1 expression by binding to the miRNA target sequence of the MOAP-1 mRNA, and down-regulation of miRNA-1228 was shown to promote MOAP-1 stabilization</data>
      <data key="d3">miRNA-1228 negatively regulates MOAP-1 expression by binding to the miRNA target sequence of the MOAP-1 mRNA, and down-regulation of miRNA-1228 was shown to promote MOAP-1 stabilization</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="Gene_MOAP-1">
      <data key="d0">Entity</data>
      <data key="d5">Gene</data>
      <data key="d6">MOAP-1</data>
      <data key="d7">MOAP-1</data>
    </node>
    <node id="PDF_07_2018_u_Result_6409500103081842803">
      <data key="d0">Result</data>
      <data key="d1">miR-25 has been reported to promote cell proliferation by promoting down-regulation of MOAP-1 expression in lung cancer</data>
      <data key="d3">miR-25 has been reported to promote cell proliferation by promoting down-regulation of MOAP-1 expression in lung cancer</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_-2911187999974191348">
      <data key="d0">Result</data>
      <data key="d1">pro-apoptotic activity of MOAP-1 was reported to be regulated by members of PNMA family</data>
      <data key="d3">pro-apoptotic activity of MOAP-1 was reported to be regulated by members of PNMA family</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_6676597599829207706">
      <data key="d0">Result</data>
      <data key="d1">Co-expression of MOAP-1 with PNMA2 resulted in inhibition of pro-apoptotic activity of MOAP-1 in transiently transfected cancer cells</data>
      <data key="d3">Co-expression of MOAP-1 with PNMA2 resulted in inhibition of pro-apoptotic activity of MOAP-1 in transiently transfected cancer cells</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_8682849258717922793">
      <data key="d0">Result</data>
      <data key="d1">Interestingly, PNMA2 has been shown to antagonize both pro-apoptotic activities of MOAP-1 and PNMA1 through heterodimeric interaction with MOAP-1 and PNMA1</data>
      <data key="d3">Interestingly, PNMA2 has been shown to antagonize both pro-apoptotic activities of MOAP-1 and PNMA1 through heterodimeric interaction with MOAP-1 and PNMA1</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_417535115365772183">
      <data key="d0">Result</data>
      <data key="d1">co-expression of MOAP-1 with PNMA5 significantly enhanced pro-apoptotic activity of MOAP-1 in transfected cancer cells</data>
      <data key="d3">co-expression of MOAP-1 with PNMA5 significantly enhanced pro-apoptotic activity of MOAP-1 in transfected cancer cells</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Result_3470336897953622803">
      <data key="d0">Result</data>
      <data key="d1">CCDC8 was found to be hyper-methylated or epigenetically silenced in breast tumors that showed metastasis potential</data>
      <data key="d3">CCDC8 was found to be hyper-methylated or epigenetically silenced in breast tumors that showed metastasis potential</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Hypothesis_-5432545647274465642">
      <data key="d0">Hypothesis</data>
      <data key="d1">the expression of PNMA family members may be regulated through other cellular mechanisms</data>
      <data key="d3">the expression of PNMA family members may be regulated through other cellular mechanisms</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <node id="PDF_07_2018_u_Method_-1891167484164689156">
      <data key="d0">Method</data>
      <data key="d1">using the Blast tool of Ensembl</data>
      <data key="d3">using the Blast tool of Ensembl</data>
      <data key="d4">PDF_07_2018_u</data>
    </node>
    <edge source="PDF_59_2021" target="PDF_59_2021_Method_8555089686631967267">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_59_2021" target="PDF_59_2021_Result_-396664699954888416">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_59_2021" target="PDF_59_2021_Result_6868027964320193478">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_59_2021" target="PDF_59_2021_Result_7083814114640163605">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_59_2021" target="PDF_59_2021_Conclusion_-3231416748386769626">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_59_2021_Result_6868027964320193478" target="Gene_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">WNN analysis exhibited superior or equivalent performance to alternative approaches for each of the 25 proteins, as well as the RNA transcriptome</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Hypothesis_-2067254802045177128">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Method_2971991304512974076">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Method_6986028135312992208">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Method_1237512635389314286">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Method_6906002643227996844">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Method_-3607690434020706431">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Result_-8141722876521394081">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015" target="PDF_47_2015_Conclusion_-7873761754406593097">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_47_2015_Hypothesis_-2067254802045177128" target="Disease_INFLUENZA VIRUS">
      <data key="d8">MENTIONS</data>
      <data key="d9">the dual use of the nanobiomaterial chimeric VLPs as a platform for vaccination against influenza A virus</data>
    </edge>
    <edge source="PDF_47_2015_Hypothesis_-2067254802045177128" target="Protein_M1">
      <data key="d8">MENTIONS</data>
      <data key="d9">the dual use of the nanobiomaterial chimeric VLPs as a platform for vaccination against influenza A virus</data>
    </edge>
    <edge source="PDF_47_2015_Hypothesis_-2067254802045177128" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">the dual use of the nanobiomaterial chimeric VLPs as a platform for vaccination against influenza A virus</data>
    </edge>
    <edge source="PDF_47_2015_Method_2971991304512974076" target="Protein_M1">
      <data key="d8">MENTIONS</data>
      <data key="d9">chimeric VLPs were prepared using gag and M1 capsid proteins</data>
    </edge>
    <edge source="PDF_47_2015_Method_2971991304512974076" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">chimeric VLPs were prepared using gag and M1 capsid proteins</data>
    </edge>
    <edge source="PDF_47_2015_Method_6986028135312992208" target="Protein_M1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Chimeric VLPs were expressed in silkworms, and larval hemolymph was collected, which was used for purification using DDDDK-tagged protein purification gel.</data>
    </edge>
    <edge source="PDF_47_2015_Method_6986028135312992208" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">Chimeric VLPs were expressed in silkworms, and larval hemolymph was collected, which was used for purification using DDDDK-tagged protein purification gel.</data>
    </edge>
    <edge source="PDF_47_2015_Method_-3607690434020706431" target="Gene_DNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">chimeric VLPs with doxorubicin a known effective chemotherapeutic reagent that intercalates DNA.</data>
    </edge>
    <edge source="PDF_47_2015_Method_-3607690434020706431" target="Compound_DOXORUBICIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">chimeric VLPs with doxorubicin a known effective chemotherapeutic reagent that intercalates DNA.</data>
    </edge>
    <edge source="PDF_47_2015_Result_-8141722876521394081" target="Disease_INFLUENZA VIRUS">
      <data key="d8">MENTIONS</data>
      <data key="d9">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
    </edge>
    <edge source="PDF_47_2015_Result_-8141722876521394081" target="Protein_M1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
    </edge>
    <edge source="PDF_47_2015_Result_-8141722876521394081" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">The serum showed specificity for chimera as well as swine flu-influenza A virus (H1N1).</data>
    </edge>
    <edge source="PDF_47_2015_Conclusion_-7873761754406593097" target="Disease_INFLUENZA VIRUS">
      <data key="d8">MENTIONS</data>
      <data key="d9">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
    </edge>
    <edge source="PDF_47_2015_Conclusion_-7873761754406593097" target="Protein_M1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
    </edge>
    <edge source="PDF_47_2015_Conclusion_-7873761754406593097" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">We prepared a nanobiomaterial with dual function of DDS and vaccination using two capsid proteins, gag-577 and M1, to target tumors and provide immunity against influenza virus</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Hypothesis_9145217608372488246">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Method_3355561105809089282">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Method_-7322543800572006856">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Method_-7411871501972655322">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Method_-2795797867525489279">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Result_1244115097555209734">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Result_-3083704486613450933">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Conclusion_8957017362153238353">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013" target="PDF_18_2013_Conclusion_-618019860618239858">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_18_2013_Hypothesis_9145217608372488246" target="Disease_DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">polymorphisms in regulatory regions probably contribute to many disease phenotypes</data>
    </edge>
    <edge source="PDF_18_2013_Result_-3083704486613450933" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Genetic variation can also influence gene expression through alterations in splicing, noncoding RNA expression and RNA stability</data>
    </edge>
    <edge source="PDF_18_2013_Conclusion_8957017362153238353" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">A large-scale GTEx resource will be a powerful tool in unraveling the complex patterns of genetic variation and gene regulation across diverse human tissue types</data>
    </edge>
    <edge source="PDF_18_2013_Conclusion_-618019860618239858" target="Disease_DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">The GTEx project will aid in the interpretation of GWAS findings for translational research by providing data and resources on eQTLs in a wide range of tissues of relevance to many diseases</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_1232533132656410363">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_6295905729555225160">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_-5005069938393570841">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_-8351889389887584085">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_-1285961404983887914">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_-2613529904302867661">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_4886046759576315579">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Result_-5040507421319311137">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015" target="PDF_43_2015_Conclusion_2995070332061102522">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_43_2015_Result_1232533132656410363" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 forms amyloid-like aggregates and that it is the amyloid-like form of Rim4 that is the active, translationally repressive form of the protein.</data>
    </edge>
    <edge source="PDF_43_2015_Result_6295905729555225160" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 aggregation is a developmentally regulated process; starvation induces the conversion of monomeric Rim4 into amyloid-like aggregates, thereby activating the protein to bring about repression of translation.</data>
    </edge>
    <edge source="PDF_43_2015_Result_-5005069938393570841" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">At the onset of meiosis II, Rim4 aggregates are abruptly degraded allowing translation to commence.</data>
    </edge>
    <edge source="PDF_43_2015_Result_-8351889389887584085" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
    </edge>
    <edge source="PDF_43_2015_Result_-8351889389887584085" target="Gene_CLB3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 binds to b-isox and does so during the stages of meiosis when the protein actively inhibits CLB3 translation.</data>
    </edge>
    <edge source="PDF_43_2015_Result_-1285961404983887914" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 forms fibrillar helical structures.</data>
    </edge>
    <edge source="PDF_43_2015_Result_-2613529904302867661" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 fibers are composed of ẞ sheets.</data>
    </edge>
    <edge source="PDF_43_2015_Result_4886046759576315579" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 structures within the cell are largely static.</data>
    </edge>
    <edge source="PDF_43_2015_Result_-5040507421319311137" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim44204C was not cleared from cells efficiently compared to Rim4-EGFP. The mutant protein persisted in cells well beyond exit from meiosis I.</data>
    </edge>
    <edge source="PDF_46_2010" target="PDF_46_2010_Hypothesis_-3405269730038062220">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_46_2010" target="PDF_46_2010_Method_13251123843783398">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_46_2010" target="PDF_46_2010_Result_-2080384439553327116">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_46_2010" target="PDF_46_2010_Result_3576297978772130101">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_46_2010" target="PDF_46_2010_Conclusion_1116816789150258791">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_46_2010" target="PDF_46_2010_Conclusion_6644930847896084558">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_46_2010_Hypothesis_-3405269730038062220" target="Protein_PUMILIO">
      <data key="d8">MENTIONS</data>
      <data key="d9">Vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
    </edge>
    <edge source="PDF_46_2010_Hypothesis_-3405269730038062220" target="Protein_EIF4E">
      <data key="d8">MENTIONS</data>
      <data key="d9">Vertebrate Pumilio can repress translation by blocking the assembly of the essential initiation complex on the cap.</data>
    </edge>
    <edge source="PDF_46_2010_Method_13251123843783398" target="Protein_PUM2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Using deletion analysis, we have mapped the cap interaction domain of Pum2 to the amino terminus of the protein and identified a conserved tryptophan residue that mediates this specific interaction.</data>
    </edge>
    <edge source="PDF_46_2010_Result_-2080384439553327116" target="Protein_PUM2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
    </edge>
    <edge source="PDF_46_2010_Result_-2080384439553327116" target="Protein_EIF4E">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pum2 binds directly to the 5' 7mG cap structure; in so doing, it precludes eIF4E from binding the cap.</data>
    </edge>
    <edge source="PDF_46_2010_Result_3576297978772130101" target="Protein_PUM2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Reporter mRNA-based assays demonstrate that Pum2 requires the conserved tryptophan to repress translation in injected Xenopus oocytes.</data>
    </edge>
    <edge source="PDF_46_2010_Conclusion_1116816789150258791" target="Protein_PUM2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pum2 represses translation by a novel mechanism.</data>
    </edge>
    <edge source="PDF_46_2010_Conclusion_6644930847896084558" target="Protein_PUM2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pum2 combines two binding specificities, with the cap and the 3' UTR PBE, to repress translation.</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Hypothesis_-1004234798704718426">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Method_-5853943805316702823">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Method_-513096850265994287">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Method_8289517316011524710">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Result_-2978051934439163862">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Result_-1004234798704718426">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Result_-2176971479370297039">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Result_-574567070756559876">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Result_7891659851682385134">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Result_6996102153578627956">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Conclusion_-8703100330869748797">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_04_2013" target="PDF_04_2013_Conclusion_-2706192554863336224">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Hypothesis_-6356674699053909287">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Method_693890980709095830">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Method_1967647359851464652">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Result_-2718178320447919999">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Result_-6694412374928544773">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Result_2739798725196345567">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021" target="PDF_44_2021_Conclusion_3631881401228220472">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_44_2021_Hypothesis_-6356674699053909287" target="Gene_NORAD">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
    </edge>
    <edge source="PDF_44_2021_Hypothesis_-6356674699053909287" target="Protein_PUMILIO">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD is able to negatively regulate PUM proteins by nucleating the formation of phase-separated cytoplasmic PUM condensates, which we termed NORAD-PUM (NP) bodies.</data>
    </edge>
    <edge source="PDF_44_2021_Result_-2718178320447919999" target="Gene_NORAD">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
    </edge>
    <edge source="PDF_44_2021_Result_-2718178320447919999" target="Protein_PUMILIO">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD drives the highly efficient condensation and sequestration of PUM proteins in NP bodies through at least two complementary mechanisms: multivalent PUM-NORAD RNA binding interactions and IDR-driven PUM-PUM interactions.</data>
    </edge>
    <edge source="PDF_44_2021_Result_-6694412374928544773" target="Gene_NORAD">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD depletion in parental, circPRE)-, or low-valency circPRE1-2-expressing cells resulted in a significant increase in chromosome segregation defects.</data>
    </edge>
    <edge source="PDF_44_2021_Result_2739798725196345567" target="Protein_PUMILIO">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of PUM condensate-inducing circPRE4 or circPRE8, at levels that supplied comparable or fewer total PREs per cell than the low-valency constructs, suppressed aberrant chromosome segregation.</data>
    </edge>
    <edge source="PDF_44_2021_Conclusion_3631881401228220472" target="Gene_NORAD">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD is able to out-compete thousands of other transcripts to bind and regulate the activity of PUM proteins by nucleating the formation of liquid-like cytoplasmic RNP condensates, termed NP bodies.</data>
    </edge>
    <edge source="PDF_44_2021_Conclusion_3631881401228220472" target="Protein_PUMILIO">
      <data key="d8">MENTIONS</data>
      <data key="d9">NORAD is able to out-compete thousands of other transcripts to bind and regulate the activity of PUM proteins by nucleating the formation of liquid-like cytoplasmic RNP condensates, termed NP bodies.</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_6760138119466857430">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_-8392518174099388496">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_1353884620932293391">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Method_5436116581824974414">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_7075937358766314031">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_-3821930742129508863">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_6190377741352676371">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_-3542001147096938638">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018" target="PDF_13_2018_Result_-1582368244051296899">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_13_2018_Result_-8392518174099388496" target="Gene_HMGA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-8392518174099388496" target="Gene_PIWIL4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-8392518174099388496" target="Gene_TEX29">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-8392518174099388496" target="Gene_SCML1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-8392518174099388496" target="Gene_CCDC112">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several stage-specific marker genes of human germ cells were identified, including HMGA1, PIWIL4, TEX29, SCML1, and CCDC112.</data>
    </edge>
    <edge source="PDF_13_2018_Result_1353884620932293391" target="Disease_NOA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Altered gene expression patterns were identified in the testicular somatic cells of one NOA patient via scRNA-seq analysis.</data>
    </edge>
    <edge source="PDF_13_2018_Method_5436116581824974414" target="Disease_NOA">
      <data key="d8">MENTIONS</data>
      <data key="d9">scRNA sequencing of 2,854 individual testicular cells from donors with normal spermatogenesis and 174 testicular cells from one donor diagnosed as having nonobstructive azoospermia (NOA) using a modified scRNA-seq method.</data>
    </edge>
    <edge source="PDF_13_2018_Result_7075937358766314031" target="Gene_GFRA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">GFRA1 and RET were highly enriched in cluster 1, which was associated with self-renewal of spermatogonia via the RET pathway.</data>
    </edge>
    <edge source="PDF_13_2018_Result_7075937358766314031" target="Gene_RET">
      <data key="d8">MENTIONS</data>
      <data key="d9">GFRA1 and RET were highly enriched in cluster 1, which was associated with self-renewal of spermatogonia via the RET pathway.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-3821930742129508863" target="Gene_FGFR3">
      <data key="d8">MENTIONS</data>
      <data key="d9">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-3821930742129508863" target="Gene_BMPR1B">
      <data key="d8">MENTIONS</data>
      <data key="d9">FGFR3 and BMPR1B were predominantly co-expressed in cluster 1.</data>
    </edge>
    <edge source="PDF_13_2018_Result_6190377741352676371" target="Gene_DMRT1">
      <data key="d8">MENTIONS</data>
      <data key="d9">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells.</data>
    </edge>
    <edge source="PDF_13_2018_Result_6190377741352676371" target="Gene_GFRA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells.</data>
    </edge>
    <edge source="PDF_13_2018_Result_6190377741352676371" target="Gene_UTF1">
      <data key="d8">MENTIONS</data>
      <data key="d9">DMRT1 was highly expressed in GFRA1highUTF1low cells but downregulated in GFRA1lowUTF1high cells.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-3542001147096938638" target="Gene_PIWIL4">
      <data key="d8">MENTIONS</data>
      <data key="d9">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs.</data>
    </edge>
    <edge source="PDF_13_2018_Result_-3542001147096938638" target="Gene_FGFR3">
      <data key="d8">MENTIONS</data>
      <data key="d9">PIWIL4 was highly expressed in a proportion of FGFR3high SSCs.</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Hypothesis_1471499653583860445">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Method_-7853830282551524773">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_-1222015465563957096">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_3646420711576390928">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_-6142646404841884170">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_-4381403732090175772">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_-4626389359787746016">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_-4895343190942377132">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_-4532093255262841035">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Result_7953584757813559338">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018" target="PDF_35_2018_Conclusion_2113275934678562524">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_35_2018_Result_-1222015465563957096" target="Gene_PTK2">
      <data key="d8">MENTIONS</data>
      <data key="d9">deletion of Ptk2 reduces the number of TZPs by about one-third</data>
    </edge>
    <edge source="PDF_35_2018_Result_-6142646404841884170" target="Gene_KITL">
      <data key="d8">MENTIONS</data>
      <data key="d9">KITL produced by the granulosa cells in the primordial follicle triggers growth of the enclosed oocyte.</data>
    </edge>
    <edge source="PDF_35_2018_Result_-4626389359787746016" target="Gene_GJA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">gap junctional communication mediated through GJA1 between the granulosa cells is required for normal oocyte development</data>
    </edge>
    <edge source="PDF_35_2018_Result_-4895343190942377132" target="Gene_GJA4">
      <data key="d8">MENTIONS</data>
      <data key="d9">GJA4 is essential in oocytes but not in granulosa cells for gap junctional coupling between the two cell types and for normal oocyte development.</data>
    </edge>
    <edge source="PDF_35_2018_Result_7953584757813559338" target="Protein_GDF9">
      <data key="d8">MENTIONS</data>
      <data key="d9">GDF9 and bone morphogenetic protein (BMP) 15 regulate differentiation of the somatic compartment of the follicle</data>
    </edge>
    <edge source="PDF_35_2018_Result_7953584757813559338" target="Protein_BMP15">
      <data key="d8">MENTIONS</data>
      <data key="d9">GDF9 and bone morphogenetic protein (BMP) 15 regulate differentiation of the somatic compartment of the follicle</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Method_-1219795650780411187">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Method_4902097279125757331">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Method_8956086421417944838">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Result_4407109962732350617">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Method_-5397861566614506470">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Method_4042852740830363960">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Result_5879963537206037678">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019" target="PDF_53_2019_Result_-1173615124721186537">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_53_2019_Method_4902097279125757331" target="Protein_HEMAGGLUTININ">
      <data key="d8">MENTIONS</data>
      <data key="d9">Using uranyl acetate stained molecular complexes of influenza hemagglutinin bound to Fab 441D6, we describe a simple and efficient means to collect several hundred micrographs with SerialEM.</data>
    </edge>
    <edge source="PDF_53_2019_Method_8956086421417944838" target="Protein_HEMAGGLUTININ">
      <data key="d8">MENTIONS</data>
      <data key="d9">Using RELION, we illustrate how tens of thousands of complexes can be auto-picked and classified to accurately describe the domain level topology of this unconventional hemagglutinin head-domain epitope.</data>
    </edge>
    <edge source="PDF_53_2019_Method_4042852740830363960" target="Protein_HEMAGGLUTININ">
      <data key="d8">MENTIONS</data>
      <data key="d9">As an example for this article, we use the molecular complex of the antibody fragment antigen-binding (Fab) 441D6 in complex with influenza hemagglutinin (HA) A/New York/653/1996.</data>
    </edge>
    <edge source="PDF_53_2019_Result_5879963537206037678" target="Protein_HEMAGGLUTININ">
      <data key="d8">MENTIONS</data>
      <data key="d9">The epitope of the 441D6 antibody targets the immunodominant head region of influenza hemagglutinin, yet 441D6 is unique in that it has broad activity against viruses spanning 90 years of evolution by the H1 subtype of influenza.</data>
    </edge>
    <edge source="PDF_53_2019_Result_-1173615124721186537" target="Protein_HEMAGGLUTININ">
      <data key="d8">MENTIONS</data>
      <data key="d9">The HA ectodomain in this complex is just 10 nm tall, but the 3 Fabs bound to HA add substantial information to the images that aid in particle alignment during 2D classification.</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Hypothesis_-6711494172673707469">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Method_-4435858006020023394">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_5862787048161013709">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_-2561575624741178409">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_8271825533067228110">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_5479638528315697116">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_-2650723884943910926">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_-31356167626557605">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_-5819687445513004650">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_2373320235939752663">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_-6856516339722873094">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_5366497761396605588">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018" target="PDF_21_2018_Result_5709093982205541626">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_21_2018_Hypothesis_-6711494172673707469" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc might bind and encapsulate RNA.</data>
    </edge>
    <edge source="PDF_21_2018_Hypothesis_-6711494172673707469" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc might bind and encapsulate RNA.</data>
    </edge>
    <edge source="PDF_21_2018_Method_-4435858006020023394" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">qRT-PCR was used to determine levels of Arc mRNA and a highly abundant bacterial mRNA, asnA.</data>
    </edge>
    <edge source="PDF_21_2018_Method_-4435858006020023394" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">qRT-PCR was used to determine levels of Arc mRNA and a highly abundant bacterial mRNA, asnA.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5862787048161013709" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc mRNA levels were ~10-fold higher than asnA in prArc capsids.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5862787048161013709" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc mRNA levels were ~10-fold higher than asnA in prArc capsids.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-2561575624741178409" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">RNase did not degrade Arc or asnA mRNA, but significantly degraded exogenous free GFP mRNA, indicating that Arc and asnA mRNA were protected from RNase degradation.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-2561575624741178409" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">RNase did not degrade Arc or asnA mRNA, but significantly degraded exogenous free GFP mRNA, indicating that Arc and asnA mRNA were protected from RNase degradation.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-2561575624741178409" target="Gene_GFP">
      <data key="d8">MENTIONS</data>
      <data key="d9">RNase did not degrade Arc or asnA mRNA, but significantly degraded exogenous free GFP mRNA, indicating that Arc and asnA mRNA were protected from RNase degradation.</data>
    </edge>
    <edge source="PDF_21_2018_Result_8271825533067228110" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc mRNA was found to selectively immunoprecipitate (IP) with Arc protein.</data>
    </edge>
    <edge source="PDF_21_2018_Result_8271825533067228110" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc mRNA was found to selectively immunoprecipitate (IP) with Arc protein.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5479638528315697116" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5479638528315697116" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Stripping RNA resulted in significantly fewer fully formed capsids, suggesting that Arc capsids require RNA for normal assembly.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-2650723884943910926" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Proper Arc capsid assembly may be required for Arc release via EVs.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-31356167626557605" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc protein and RNA were protected or bound in a complex within EVs.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-31356167626557605" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc protein and RNA were protected or bound in a complex within EVs.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-5819687445513004650" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc is present in a subpopulation of EVs.</data>
    </edge>
    <edge source="PDF_21_2018_Result_2373320235939752663" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">KCI treatment, which increases neuronal activity, resulted in significantly more Arc released into the media.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-6856516339722873094" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Uptake of Arc protein and mRNA was endocytosis-dependent.</data>
    </edge>
    <edge source="PDF_21_2018_Result_-6856516339722873094" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Uptake of Arc protein and mRNA was endocytosis-dependent.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5366497761396605588" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc EVs released from HEK cells are capable of transferring highly abundant mRNAs cell-to-cell.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5366497761396605588" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc EVs released from HEK cells are capable of transferring highly abundant mRNAs cell-to-cell.</data>
    </edge>
    <edge source="PDF_21_2018_Result_5709093982205541626" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc KO neurons incubated with WT EVs showed a clear increase in dendritic Arc levels, while KO neurons incubated with EVs derived from KO cells exhibited no increase in dendritic Arc levels</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Hypothesis_1007946484764416786">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Method_-2517075424149377844">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Method_5718292584660158798">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-7590350723895944720">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-2390999112066596134">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-8304336012457207293">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Conclusion_-9175436270815840847">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-7180594045898953281">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_2996698402664526239">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-1997307962784977924">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-226380008784307942">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-8336969885079060192">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018" target="PDF_15_2018_Result_-6850924898633484190">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_15_2018_Hypothesis_1007946484764416786" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL regulates germ cell survival through mRNA interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Hypothesis_1007946484764416786" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL regulates germ cell survival through mRNA interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Hypothesis_1007946484764416786" target="Process_GERM CELL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL regulates germ cell survival through mRNA interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Method_-2517075424149377844" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Transcriptome-wide DAZL-RNA interactions were mapped in vivo.</data>
    </edge>
    <edge source="PDF_15_2018_Method_-2517075424149377844" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Transcriptome-wide DAZL-RNA interactions were mapped in vivo.</data>
    </edge>
    <edge source="PDF_15_2018_Method_5718292584660158798" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Fluorescence-activated cell sorting and RNA-seq were used to identify mRNAs sensitive to DAZL deletion in male germ cells.</data>
    </edge>
    <edge source="PDF_15_2018_Method_5718292584660158798" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Fluorescence-activated cell sorting and RNA-seq were used to identify mRNAs sensitive to DAZL deletion in male germ cells.</data>
    </edge>
    <edge source="PDF_15_2018_Method_5718292584660158798" target="Process_GERM CELL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Fluorescence-activated cell sorting and RNA-seq were used to identify mRNAs sensitive to DAZL deletion in male germ cells.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-7590350723895944720" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL binds thousands of mRNAs via polyA-proximal 3' UTR interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-7590350723895944720" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL binds thousands of mRNAs via polyA-proximal 3' UTR interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-2390999112066596134" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL post-transcriptionally controls a subset of its mRNA targets critical for germ cell proliferation and survival.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-2390999112066596134" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL post-transcriptionally controls a subset of its mRNA targets critical for germ cell proliferation and survival.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-2390999112066596134" target="Process_GERM CELL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL post-transcriptionally controls a subset of its mRNA targets critical for germ cell proliferation and survival.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-8304336012457207293" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">PolyA sequences have key roles in specifying DAZL-RNA interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-8304336012457207293" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">PolyA sequences have key roles in specifying DAZL-RNA interactions.</data>
    </edge>
    <edge source="PDF_15_2018_Conclusion_-9175436270815840847" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
    </edge>
    <edge source="PDF_15_2018_Conclusion_-9175436270815840847" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
    </edge>
    <edge source="PDF_15_2018_Conclusion_-9175436270815840847" target="Process_GERM CELL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL functions as a master regulator of a post-transcriptional mRNA program essential for germ cell survival.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-7180594045898953281" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL directly and reproducibly binds distinct sites in &gt;3,900 transcripts in adult testis.</data>
    </edge>
    <edge source="PDF_15_2018_Result_2996698402664526239" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL predominantly binds GUU-rich sequences in vivo.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-1997307962784977924" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">The majority of DAZL BR3 sites mapped to 3' UTRs of protein-coding genes.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-226380008784307942" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL preferentially binds GUU sites in close proximity to polyA sequences.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-8336969885079060192" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL directly enhances steady-state mRNA levels of a subset of in vivo targets.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-8336969885079060192" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL directly enhances steady-state mRNA levels of a subset of in vivo targets.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-6850924898633484190" target="Protein_DDX4">
      <data key="d8">MENTIONS</data>
      <data key="d9">reduced levels of DDX4 and SYCP3 proteins previously observed in Dazl KO germ cells by IF and attributed to reduced translation are associated with significant reductions in their corresponding mRNAs.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-6850924898633484190" target="Protein_SYCP3">
      <data key="d8">MENTIONS</data>
      <data key="d9">reduced levels of DDX4 and SYCP3 proteins previously observed in Dazl KO germ cells by IF and attributed to reduced translation are associated with significant reductions in their corresponding mRNAs.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-6850924898633484190" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">reduced levels of DDX4 and SYCP3 proteins previously observed in Dazl KO germ cells by IF and attributed to reduced translation are associated with significant reductions in their corresponding mRNAs.</data>
    </edge>
    <edge source="PDF_15_2018_Result_-6850924898633484190" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">reduced levels of DDX4 and SYCP3 proteins previously observed in Dazl KO germ cells by IF and attributed to reduced translation are associated with significant reductions in their corresponding mRNAs.</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Hypothesis_3273825756331219900">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Method_-1338264431741246350">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Method_5955775648555630888">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Method_-5447054642637606006">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_-5065714469652562922">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_9174890333036180457">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_-5182484237894007855">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_6917212919736409197">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_3560183569788301579">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_6591773665246235238">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_2221211531204752477">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_-292792670483097922">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_5112885719545256709">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Result_6830106072038905142">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Conclusion_-3138037747815046499">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024" target="PDF_48_2024_Conclusion_-3012642342870324051">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_48_2024_Hypothesis_3273825756331219900" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
    </edge>
    <edge source="PDF_48_2024_Hypothesis_3273825756331219900" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">orchestrating PNMA2 disassembly and reassembly around RNA might facilitate RNA packaging</data>
    </edge>
    <edge source="PDF_48_2024_Method_-1338264431741246350" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2</data>
    </edge>
    <edge source="PDF_48_2024_Method_5955775648555630888" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
    </edge>
    <edge source="PDF_48_2024_Method_5955775648555630888" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">structure-guided engineering to modify the PNMA2 protein capsid to package mRNA</data>
    </edge>
    <edge source="PDF_48_2024_Method_-5447054642637606006" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">We used cryoelectron microscopy (cryo-EM) to resolve the structure of recombinant human PNMA2 expressed in E. coli at 3.1 Å resolution</data>
    </edge>
    <edge source="PDF_48_2024_Result_-5065714469652562922" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 forms icosahedral capsids efficiently but does not naturally encapsidate nucleic acids</data>
    </edge>
    <edge source="PDF_48_2024_Result_9174890333036180457" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 Is Secreted by Human Cells as a Non-enveloped Capsid</data>
    </edge>
    <edge source="PDF_48_2024_Result_-5182484237894007855" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 capsids are secreted from human cells without encapsidated RNA</data>
    </edge>
    <edge source="PDF_48_2024_Result_-5182484237894007855" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 capsids are secreted from human cells without encapsidated RNA</data>
    </edge>
    <edge source="PDF_48_2024_Result_6917212919736409197" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 purified from Escherichia coli readily assembles into capsid structures</data>
    </edge>
    <edge source="PDF_48_2024_Result_3560183569788301579" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 does not package its own mRNA</data>
    </edge>
    <edge source="PDF_48_2024_Result_3560183569788301579" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 does not package its own mRNA</data>
    </edge>
    <edge source="PDF_48_2024_Result_2221211531204752477" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">the interior of the capsid is therefore predicted to have a negative charge, likely accounting for the capsid's lack of RNA cargo</data>
    </edge>
    <edge source="PDF_48_2024_Result_-292792670483097922" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
    </edge>
    <edge source="PDF_48_2024_Result_-292792670483097922" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">engineered PNMA2 capsids can functionally deliver mRNA into recipient cells, demonstrating promise as a therapeutic mRNA delivery vehicle</data>
    </edge>
    <edge source="PDF_48_2024_Result_5112885719545256709" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">LAH4 treatment of ePNMA2 before addition to cells increased the cytosolic localization of ePNMA2</data>
    </edge>
    <edge source="PDF_48_2024_Result_6830106072038905142" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">ePNMA2(Cre) induced higher levels of GFP reporter expression relative to an equivalent amount of undigested and unpackaged RNA</data>
    </edge>
    <edge source="PDF_48_2024_Conclusion_-3012642342870324051" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 naturally forms capsids in human cells</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Method_7688401019906258025">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Method_-8451411964774970506">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Method_4197064974108894589">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Result_1955790977945443604">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Result_2303491669298692077">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Method_8797155108939160349">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Result_3145381923885660515">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Result_7490295063878879849">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Result_1273554299323043190">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Result_4224012381800641735">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017" target="PDF_54_2017_Conclusion_2631602889920519487">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_54_2017_Result_1955790977945443604" target="Gene_TRPV1">
      <data key="d8">MENTIONS</data>
      <data key="d9">With 35,645 TRPV1 particle images SGD optimization resulted in a low-resolution 3-D map in 75 minutes from random initialization</data>
    </edge>
    <edge source="PDF_54_2017_Result_2303491669298692077" target="Protein_THERMUS THERMOPHILUS V/A-ATPASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">When applied to a dataset of conformationally heterogeneous Thermus thermophilus V/A-ATPase particle images, the algorithm was able to discern three different conformational states for the enzyme, again from random initializations.</data>
    </edge>
    <edge source="PDF_54_2017_Method_8797155108939160349" target="Gene_TRPV1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We implemented the branch and bound approach and applied it to high-resolution structure determination from several published datasets: the 20S proteasome from Thermoplasma acidophilum, the 80S ribosome from Plasmodium falciparum, amphipol-solubilized rat TRPV1, as well as the T. thermophilus V/A-ATPase .</data>
    </edge>
    <edge source="PDF_54_2017_Method_8797155108939160349" target="Protein_THERMUS THERMOPHILUS V/A-ATPASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We implemented the branch and bound approach and applied it to high-resolution structure determination from several published datasets: the 20S proteasome from Thermoplasma acidophilum, the 80S ribosome from Plasmodium falciparum, amphipol-solubilized rat TRPV1, as well as the T. thermophilus V/A-ATPase .</data>
    </edge>
    <edge source="PDF_54_2017_Result_3145381923885660515" target="Gene_TRPV1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Applied to 35,645 TRPV1 particle images, branch and bound orientation determination produced a 3.3 Å resolution map in 66 minutes with C4 symmetry enforced using a gold-standard refinement procedure, the FSC=0.143 resolution criterion, and correction for effects of masking on the FSC by high-resolution noise substitution</data>
    </edge>
    <edge source="PDF_54_2017_Result_7490295063878879849" target="Protein_THERMUS THERMOPHILUS V/A-ATPASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">With T. thermophilus V/A-ATPase particle images sorted into three classes by SGD, the branch and bound search produced maps of all three states in a total of 2.4 hours</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_-7544974436239366695">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_-6249181255683326149">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_-3175201880659129245">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_6682932568176380007">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_-2653877741772185867">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Result_6375044658037731477">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Result_1917330146686069319">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Result_-8371129532705357537">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Result_-4197258645961450816">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_5416173883783034744">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013" target="PDF_56_2013_Method_-4908543325136705783">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_56_2013_Method_-2653877741772185867" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">The strategy extends easily to find exon junctions, by locating reads that contain sets of subreads mapping to different exons of the same gene.</data>
    </edge>
    <edge source="PDF_56_2013_Result_1917330146686069319" target="Disease_DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Insertions and deletions are genomic variants that have been linked to the onset and progression of a number of diseases.</data>
    </edge>
    <edge source="PDF_56_2013_Result_-8371129532705357537" target="Gene_CASPASE-8">
      <data key="d8">MENTIONS</data>
      <data key="d9">A 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
    </edge>
    <edge source="PDF_56_2013_Result_-8371129532705357537" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">A 6 bp indel in the promoter region of gene Casp8 was identified to be associated with susceptibility to multiple cancers</data>
    </edge>
    <edge source="PDF_56_2013_Result_-4197258645961450816" target="Gene_NCX1">
      <data key="d8">MENTIONS</data>
      <data key="d9">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
    </edge>
    <edge source="PDF_56_2013_Result_-4197258645961450816" target="Disease_ALZHEIMER'S DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">A 14 bp indel in the gene Ncx1 was found to modulate the age at onset in late-onset Alzheimer's disease</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Hypothesis_4007391546585230220">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_4022060413640833732">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_3964162956670131810">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_-6742168171520011431">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_-5517693063529632874">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_-2624458770473747325">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_-2258982936542749936">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Result_859948616927543380">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023" target="PDF_58_2023_Conclusion_-5717137549867826958">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_58_2023_Hypothesis_4007391546585230220" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">We propose that Rim4 assembly, triggered by its IDR, stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
    </edge>
    <edge source="PDF_58_2023_Hypothesis_4007391546585230220" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">We propose that Rim4 assembly, triggered by its IDR, stimulates RRM-mediated binding of its target RNAs, a requisite for its function as a translational repressor.</data>
    </edge>
    <edge source="PDF_58_2023_Result_4022060413640833732" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression.</data>
    </edge>
    <edge source="PDF_58_2023_Result_4022060413640833732" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Assembled Rim4 binds RNA more efficiently than its monomeric form, a requirement for effective translational repression.</data>
    </edge>
    <edge source="PDF_58_2023_Result_3964162956670131810" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 represses translation when it binds the transcripts at their 5' end, while it does not have any effect when it binds their 3' end.</data>
    </edge>
    <edge source="PDF_58_2023_Result_-6742168171520011431" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 assembly depends exclusively on its intrinsically disordered region (IDR), which contains the regulatory elements to control this process.</data>
    </edge>
    <edge source="PDF_58_2023_Result_-5517693063529632874" target="Protein_PKA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Assembly is prevented by protein kinase A (PKA) which promotes growth and suppresses meiotic entry.</data>
    </edge>
    <edge source="PDF_58_2023_Result_-2624458770473747325" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">The presence of a non-fermentable carbon source combined with the absence of a fermentable one is the prime nutrient stimulus for Rim4 assembly.</data>
    </edge>
    <edge source="PDF_58_2023_Result_-2258982936542749936" target="Protein_PKA">
      <data key="d8">MENTIONS</data>
      <data key="d9">The PKA signaling pathway transduces the carbon source input into Rim4 assembly. Moreover, prevention of assembly in starvation also prevents translational repression.</data>
    </edge>
    <edge source="PDF_58_2023_Result_-2258982936542749936" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">The PKA signaling pathway transduces the carbon source input into Rim4 assembly. Moreover, prevention of assembly in starvation also prevents translational repression.</data>
    </edge>
    <edge source="PDF_58_2023_Result_859948616927543380" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 is phosphorylated by PKA and that this phosphorylation negatively correlates with assembly.</data>
    </edge>
    <edge source="PDF_58_2023_Result_859948616927543380" target="Protein_PKA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 is phosphorylated by PKA and that this phosphorylation negatively correlates with assembly.</data>
    </edge>
    <edge source="PDF_58_2023_Conclusion_-5717137549867826958" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Rim4 assemblies prevent translation because they bind the 5' region of a transcript, likely making the start codon invisible to ribosomes.</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Hypothesis_-6101710439350279351">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Method_7250690860974551574">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Method_-1748601871715343443">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Method_-4938452527471818004">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Method_-4152828870250651972">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Result_2404442980995303048">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Result_-2644096955943264538">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Result_-4701501202074256566">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Result_4639059725475883834">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Result_5155631779279264016">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Result_3921908020221437532">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016" target="PDF_45_2016_Conclusion_-4496265613559077990">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_45_2016_Hypothesis_-6101710439350279351" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
    </edge>
    <edge source="PDF_45_2016_Hypothesis_-6101710439350279351" target="Protein_CPEB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
    </edge>
    <edge source="PDF_45_2016_Hypothesis_-6101710439350279351" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL cooperates with CPEB1 to regulate maternal mRNA translation.</data>
    </edge>
    <edge source="PDF_45_2016_Method_7250690860974551574" target="Protein_CPEB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">RiboTag RNA immunoprecipitation (RIP) was used to discover a synergy between CPEB1 and DAZL as translation regulators.</data>
    </edge>
    <edge source="PDF_45_2016_Method_7250690860974551574" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">RiboTag RNA immunoprecipitation (RIP) was used to discover a synergy between CPEB1 and DAZL as translation regulators.</data>
    </edge>
    <edge source="PDF_45_2016_Method_-4938452527471818004" target="Protein_CPEB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">RNA immunoprecipitation was performed with CPEB1-specific antibodies.</data>
    </edge>
    <edge source="PDF_45_2016_Method_-4152828870250651972" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Site-directed mutagenesis of the Tex19.1 3' UTR was used to investigate DAZL element cooperation.</data>
    </edge>
    <edge source="PDF_45_2016_Method_-4152828870250651972" target="Gene_TEX19.1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Site-directed mutagenesis of the Tex19.1 3' UTR was used to investigate DAZL element cooperation.</data>
    </edge>
    <edge source="PDF_45_2016_Result_2404442980995303048" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ribosome loading is induced in a DAZL- and CPEB1-dependent manner.</data>
    </edge>
    <edge source="PDF_45_2016_Result_2404442980995303048" target="Protein_CPEB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ribosome loading is induced in a DAZL- and CPEB1-dependent manner.</data>
    </edge>
    <edge source="PDF_45_2016_Result_-2644096955943264538" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL and cytoplasmic polyadenylation elements (CPEs) synergize in the translation pattern of maternal mRNAs.</data>
    </edge>
    <edge source="PDF_45_2016_Result_-4701501202074256566" target="Protein_CPEB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Knockdown of CPEB1 was associated with a reduction in the number of oocytes that reached MII.</data>
    </edge>
    <edge source="PDF_45_2016_Result_4639059725475883834" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Depletion in DAZL resulted in an almost complete block of progression into MII.</data>
    </edge>
    <edge source="PDF_45_2016_Result_3921908020221437532" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">The three identified DAZL elements are functional in that they are bound by DAZL and contribute to the overall rate of translation.</data>
    </edge>
    <edge source="PDF_45_2016_Conclusion_-4496265613559077990" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">The number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
    </edge>
    <edge source="PDF_45_2016_Conclusion_-4496265613559077990" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">The number of DAZL proteins loaded onto the mRNA and the characteristics of the CPE might define the degree of cooperation between the two RBPs in activating translation and meiotic progression.</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Hypothesis_-7026073560641975375">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Method_-1419310273261393209">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Result_-4452401184474898440">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Result_3177950791281978896">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Result_-4997145210810257954">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Result_5221699065262225750">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001" target="PDF_42_2001_Conclusion_4445681050503740959">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_42_2001_Hypothesis_-7026073560641975375" target="Protein_MAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Hypothesis_-7026073560641975375" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Hypothesis_-7026073560641975375" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 mediates apoptosis through a mechanism that involves binding to Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Method_-1419310273261393209" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Yeast two-hybrid screen was performed to identify Bax-associating proteins.</data>
    </edge>
    <edge source="PDF_42_2001_Result_-4452401184474898440" target="Protein_MAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
    </edge>
    <edge source="PDF_42_2001_Result_-4452401184474898440" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
    </edge>
    <edge source="PDF_42_2001_Result_-4452401184474898440" target="Protein_BCL-2">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
    </edge>
    <edge source="PDF_42_2001_Result_-4452401184474898440" target="Protein_BCL-XL">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 homodimerizes and associates with Bax, Bcl-2, and Bcl-X₁ in vitro and in vivo in mammalian cells.</data>
    </edge>
    <edge source="PDF_42_2001_Result_3177950791281978896" target="Protein_MAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The BH3-like domain in MAP-1 appeared to be required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
    </edge>
    <edge source="PDF_42_2001_Result_3177950791281978896" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">The BH3-like domain in MAP-1 appeared to be required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
    </edge>
    <edge source="PDF_42_2001_Result_3177950791281978896" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">The BH3-like domain in MAP-1 appeared to be required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
    </edge>
    <edge source="PDF_42_2001_Result_3177950791281978896" target="Protein_BCL-XL">
      <data key="d8">MENTIONS</data>
      <data key="d9">The BH3-like domain in MAP-1 appeared to be required for mediating apoptosis and its binding to Bax, but not Bcl-XL.</data>
    </edge>
    <edge source="PDF_42_2001_Result_-4997145210810257954" target="Protein_MAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Result_-4997145210810257954" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">The binding of MAP-1 to Bax requires all three BH (BH1, BH2, and BH3) domains of Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Result_5221699065262225750" target="Protein_MAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
    </edge>
    <edge source="PDF_42_2001_Result_5221699065262225750" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 induces caspase-dependent apoptosis in mammalian cells when overexpressed.</data>
    </edge>
    <edge source="PDF_42_2001_Conclusion_4445681050503740959" target="Protein_MAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Conclusion_4445681050503740959" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
    </edge>
    <edge source="PDF_42_2001_Conclusion_4445681050503740959" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MAP-1 represents a novel Bax-associating protein that may mediate apoptosis through binding to Bax.</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Hypothesis_2284572265749887740">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Method_-8850148362164679445">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Method_2642830594039964302">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-5959770185381564212">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_2075076618419982025">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-7173593530584593532">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-6536138405992685902">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_245597328199661046">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-965682607400442980">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_1437644137961784082">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-8993382840130368184">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-1014845171459318107">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-1636690093800803172">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Result_-8566290086651872475">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Conclusion_5498347170205855405">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020" target="PDF_17_2020_Conclusion_-7127879931028460419">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_17_2020_Hypothesis_2284572265749887740" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL binding to maternal mRNA leads to an increase and decrease in translation.</data>
    </edge>
    <edge source="PDF_17_2020_Method_2642830594039964302" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL RIP-Chip dataset</data>
    </edge>
    <edge source="PDF_17_2020_Result_-5959770185381564212" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL protein is detectable in full-grown GV-arrested oocytes with protein levels increasing up to MII.</data>
    </edge>
    <edge source="PDF_17_2020_Result_2075076618419982025" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Blockage of Dazl mRNA translation markedly reduces the endogenous DAZL protein expression.</data>
    </edge>
    <edge source="PDF_17_2020_Result_2075076618419982025" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Blockage of Dazl mRNA translation markedly reduces the endogenous DAZL protein expression.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-7173593530584593532" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL depletion disrupts oocyte maturation to MII</data>
    </edge>
    <edge source="PDF_17_2020_Result_-6536138405992685902" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL depletion causes increases and decreases in translational efficiency of a wide range of transcripts expressed in the oocyte.</data>
    </edge>
    <edge source="PDF_17_2020_Result_245597328199661046" target="Gene_TEX19.1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ribosome loading onto Tex19.1 mRNA is decreased after injection of DAZL-MO at the MI stage.</data>
    </edge>
    <edge source="PDF_17_2020_Result_245597328199661046" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ribosome loading onto Tex19.1 mRNA is decreased after injection of DAZL-MO at the MI stage.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-965682607400442980" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-965682607400442980" target="Gene_CCNB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Knockdown of DAZL had no effect on ribosome loading onto the non-target CcnB1.</data>
    </edge>
    <edge source="PDF_17_2020_Result_1437644137961784082" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL depletion disrupts DAZL target loading onto ribosomes with high selectivity.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8993382840130368184" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Decrease in ribosome loading onto a group of transcripts after DAZL depletion.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-1014845171459318107" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation increases for a group of transcripts after DAZL removal.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-1636690093800803172" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL functions as a translational activator and a translational repressor during the GV-to-MI transition.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Gene_AKAP10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Gene_CENPE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Gene_NSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Gene_YWHAZ">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Gene_NIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Gene_YTHDF3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Result_-8566290086651872475" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Translation of transcripts coding for Akap10, Cenpe, Nsf, Ywhaz, Nin, and YTHDF3 is upregulated after DAZL removal, while the overall transcript levels are not changed.</data>
    </edge>
    <edge source="PDF_17_2020_Conclusion_5498347170205855405" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL regulates translation of maternal mRNAs, functioning both as the translational repressor and activator during oocyte maturation.</data>
    </edge>
    <edge source="PDF_17_2020_Conclusion_-7127879931028460419" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">DAZL may play a dual function (both translational activator and repressor) during oocyte maturation.</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Hypothesis_-5270005329799762989">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Method_-8841708259132838578">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Method_5684873237306666875">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Method_-7029910440999784406">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_-9206730576478353418">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_5977352559163050716">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_-4131538449364110313">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_3613349482426608506">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_-2185178392975473183">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_4712298205867309804">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_2103985303404241334">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_-4154989696111793623">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Result_2218025804671713400">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019" target="PDF_24_2019_Conclusion_-4262552190683583444">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_24_2019_Method_-8841708259132838578" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">electron tomography (ET) of immature and mature Ty3 particles within cells</data>
    </edge>
    <edge source="PDF_24_2019_Method_5684873237306666875" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">cryo-ET and cryo-electron microscopy of purified, immature Ty3 particles</data>
    </edge>
    <edge source="PDF_24_2019_Result_-9206730576478353418" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ty3 particles do not change size or shape upon maturation.</data>
    </edge>
    <edge source="PDF_24_2019_Result_5977352559163050716" target="Gene_HIV-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ty3 capsid revealed an irregular fullerene geometry previously described for mature retrovirus core particles and a tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid that is conserved with mature HIV-1.</data>
    </edge>
    <edge source="PDF_24_2019_Result_5977352559163050716" target="Protein_CA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ty3 capsid revealed an irregular fullerene geometry previously described for mature retrovirus core particles and a tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid that is conserved with mature HIV-1.</data>
    </edge>
    <edge source="PDF_24_2019_Result_5977352559163050716" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ty3 capsid revealed an irregular fullerene geometry previously described for mature retrovirus core particles and a tertiary and quaternary arrangement of the capsid (CA) C-terminal domain within the assembled capsid that is conserved with mature HIV-1.</data>
    </edge>
    <edge source="PDF_24_2019_Result_-4131538449364110313" target="Protein_GAG3">
      <data key="d8">MENTIONS</data>
      <data key="d9">The particles we observed in cells expressing PR- Ty3, in which Gag3 is uncleaved, exhibited exclusively the morphology of the first type, confirming that this represents the immature form.</data>
    </edge>
    <edge source="PDF_24_2019_Result_-4131538449364110313" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">The particles we observed in cells expressing PR- Ty3, in which Gag3 is uncleaved, exhibited exclusively the morphology of the first type, confirming that this represents the immature form.</data>
    </edge>
    <edge source="PDF_24_2019_Result_3613349482426608506" target="Protein_PGR">
      <data key="d8">MENTIONS</data>
      <data key="d9">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
    </edge>
    <edge source="PDF_24_2019_Result_3613349482426608506" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
    </edge>
    <edge source="PDF_24_2019_Result_3613349482426608506" target="Protein_GAG3">
      <data key="d8">MENTIONS</data>
      <data key="d9">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
    </edge>
    <edge source="PDF_24_2019_Result_3613349482426608506" target="Protein_CA">
      <data key="d8">MENTIONS</data>
      <data key="d9">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
    </edge>
    <edge source="PDF_24_2019_Result_3613349482426608506" target="Protein_NC">
      <data key="d8">MENTIONS</data>
      <data key="d9">PR- Ty3 particles have indistinguishable thick-ring radial density profiles, supporting the assertion that both represent Gag3 particles that have not undergone cleavage between CA and NC and are immature.</data>
    </edge>
    <edge source="PDF_24_2019_Result_4712298205867309804" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">39 of the 42 complete Ty3 particles were T = 9 icosahedra, where two nearest pentamers in the lattice are always separated by two hexamers sitting along one vector</data>
    </edge>
    <edge source="PDF_24_2019_Result_2103985303404241334" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ty3 particles have a radius to the center of the CA layer of ~24 nm. The location of pentamers confirmed the T = 9 symmetry identified by cryo-ET and subtomogram averaging.</data>
    </edge>
    <edge source="PDF_24_2019_Result_2103985303404241334" target="Protein_CA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ty3 particles have a radius to the center of the CA layer of ~24 nm. The location of pentamers confirmed the T = 9 symmetry identified by cryo-ET and subtomogram averaging.</data>
    </edge>
    <edge source="PDF_24_2019_Result_-4154989696111793623" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">the Ty3 CA-NTD is a bundle of four a-helices, while CA-CTD consists of five a-helices</data>
    </edge>
    <edge source="PDF_24_2019_Result_-4154989696111793623" target="Protein_CA">
      <data key="d8">MENTIONS</data>
      <data key="d9">the Ty3 CA-NTD is a bundle of four a-helices, while CA-CTD consists of five a-helices</data>
    </edge>
    <edge source="PDF_24_2019_Result_2218025804671713400" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">the protruding capsomers of the Ty3 capsid are formed by the CA-NTD, while the inner layer, linking the capsomers together, is formed by the CA-CTD.</data>
    </edge>
    <edge source="PDF_24_2019_Result_2218025804671713400" target="Protein_CA">
      <data key="d8">MENTIONS</data>
      <data key="d9">the protruding capsomers of the Ty3 capsid are formed by the CA-NTD, while the inner layer, linking the capsomers together, is formed by the CA-CTD.</data>
    </edge>
    <edge source="PDF_51_2019" target="PDF_51_2019_Hypothesis_8115540044170500196">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_51_2019" target="PDF_51_2019_Method_-5735195520754807737">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_51_2019" target="PDF_51_2019_Result_2712254139860532268">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_51_2019" target="PDF_51_2019_Conclusion_6582000612346819448">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_51_2019_Hypothesis_8115540044170500196" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">actin filaments that are embedded inside meiotic spindles (spindle actin) are needed for accurate chromosome segregation in mammalian oocytes.</data>
    </edge>
    <edge source="PDF_51_2019_Hypothesis_8115540044170500196" target="Gene_CHROMOSOME">
      <data key="d8">MENTIONS</data>
      <data key="d9">actin filaments that are embedded inside meiotic spindles (spindle actin) are needed for accurate chromosome segregation in mammalian oocytes.</data>
    </edge>
    <edge source="PDF_51_2019_Method_-5735195520754807737" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">high-resolution and super-resolution live and immunofluorescence microscopy assays</data>
    </edge>
    <edge source="PDF_51_2019_Result_2712254139860532268" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">the actin cytoskeleton plays a vital role inside the meiotic spindle—actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
    </edge>
    <edge source="PDF_51_2019_Result_2712254139860532268" target="Protein_MICROTUBULES">
      <data key="d8">MENTIONS</data>
      <data key="d9">the actin cytoskeleton plays a vital role inside the meiotic spindle—actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
    </edge>
    <edge source="PDF_51_2019_Result_2712254139860532268" target="Gene_CHROMOSOME">
      <data key="d8">MENTIONS</data>
      <data key="d9">the actin cytoskeleton plays a vital role inside the meiotic spindle—actin filaments embedded inside the spindle help to organize microtubules into functional bundles that can accurately separate the chromosomes</data>
    </edge>
    <edge source="PDF_31_2019" target="PDF_31_2019_Hypothesis_-1505715401570687279">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_31_2019" target="PDF_31_2019_Method_-709854425819029840">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_31_2019" target="PDF_31_2019_Method_6647634106377694263">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_31_2019" target="PDF_31_2019_Method_7702720213570326580">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_31_2019" target="PDF_31_2019_Result_-338647571991638286">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_31_2019" target="PDF_31_2019_Conclusion_-5067430079113536512">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_31_2019_Method_-709854425819029840" target="Gene_SNP">
      <data key="d8">MENTIONS</data>
      <data key="d9">uses polygenic modeling to weight SNPs according to how well they tag functional categories that are enriched for heritability</data>
    </edge>
    <edge source="PDF_31_2019_Method_6647634106377694263" target="Gene_SNP">
      <data key="d8">MENTIONS</data>
      <data key="d9">stratified LD score regression to compute the expected x2 statistic of each SNP based on the functional annotations that it tags</data>
    </edge>
    <edge source="PDF_31_2019_Method_7702720213570326580" target="Gene_SNP">
      <data key="d8">MENTIONS</data>
      <data key="d9">stratify SNPs into bins of expected x² and estimate the proportion of null (π0) and alternative (1) SNPs within each bin using the Storey π0 estimator to obtain bin-specific weights</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_5185360021543371970">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_-184328622009993282">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_-5336804443890382792">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_568344526147719102">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_2198496925447455445">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_5181139286335260250">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_4676797937516684910">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_4766238233594093224">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_7791584285453694810">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_-1893416914845820382">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_-6312226490387712209">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_5428752849094157889">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_-4927905169314473897">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Method_-8431858731903342285">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_27_2021" target="PDF_27_2021_Conclusion_3957623437691924036">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Hypothesis_4467084021045422591">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Method_4671185371064331777">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Method_-3379669466993812965">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Method_-8141248330658761304">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Method_8941480093709857562">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Method_2187362492794927034">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Method_-8413006734587928990">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-5486377703570402137">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_8651207074546910418">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-3634584178799983258">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-1701831125906101092">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-3445624113107174785">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-6065715060686981222">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Conclusion_-6011584818940328899">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Conclusion_-2703974928012477476">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-2528330424662017208">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_-8493437373168743840">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024" target="PDF_23_2024_Result_5631681551773626603">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_23_2024_Hypothesis_4467084021045422591" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Aberrant PNMA2 capsids released outside the central nervous system may cause autoantibody generation.</data>
    </edge>
    <edge source="PDF_23_2024_Method_4671185371064331777" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mice were injected with recombinant PNMA2 capsids to induce autoantibodies.</data>
    </edge>
    <edge source="PDF_23_2024_Method_-3379669466993812965" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cryoelectron microscopy (cryo-EM) was used to determine atomic resolution structures of PNMA2 capsids and design PNMA2 mutants.</data>
    </edge>
    <edge source="PDF_23_2024_Method_-8141248330658761304" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">ELISA was used to measure autoantibodies binding to PNMA2 capsids.</data>
    </edge>
    <edge source="PDF_23_2024_Method_8941480093709857562" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Size-exclusion chromatography was used to analyze the formation of PNMA2 capsids.</data>
    </edge>
    <edge source="PDF_23_2024_Method_2187362492794927034" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Iodixanol gradient ultracentrifugation was used to separate proteins by density and size to determine if PNMA2 is released in EVs.</data>
    </edge>
    <edge source="PDF_23_2024_Method_-8413006734587928990" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Proteinase K protection assay was performed to determine whether released PNMA2 protein is enveloped by a membrane.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-5486377703570402137" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 proteins self-assemble into T = 1 icosahedral virus-like capsids.</data>
    </edge>
    <edge source="PDF_23_2024_Result_8651207074546910418" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 is released from cells as non-enveloped capsids.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-3634584178799983258" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 capsids induce autoantibody production.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-1701831125906101092" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 autoantibodies from injected mice and CSF from patients with anti-Ma2 paraneoplastic disease preferentially bind to exterior surface spike epitopes of PNMA2 capsids.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-3445624113107174785" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 capsids are capable of inducing maturation of dendritic cells in vitro.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-6065715060686981222" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mice injected with PNMA2 capsids develop significant deficits in fear learning and memory.</data>
    </edge>
    <edge source="PDF_23_2024_Conclusion_-6011584818940328899" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 is a Gag-like protein that forms endogenous virus-like capsids that are released without a membrane and can trigger a robust immune response when ectopically expressed outside the CNS, which results in neurological deficits.</data>
    </edge>
    <edge source="PDF_23_2024_Conclusion_-2703974928012477476" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">The virus-like properties of PNMA2 protein may underlie some of the neurological symptoms associated with anti-Ma2 paraneoplastic disease.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-2528330424662017208" target="Gene_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 mRNA is expressed in excitatory and inhibitory neurons.</data>
    </edge>
    <edge source="PDF_23_2024_Result_-8493437373168743840" target="Gene_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 is highly and almost exclusively expressed in human brain tissue samples.</data>
    </edge>
    <edge source="PDF_23_2024_Result_5631681551773626603" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 protein was isolated in early fractions that are also enriched with canonical EV proteins such as the ESCRT protein ALIX</data>
    </edge>
    <edge source="PDF_23_2024_Result_5631681551773626603" target="Protein_ALIX">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 protein was isolated in early fractions that are also enriched with canonical EV proteins such as the ESCRT protein ALIX</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Hypothesis_6193989128551963948">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Method_-66702390253835033">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Method_-8638589072930922688">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_-5669282480205138710">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_6697060852037958138">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_8451587848992825607">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_-8620483130168636363">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_-1419816334220739220">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Method_-3586676997868765252">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_6335271355366042181">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Result_2635079953497084240">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021" target="PDF_22_2021_Conclusion_7691408861461016036">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_22_2021_Method_-66702390253835033" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">We searched the human and mouse genomes for gag homologs.</data>
    </edge>
    <edge source="PDF_22_2021_Method_-8638589072930922688" target="Process_N2A CELLS">
      <data key="d8">MENTIONS</data>
      <data key="d9">CRISPR activation to induce expression of endogenous genes in mouse N2a cells.</data>
    </edge>
    <edge source="PDF_22_2021_Result_-5669282480205138710" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">MmPeg10 transcriptional activation led to accumulation of significant amounts of full length MmPeg10 mRNA transcripts in the VLP fraction</data>
    </edge>
    <edge source="PDF_22_2021_Result_6697060852037958138" target="Protein_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 contains two putative nucleic acid binding domains, namely the NC and RT, which are released from the polypeptide upon PEG10 self processing.</data>
    </edge>
    <edge source="PDF_22_2021_Result_8451587848992825607" target="Protein_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">mRNA export depends on the MmPEG10 NC, as loss of the nucleic acid-binding zinc finger CCHC motif (residues 416-429) from the MmPEG10 NC substantially reduced export of its mRNA</data>
    </edge>
    <edge source="PDF_22_2021_Result_-8620483130168636363" target="Protein_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">MmPEG10 strongly bound a number of mRNAs in N2a cells including its own mRNA</data>
    </edge>
    <edge source="PDF_22_2021_Result_-1419816334220739220" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">The mRNAs of 49 genes downregulated in the brain upon MmPeg10 knockout are bound to MmPEG10 in the age-matched mouse brain, suggesting that one of the functions of MmPEG10 is to bind and stabilize mRNAs with fundamental roles in neurodevelopment.</data>
    </edge>
    <edge source="PDF_22_2021_Result_2635079953497084240" target="Protein_CAS9">
      <data key="d8">MENTIONS</data>
      <data key="d9">SEND was able to functionally transfer SpCas9, leading to ~60% indels in recipient cells</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Hypothesis_-93077183457633057">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Method_-7105474563644511331">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Method_6083705114603944930">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Method_-6046330054613322383">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Result_-4507820774077407011">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Result_3043543269034543926">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Conclusion_-1693031729440580785">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017" target="PDF_16_2017_Conclusion_7572226408189671675">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_16_2017_Hypothesis_-93077183457633057" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Can novel meiotic RNA targets of DAZL (deleted in azoospermia-like) be identified in the human foetal ovary?</data>
    </edge>
    <edge source="PDF_16_2017_Method_-7105474563644511331" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">We carried out RNA sequencing after immunoprecipitation of endogenous DAZL from human foetal ovarian tissue (17 weeks of gestation, obtained after elective termination of pregnancy) to identify novel DAZL targets involved in meiosis (n = 3 biological replicates).</data>
    </edge>
    <edge source="PDF_16_2017_Method_6083705114603944930" target="Protein_SMCIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
    </edge>
    <edge source="PDF_16_2017_Method_6083705114603944930" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Using quantitative RT-PCR, we examined the expression of selected RNAs identified by our immunoprecipitation across gestation, and visualised the expression of potential target SMCIB in relation to DAZL, with a combination of in situ hybridisation and immunohistochemistry.</data>
    </edge>
    <edge source="PDF_16_2017_Method_-6046330054613322383" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
    </edge>
    <edge source="PDF_16_2017_Method_-6046330054613322383" target="Protein_SYCP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
    </edge>
    <edge source="PDF_16_2017_Method_-6046330054613322383" target="Protein_TEX11">
      <data key="d8">MENTIONS</data>
      <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
    </edge>
    <edge source="PDF_16_2017_Method_-6046330054613322383" target="Protein_SMCIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">3' untranslated region (3'UTR)-luciferase reporter assays and polysome profile analysis were used to investigate the regulation of three RNA targets by DAZL, representing key functionalities: SYCPI, TEXII and SMCIB.</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Protein_SYCP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Protein_SYCP3">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Protein_SMCIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_RAD21">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_MAD2L1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_TRIP13">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_HORMADI">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Protein_TEX11">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_RAD18">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_-4507820774077407011" target="Gene_RAD51">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 764 potential RNA targets of DAZL in the human foetal ovary (false discovery rate 0.05 and log-fold change ≥ 2), with functions in synaptonemal complex formation (SYCPI, SYCP3), cohesin formation (SMCIB, RAD21), spindle assembly checkpoint (MAD2LI, TRIP13) and recombination and DNA repair (HORMADI, TRIP 13, TEXII, RAD18, RAD51).</data>
    </edge>
    <edge source="PDF_16_2017_Result_3043543269034543926" target="Protein_SYCP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We demonstrated that the translation of novel targets SYCPI (P = 0.004), TEXII (P = 0.004) and SMCIB (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
    </edge>
    <edge source="PDF_16_2017_Result_3043543269034543926" target="Protein_TEX11">
      <data key="d8">MENTIONS</data>
      <data key="d9">We demonstrated that the translation of novel targets SYCPI (P = 0.004), TEXII (P = 0.004) and SMCIB (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
    </edge>
    <edge source="PDF_16_2017_Result_3043543269034543926" target="Protein_SMCIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">We demonstrated that the translation of novel targets SYCPI (P = 0.004), TEXII (P = 0.004) and SMCIB (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
    </edge>
    <edge source="PDF_16_2017_Result_3043543269034543926" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">We demonstrated that the translation of novel targets SYCPI (P = 0.004), TEXII (P = 0.004) and SMCIB (P = 0.002) is stimulated by the presence of DAZL but not by a mutant DAZL with impaired RNA-binding activity.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_-1693031729440580785" target="Protein_SYCP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">SYCPI (synaptonemal complex protein-1), TEXII (testis expressed 11) and SMCIB (structural maintenance of chromosomes IB) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_-1693031729440580785" target="Protein_TEX11">
      <data key="d8">MENTIONS</data>
      <data key="d9">SYCPI (synaptonemal complex protein-1), TEXII (testis expressed 11) and SMCIB (structural maintenance of chromosomes IB) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_-1693031729440580785" target="Protein_SMCIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">SYCPI (synaptonemal complex protein-1), TEXII (testis expressed 11) and SMCIB (structural maintenance of chromosomes IB) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_-1693031729440580785" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">SYCPI (synaptonemal complex protein-1), TEXII (testis expressed 11) and SMCIB (structural maintenance of chromosomes IB) are novel DAZL targets in the human foetal ovary, thus DAZL may have previously unrecognised roles in the translational regulation of RNAs involved in chromosome cohesion and DNA recombination in the oocyte from the time of initiation of meiosis.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_7572226408189671675" target="Gene_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_7572226408189671675" target="Protein_SMCIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
    </edge>
    <edge source="PDF_16_2017_Conclusion_7572226408189671675" target="Protein_TEX11">
      <data key="d8">MENTIONS</data>
      <data key="d9">These data indicate roles for DAZL in the regulation of several key functions in human oocytes. Through the translational regulation of novel RNA targets SMCIB and TEXII, DAZL may have a key role in regulating chromosome cohesion and DNA recombination; two processes fundamental in determining oocyte quality and whose establishment in foetal life may support lifelong fertility.</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Hypothesis_2160001289349944145">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Method_-4320380909749958002">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Method_-7985357732871102285">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Method_-5705176645279342252">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Result_-8635379153542959884">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Result_-7595614694216120791">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Result_-7208524670598810401">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Result_-4071101592301487076">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Result_-294535297058227258">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Result_6142259157110338341">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Conclusion_-4318441215335671446">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021" target="PDF_30_2021_Conclusion_5730400630930705530">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_30_2021_Result_-7208524670598810401" target="Gene_NPR2">
      <data key="d8">MENTIONS</data>
      <data key="d9">At NPR2, which encodes a natriuretic peptide receptor involved in bone growth regulation, 11 rare coding variants independently associated with height.</data>
    </edge>
    <edge source="PDF_30_2021_Result_-4071101592301487076" target="Gene_APOC3">
      <data key="d8">MENTIONS</data>
      <data key="d9">APOC3 exhibited the widest variety of likely-causal associations, with the splice donor variant rs138326449 associating with 13 distinct traits including lipid levels, white blood cell and red blood cell traits, and kidney biomarkers.</data>
    </edge>
    <edge source="PDF_30_2021_Result_-294535297058227258" target="Gene_PDE3B">
      <data key="d8">MENTIONS</data>
      <data key="d9">In PDE3B, the stop gain variant rs150090666 associated likely-causally with 10 distinct traits, including expected associations with waist-hip-ratio and lipid measurements, but also associations with red blood cell traits, SHBG levels, and height.</data>
    </edge>
    <edge source="PDF_30_2021_Result_6142259157110338341" target="Gene_MC4R">
      <data key="d8">MENTIONS</data>
      <data key="d9">We also detected one very-large-effect variant for BMI in MC4R (+0.62 (0.12) s.d.; Supplementary Table 10); this variant had previously been associated with obesity in a Mendelian fashion</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-5536773674226873468">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_928844818076935177">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_6627841982578422952">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_281207146266776335">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_3049487649392500733">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-4138664636761175751">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-8973457162758577703">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-1107127596074901886">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_7490987086473275578">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_7686857928769654649">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_2176240826659309713">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_2054776320862152537">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-2628623931096176784">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_5722336715795250337">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-3926302964775411936">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-4313129312883767923">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014" target="PDF_57_2014_Method_-7148381996951902563">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_57_2014_Method_3049487649392500733" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">In DESeq2, we assume that genes of similar average expression strength have similar dispersion.</data>
    </edge>
    <edge source="PDF_57_2014_Method_-8973457162758577703" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">DESeq2 handles these cases by using the gene-wise estimate instead of the shrunken estimate when the former is more than 2 residual standard deviations above the curve.</data>
    </edge>
    <edge source="PDF_57_2014_Method_2176240826659309713" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">DESeq2 by default will choose a threshold that maximizes the number of genes found at a user-specified target FDR.</data>
    </edge>
    <edge source="PDF_57_2014_Method_2054776320862152537" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">For such analyses, DESeq2 offers a test of the composite null hypothesis |ẞir| ≥ 0, which will report genes as significant for which there is evidence that their LFC is weaker than 0.</data>
    </edge>
    <edge source="PDF_57_2014_Method_-2628623931096176784" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">DESeq2 flags, for each gene, those samples that have a Cook's distance greater than the 0.99 quantile of the F(p, m - p) distribution, where p is the number of model parameters including the intercept, and m is the number of samples.</data>
    </edge>
    <edge source="PDF_57_2014_Method_5722336715795250337" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">By default, outliers in conditions with six or fewer replicates cause the whole gene to be flagged and removed from subsequent analysis, including P value adjustment for multiple testing.</data>
    </edge>
    <edge source="PDF_57_2014_Method_-7148381996951902563" target="Gene_GENE">
      <data key="d8">MENTIONS</data>
      <data key="d9">The rlog transformation is calculated by fitting for each gene a GLM with a baseline expression (i.e., intercept only) and, computing for each sample, shrunken LFCs with respect to the baseline, using the same empirical Bayes procedure as before (Methods).</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Hypothesis_2414538738140634289">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Method_-4679836695388845332">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_-969201998017372530">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_-7406233373455181378">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_-1103732407464580779">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_7862179539634199818">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_7737093034733274042">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_5963463901830595246">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_-3397886118733152105">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_7535285844095637219">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_8086110237662957897">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_3050807498403910935">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Result_-3298673367396207587">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023" target="PDF_55_2023_Conclusion_-1110881446195742522">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_55_2023_Result_-969201998017372530" target="Gene_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">The most severe entry mutant we observed was riel∆, which showed ~15% of cells entering meiotic prophase at 6 h.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-7406233373455181378" target="Protein_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-7406233373455181378" target="Protein_IME2">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-7406233373455181378" target="Protein_IME4">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-7406233373455181378" target="Gene_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Imel, Ime2, and Ime4 protein levels were all decreased in riel∆.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-1103732407464580779" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-1103732407464580779" target="Gene_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Riel binds IMEI mRNA compared with a control protein, bovine serum albumin (BSA), which does not bind.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7862179539634199818" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We observed increased abundance of Riel in actively translating fractions (i.e., ribosomes and polysomes) in the crosslinked samples throughout pre-meiotic S-phase.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7737093034733274042" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that the presence or absence of Riel did not affect poly(A) tail length of IMEI.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7737093034733274042" target="Gene_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that the presence or absence of Riel did not affect poly(A) tail length of IMEI.</data>
    </edge>
    <edge source="PDF_55_2023_Result_5963463901830595246" target="Protein_SGN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The most highly enriched protein was another RNA-binding protein Sgnl which harbors significant similarity to the translation initiation factor eIF4B.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-3397886118733152105" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-3397886118733152105" target="Protein_SGN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We validated the interaction between Riel and Sgn1 by reciprocal co-IP in which FLAG-tagged Sgnl was pulled down and co-purified V5-tagged Riel abundance was measured by immunoblot.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7535285844095637219" target="Protein_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7535285844095637219" target="Gene_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7535285844095637219" target="Gene_SGN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels.</data>
    </edge>
    <edge source="PDF_55_2023_Result_7535285844095637219" target="Gene_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that both riel∆ and sgnl∆ exhibited decreased Imel protein levels without corresponding downregulation of IMEI mRNA levels.</data>
    </edge>
    <edge source="PDF_55_2023_Result_8086110237662957897" target="Protein_SGN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Sgnl binds IME1 mRNA compared with the BSA control.</data>
    </edge>
    <edge source="PDF_55_2023_Result_8086110237662957897" target="Gene_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that Sgnl binds IME1 mRNA compared with the BSA control.</data>
    </edge>
    <edge source="PDF_55_2023_Result_3050807498403910935" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
    </edge>
    <edge source="PDF_55_2023_Result_3050807498403910935" target="Protein_SGN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">In support of our model, we found that riel predicted interface mutations partially disrupted the physical interaction between Riel and Sgnl.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-3298673367396207587" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type.</data>
    </edge>
    <edge source="PDF_55_2023_Result_-3298673367396207587" target="Protein_IME1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that riel D429A-S433A-S435A mutants exhibited defective Imel accumulation and delayed appearance of bi- and tetranucleate cells compared with wild type.</data>
    </edge>
    <edge source="PDF_55_2023_Conclusion_-1110881446195742522" target="Protein_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
    </edge>
    <edge source="PDF_55_2023_Conclusion_-1110881446195742522" target="Protein_SGN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Taken together, our results support a model in which Riel and Sgnl form a complex that acts to enforce the meiotic cell fate decision.</data>
    </edge>
    <edge source="PDF_06_2021" target="PDF_06_2021_Result_8382118199712686593">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_06_2021" target="PDF_06_2021_Result_-3259732354378302525">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_06_2021" target="PDF_06_2021_Result_6013483683489674608">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_06_2021" target="PDF_06_2021_Result_-6752065244819639597">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_06_2021_Result_8382118199712686593" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">The transcriptional activation of Ty3/Gypsy retrotransposons and host defense are controlled by master meiotic regulators.</data>
    </edge>
    <edge source="PDF_06_2021_Result_-3259732354378302525" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
    </edge>
    <edge source="PDF_06_2021_Result_-3259732354378302525" target="Protein_NDT80">
      <data key="d8">MENTIONS</data>
      <data key="d9">budding yeast Ty3/Gypsy co-opts binding sites of the essential meiotic transcription factor Ndt80 upstream of the integration site, thereby tightly linking its transcriptional activation to meiotic progression.</data>
    </edge>
    <edge source="PDF_06_2021_Result_6013483683489674608" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
    </edge>
    <edge source="PDF_06_2021_Result_6013483683489674608" target="Protein_RIM4">
      <data key="d8">MENTIONS</data>
      <data key="d9">yeast cells thwart Ty3/Gypsy proliferation by blocking translation of the retrotransposon mRNA using amyloid-like assemblies of the RNA-binding protein Rim4.</data>
    </edge>
    <edge source="PDF_06_2021_Result_-6752065244819639597" target="Protein_STRA8">
      <data key="d8">MENTIONS</data>
      <data key="d9">mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
    </edge>
    <edge source="PDF_06_2021_Result_-6752065244819639597" target="Protein_MYBL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
    </edge>
    <edge source="PDF_06_2021_Result_-6752065244819639597" target="Protein_DAZL">
      <data key="d8">MENTIONS</data>
      <data key="d9">mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
    </edge>
    <edge source="PDF_06_2021_Result_-6752065244819639597" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">mammals utilize equivalent master meiotic regulators (Stra8, Mybl1, Dazl) to regulate Ty3/Gypsy-derived genes in developing gametes.</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-859609404261212333">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-622129940698925204">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_1141399373227490210">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_4026234273222297620">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_6195547222244729274">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-5010782213656739121">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-3097834726290967901">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_8930972293622260889">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_3312376890371302347">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-5542923386328879516">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-4940940051045183701">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-2977154365048100006">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-287882437199433340">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_4381616005818362437">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016" target="PDF_39_2016_Result_-1699613784156464021">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_39_2016_Result_-859609404261212333" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1-deficient mice are resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-859609404261212333" target="Protein_FAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1-deficient mice are resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-859609404261212333" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1-deficient mice are resistant to Fas-induced hepatocellular apoptosis and lethality.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-622129940698925204" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the absence of MOAP-1, mitochondrial accumulation of tBid is markedly impaired.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-622129940698925204" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the absence of MOAP-1, mitochondrial accumulation of tBid is markedly impaired.</data>
    </edge>
    <edge source="PDF_39_2016_Result_1141399373227490210" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 binds to MTCH2, and this interaction appears necessary for MTCH2 to engage tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_1141399373227490210" target="Protein_MTCH2">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 binds to MTCH2, and this interaction appears necessary for MTCH2 to engage tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_1141399373227490210" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 binds to MTCH2, and this interaction appears necessary for MTCH2 to engage tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_4026234273222297620" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 is required to mediate Fas apoptotic signaling in liver</data>
    </edge>
    <edge source="PDF_39_2016_Result_4026234273222297620" target="Protein_FAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 is required to mediate Fas apoptotic signaling in liver</data>
    </edge>
    <edge source="PDF_39_2016_Result_4026234273222297620" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 is required to mediate Fas apoptotic signaling in liver</data>
    </edge>
    <edge source="PDF_39_2016_Result_6195547222244729274" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Loss of MOAP-1 protects mice from Fas-induced liver injury and lethality</data>
    </edge>
    <edge source="PDF_39_2016_Result_6195547222244729274" target="Protein_FAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Loss of MOAP-1 protects mice from Fas-induced liver injury and lethality</data>
    </edge>
    <edge source="PDF_39_2016_Result_-5010782213656739121" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 is required for efficient tBid recruitment to mitochondria</data>
    </edge>
    <edge source="PDF_39_2016_Result_-5010782213656739121" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 is required for efficient tBid recruitment to mitochondria</data>
    </edge>
    <edge source="PDF_39_2016_Result_-3097834726290967901" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Binding of MOAP-1 to MTCH2 engages the receptor function of MTCH2 for tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_-3097834726290967901" target="Protein_MTCH2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Binding of MOAP-1 to MTCH2 engages the receptor function of MTCH2 for tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_-3097834726290967901" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Binding of MOAP-1 to MTCH2 engages the receptor function of MTCH2 for tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_8930972293622260889" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO MEFs also demonstrated resistance to apoptosis induced by overexpression of Bax or tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_8930972293622260889" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO MEFs also demonstrated resistance to apoptosis induced by overexpression of Bax or tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_8930972293622260889" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO MEFs also demonstrated resistance to apoptosis induced by overexpression of Bax or tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_8930972293622260889" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO MEFs also demonstrated resistance to apoptosis induced by overexpression of Bax or tBid.</data>
    </edge>
    <edge source="PDF_39_2016_Result_3312376890371302347" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">isolated mitochondria prepared from the MOAP-1 KO liver were markedly resistant to the cytochrome c releasing effect of recombinant Bax and tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_3312376890371302347" target="Protein_CYTOCHROME C">
      <data key="d8">MENTIONS</data>
      <data key="d9">isolated mitochondria prepared from the MOAP-1 KO liver were markedly resistant to the cytochrome c releasing effect of recombinant Bax and tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_3312376890371302347" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">isolated mitochondria prepared from the MOAP-1 KO liver were markedly resistant to the cytochrome c releasing effect of recombinant Bax and tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_3312376890371302347" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">isolated mitochondria prepared from the MOAP-1 KO liver were markedly resistant to the cytochrome c releasing effect of recombinant Bax and tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_-5542923386328879516" target="Protein_CASPASE-8">
      <data key="d8">MENTIONS</data>
      <data key="d9">caspase-8 activation remained unaffected, while activation of caspase-3 and caspase-7 was significantly impaired</data>
    </edge>
    <edge source="PDF_39_2016_Result_-5542923386328879516" target="Protein_CASPASE-3">
      <data key="d8">MENTIONS</data>
      <data key="d9">caspase-8 activation remained unaffected, while activation of caspase-3 and caspase-7 was significantly impaired</data>
    </edge>
    <edge source="PDF_39_2016_Result_-5542923386328879516" target="Protein_CASPASE-7">
      <data key="d8">MENTIONS</data>
      <data key="d9">caspase-8 activation remained unaffected, while activation of caspase-3 and caspase-7 was significantly impaired</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_CASPASE-9">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_CYTOCHROME C">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_SMAC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_AIF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_BAK">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-4940940051045183701" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activation of caspase-9, release of cytochrome c, Smac, and AIF to the cytosol, and oligomerization of Bax and Bak were all inhibited in the livers of the MOAP-1-deficient mice.</data>
    </edge>
    <edge source="PDF_39_2016_Result_-2977154365048100006" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO hepatocytes treated with increasing concentrations of recombinant Flag-tagged soluble Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor by aggregation, exhibited significant reduction in cell death and caspase-3 activation</data>
    </edge>
    <edge source="PDF_39_2016_Result_-2977154365048100006" target="Protein_FASL">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO hepatocytes treated with increasing concentrations of recombinant Flag-tagged soluble Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor by aggregation, exhibited significant reduction in cell death and caspase-3 activation</data>
    </edge>
    <edge source="PDF_39_2016_Result_-2977154365048100006" target="Protein_FAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO hepatocytes treated with increasing concentrations of recombinant Flag-tagged soluble Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor by aggregation, exhibited significant reduction in cell death and caspase-3 activation</data>
    </edge>
    <edge source="PDF_39_2016_Result_-2977154365048100006" target="Protein_CASPASE-3">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 KO hepatocytes treated with increasing concentrations of recombinant Flag-tagged soluble Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor by aggregation, exhibited significant reduction in cell death and caspase-3 activation</data>
    </edge>
    <edge source="PDF_39_2016_Result_-287882437199433340" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">mitochondrial accumulation of tBid was markedly hindered in the absence of MOAP-1</data>
    </edge>
    <edge source="PDF_39_2016_Result_-287882437199433340" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">mitochondrial accumulation of tBid was markedly hindered in the absence of MOAP-1</data>
    </edge>
    <edge source="PDF_39_2016_Result_4381616005818362437" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 associates with MTCH2 and Fas Activation Promotes Their Interaction</data>
    </edge>
    <edge source="PDF_39_2016_Result_4381616005818362437" target="Protein_MTCH2">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 associates with MTCH2 and Fas Activation Promotes Their Interaction</data>
    </edge>
    <edge source="PDF_39_2016_Result_4381616005818362437" target="Protein_FAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 associates with MTCH2 and Fas Activation Promotes Their Interaction</data>
    </edge>
    <edge source="PDF_39_2016_Result_-1699613784156464021" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interaction of MOAP-1 with MTCH2 Is Necessary for Mediating the Mitochondrial Receptor Function of MTCH2 for tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_-1699613784156464021" target="Protein_MTCH2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interaction of MOAP-1 with MTCH2 Is Necessary for Mediating the Mitochondrial Receptor Function of MTCH2 for tBid</data>
    </edge>
    <edge source="PDF_39_2016_Result_-1699613784156464021" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interaction of MOAP-1 with MTCH2 Is Necessary for Mediating the Mitochondrial Receptor Function of MTCH2 for tBid</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Hypothesis_-1505558058449884577">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-4918474746629675554">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_2263818987114240670">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-6247892651716705642">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-7098461936421922945">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_3556966989706529864">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_879410794103001418">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-2443396244489801236">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-731319792273618549">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_2718246493069241434">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-6753965463531387508">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-1014798711374166906">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-7631635505600857314">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017" target="PDF_02_2017_Result_-5670819990802419644">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_02_2017_Result_-4918474746629675554" target="Protein_RAG1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib</data>
    </edge>
    <edge source="PDF_02_2017_Result_-4918474746629675554" target="Gene_TRANSIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">The catalytic core of RAG1, the protein that is responsible for cleavage activity, is a domesticated transposase derived from an ancient lineage of DNA transposons dubbed Transib</data>
    </edge>
    <edge source="PDF_02_2017_Result_2263818987114240670" target="Protein_RAG1">
      <data key="d8">MENTIONS</data>
      <data key="d9">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
    </edge>
    <edge source="PDF_02_2017_Result_2263818987114240670" target="Protein_RAG2">
      <data key="d8">MENTIONS</data>
      <data key="d9">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
    </edge>
    <edge source="PDF_02_2017_Result_2263818987114240670" target="Gene_TRANSIB">
      <data key="d8">MENTIONS</data>
      <data key="d9">RAG2 also was shown to have TE origins and several lines of evidence suggested that both RAG1 and RAG2 were domesticated from the same ancestral Transib element</data>
    </edge>
    <edge source="PDF_02_2017_Result_-6247892651716705642" target="Protein_CAS1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
    </edge>
    <edge source="PDF_02_2017_Result_-6247892651716705642" target="Gene_CASPOSONS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cas1, the most prominent Cas protein found in CRISPR-Cas systems, shares sequence similarity to the transposases encoded by a group of TEs called Casposons</data>
    </edge>
    <edge source="PDF_02_2017_Result_-7098461936421922945" target="Protein_CAS9">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
    </edge>
    <edge source="PDF_02_2017_Result_-7098461936421922945" target="Protein_TNPB">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cas9-like proteins, which act as effectors in most class 2 systems, show sequence similarity to proteins called TnpB, which are poorly characterized but are commonly found in both autonomous and non-autonomous TEs</data>
    </edge>
    <edge source="PDF_02_2017_Result_3556966989706529864" target="Gene_ENV">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several proteins derived from the Envelope (Env) gene of endogenous retroviruses are known to aid in the protection of the host cell by restricting infection of related retroviruses</data>
    </edge>
    <edge source="PDF_02_2017_Result_879410794103001418" target="Gene_FV1">
      <data key="d8">MENTIONS</data>
      <data key="d9">A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
    </edge>
    <edge source="PDF_02_2017_Result_879410794103001418" target="Gene_GAG">
      <data key="d8">MENTIONS</data>
      <data key="d9">A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
    </edge>
    <edge source="PDF_02_2017_Result_879410794103001418" target="Gene_ERV-L">
      <data key="d8">MENTIONS</data>
      <data key="d9">A classic example is the mouse Fvl gene which is derived from the Gag gene of a member of the endogenous retrovirus family ERV-L</data>
    </edge>
    <edge source="PDF_02_2017_Result_-2443396244489801236" target="Protein_ABP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the fission yeast Schizosaccharomyces pombe, three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements</data>
    </edge>
    <edge source="PDF_02_2017_Result_-2443396244489801236" target="Protein_CBH1">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the fission yeast Schizosaccharomyces pombe, three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements</data>
    </edge>
    <edge source="PDF_02_2017_Result_-2443396244489801236" target="Protein_CBH2">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the fission yeast Schizosaccharomyces pombe, three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements</data>
    </edge>
    <edge source="PDF_02_2017_Result_-2443396244489801236" target="Gene_TF2">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the fission yeast Schizosaccharomyces pombe, three transposase-derived proteins (Abp1, Cbh1 and Cbh2) originated from pogo transposons have taken on partially overlapping function in controlling unrelated retrotransposons called Tf2 elements</data>
    </edge>
    <edge source="PDF_02_2017_Result_-731319792273618549" target="Gene_MAIL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms and partake in an epigenetic silencing pathway that transcriptionally represses a broad array of TEs</data>
    </edge>
    <edge source="PDF_02_2017_Result_-731319792273618549" target="Gene_MAIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms and partake in an epigenetic silencing pathway that transcriptionally represses a broad array of TEs</data>
    </edge>
    <edge source="PDF_02_2017_Result_-731319792273618549" target="Gene_TY3/GYPSY">
      <data key="d8">MENTIONS</data>
      <data key="d9">In Arabidopsis, two genes MAIL1 and MAIN encode related proteins that appear to be evolutionarily derived from a subset of Ty3/gypsy retrotransposons found in angiosperms and partake in an epigenetic silencing pathway that transcriptionally represses a broad array of TEs</data>
    </edge>
    <edge source="PDF_02_2017_Result_2718246493069241434" target="Protein_ALP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway and directly derives from a PIF-like transposase</data>
    </edge>
    <edge source="PDF_02_2017_Result_2718246493069241434" target="Gene_PIF">
      <data key="d8">MENTIONS</data>
      <data key="d9">ALP1 is another domesticated TE protein identified in Arabidopsis that is involved in yet another epigenetic silencing pathway and directly derives from a PIF-like transposase</data>
    </edge>
    <edge source="PDF_02_2017_Result_-6753965463531387508" target="Protein_L1TD1">
      <data key="d8">MENTIONS</data>
      <data key="d9">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s)</data>
    </edge>
    <edge source="PDF_02_2017_Result_-6753965463531387508" target="Gene_LINE-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">LINE-1 type Transposase Domain-containing 1 (L1TD1) was coopted in the ancestor of placental mammals from the ORF1 coding region of long interspersed nuclear elements LINE-1 (or L1s)</data>
    </edge>
    <edge source="PDF_02_2017_Result_-1014798711374166906" target="Protein_PIGGYMAC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
    </edge>
    <edge source="PDF_02_2017_Result_-1014798711374166906" target="Gene_PGM">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
    </edge>
    <edge source="PDF_02_2017_Result_-1014798711374166906" target="Protein_TPB2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
    </edge>
    <edge source="PDF_02_2017_Result_-1014798711374166906" target="Protein_TPB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
    </edge>
    <edge source="PDF_02_2017_Result_-1014798711374166906" target="Protein_TBP6">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
    </edge>
    <edge source="PDF_02_2017_Result_-1014798711374166906" target="Protein_LIA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paramecium uses PiggyMac (Pgm), a domesticated transposase, while in Tetrahymena at least four other transposase-derived proteins (TPB2, TPB1, TBP6, and Lia5) are required for IES removal</data>
    </edge>
    <edge source="PDF_02_2017_Result_-7631635505600857314" target="Protein_PRP8">
      <data key="d8">MENTIONS</data>
      <data key="d9">the prp8 protein, which is an integral component of the spliceosomal complex, displays significant sequence similarity with reverse transcriptases and as such has been proposed to derive from an anciently domesticated retroelement</data>
    </edge>
    <edge source="PDF_02_2017_Result_-5670819990802419644" target="Protein_SYNCYTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
    </edge>
    <edge source="PDF_02_2017_Result_-5670819990802419644" target="Gene_ENV">
      <data key="d8">MENTIONS</data>
      <data key="d9">Syncytins are proteins derived from the Env gene of retroviruses that have been coopted at least nine times during mammal evolution and are thought to play a role in placentation</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_-2246670777324478465">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_4392848714266283568">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_3293424466776908951">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_-5852185682534259895">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_-7671793743846407121">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_1695621361997568259">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_-7276153623578830034">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_-8996690323318280995">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_-7691746358260924415">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024" target="PDF_19_2024_Result_1481681276088822288">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_19_2024_Result_-8996690323318280995" target="Gene_CD300E">
      <data key="d8">MENTIONS</data>
      <data key="d9">Monocytes that express CD300e, which negatively regulates T cell activation, were identified only in the aged ovaries.</data>
    </edge>
    <edge source="PDF_19_2024_Result_-7691746358260924415" target="Gene_CD90">
      <data key="d8">MENTIONS</data>
      <data key="d9">Observed a higher percentage and number of CD90+ cells (T cells and innate lymphoid cells) in aged ovaries, which aligns with the scRNA-seq findings.</data>
    </edge>
    <edge source="PDF_49_2017" target="PDF_49_2017_Result_1583259639433620737">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_49_2017" target="PDF_49_2017_Result_-2238772983670542827">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_49_2017" target="PDF_49_2017_Result_-2305178240930469589">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_49_2017" target="PDF_49_2017_Result_-7341262223599777269">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_49_2017_Result_1583259639433620737" target="Protein_CD3">
      <data key="d8">MENTIONS</data>
      <data key="d9">A statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8 (log-rank test, p-values 0.006 and 0.007 respectively; Fig. 2a,b).</data>
    </edge>
    <edge source="PDF_49_2017_Result_1583259639433620737" target="Protein_CD8">
      <data key="d8">MENTIONS</data>
      <data key="d9">A statistically significant association between disease-specific survival and positive cell density scores was demonstrated for both CD3 and CD8 (log-rank test, p-values 0.006 and 0.007 respectively; Fig. 2a,b).</data>
    </edge>
    <edge source="PDF_49_2017_Result_-2238772983670542827" target="Protein_TP53">
      <data key="d8">MENTIONS</data>
      <data key="d9">Aberrant p53 expression (diffuse intense or completely absent immunoreactivity) is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression (p=0.003 extreme negative/positive vs. intermediate; Fig. 2c).</data>
    </edge>
    <edge source="PDF_49_2017_Result_-2238772983670542827" target="Gene_TP53">
      <data key="d8">MENTIONS</data>
      <data key="d9">Aberrant p53 expression (diffuse intense or completely absent immunoreactivity) is associated with significantly poorer unadjusted disease-specific survival when compared with intermediate, 'wild-type' expression (p=0.003 extreme negative/positive vs. intermediate; Fig. 2c).</data>
    </edge>
    <edge source="PDF_49_2017_Result_-2305178240930469589" target="Protein_PD-L1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher PD-L1 expression to be significantly associated with improved disease-specific survival in unadjusted analysis (p=0.004, Fig. 2d).</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-6668271628605658249">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-8618075455610814167">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-101941758172532081">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_1248226264167135126">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-1863785578001539891">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-789076811375776843">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-8472704266374613823">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_6532212628664238437">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_236672704149590749">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_4612942148811822835">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Result_-2120443794230431094">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021" target="PDF_29_2021_Hypothesis_-8359145954004597191">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8618075455610814167" target="Compound_URATE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8618075455610814167" target="Disease_GOUT">
      <data key="d8">MENTIONS</data>
      <data key="d9">Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8618075455610814167" target="Protein_CYSTATIN C">
      <data key="d8">MENTIONS</data>
      <data key="d9">Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8618075455610814167" target="Disease_STROKE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Through Mendelian Randomization analysis, we discover 51 causal relationships, including previously known agonistic effects of urate on gout and cystatin C on stroke.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-101941758172532081" target="Disease_CHRONIC KIDNEY DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset relative to single-disease PRSs.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-101941758172532081" target="Disease_TYPE 2 DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset relative to single-disease PRSs.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-101941758172532081" target="Disease_GOUT">
      <data key="d8">MENTIONS</data>
      <data key="d9">develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset relative to single-disease PRSs.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-101941758172532081" target="Disease_ALCOHOLIC CIRRHOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">develop polygenic risk scores for each biomarker and built 'multi-PRS' models for diseases using 35 PRSs simultaneously, which improved chronic kidney disease, type 2 diabetes, gout, and alcoholic cirrhosis genetic risk stratification in an independent dataset relative to single-disease PRSs.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_TGFB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_AXL">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_PFN1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_GYPC">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_IL6R">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_VEGFA">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_HFE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Disease_HEMOCHROMATOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_CD33">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-1863785578001539891" target="Gene_CD36">
      <data key="d8">MENTIONS</data>
      <data key="d9">We discovered fine-mapped associations for glycemic traits, including multiple variants at the_TGFB1/AXL locus; rare missense variants in PFN1 and GYPC (previously implicated in a small GWAS of Mexican Americans)40; an intronic variant at the cytokine receptor IL6R; a downstream variant at VEGFA41; a missense variant at HFE, the gene responsible for hemochromatosis42,43; and an intronic variant at CD33 and 3'UTR variant at CD36 (Supplementary Table 14a).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-789076811375776843" target="Gene_SLCO1B1">
      <data key="d8">MENTIONS</data>
      <data key="d9">We find several heterozygous deletion events, and single-nucleotide variants that we fine-mapped to two main signals: a missense variant in SLCO1B1 (rs34671512, marginal beta = -0.11 sd, p = 1.25 × 10–95) and a non-coding association in an intron of SLCO1B3 (rs11045598, marginal beta = 0.076 sd, p = 1.31 × 10-139).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-789076811375776843" target="Gene_SLCO1B3">
      <data key="d8">MENTIONS</data>
      <data key="d9">We find several heterozygous deletion events, and single-nucleotide variants that we fine-mapped to two main signals: a missense variant in SLCO1B1 (rs34671512, marginal beta = -0.11 sd, p = 1.25 × 10–95) and a non-coding association in an intron of SLCO1B3 (rs11045598, marginal beta = 0.076 sd, p = 1.31 × 10-139).</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8472704266374613823" target="Protein_IGF-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">we discovered two independent fine-mapped variants, rs114303452 (a missense variant with MAF = 1%) and rs59950280 (a non-coding variant with MAF = 34%). These two variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium (Figure 3d). In addition, rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8472704266374613823" target="Gene_HGFAC">
      <data key="d8">MENTIONS</data>
      <data key="d9">we discovered two independent fine-mapped variants, rs114303452 (a missense variant with MAF = 1%) and rs59950280 (a non-coding variant with MAF = 34%). These two variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium (Figure 3d). In addition, rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-8472704266374613823" target="Protein_HEPATOCYTE GROWTH FACTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">we discovered two independent fine-mapped variants, rs114303452 (a missense variant with MAF = 1%) and rs59950280 (a non-coding variant with MAF = 34%). These two variants show significant associations with a number of diverse biomarker traits, including lipids, IGF-1, albumin, and calcium (Figure 3d). In addition, rs114303452 has been previously associated with serum HGF levels47, supporting the role of HGFAC in control of a number of other serum biomarkers through regulation of hepatocyte growth factor.</data>
    </edge>
    <edge source="PDF_29_2021_Result_6532212628664238437" target="Protein_SHBG">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports53–54, of ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)55–57, as well as an increasing effect of alanine aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)58,59.</data>
    </edge>
    <edge source="PDF_29_2021_Result_6532212628664238437" target="Disease_DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports53–54, of ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)55–57, as well as an increasing effect of alanine aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)58,59.</data>
    </edge>
    <edge source="PDF_29_2021_Result_6532212628664238437" target="Protein_APOA">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports53–54, of ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)55–57, as well as an increasing effect of alanine aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)58,59.</data>
    </edge>
    <edge source="PDF_29_2021_Result_6532212628664238437" target="Protein_ALANINE AMINOTRANSFERASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found genetic evidence supporting the protective effect of sex hormone binding globulin on diabetes (0.7 OR/SD) consistent with existing reports53–54, of ApoA on fasting glucose (0.84 OR/SD, FDR-adjusted p = 0.02)55–57, as well as an increasing effect of alanine aminotransferase levels on diabetes (1.53 OR/SD, FDR-adjusted p = 0.0018)58,59.</data>
    </edge>
    <edge source="PDF_29_2021_Result_236672704149590749" target="Protein_CYSTATIN C">
      <data key="d8">MENTIONS</data>
      <data key="d9">There was a consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)60,61.</data>
    </edge>
    <edge source="PDF_29_2021_Result_236672704149590749" target="Disease_STROKE">
      <data key="d8">MENTIONS</data>
      <data key="d9">There was a consistent effect of cystatin C on stroke (1.2 OR/SD, FDR-adjusted p = 8.7×10−4 for any stroke and 1.21 OR/SD, FDR-adjusted p = 2.8×10−3 for ischemic stroke)60,61.</data>
    </edge>
    <edge source="PDF_29_2021_Result_4612942148811822835" target="Protein_HDL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Finally, both HDL and ApoA were associated with increased risk of age-related macular degeneration62, as was cystatin C63–65.</data>
    </edge>
    <edge source="PDF_29_2021_Result_4612942148811822835" target="Protein_APOA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Finally, both HDL and ApoA were associated with increased risk of age-related macular degeneration62, as was cystatin C63–65.</data>
    </edge>
    <edge source="PDF_29_2021_Result_4612942148811822835" target="Disease_AGE-RELATED MACULAR DEGENERATION">
      <data key="d8">MENTIONS</data>
      <data key="d9">Finally, both HDL and ApoA were associated with increased risk of age-related macular degeneration62, as was cystatin C63–65.</data>
    </edge>
    <edge source="PDF_29_2021_Result_4612942148811822835" target="Protein_CYSTATIN C">
      <data key="d8">MENTIONS</data>
      <data key="d9">Finally, both HDL and ApoA were associated with increased risk of age-related macular degeneration62, as was cystatin C63–65.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-2120443794230431094" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We estimated a causal protective effect of testosterone on inflammatory bowel disease (0.70 OR/SD, FDR-adjusted p = 3.86×10−3)66,67, and a protective effect of urate on breast cancer risk (0.87 OR/SD, FDR-adjusted p = 0.033)68.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-2120443794230431094" target="Disease_INFLAMMATORY BOWEL DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We estimated a causal protective effect of testosterone on inflammatory bowel disease (0.70 OR/SD, FDR-adjusted p = 3.86×10−3)66,67, and a protective effect of urate on breast cancer risk (0.87 OR/SD, FDR-adjusted p = 0.033)68.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-2120443794230431094" target="Compound_URATE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We estimated a causal protective effect of testosterone on inflammatory bowel disease (0.70 OR/SD, FDR-adjusted p = 3.86×10−3)66,67, and a protective effect of urate on breast cancer risk (0.87 OR/SD, FDR-adjusted p = 0.033)68.</data>
    </edge>
    <edge source="PDF_29_2021_Result_-2120443794230431094" target="Disease_BREAST CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">We estimated a causal protective effect of testosterone on inflammatory bowel disease (0.70 OR/SD, FDR-adjusted p = 3.86×10−3)66,67, and a protective effect of urate on breast cancer risk (0.87 OR/SD, FDR-adjusted p = 0.033)68.</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Method_-2036723048305678366">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Method_-5430434396878724885">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Result_1420458054246977434">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Result_-1862653331997825808">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Result_-1370368055683610152">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Result_-477183488283338742">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Result_-2720929313772291954">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Conclusion_223876976186484895">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015" target="PDF_25_2015_Conclusion_424253452703904926">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_25_2015_Method_-5430434396878724885" target="Process_VIRUS-LIKE PARTICLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">A protocol for the gentle purification of virus-like particles (VLPs) that have been produced in plants.</data>
    </edge>
    <edge source="PDF_25_2015_Result_-1862653331997825808" target="Compound_SUCROSE">
      <data key="d8">MENTIONS</data>
      <data key="d9">The double sucrose cushion will always result in a green band of dense impurities forming at the interface between the 25% and 70% sucrose layers</data>
    </edge>
    <edge source="PDF_25_2015_Result_-1370368055683610152" target="Process_VIRUS-LIKE PARTICLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
    </edge>
    <edge source="PDF_25_2015_Result_-1370368055683610152" target="Compound_SUCROSE">
      <data key="d8">MENTIONS</data>
      <data key="d9">VLPs are detectable in the 70% sucrose fraction as well as in the interface, although the 70% fraction will normally look cleaner</data>
    </edge>
    <edge source="PDF_25_2015_Result_-477183488283338742" target="Process_VIRUS-LIKE PARTICLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">the concentrate can be centrifuged to remove some of these impurities, but the Nycodenz gradient will separate them from the VLPs much more efficiently.</data>
    </edge>
    <edge source="PDF_25_2015_Result_-477183488283338742" target="Compound_NYCODENZ">
      <data key="d8">MENTIONS</data>
      <data key="d9">the concentrate can be centrifuged to remove some of these impurities, but the Nycodenz gradient will separate them from the VLPs much more efficiently.</data>
    </edge>
    <edge source="PDF_25_2015_Result_-2720929313772291954" target="Process_VIRUS-LIKE PARTICLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
    </edge>
    <edge source="PDF_25_2015_Result_-2720929313772291954" target="Compound_NYCODENZ">
      <data key="d8">MENTIONS</data>
      <data key="d9">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
    </edge>
    <edge source="PDF_25_2015_Result_-2720929313772291954" target="Compound_SUCROSE">
      <data key="d8">MENTIONS</data>
      <data key="d9">TEM analysis of Nycodenz gradient fractions containing VLPs will appear cleaner than fractions obtained from the sucrose cushion</data>
    </edge>
    <edge source="PDF_25_2015_Conclusion_223876976186484895" target="Process_VIRUS-LIKE PARTICLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">The protocol described here is suitable for determining whether VLPs are formed after recombinant protein expression in plants.</data>
    </edge>
    <edge source="PDF_25_2015_Conclusion_424253452703904926" target="Process_VIRUS-LIKE PARTICLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">This protocol is therefore a powerful tool for testing whether a gene construct directs the formation of VLPs in plants</data>
    </edge>
    <edge source="PDF_09_2017" target="PDF_09_2017_Hypothesis_1393163785014218773">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_09_2017" target="PDF_09_2017_Result_-5221559463308174901">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_09_2017" target="PDF_09_2017_Result_-6606755681523707516">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_09_2017" target="PDF_09_2017_Result_7708946650816017519">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_09_2017" target="PDF_09_2017_Result_2749814980667974658">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_09_2017" target="PDF_09_2017_Conclusion_2201721553397396131">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_09_2017_Hypothesis_1393163785014218773" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 might play important roles in meiosis.</data>
    </edge>
    <edge source="PDF_09_2017_Hypothesis_1393163785014218773" target="Process_MEIOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 might play important roles in meiosis.</data>
    </edge>
    <edge source="PDF_09_2017_Result_-5221559463308174901" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
    </edge>
    <edge source="PDF_09_2017_Result_-5221559463308174901" target="Process_MEIOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">loss of Pnma5 significantly delayed the progression of meiosis I and increased chromosome segregation errors during anaphase I.</data>
    </edge>
    <edge source="PDF_09_2017_Result_-6606755681523707516" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 knockdown caused significantly lower fertilization</data>
    </edge>
    <edge source="PDF_09_2017_Result_7708946650816017519" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 knockdown was found to significantly decrease the stability of spindle microtubules and altered F-actin organization within actin cap regions, cause significantly abnormal mitochondria aggregation and lower ATP concentration</data>
    </edge>
    <edge source="PDF_09_2017_Result_2749814980667974658" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
    </edge>
    <edge source="PDF_09_2017_Result_2749814980667974658" target="Protein_AKT1">
      <data key="d8">MENTIONS</data>
      <data key="d9">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
    </edge>
    <edge source="PDF_09_2017_Result_2749814980667974658" target="Protein_GSK3B">
      <data key="d8">MENTIONS</data>
      <data key="d9">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
    </edge>
    <edge source="PDF_09_2017_Result_2749814980667974658" target="Gene_SRC">
      <data key="d8">MENTIONS</data>
      <data key="d9">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
    </edge>
    <edge source="PDF_09_2017_Result_2749814980667974658" target="Protein_ERK1/2">
      <data key="d8">MENTIONS</data>
      <data key="d9">phosphorylation at Thr533 re-located Pnma5 strongly to spindles &amp; cortex and was required for the phosphorylation of Akt and Gsk3ẞ, while Src and Erk1/2 phosphorylation was required for the phosphorylation of Pnma5, indicating that phosphorylated Pnma5 is the active form and subsequently activates Akt and Gsk3ẞ</data>
    </edge>
    <edge source="PDF_09_2017_Conclusion_2201721553397396131" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
    </edge>
    <edge source="PDF_09_2017_Conclusion_2201721553397396131" target="Process_MEIOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
    </edge>
    <edge source="PDF_09_2017_Conclusion_2201721553397396131" target="Gene_SRC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
    </edge>
    <edge source="PDF_09_2017_Conclusion_2201721553397396131" target="Protein_ERK1/2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
    </edge>
    <edge source="PDF_09_2017_Conclusion_2201721553397396131" target="Protein_AKT1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
    </edge>
    <edge source="PDF_09_2017_Conclusion_2201721553397396131" target="Protein_GSK3B">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma5 is important for meiosis and is the pivot of Src→Erk1/2→Pnma5→Akt→Gsk3ẞ pathway.</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_-7806054370102963390">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_825622307980447196">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_3339080492896259986">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_7269316006305881669">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_3414348154684077920">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_8722671742599844941">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_6825218308017713514">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_-8953127831898435091">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_-5825267102230932480">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_2162731638846710996">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_-1517347387119099141">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_-38064801075553443">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_8950524083492213155">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021" target="PDF_08_2021_Result_1766543395992789895">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_08_2021_Result_-7806054370102963390" target="Protein_ANNA-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
    </edge>
    <edge source="PDF_08_2021_Result_-7806054370102963390" target="Gene_HU">
      <data key="d8">MENTIONS</data>
      <data key="d9">ANNA-1 or "anti-Hu" has been described with various paraneoplastic manifestations including sensory neuronopathy, gastroparesis, and limbic encephalitis.</data>
    </edge>
    <edge source="PDF_08_2021_Result_825622307980447196" target="Protein_PCA-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The most common clinical syndrome associated with PCA-1 IgG is paraneoplastic cerebellar degeneration (PCD).</data>
    </edge>
    <edge source="PDF_08_2021_Result_3339080492896259986" target="Protein_CRMP5">
      <data key="d8">MENTIONS</data>
      <data key="d9">CRMP5 IgG has been described in association with paraneoplastic peripheral neuropathy, cranial neuropathy, gastroparesis, encephalitis, cerebellar ataxia, myelopathy, and chorea.</data>
    </edge>
    <edge source="PDF_08_2021_Result_7269316006305881669" target="Protein_MA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Paraneoplastic limbic and/or diencephalic encephalitis is the typical clinical phenotype associated with Ma2 IgG.</data>
    </edge>
    <edge source="PDF_08_2021_Result_3414348154684077920" target="Protein_AMPHIPHYSIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Amphiphysin IgG was initially described in women with paraneoplastic stiff person syndrome and breast cancer.</data>
    </edge>
    <edge source="PDF_08_2021_Result_8722671742599844941" target="Protein_SOX1">
      <data key="d8">MENTIONS</data>
      <data key="d9">SOX1 antibodies have been described in association with PNS and small-cell cancer, especially Lambert-Eaton myasthenic syndrome (LEMS).</data>
    </edge>
    <edge source="PDF_08_2021_Result_6825218308017713514" target="Protein_KLHL11">
      <data key="d8">MENTIONS</data>
      <data key="d9">KLHL11 is a novel onconeural antibody associated with rhombencephalitis phenotype (brainstem and/or cerebellar involvement) and a few cases of limbic encephalitis with or without rhombencephalitis.</data>
    </edge>
    <edge source="PDF_08_2021_Result_-8953127831898435091" target="Protein_PDE10A">
      <data key="d8">MENTIONS</data>
      <data key="d9">PDE10A IgG was recently described among seven patients with PNS, with movement disorders as the predominant presentation.</data>
    </edge>
    <edge source="PDF_08_2021_Result_-5825267102230932480" target="Protein_GABA-B-R">
      <data key="d8">MENTIONS</data>
      <data key="d9">GABA-B-R encephalitis commonly presents with refractory non-convulsive status epilepticus and/or limbic encephalitis.</data>
    </edge>
    <edge source="PDF_08_2021_Result_2162731638846710996" target="Protein_MGLUR5">
      <data key="d8">MENTIONS</data>
      <data key="d9">mGlur5 autoantibodies have been described in association with Ophelia syndrome which presents with encephalopathy, mood disturbances, and seizures.</data>
    </edge>
    <edge source="PDF_08_2021_Result_-1517347387119099141" target="Protein_AMPA-R">
      <data key="d8">MENTIONS</data>
      <data key="d9">Limbic encephalitis is a common neurological presentation for AMPA-R IgG-seropositive cases, though phenotypic variability ranges from minimal symptoms to fulminant panencephalitis.</data>
    </edge>
    <edge source="PDF_08_2021_Result_-38064801075553443" target="Protein_NMDA-R">
      <data key="d8">MENTIONS</data>
      <data key="d9">NMDA-R encephalitis can be associated with a neoplasm in 20-40% of cases.</data>
    </edge>
    <edge source="PDF_08_2021_Result_8950524083492213155" target="Protein_CASPR2">
      <data key="d8">MENTIONS</data>
      <data key="d9">CASPR2-IgG is associated with thymomas in about 20% of cases, though other tumors have been reported rarely (melanomas).</data>
    </edge>
    <edge source="PDF_08_2021_Result_1766543395992789895" target="Protein_LGI1">
      <data key="d8">MENTIONS</data>
      <data key="d9">LGI1-IgG is associated with thymoma in about 5-15% of cases; rare cases of squamous cell lung cancer have also been reported.</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Hypothesis_-689113054231307486">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Method_5338535536287173866">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Method_1032877104525586277">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Method_8309077585871600362">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Method_7431052621562894497">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Result_9034946831122568883">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Result_-8785409896595452916">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Result_1496278862152900520">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Result_3164139135748833122">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Result_7124440656041761807">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Result_240844253262632726">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007" target="PDF_41_2007_Conclusion_-2415286575872238197">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_41_2007_Hypothesis_-689113054231307486" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
    </edge>
    <edge source="PDF_41_2007_Hypothesis_-689113054231307486" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Apoptotic stimuli can facilitate the proapoptotic function of Bax in mitochondria through stabilization of MOAP-1.</data>
    </edge>
    <edge source="PDF_41_2007_Result_9034946831122568883" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 protein levels were rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
    </edge>
    <edge source="PDF_41_2007_Result_9034946831122568883" target="Protein_TRAIL">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 protein levels were rapidly up-regulated in HCT116, H1299, SY5Y, and HeLa cells upon tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment</data>
    </edge>
    <edge source="PDF_41_2007_Result_-8785409896595452916" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">the up-regulation of MOAP-1 by DNA-damaging stimuli involves a p53-independent mechanism.</data>
    </edge>
    <edge source="PDF_41_2007_Result_-8785409896595452916" target="Protein_TP53">
      <data key="d8">MENTIONS</data>
      <data key="d9">the up-regulation of MOAP-1 by DNA-damaging stimuli involves a p53-independent mechanism.</data>
    </edge>
    <edge source="PDF_41_2007_Result_1496278862152900520" target="Protein_TRAIL">
      <data key="d8">MENTIONS</data>
      <data key="d9">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
    </edge>
    <edge source="PDF_41_2007_Result_1496278862152900520" target="Compound_ETOP">
      <data key="d8">MENTIONS</data>
      <data key="d9">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
    </edge>
    <edge source="PDF_41_2007_Result_1496278862152900520" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">TRAIL or ETOP treatment led to a pronounced extension of MOAP-1 half-life compared with the untreated control</data>
    </edge>
    <edge source="PDF_41_2007_Result_3164139135748833122" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Polyubiquitinated forms of myc-tagged MOAP-1 were readily observed in the transfected cells in the presence of MG132</data>
    </edge>
    <edge source="PDF_41_2007_Result_3164139135748833122" target="Compound_MG132">
      <data key="d8">MENTIONS</data>
      <data key="d9">Polyubiquitinated forms of myc-tagged MOAP-1 were readily observed in the transfected cells in the presence of MG132</data>
    </edge>
    <edge source="PDF_41_2007_Result_7124440656041761807" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher levels of MOAP-1 promote TRAIL-induced Bax activation.</data>
    </edge>
    <edge source="PDF_41_2007_Result_7124440656041761807" target="Protein_TRAIL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher levels of MOAP-1 promote TRAIL-induced Bax activation.</data>
    </edge>
    <edge source="PDF_41_2007_Result_7124440656041761807" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher levels of MOAP-1 promote TRAIL-induced Bax activation.</data>
    </edge>
    <edge source="PDF_41_2007_Result_240844253262632726" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid-mediated Cyto c release</data>
    </edge>
    <edge source="PDF_41_2007_Result_240844253262632726" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid-mediated Cyto c release</data>
    </edge>
    <edge source="PDF_41_2007_Result_240844253262632726" target="Protein_CYTOCHROME C">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 knockdown by RNAi has been shown to attenuate recombinant Bax- and tBid-mediated Cyto c release</data>
    </edge>
    <edge source="PDF_41_2007_Conclusion_-2415286575872238197" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">protein stabilization, possibly by inhibition of its degradation, is likely to be a predominant mechanism underlying the up-regulation of MOAP-1 induced by apoptotic stimuli.</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Result_-6325789410598421256">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Result_7573320034497081939">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Result_4221648513671489682">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Result_-1118987072125800902">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Method_-628012974630234620">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Method_2027951336582469118">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Method_-1581565459935259450">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Method_6756882782261408350">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012" target="PDF_60_2012_Method_7392739741379220742">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_60_2012_Result_-6325789410598421256" target="Gene_SHANK3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Both homozygous and heterozygous mice showed reduced glutamatergic transmission and long-term potentiation in the hippocampus with more severe deficits detected in the homozygous mice.</data>
    </edge>
    <edge source="PDF_60_2012_Result_7573320034497081939" target="Gene_SHANK3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mild social impairments were detected, primarily in juveniles during reciprocal interactions, while all genotypes displayed normal adult sociability on the three-chambered task.</data>
    </edge>
    <edge source="PDF_60_2012_Result_4221648513671489682" target="Gene_SHANK3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Impaired novel object recognition and rotarod performance were consistent across cohorts of null mutants.</data>
    </edge>
    <edge source="PDF_60_2012_Result_-1118987072125800902" target="Gene_SHANK3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Repetitive self-grooming, reduced ultrasonic vocalizations, and deficits in reversal of water maze learning were detected only in some cohorts, emphasizing the importance of replication analyses.</data>
    </edge>
    <edge source="PDF_60_2012_Method_-628012974630234620" target="Gene_SHANK3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mice with mutations in the gene coding for the Shank3 protein were generated at the Mount Sinai School of Medicine as previously described (Bozdagi et al., 2010).</data>
    </edge>
    <edge source="PDF_11_2021" target="PDF_11_2021_Result_-5378304781096126423">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_11_2021" target="PDF_11_2021_Result_-5129435826745893698">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_11_2021" target="PDF_11_2021_Result_4041609895537003458">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_11_2021" target="PDF_11_2021_Conclusion_7055719392448873627">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_11_2021" target="PDF_11_2021_Method_-524147421028985117">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_UBE2C">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_UBC">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_CDC34">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_UBR1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_KIF11">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_ASF1B">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_PRC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_ESPL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_GTSE1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_EXO1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_UBA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_KIF4A">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_UBA52">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_UBE2V2">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_SKP1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_CCNB1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_-5129435826745893698" target="Gene_MAD2L1">
      <data key="d8">MENTIONS</data>
      <data key="d9">17 hub genes were identified including 12 upregulated genes (UBE2C, UBC, CDC34, UBR1, KIF11, ASF1B, PRC1, ESPL1, GTSE1, EXO1, UBA1, KIF4A) and 5 downregulated genes (UBA52, UBE2V2, SKP1, CCNB1, MAD2L1).</data>
    </edge>
    <edge source="PDF_11_2021_Result_4041609895537003458" target="Process_UBIQUITINATION">
      <data key="d8">MENTIONS</data>
      <data key="d9">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
    </edge>
    <edge source="PDF_11_2021_Result_4041609895537003458" target="Process_MEIOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
    </edge>
    <edge source="PDF_11_2021_Result_4041609895537003458" target="Process_CELL CYCLE">
      <data key="d8">MENTIONS</data>
      <data key="d9">significant key biological processes that are associated with these hub genes include ubiquitin-mediated proteolysis, ubiquitination-related pathways, oocyte meiosis, and cell cycle</data>
    </edge>
    <edge source="PDF_11_2021_Conclusion_7055719392448873627" target="Gene_UBE2C">
      <data key="d8">MENTIONS</data>
      <data key="d9">UBE2C may play a crucial role in human oocyte ageing.</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Result_-8438249765820968018">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Result_-9067956160207902124">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Result_1689558169658718004">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Result_-6654145113654609864">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Result_3173920965600668476">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Result_-1945302862363437988">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_-8785663842181427493">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_-8645387118691467615">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_8827718208517569856">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_-2027175557915624560">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_-4237319117149186885">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_3956828076427853317">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022" target="PDF_50_2022_Method_2914987445334635170">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_50_2022_Result_-8438249765820968018" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mammalian oocyte nuclei contain prominent F-actin structures</data>
    </edge>
    <edge source="PDF_50_2022_Result_-9067956160207902124" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">nuclear F-actin structures are a common feature of healthy, non-manipulated mammalian oocytes</data>
    </edge>
    <edge source="PDF_50_2022_Result_-9067956160207902124" target="Process_OOCYTE">
      <data key="d8">MENTIONS</data>
      <data key="d9">nuclear F-actin structures are a common feature of healthy, non-manipulated mammalian oocytes</data>
    </edge>
    <edge source="PDF_50_2022_Result_1689558169658718004" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cytoplasmic F-actin disruption induces excessive nuclear F-actin assembly</data>
    </edge>
    <edge source="PDF_50_2022_Result_1689558169658718004" target="Compound_CYTOCHALASIN D">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cytoplasmic F-actin disruption induces excessive nuclear F-actin assembly</data>
    </edge>
    <edge source="PDF_50_2022_Result_-6654145113654609864" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Excess G-actin causes uncontrolled cytoplasmic and nuclear F-actin assembly</data>
    </edge>
    <edge source="PDF_50_2022_Result_3173920965600668476" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
    </edge>
    <edge source="PDF_50_2022_Result_3173920965600668476" target="Process_OOCYTE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Maintenance of oocyte cytoplasmic F-actin network organisation requires nuclear import activity</data>
    </edge>
    <edge source="PDF_50_2022_Result_-1945302862363437988" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
    </edge>
    <edge source="PDF_50_2022_Result_-1945302862363437988" target="Process_OOCYTE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Stable nuclear actin filaments restrict chromatin mobility in oocytes</data>
    </edge>
    <edge source="PDF_50_2022_Method_8827718208517569856" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">super-resolution live imaging of nuclear F-actin using fluorescence-labelled actin nanobody</data>
    </edge>
    <edge source="PDF_50_2022_Method_-2027175557915624560" target="Protein_UTROPHIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">targeting F-tractin and the calponin homology domain of utrophin to the nucleus</data>
    </edge>
    <edge source="PDF_50_2022_Method_-4237319117149186885" target="Protein_ACTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment</data>
    </edge>
    <edge source="PDF_50_2022_Method_-4237319117149186885" target="Compound_CYTOCHALASIN D">
      <data key="d8">MENTIONS</data>
      <data key="d9">disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment</data>
    </edge>
    <edge source="PDF_50_2022_Method_-4237319117149186885" target="Process_OOCYTE">
      <data key="d8">MENTIONS</data>
      <data key="d9">disruption of the oocyte cytoplasmic actin network by Cytochalasin D treatment</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Hypothesis_-2277325410450353680">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Method_-1656248677016132372">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Method_-5344327631043359523">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Method_480367400685621251">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Method_-6882647881110000094">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Method_-644288147001791370">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_-2797600141949413289">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_-5204513441619088489">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_-6715708487462895540">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_7537782149737195130">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_-6403490340212377427">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_3083881529455983430">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_7408676244789082373">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_1163457062016506767">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_-5762510954293473928">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Result_-7911249017561744152">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018" target="PDF_20_2018_Conclusion_-8716216063639187595">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_20_2018_Hypothesis_-2277325410450353680" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">dArc1 influences synaptic plasticity by utilizing a retroviral-like mechanism for transport between synaptic partners in Drosophila.</data>
    </edge>
    <edge source="PDF_20_2018_Method_-1656248677016132372" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Downregulation of darc1 in motorneurons using Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
    </edge>
    <edge source="PDF_20_2018_Method_-1656248677016132372" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Downregulation of darc1 in motorneurons using Gal4 driver C380-Gal4 to express UAS-dArc1-RNAi and examined the pre-and postsynaptic levels of dArc1 mRNA via FISH.</data>
    </edge>
    <edge source="PDF_20_2018_Method_480367400685621251" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
    </edge>
    <edge source="PDF_20_2018_Method_480367400685621251" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of a dArc1 transgene in neurons, in a darc1E8/darc1esm113 mutant background.</data>
    </edge>
    <edge source="PDF_20_2018_Method_-6882647881110000094" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of darc1-3'UTR alone in neurons fused to GFP.</data>
    </edge>
    <edge source="PDF_20_2018_Method_-6882647881110000094" target="Protein_GFP">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of darc1-3'UTR alone in neurons fused to GFP.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-2797600141949413289" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in darc 1 FISH signal, not only at presynaptic boutons, but also at the muscle postsynaptic region.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-5204513441619088489" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expressing dArc1-RNAi in motorneurons resulted in a significant decrease in dArc1 protein immunoreactive signal, both in pre- and postsynaptic compartments.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-6715708487462895540" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expressing dArc1-RNAi with a muscle Gal4 driver, C57-Gal4, did not affect dArc1 RNA nor dArc1 protein levels.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-6715708487462895540" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expressing dArc1-RNAi with a muscle Gal4 driver, C57-Gal4, did not affect dArc1 RNA nor dArc1 protein levels.</data>
    </edge>
    <edge source="PDF_20_2018_Result_7537782149737195130" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of Rab11 dominant-negative (Rab11-DN) resulted in a highly significant reduction in darc1 RNA and protein in the postsynaptic region.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-6403490340212377427" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of Rab11DN in neurons, we observed a decrease in dArc1 levels in both the pre- and postsynaptic compartments.</data>
    </edge>
    <edge source="PDF_20_2018_Result_3083881529455983430" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The ratio of postsynaptic dArc1 levels relative to presynaptic levels was significantly decreased upon expressing Rab11DN in neurons.</data>
    </edge>
    <edge source="PDF_20_2018_Result_7408676244789082373" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of a dArc1 transgene composed of the darc1 ORF, plus the UTR, resulted in the presence of dArc1, not only in presynaptic boutons, but also at the postsynaptic region.</data>
    </edge>
    <edge source="PDF_20_2018_Result_7408676244789082373" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of a dArc1 transgene composed of the darc1 ORF, plus the UTR, resulted in the presence of dArc1, not only in presynaptic boutons, but also at the postsynaptic region.</data>
    </edge>
    <edge source="PDF_20_2018_Result_1163457062016506767" target="Protein_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expressing a dArc1 transgene lacking the 3' UTR resulted in accumulation of the dArc1 signal in presynaptic terminals, but virtually no signal was observed at the postsynaptic region.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-5762510954293473928" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of darc1-3'UTR-GFP resulted in the presence of GFP signal in the muscle.</data>
    </edge>
    <edge source="PDF_20_2018_Result_-5762510954293473928" target="Protein_GFP">
      <data key="d8">MENTIONS</data>
      <data key="d9">Expression of darc1-3'UTR-GFP resulted in the presence of GFP signal in the muscle.</data>
    </edge>
    <edge source="PDF_20_2018_Conclusion_-8716216063639187595" target="Gene_DARC1">
      <data key="d8">MENTIONS</data>
      <data key="d9">darc1 mRNA can be transferred from neurons to postsynaptic muscles in a manner dependent on its 3' UTR.</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_698617080513532731">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-988406403681697774">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_9206975857790275680">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-4327315747016988718">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-8568622846752454557">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_7866887381660180214">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_1807411026894976387">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_8551616417210739611">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-2280256764557005638">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-8640295239952696749">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-9187319836934874983">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Result_-8703015156211998918">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Method_-4468557934955342655">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024" target="PDF_14_2024_Conclusion_8678426044594854731">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_14_2024_Result_698617080513532731" target="Protein_MTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our analyses reveal coordinated changes in transcriptomes and chromatin accessibilities across cell types in the ovary during aging, notably mTOR signaling being a prominent ovary-specific aging pathway.</data>
    </edge>
    <edge source="PDF_14_2024_Result_-988406403681697774" target="Gene_CEBPD">
      <data key="d8">MENTIONS</data>
      <data key="d9">Cell-type-specific regulatory networks reveal enhanced activity of the transcription factor CEBPD across cell types in the aged ovary.</data>
    </edge>
    <edge source="PDF_14_2024_Result_1807411026894976387" target="Gene_RICTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes (Fig. 2c). Among 'common DEGs' differentially expressed in at least four cell types, 218 were upregulated and 182 were downregulated in aged ovaries (Extended Data Fig. 3d). Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
    </edge>
    <edge source="PDF_14_2024_Result_1807411026894976387" target="Gene_IGF1R">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes (Fig. 2c). Among 'common DEGs' differentially expressed in at least four cell types, 218 were upregulated and 182 were downregulated in aged ovaries (Extended Data Fig. 3d). Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
    </edge>
    <edge source="PDF_14_2024_Result_1807411026894976387" target="Gene_MAP3K5">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes (Fig. 2c). Among 'common DEGs' differentially expressed in at least four cell types, 218 were upregulated and 182 were downregulated in aged ovaries (Extended Data Fig. 3d). Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
    </edge>
    <edge source="PDF_14_2024_Result_1807411026894976387" target="Gene_APOE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified 3,455 ovarian aging-associated DEGs (Supplementary Table 4), with granulosa cells showing the largest number (Extended Data Fig. 3b). Most aging-associated DEGs are shared among cell types (Extended Data Fig. 3c) and show congruent expression changes (Fig. 2c). Among 'common DEGs' differentially expressed in at least four cell types, 218 were upregulated and 182 were downregulated in aged ovaries (Extended Data Fig. 3d). Common DEGs include known aging-related genes such as RICTOR, IGF1R, MAP3K5 and APOE</data>
    </edge>
    <edge source="PDF_14_2024_Result_8551616417210739611" target="Protein_MTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">Gene expression in histone modification, cellular senescence and nutrient-sensing signaling pathways, including mTOR and insulin pathways, increased in aged ovaries across cell types.</data>
    </edge>
    <edge source="PDF_14_2024_Result_-2280256764557005638" target="Protein_MTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
    </edge>
    <edge source="PDF_14_2024_Result_-2280256764557005638" target="Gene_RICTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
    </edge>
    <edge source="PDF_14_2024_Result_-2280256764557005638" target="Gene_MT-ATP6">
      <data key="d8">MENTIONS</data>
      <data key="d9">We validated these age-related changes using in situ hybridization assays, confirming increased expression of the mTOR signaling gene RICTOR and decreased expression of the oxidative phosphorylation gene MT-ATP6 in aged ovaries</data>
    </edge>
    <edge source="PDF_14_2024_Result_-8640295239952696749" target="Protein_MTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">Notably, mTOR signaling emerged as an ovary-specific aging-prevalent pathway (Fig. 2j), highlighting its unique and central role in ovarian aging.</data>
    </edge>
    <edge source="PDF_14_2024_Result_-9187319836934874983" target="Protein_MTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">GO analysis indicated that those genes were predominantly enriched in cytoplasmic translation (Extended Data Fig. 6k), a process centrally regulated by mTOR signaling.</data>
    </edge>
    <edge source="PDF_14_2024_Result_-8703015156211998918" target="Gene_CDKN2A">
      <data key="d8">MENTIONS</data>
      <data key="d9">Few ovarian cells expressed CDKN2A (-0.43%), whereas a higher proportion expressed CDKNIA in young (~9.49%) and aged (-15.56%) ovaries (Extended Data Fig. 7a,b). We found significant increases in CDKN1A+ cells with age in several cell types (Fig. 3a). Using in situ hybridization, we observed approximately threefold increases in both the proportion of CDKN1A+ cells and CDKN1A expression in aged ovaries</data>
    </edge>
    <edge source="PDF_14_2024_Result_-8703015156211998918" target="Gene_CDKN1A">
      <data key="d8">MENTIONS</data>
      <data key="d9">Few ovarian cells expressed CDKN2A (-0.43%), whereas a higher proportion expressed CDKNIA in young (~9.49%) and aged (-15.56%) ovaries (Extended Data Fig. 7a,b). We found significant increases in CDKN1A+ cells with age in several cell types (Fig. 3a). Using in situ hybridization, we observed approximately threefold increases in both the proportion of CDKN1A+ cells and CDKN1A expression in aged ovaries</data>
    </edge>
    <edge source="PDF_14_2024_Conclusion_8678426044594854731" target="Protein_MTOR">
      <data key="d8">MENTIONS</data>
      <data key="d9">In conclusion, our comprehensive analysis reveals the distinct and accelerated nature of ovarian aging, characterized by high transcriptomic coordination and distinct pathway activity changes. Notably, we identify mTOR signaling as a unique factor in ovarian aging, offering potential insights into sex-specific longevity responses.</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Hypothesis_-4581629201792558485">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Method_-6235652054259386671">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Method_8353492016227027839">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Method_-1186184607536260342">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_701997354051037417">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_5618481464386920812">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_-4290939226307115869">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_2825853247146102558">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_8661057302304770805">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_840697272430828145">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_-1672728848851353053">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_6027862475993588056">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_-1777460526827516678">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Result_6629279409665764727">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014" target="PDF_36_2014_Conclusion_-2309782612301189427">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_36_2014_Hypothesis_-4581629201792558485" target="Compound_MRNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">We hypothesized that the cumulus cells transfer mRNAs benefitting oocyte maturation in an orchestrated fashion.</data>
    </edge>
    <edge source="PDF_36_2014_Result_-4290939226307115869" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Evidence of active transfer of RNA from the cumulus cells to the oocyte was found by comparing signal distribution of labeled nascent RNA within a fully enclosed oocyte to the signal detected in a partially denuded oocyte.</data>
    </edge>
    <edge source="PDF_36_2014_Result_2825853247146102558" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">None of the cumulus enclosed oocytes showed any trend in regional signal difference whereas of the 11 partially denuded oocytes evaluated, 8 demonstrated a significantly higher RNA signal in the regions of ooplasm proximal to the cumulus cells compared to their distal regions (p &lt; 0.05).</data>
    </edge>
    <edge source="PDF_36_2014_Result_8661057302304770805" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">total RNA staining in living COCs was carried out using confocal live-cell imaging and revealed the displacement of RNA granules in TZPs</data>
    </edge>
    <edge source="PDF_36_2014_Result_6629279409665764727" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Oocytes demonstrated an increasing number of RNA bearing TZPs over time, significantly increasing between 0 h, 2 h and 4 h post slaughter and appearing to plateau by 6 h</data>
    </edge>
    <edge source="PDF_36_2014_Conclusion_-2309782612301189427" target="Compound_RNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">The presented results highlight the additional contribution of the cumulus cells to the oocyte in the form of large cargo transfer. We focused on RNA transfer from the cumulus cells, and its importance for gamete maturation.</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Hypothesis_-2141755271873352750">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Method_4203238487998385059">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Method_8826136706996301483">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Method_3553343200590021148">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_2965268241399295019">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_6705156232853208908">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_7465759539642683672">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_2283355659124299239">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_-5112193740278983862">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_-1895649761733174660">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_4625010045828912386">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_8225931682651769769">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_-3702318993863419222">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_1567204159337948278">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Result_3416407546144195946">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021" target="PDF_26_2021_Conclusion_-2741862318158167987">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_26_2021_Result_2283355659124299239" target="Gene_PHLDA3">
      <data key="d8">MENTIONS</data>
      <data key="d9">missense variant rs35383942, associated with breast cancer20,26, which is a predicted deleterious missense variant (Arg28Gln, CADD = 24.3) in PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3). PHLDA3 is the direct target of TP53 and acts as a tumor suppressor gene through inhibition of AKT1, an oncogene that plays a pivotal role in cell proliferation and survival27.</data>
    </edge>
    <edge source="PDF_26_2021_Result_2283355659124299239" target="Gene_TP53">
      <data key="d8">MENTIONS</data>
      <data key="d9">missense variant rs35383942, associated with breast cancer20,26, which is a predicted deleterious missense variant (Arg28Gln, CADD = 24.3) in PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3). PHLDA3 is the direct target of TP53 and acts as a tumor suppressor gene through inhibition of AKT1, an oncogene that plays a pivotal role in cell proliferation and survival27.</data>
    </edge>
    <edge source="PDF_26_2021_Result_2283355659124299239" target="Gene_AKT1">
      <data key="d8">MENTIONS</data>
      <data key="d9">missense variant rs35383942, associated with breast cancer20,26, which is a predicted deleterious missense variant (Arg28Gln, CADD = 24.3) in PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3). PHLDA3 is the direct target of TP53 and acts as a tumor suppressor gene through inhibition of AKT1, an oncogene that plays a pivotal role in cell proliferation and survival27.</data>
    </edge>
    <edge source="PDF_26_2021_Result_2283355659124299239" target="Disease_BREAST CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">missense variant rs35383942, associated with breast cancer20,26, which is a predicted deleterious missense variant (Arg28Gln, CADD = 24.3) in PHLDA3 (Pleckstrin Homology Like Domain Family A Member 3). PHLDA3 is the direct target of TP53 and acts as a tumor suppressor gene through inhibition of AKT1, an oncogene that plays a pivotal role in cell proliferation and survival27.</data>
    </edge>
    <edge source="PDF_26_2021_Result_-1895649761733174660" target="Disease_ASTHMA">
      <data key="d8">MENTIONS</data>
      <data key="d9">One example is a locus on chromosome 6 that colocalizes with asthma (6_90220794_T_C) and Crohn's disease (6_90263440_C_A), suggesting that the two diseases may share common genetic etiology at this locus.</data>
    </edge>
    <edge source="PDF_26_2021_Result_-1895649761733174660" target="Disease_CROHN'S DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">One example is a locus on chromosome 6 that colocalizes with asthma (6_90220794_T_C) and Crohn's disease (6_90263440_C_A), suggesting that the two diseases may share common genetic etiology at this locus.</data>
    </edge>
    <edge source="PDF_26_2021_Result_4625010045828912386" target="Gene_TCNI">
      <data key="d8">MENTIONS</data>
      <data key="d9">missense variant rs34324219 is causal of changes in TCNI RNA and protein expression in whole blood16,18 and also colocalizes (H4 &gt; 0.99) with pernicious anemia, a disorder in which too few red blood cells are produced due to vitamin B12 deficiency. TCNI encodes the protein haptocorrin (also known as Transcobalamin-1), which binds vitamin B12 and is involved in its uptake30.</data>
    </edge>
    <edge source="PDF_26_2021_Result_4625010045828912386" target="Disease_PERNICIOUS ANEMIA">
      <data key="d8">MENTIONS</data>
      <data key="d9">missense variant rs34324219 is causal of changes in TCNI RNA and protein expression in whole blood16,18 and also colocalizes (H4 &gt; 0.99) with pernicious anemia, a disorder in which too few red blood cells are produced due to vitamin B12 deficiency. TCNI encodes the protein haptocorrin (also known as Transcobalamin-1), which binds vitamin B12 and is involved in its uptake30.</data>
    </edge>
    <edge source="PDF_26_2021_Result_8225931682651769769" target="Gene_UBASH3A">
      <data key="d8">MENTIONS</data>
      <data key="d9">splice region variant rs1893592 causes increased expression of UBASH3A in most GTEx tissues, including thyroid. This signal colocalizes (H4 &gt; 0.87) with self-reported treatment using the thyroid hormone sodium levothyroxine.</data>
    </edge>
    <edge source="PDF_26_2021_Result_-3702318993863419222" target="Gene_ADORA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">the synonymous variant rs2228079 is the only credibly causal variant for an eQTL associated with altered ADORA1 expression in whole blood (eQTLGen) and colocalizes with asthma in UK Biobank (H4 &gt; 0.99). ADORA1 encodes a type of adenosine receptor, a class of proteins targeted by an approved drug (Theophylline) for the treatment of asthma.</data>
    </edge>
    <edge source="PDF_26_2021_Result_-3702318993863419222" target="Disease_ASTHMA">
      <data key="d8">MENTIONS</data>
      <data key="d9">the synonymous variant rs2228079 is the only credibly causal variant for an eQTL associated with altered ADORA1 expression in whole blood (eQTLGen) and colocalizes with asthma in UK Biobank (H4 &gt; 0.99). ADORA1 encodes a type of adenosine receptor, a class of proteins targeted by an approved drug (Theophylline) for the treatment of asthma.</data>
    </edge>
    <edge source="PDF_26_2021_Result_1567204159337948278" target="Gene_ADAM15">
      <data key="d8">MENTIONS</data>
      <data key="d9">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease32. ADAM15, a disintegrin and metalloproteinase, is strongly upregulated in colon tissues from inflammatory bowel disease patients compared to healthy controls and plays a role in leukocyte trans-migration across epithelial and endothelial barriers as well as the differentiation of regenerative colonic mucosa33.</data>
    </edge>
    <edge source="PDF_26_2021_Result_1567204159337948278" target="Disease_CROHN'S DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease32. ADAM15, a disintegrin and metalloproteinase, is strongly upregulated in colon tissues from inflammatory bowel disease patients compared to healthy controls and plays a role in leukocyte trans-migration across epithelial and endothelial barriers as well as the differentiation of regenerative colonic mucosa33.</data>
    </edge>
    <edge source="PDF_26_2021_Result_1567204159337948278" target="Disease_INFLAMMATORY BOWEL DISEASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">splice region variant rs11589479, which causes increase in ADAM15 expression in several monocytes states and also colocalizes (H4 = 0.99) with Crohn's disease32. ADAM15, a disintegrin and metalloproteinase, is strongly upregulated in colon tissues from inflammatory bowel disease patients compared to healthy controls and plays a role in leukocyte trans-migration across epithelial and endothelial barriers as well as the differentiation of regenerative colonic mucosa33.</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_7486583060309970973">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_8933350561417510806">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-6140916622838638125">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-4703424313083051490">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Method_-2021815697879481789">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-2939370240858087120">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-788479294020660724">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-3702855254991307585">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-3203383090689864948">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-6971313324989892593">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-81438276525384463">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-7407277092437647686">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_944240677981491619">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-2160727510158328070">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-6172522668642341516">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-4039650709046783173">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018" target="PDF_12_2018_Result_-5315904747595834147">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_12_2018_Result_-3203383090689864948" target="Gene_ZP2">
      <data key="d8">MENTIONS</data>
      <data key="d9">The expression levels of ZP2, ZP3, and ZP4 remained stable across all stages.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-3203383090689864948" target="Gene_ZP3">
      <data key="d8">MENTIONS</data>
      <data key="d9">The expression levels of ZP2, ZP3, and ZP4 remained stable across all stages.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-3203383090689864948" target="Gene_ZP4">
      <data key="d8">MENTIONS</data>
      <data key="d9">The expression levels of ZP2, ZP3, and ZP4 remained stable across all stages.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-6971313324989892593" target="Gene_NANOG">
      <data key="d8">MENTIONS</data>
      <data key="d9">NANOG and POU5F1 were under-expressed in most stages in oocytes.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-6971313324989892593" target="Gene_POU5F1">
      <data key="d8">MENTIONS</data>
      <data key="d9">NANOG and POU5F1 were under-expressed in most stages in oocytes.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-81438276525384463" target="Gene_DNMT1">
      <data key="d8">MENTIONS</data>
      <data key="d9">DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-81438276525384463" target="Gene_DNMT3A">
      <data key="d8">MENTIONS</data>
      <data key="d9">DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-81438276525384463" target="Gene_DNMT3B">
      <data key="d8">MENTIONS</data>
      <data key="d9">DNMT1, DNMT3A, and DNMT3B in the oocytes of all stages with mounting abundance, indicating that the degree of DNA methylation is continually increasing with oocyte maturation.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-7407277092437647686" target="Gene_TET">
      <data key="d8">MENTIONS</data>
      <data key="d9">ten-eleven translocation (TET) family genes were under-expressed in oocytes at all stages of follicular development</data>
    </edge>
    <edge source="PDF_12_2018_Result_944240677981491619" target="Gene_CYP11A1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregulated in the antral follicles, with a peak expression level in the pre-ovulatory follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_944240677981491619" target="Gene_CYP19A1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregulated in the antral follicles, with a peak expression level in the pre-ovulatory follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_944240677981491619" target="Gene_HSD17B1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregulated in the antral follicles, with a peak expression level in the pre-ovulatory follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_944240677981491619" target="Gene_HSD3B2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Several genes that encode steroidogenic enzymes, including CYP11A1, CYP19A1, HSD17B1, and HSD3B2, were upregulated in the antral follicles, with a peak expression level in the pre-ovulatory follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-2160727510158328070" target="Gene_NR5A1">
      <data key="d8">MENTIONS</data>
      <data key="d9">NR5A1, a key regulator of the steroidogenic enzyme-encoding genes exhibited an upregulation with the progression of follicular growth.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-6172522668642341516" target="Gene_AR">
      <data key="d8">MENTIONS</data>
      <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-6172522668642341516" target="Gene_ESR1">
      <data key="d8">MENTIONS</data>
      <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-6172522668642341516" target="Gene_ESR2">
      <data key="d8">MENTIONS</data>
      <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-6172522668642341516" target="Gene_PGR">
      <data key="d8">MENTIONS</data>
      <data key="d9">AR, ESR (ESR1 and ESR2), and PGR, encoding for androgen, estrogen, and progesterone hormone receptors, respectively, were expressed in GCs from primary follicles, with the highest expression level in antral follicles.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-4039650709046783173" target="Gene_NTF4">
      <data key="d8">MENTIONS</data>
      <data key="d9">The distinct stage-specific expression patterns of NTF4 and LCP2 in oocytes were further confirmed by the IHC staining, showing that these genes were preferentially expressed in the oocyte of antral stage.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-4039650709046783173" target="Gene_LCP2">
      <data key="d8">MENTIONS</data>
      <data key="d9">The distinct stage-specific expression patterns of NTF4 and LCP2 in oocytes were further confirmed by the IHC staining, showing that these genes were preferentially expressed in the oocyte of antral stage.</data>
    </edge>
    <edge source="PDF_12_2018_Result_-5315904747595834147" target="Gene_NTF4">
      <data key="d8">MENTIONS</data>
      <data key="d9">NTF4 was proposed to facilitate follicular development by inducing FSH receptor (Fshr) in mouse.</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-1885943170887345517">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_7725767464489587165">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-4192911723484206628">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-8153798442757081942">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-8494411155176871299">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-255612553421251552">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-6139091716181816132">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-7874717298818535336">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_-4414499184920452212">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_5215376643377076169">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Result_4759294671080592958">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Conclusion_-3876279374405834021">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013" target="PDF_10_2013_Conclusion_1181494436016370092">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_10_2013_Result_-1885943170887345517" target="Process_TESTIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Transcription of the genome is substantially more widespread in the testis than in other organs across representative mammals.</data>
    </edge>
    <edge source="PDF_10_2013_Result_7725767464489587165" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
    </edge>
    <edge source="PDF_10_2013_Result_7725767464489587165" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
    </edge>
    <edge source="PDF_10_2013_Result_7725767464489587165" target="Process_TESTIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Meiotic spermatocytes and especially postmeiotic round spermatids have remarkably diverse transcriptomes, which explains the high transcriptome complexity of the testis as a whole.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-4192911723484206628" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">The widespread transcriptional activity in spermatocytes and spermatids encompasses protein-coding and long noncoding RNA genes but also poorly conserved intergenic sequences.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-4192911723484206628" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">The widespread transcriptional activity in spermatocytes and spermatids encompasses protein-coding and long noncoding RNA genes but also poorly conserved intergenic sequences.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-8153798442757081942" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">Transcription of duplicated genes is facilitated in spermatocytes and spermatids.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-8153798442757081942" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Transcription of duplicated genes is facilitated in spermatocytes and spermatids.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-8494411155176871299" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Retrocopies with truncated open reading frames are transcribed at significantly higher levels in spermatids than in the other tissues.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-255612553421251552" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Functional retrocopies show a striking upregulation in both spermatids and spermatocytes.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-255612553421251552" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">Functional retrocopies show a striking upregulation in both spermatids and spermatocytes.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-6139091716181816132" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">Analyses revealed reduced expression levels of protein-coding genes on the X chromosome in spermatocytes and spermatids, consistent with the action of meiotic sex chromosome inactivation (MSCI).</data>
    </edge>
    <edge source="PDF_10_2013_Result_-6139091716181816132" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Analyses revealed reduced expression levels of protein-coding genes on the X chromosome in spermatocytes and spermatids, consistent with the action of meiotic sex chromosome inactivation (MSCI).</data>
    </edge>
    <edge source="PDF_10_2013_Result_-7874717298818535336" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Spermatid-specific genes are highly enriched among recent X-linked genes.</data>
    </edge>
    <edge source="PDF_10_2013_Result_-4414499184920452212" target="Process_TESTIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Transcribed intergenic sequences tend to be closer to the 3' end of genes in somatic tissues than in testis and meiotic/postmeiotic germ cells.</data>
    </edge>
    <edge source="PDF_10_2013_Result_5215376643377076169" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">Potentially functional IncRNAs, retrogenes, and pseudogenes also show significantly lower promoter CpG methylation levels in the germline (in particular in spermatids) than in brain and liver</data>
    </edge>
    <edge source="PDF_10_2013_Result_4759294671080592958" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">High Levels of H3K4me2 Suggest an Overall Open Chromatin State in Spermatocytes and Spermatids</data>
    </edge>
    <edge source="PDF_10_2013_Result_4759294671080592958" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">High Levels of H3K4me2 Suggest an Overall Open Chromatin State in Spermatocytes and Spermatids</data>
    </edge>
    <edge source="PDF_10_2013_Conclusion_-3876279374405834021" target="Process_TESTIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Promiscuous transcriptional activity in the testis is common to amniotes.</data>
    </edge>
    <edge source="PDF_10_2013_Conclusion_1181494436016370092" target="Process_TESTIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">High transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
    </edge>
    <edge source="PDF_10_2013_Conclusion_1181494436016370092" target="Process_SPERMATID">
      <data key="d8">MENTIONS</data>
      <data key="d9">High transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
    </edge>
    <edge source="PDF_10_2013_Conclusion_1181494436016370092" target="Process_SPERMATOCYTES">
      <data key="d8">MENTIONS</data>
      <data key="d9">High transcriptome complexity of the amniote testis stems largely from extensive transcriptional activity in round spermatids and pachytene spermatocytes.</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Hypothesis_-5734895547226781640">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Method_6159908519209120681">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Method_-1679159450622589730">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Method_4914478715813577696">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Method_-5706840038920429083">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Method_6168529183989123255">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Result_4850446997388966157">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Result_2225262699681295805">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Result_-8681156170595938174">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Conclusion_8110779714584621644">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013" target="PDF_52_2013_Conclusion_-8661795774046833844">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_52_2013_Hypothesis_-5734895547226781640" target="Protein_E. COLI">
      <data key="d8">MENTIONS</data>
      <data key="d9">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering.</data>
    </edge>
    <edge source="PDF_52_2013_Hypothesis_-5734895547226781640" target="Protein_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering.</data>
    </edge>
    <edge source="PDF_52_2013_Hypothesis_-5734895547226781640" target="Protein_SLYD">
      <data key="d8">MENTIONS</data>
      <data key="d9">We designed a new E. coli expression strain named LOBSTR (low-background-strain), which features genomic modifications in arnA and slyD based on surface engineering.</data>
    </edge>
    <edge source="PDF_52_2013_Method_6159908519209120681" target="Protein_E. COLI">
      <data key="d8">MENTIONS</data>
      <data key="d9">Wild-type arnA was PCR amplified from E. coli genomic DNA with Ndel and Xhol restriction site overhangs on the 5' and 3' ends, respectively, using primers 1F and 1R, and cloned into the bacterial expression vector pColaDuet.</data>
    </edge>
    <edge source="PDF_52_2013_Method_6159908519209120681" target="Gene_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Wild-type arnA was PCR amplified from E. coli genomic DNA with Ndel and Xhol restriction site overhangs on the 5' and 3' ends, respectively, using primers 1F and 1R, and cloned into the bacterial expression vector pColaDuet.</data>
    </edge>
    <edge source="PDF_52_2013_Method_-1679159450622589730" target="Gene_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Two serine point mutations were introduced at site 1 (H359S and H361S) using primers 2F and 2R. Two additional serine point mutations were introduced at site 2 (H592S and H593S) using primers 3F and 3R to generate the final arnA mutant containing a total of four histidine to serine mutations.</data>
    </edge>
    <edge source="PDF_52_2013_Method_4914478715813577696" target="Gene_SLYD">
      <data key="d8">MENTIONS</data>
      <data key="d9">For the modification in slyD, the arnA mutant strain was transformed with a PCR product (generated using primers 5F and 5R) containing a selectable marker flanked by homologous overhangs that, after recombination, result in the elimination of the 46-residue C-terminal, histidine-rich segment of SlyD.</data>
    </edge>
    <edge source="PDF_52_2013_Method_4914478715813577696" target="Gene_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">For the modification in slyD, the arnA mutant strain was transformed with a PCR product (generated using primers 5F and 5R) containing a selectable marker flanked by homologous overhangs that, after recombination, result in the elimination of the 46-residue C-terminal, histidine-rich segment of SlyD.</data>
    </edge>
    <edge source="PDF_52_2013_Method_-5706840038920429083" target="Protein_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">The binding affinity of wild-type and mutant ArnA were assessed by immobilizing purified protein onto a 1 ml His-Trap FF column (GE Healthcare) equilibrated in 50 mM potassium phosphate pH 8.0, 300 mM NaCl, and 5 mM beta-mercaptoethanol. Protein was eluted with a linear gradient of 0-150 mM imidazole. The imidazole concentration at the elution peak of each protein was recorded and compared.</data>
    </edge>
    <edge source="PDF_52_2013_Result_4850446997388966157" target="Protein_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Wild-type ArnA eluted at a concentration of ~60 mM imidazole, while mutant ArnA showed significantly weaker binding affinity, eluting at ~30 mM imidazole (Supporting Information Fig. S3).</data>
    </edge>
    <edge source="PDF_52_2013_Result_-8681156170595938174" target="Protein_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the BL21(DE3) strain background, high levels of contamination by both ArnA and SlyD can be seen in the elutions (Fig. 2).</data>
    </edge>
    <edge source="PDF_52_2013_Result_-8681156170595938174" target="Protein_SLYD">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the BL21(DE3) strain background, high levels of contamination by both ArnA and SlyD can be seen in the elutions (Fig. 2).</data>
    </edge>
    <edge source="PDF_52_2013_Conclusion_8110779714584621644" target="Protein_E. COLI">
      <data key="d8">MENTIONS</data>
      <data key="d9">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
    </edge>
    <edge source="PDF_52_2013_Conclusion_8110779714584621644" target="Protein_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
    </edge>
    <edge source="PDF_52_2013_Conclusion_8110779714584621644" target="Protein_SLYD">
      <data key="d8">MENTIONS</data>
      <data key="d9">LOBSTR enables the pursuit of poorly expressed protein targets in E. coli by lowering the background contamination of ArnA and SlyD.</data>
    </edge>
    <edge source="PDF_52_2013_Conclusion_-8661795774046833844" target="Gene_ARNA">
      <data key="d8">MENTIONS</data>
      <data key="d9">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
    </edge>
    <edge source="PDF_52_2013_Conclusion_-8661795774046833844" target="Gene_SLYD">
      <data key="d8">MENTIONS</data>
      <data key="d9">LOBSTR incorporates genomic modifications to arnA and slyD in order to reduce the affinity of their gene products for metal affinity resins, eliminating them from co-purification with recombinant proteins of interest.</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Hypothesis_-223572616346477788">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Method_-4401955429965563503">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_4306185755151122737">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_4378009987062824907">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_3224092205729395042">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_-489932016778249674">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Hypothesis_-8517930215337802133">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Method_4376635027615082468">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_7299610866587252928">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_6561237049069652966">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_8073478051405116997">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_-6518587417760608308">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_4162469824736645289">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Conclusion_-7381205409386493005">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Hypothesis_5889087032916649007">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Method_-462396753919817674">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_7449037887177630701">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_2955274227378749766">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_-6339374513486062175">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_895454001165733164">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_-308545013131585826">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_1768535996649763872">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_6375873074088976139">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_4966564730208617556">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_6458589539598536726">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_2095598226064636887">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_6383333419769449458">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024" target="PDF_38_2024_Result_-4299649364787469483">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_38_2024_Result_2095598226064636887" target="Gene_REC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">the level of chromosomal Rec8 in oocytes from AY RCFs was significantly higher than that in AA RCFs</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_2142836395188910664">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-7678692972089207567">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Conclusion_329299745985449097">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_6157335559941784404">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-1393423759134320958">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_7593594633745370916">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-3921433967535018377">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_2019707484135489002">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-2067314764590101881">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-7322599711768990899">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_9148938541017551914">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-172222816078977826">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_7867362277137198711">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_455890509852084009">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_6870654001407870672">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_-1528068561029024688">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_4512747853279298078">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Result_5174667025981830920">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Method_8728923512696910364">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012" target="PDF_01_2012_Method_-5642058330234326169">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_01_2012_Result_2142836395188910664" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 and PEG11/RTL1 play essential but different roles in placental development.</data>
    </edge>
    <edge source="PDF_01_2012_Result_2142836395188910664" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 and PEG11/RTL1 play essential but different roles in placental development.</data>
    </edge>
    <edge source="PDF_01_2012_Result_-7678692972089207567" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 is conserved in both the marsupials and the eutherians, while PEG11/RTL1 is a eutherian-specific gene.</data>
    </edge>
    <edge source="PDF_01_2012_Result_-7678692972089207567" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 is conserved in both the marsupials and the eutherians, while PEG11/RTL1 is a eutherian-specific gene.</data>
    </edge>
    <edge source="PDF_01_2012_Result_6157335559941784404" target="Gene_SYNCYTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Human SYNCYTIN (ERVWE1) mediates placental cytotrophoblast fusion so as to produce syncytiotrophoblast cells in human placental morphogenesis</data>
    </edge>
    <edge source="PDF_01_2012_Result_-1393423759134320958" target="Gene_SYNCYTIN-A">
      <data key="d8">MENTIONS</data>
      <data key="d9">mouse SyncytinA and B have been to be essential placental genes using knockout mice</data>
    </edge>
    <edge source="PDF_01_2012_Result_-1393423759134320958" target="Gene_SYNCYTINB">
      <data key="d8">MENTIONS</data>
      <data key="d9">mouse SyncytinA and B have been to be essential placental genes using knockout mice</data>
    </edge>
    <edge source="PDF_01_2012_Result_7593594633745370916" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
    </edge>
    <edge source="PDF_01_2012_Result_7593594633745370916" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
    </edge>
    <edge source="PDF_01_2012_Result_-3921433967535018377" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mouse Peg10 and Peg11/Rtl1 are the major genes responsible for the lethal phenotypes observed in these imprinted regions, respectively</data>
    </edge>
    <edge source="PDF_01_2012_Result_-3921433967535018377" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mouse Peg10 and Peg11/Rtl1 are the major genes responsible for the lethal phenotypes observed in these imprinted regions, respectively</data>
    </edge>
    <edge source="PDF_01_2012_Result_2019707484135489002" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
    </edge>
    <edge source="PDF_01_2012_Result_2019707484135489002" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
    </edge>
    <edge source="PDF_01_2012_Result_-2067314764590101881" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 is highly expressed in a great majority of hepatocellular carcinomas and confers oncogenic activity.</data>
    </edge>
    <edge source="PDF_01_2012_Result_-7322599711768990899" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis. Overexpression of PEG10 decreased the cell death mediated by SIAH1, suggesting that PEG10 has a growth promoting function related to apoptosis in somatic cells</data>
    </edge>
    <edge source="PDF_01_2012_Result_-7322599711768990899" target="Protein_SIAH1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 protein is reportedly associated with a member of the "seven in absentia homolog" family (SIAH1 protein) that acts as a mediator of apoptosis. Overexpression of PEG10 decreased the cell death mediated by SIAH1, suggesting that PEG10 has a growth promoting function related to apoptosis in somatic cells</data>
    </edge>
    <edge source="PDF_01_2012_Result_9148938541017551914" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">loss and overexpression of PEG11/RTL1 are thought to attribute to the etiology of two different human imprinted diseases, maternal and paternal disomies of human chromosome 14 (matUPD14 and patUPD14)</data>
    </edge>
    <edge source="PDF_01_2012_Result_-172222816078977826" target="Gene_PNMA4">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA4-deficient cells exhibit aggressive anchorage-independent growth, suggesting that PNMA4 has an important role in regulating apoptosis signaling in a strict temporal manner in mammalian cells</data>
    </edge>
    <edge source="PDF_01_2012_Result_7867362277137198711" target="Gene_PNMA10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA10 to be a candidate gene for X-linked mental retardation (XLMR) in humans</data>
    </edge>
    <edge source="PDF_01_2012_Result_7867362277137198711" target="Disease_X-LINKED MENTAL RETARDATION">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA10 to be a candidate gene for X-linked mental retardation (XLMR) in humans</data>
    </edge>
    <edge source="PDF_01_2012_Result_455890509852084009" target="Gene_PNMA14/CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome</data>
    </edge>
    <edge source="PDF_01_2012_Result_455890509852084009" target="Disease_3-M SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma14/CCDC8 was suggested to be one of the genes responsible for 3-M syndrome</data>
    </edge>
    <edge source="PDF_01_2012_Result_6870654001407870672" target="Gene_FILAGGRIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
    </edge>
    <edge source="PDF_01_2012_Result_6870654001407870672" target="Disease_ATOPIC DERMATITIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Filaggrin gene has recently been identified to be etiologically responsible for atopic dermatitis</data>
    </edge>
    <edge source="PDF_01_2012_Result_-1528068561029024688" target="Protein_SASPASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Aberrant SASPase expression in transgenic mice reportedly leads to impaired skin regeneration and skin remodeling after cutaneous injury or chemically induced hyperplasia</data>
    </edge>
    <edge source="PDF_01_2012_Result_4512747853279298078" target="Gene_PEG3">
      <data key="d8">MENTIONS</data>
      <data key="d9">loss of PEG3 expression is reportedly observed in gliomas</data>
    </edge>
    <edge source="PDF_01_2012_Result_4512747853279298078" target="Disease_GLIOMA">
      <data key="d8">MENTIONS</data>
      <data key="d9">loss of PEG3 expression is reportedly observed in gliomas</data>
    </edge>
    <edge source="PDF_01_2012_Result_5174667025981830920" target="Gene_PEG3">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG3 was reported to be essential for maternal nursing behavior as well as promoting embryonic growth</data>
    </edge>
    <edge source="PDF_01_2012_Method_8728923512696910364" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">using knockout mice, we demonstrated that Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
    </edge>
    <edge source="PDF_01_2012_Method_8728923512696910364" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">using knockout mice, we demonstrated that Peg10 and Peg11/Rtll play essential roles in early placenta formation and maintenance of the placenta in the mid-to-late stages of gestation, respectively</data>
    </edge>
    <edge source="PDF_01_2012_Method_-5642058330234326169" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Combined with definitive genetic studies using knockout mice, PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
    </edge>
    <edge source="PDF_01_2012_Method_-5642058330234326169" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Combined with definitive genetic studies using knockout mice, PEG10 and PEG11/RTL1 have been shown to be essential for mammalian development via placenta formation and the subsequent maintenance of its placental function</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-7190858703012765987">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_2195511883558240892">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-9015728083642480272">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-600778431407090884">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-3950286069808651736">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_3731139472958919123">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_4215729786201325231">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-5114934817590951090">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_5673621412415047231">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-646070942496193452">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_5319186395597754623">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-2403631607639503096">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-279265792154362175">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_6877622394219411371">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_5404182611834045705">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_4768121198739981723">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_2436937814848041185">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020" target="PDF_32_2020_Result_-2230303066513665884">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_32_2020_Result_3731139472958919123" target="Gene_LIN28B">
      <data key="d8">MENTIONS</data>
      <data key="d9">The most significantly associated variant (rs11156429,GWAS-P = 3.5 × 10-52) was located in/near LIN28B</data>
    </edge>
    <edge source="PDF_32_2020_Result_-646070942496193452" target="Gene_SIM1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Only one signal showed significant directionally opposite effects (i.e. the allele that conferred earlier puberty timing in one sex delayed puberty in the other sex); rs6931884 at SIM1/PRDM13/MCHR2</data>
    </edge>
    <edge source="PDF_32_2020_Result_-646070942496193452" target="Gene_PRDM13">
      <data key="d8">MENTIONS</data>
      <data key="d9">Only one signal showed significant directionally opposite effects (i.e. the allele that conferred earlier puberty timing in one sex delayed puberty in the other sex); rs6931884 at SIM1/PRDM13/MCHR2</data>
    </edge>
    <edge source="PDF_32_2020_Result_-646070942496193452" target="Gene_MCHR2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Only one signal showed significant directionally opposite effects (i.e. the allele that conferred earlier puberty timing in one sex delayed puberty in the other sex); rs6931884 at SIM1/PRDM13/MCHR2</data>
    </edge>
    <edge source="PDF_32_2020_Result_5319186395597754623" target="Gene_MKRN3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Two variants located near to genes that are disrupted in rare disorders of puberty 12,13 showed no effect or weaker effect in males than in females: rs184950120, 5'UTR to MKRN3 (ẞvoice-breaking 0.085 years/allele; ẞmenarche = 0.396_years/allele, Pheterogeneity = 3.6 × 10-3), and rs62342064, one of 3 AAM variants in/near TACR3 (ẞvoice-breaking = -0.017 years/allele; ẞmenarche = 0.057 years/allele, Pheterogeneity = 4.2 × 10-5).</data>
    </edge>
    <edge source="PDF_32_2020_Result_5319186395597754623" target="Gene_TACR3">
      <data key="d8">MENTIONS</data>
      <data key="d9">Two variants located near to genes that are disrupted in rare disorders of puberty 12,13 showed no effect or weaker effect in males than in females: rs184950120, 5'UTR to MKRN3 (ẞvoice-breaking 0.085 years/allele; ẞmenarche = 0.396_years/allele, Pheterogeneity = 3.6 × 10-3), and rs62342064, one of 3 AAM variants in/near TACR3 (ẞvoice-breaking = -0.017 years/allele; ẞmenarche = 0.057 years/allele, Pheterogeneity = 4.2 × 10-5).</data>
    </edge>
    <edge source="PDF_32_2020_Result_-2403631607639503096" target="Gene_KDM4C">
      <data key="d8">MENTIONS</data>
      <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism14.</data>
    </edge>
    <edge source="PDF_32_2020_Result_-2403631607639503096" target="Gene_ALX4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism14.</data>
    </edge>
    <edge source="PDF_32_2020_Result_-2403631607639503096" target="Protein_FGF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Two of the 76 lead variants associated with male pubertal timing were non-synonymous: a previously reported AAM signal in KDM4C (rs913588), encoding a lysine-specific demethylase, and a male-specific signal in ALX4 (rs3824915), encoding a homeobox gene involved in fibroblast growth factor (FGF) signalling that is mutated in rare disorders of cranium/central neural system (CNS) development with male-specific hypogonadism14.</data>
    </edge>
    <edge source="PDF_32_2020_Result_-279265792154362175" target="Gene_FGF">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further 10 lead variants were in strong LD (r² &gt; 0.8) with one or more non-synonymous variants, of which three have not previously been associated with puberty timing: FGF11, which encodes a FGF expressed in the developing CNS and promotes peripheral androgen receptor expression15, TFAP4, which encodes a transcription factor of the basic helix-loop-helix-zipper family16, and GCKR, which encodes a regulatory protein that inhibits glucokinase in liver and pancreatic islets and is associated with a range of cardiometabolic traits17</data>
    </edge>
    <edge source="PDF_32_2020_Result_-279265792154362175" target="Protein_FGF">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further 10 lead variants were in strong LD (r² &gt; 0.8) with one or more non-synonymous variants, of which three have not previously been associated with puberty timing: FGF11, which encodes a FGF expressed in the developing CNS and promotes peripheral androgen receptor expression15, TFAP4, which encodes a transcription factor of the basic helix-loop-helix-zipper family16, and GCKR, which encodes a regulatory protein that inhibits glucokinase in liver and pancreatic islets and is associated with a range of cardiometabolic traits17</data>
    </edge>
    <edge source="PDF_32_2020_Result_-279265792154362175" target="Gene_TFAP4">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further 10 lead variants were in strong LD (r² &gt; 0.8) with one or more non-synonymous variants, of which three have not previously been associated with puberty timing: FGF11, which encodes a FGF expressed in the developing CNS and promotes peripheral androgen receptor expression15, TFAP4, which encodes a transcription factor of the basic helix-loop-helix-zipper family16, and GCKR, which encodes a regulatory protein that inhibits glucokinase in liver and pancreatic islets and is associated with a range of cardiometabolic traits17</data>
    </edge>
    <edge source="PDF_32_2020_Result_-279265792154362175" target="Gene_GCKR">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further 10 lead variants were in strong LD (r² &gt; 0.8) with one or more non-synonymous variants, of which three have not previously been associated with puberty timing: FGF11, which encodes a FGF expressed in the developing CNS and promotes peripheral androgen receptor expression15, TFAP4, which encodes a transcription factor of the basic helix-loop-helix-zipper family16, and GCKR, which encodes a regulatory protein that inhibits glucokinase in liver and pancreatic islets and is associated with a range of cardiometabolic traits17</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_SRD5A2">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_LEPR">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_SMARCAD1">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_BDNF">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_FNDC9">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_FAM118A">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Gene_ZNF446">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_32_2020_Result_6877622394219411371" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">A further seven are reported signals for AAM, but were not previously reported for voice-breaking. These missense variants are in the following genes: SRD5A2, encoding for Steroid 5-alpha-reductase, which converts testosterone into the more potent androgen dihydrotestosterone; LEPR, encoding the receptor for appetite and reproduction hormone leptin; SMARCAD1, encoding a mediator of histone H3/H4 deacetylation; BDNF, FNDC9, FAM118A and ZNF446.</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Hypothesis_-7729659190863877600">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Method_-1851821532008149103">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Method_7867957586338794398">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Method_2907123142089443626">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Method_6525108347789616891">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-6166309786436243553">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-1821673362539447090">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_5799130818778099298">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_948731372623059496">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-957024816232778490">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_5648813083697518686">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-1854708955097321731">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-1632554297047910644">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_5908750418673841027">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-6442075429125860034">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-7396215420825107056">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_6250568740775828390">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-7818253702727186456">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-7616297845824850474">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-489717104173259498">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_-6659723526613081581">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Result_6818911312146639850">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006" target="PDF_40_2006_Conclusion_-6905685080099351152">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_40_2006_Hypothesis_-7729659190863877600" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis.</data>
    </edge>
    <edge source="PDF_40_2006_Hypothesis_-7729659190863877600" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis.</data>
    </edge>
    <edge source="PDF_40_2006_Hypothesis_-7729659190863877600" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">We have hypothesized that RASSF family proteins may serve as effectors that mediate some of the growth inhibitory aspects of Ras, including Ras-induced apoptosis.</data>
    </edge>
    <edge source="PDF_40_2006_Method_-1851821532008149103" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Yeast two-hybrid analysis was performed using a full-length RASSF1A clone.</data>
    </edge>
    <edge source="PDF_40_2006_Method_7867957586338794398" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
    </edge>
    <edge source="PDF_40_2006_Method_7867957586338794398" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfected RFP-RASSF1A and GFP-MOAP-1 into 293-T cells and examined expressing cells by fluorescence microscopy</data>
    </edge>
    <edge source="PDF_40_2006_Method_2907123142089443626" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">We used expression vectors to generate H1299 cell lines (negative for endogenous RASSF1A expression) that stably re-express exogenous wild type or mutant RASSF1A protein at a level that is comparable with the endogenous protein levels found in the RASSF1A-positive cell H1792.</data>
    </edge>
    <edge source="PDF_40_2006_Method_6525108347789616891" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">H1792 cells were transfected with 1-5 µg of shRNA vector and selected in puromycin. Selected cells were examined for loss of RASSF1A expression by Western analysis using a RASSF1A polyclonal antibody and by qRT-PCR.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6166309786436243553" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A directly binds the protein Modulator of Apoptosis-1 (MOAP-1)</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6166309786436243553" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A directly binds the protein Modulator of Apoptosis-1 (MOAP-1)</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1821673362539447090" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was determined to be a RASSF1A interaction partner in a yeast two-hybrid screen.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1821673362539447090" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was determined to be a RASSF1A interaction partner in a yeast two-hybrid screen.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5799130818778099298" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A and MOAP-1 can interact in mammalian cells and that the interaction is enhanced in the presence of activated K-Ras.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5799130818778099298" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A and MOAP-1 can interact in mammalian cells and that the interaction is enhanced in the presence of activated K-Ras.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5799130818778099298" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A and MOAP-1 can interact in mammalian cells and that the interaction is enhanced in the presence of activated K-Ras.</data>
    </edge>
    <edge source="PDF_40_2006_Result_948731372623059496" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Wild type RASSF1A but not a tumor derived point mutant can activate Bax via MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_948731372623059496" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Wild type RASSF1A but not a tumor derived point mutant can activate Bax via MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_948731372623059496" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Wild type RASSF1A but not a tumor derived point mutant can activate Bax via MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-957024816232778490" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-957024816232778490" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-957024816232778490" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-957024816232778490" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-957024816232778490" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">K-Ras not only enhanced the interaction of RASSF1A and MOAP-1 but also stimulated the ability of RASSF1A to activate Bax and induce cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5648813083697518686" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">The ability of K-Ras 12v to activate Bax is dependent upon RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5648813083697518686" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">The ability of K-Ras 12v to activate Bax is dependent upon RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5648813083697518686" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">The ability of K-Ras 12v to activate Bax is dependent upon RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1854708955097321731" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the presence of RASSF1A, MOAP-1 is recruited to microtubule structures with RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1854708955097321731" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the presence of RASSF1A, MOAP-1 is recruited to microtubule structures with RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1632554297047910644" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">The co-immunoprecipitation of RASSF1A and MOAP-1 was only readily detectable in the samples derived form the stromal tissue surrounding the tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1632554297047910644" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The co-immunoprecipitation of RASSF1A and MOAP-1 was only readily detectable in the samples derived form the stromal tissue surrounding the tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-1632554297047910644" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">The co-immunoprecipitation of RASSF1A and MOAP-1 was only readily detectable in the samples derived form the stromal tissue surrounding the tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5908750418673841027" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Upon the addition of activated K-Ras to the transfection, the level of MOAP-1 co-precipitation with RASSF1A increased substantially.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5908750418673841027" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Upon the addition of activated K-Ras to the transfection, the level of MOAP-1 co-precipitation with RASSF1A increased substantially.</data>
    </edge>
    <edge source="PDF_40_2006_Result_5908750418673841027" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Upon the addition of activated K-Ras to the transfection, the level of MOAP-1 co-precipitation with RASSF1A increased substantially.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6442075429125860034" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">The C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6442075429125860034" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">The C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6442075429125860034" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">The C65R mutant of RASSF1A is defective for MOAP-1 binding and does not exhibit enhanced MOAP-1 binding in the presence of activated K-Ras</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7396215420825107056" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activated K-Ras promoted the formation of a complex between RASSF1A and MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7396215420825107056" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activated K-Ras promoted the formation of a complex between RASSF1A and MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7396215420825107056" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Activated K-Ras promoted the formation of a complex between RASSF1A and MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6250568740775828390" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of K-Ras 12v, RASSF1A, and MOAP-1 induced synergistic cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6250568740775828390" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of K-Ras 12v, RASSF1A, and MOAP-1 induced synergistic cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6250568740775828390" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of K-Ras 12v, RASSF1A, and MOAP-1 induced synergistic cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6250568740775828390" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of K-Ras 12v, RASSF1A, and MOAP-1 induced synergistic cell death.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7818253702727186456" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A induces the relocalization and clustering of Bax.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7818253702727186456" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A induces the relocalization and clustering of Bax.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7616297845824850474" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax, suggesting that RASSF1A activates Bax via MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7616297845824850474" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax, suggesting that RASSF1A activates Bax via MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-7616297845824850474" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-transfection of the BH3 domain of MOAP-1 blocked the ability of RASSF1A to activate Bax, suggesting that RASSF1A activates Bax via MOAP-1.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-489717104173259498" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-489717104173259498" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-489717104173259498" target="Disease_LUNG CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A C65R is defective for Bax activation in H1299 lung tumor cells.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6659723526613081581" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6659723526613081581" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_-6659723526613081581" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">A strong activation of Bax by K-Ras12v was only detected in the cells expressing RASSF1A.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6818911312146639850" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">The cells where the expression of endogenous RASSF1A is inhibited by the shRNA construct are defective for K-Ras12v mediated Bax activation.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6818911312146639850" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">The cells where the expression of endogenous RASSF1A is inhibited by the shRNA construct are defective for K-Ras12v mediated Bax activation.</data>
    </edge>
    <edge source="PDF_40_2006_Result_6818911312146639850" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">The cells where the expression of endogenous RASSF1A is inhibited by the shRNA construct are defective for K-Ras12v mediated Bax activation.</data>
    </edge>
    <edge source="PDF_40_2006_Conclusion_-6905685080099351152" target="Protein_RAS">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Conclusion_-6905685080099351152" target="Gene_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Conclusion_-6905685080099351152" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Conclusion_-6905685080099351152" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
    </edge>
    <edge source="PDF_40_2006_Conclusion_-6905685080099351152" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identify a novel pro-apoptotic pathway connecting K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Conclusion_-5540540946875681424">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_8932776040224861331">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_5008136592909895597">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-4912794319540144318">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_8188781800364835129">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-4666806675382766829">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_7814833608294222903">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-4847374812115247732">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_6382256618424890930">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_4354168392301783316">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_30824326631533312">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_2318753918519824998">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_4563320361831730202">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_4969557758143124656">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_7082405829594301175">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_5091741717295391460">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-8730759386501864041">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_1684840525726849843">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-6800160112503435970">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_7772321383417943399">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_503518524870890840">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-5773482404300397553">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_7673383833239711187">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_6686826447617577678">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_-6836807137793278398">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_498231358140566558">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_4642051770203850366">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_2937187592715934021">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_1928585347851698732">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_4500971345532382777">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016" target="PDF_03_2016_Result_7044040300036239640">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_03_2016_Result_-4912794319540144318" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Peg10 knockout mice display defects in placenta formation leading to early embryonic lethality.</data>
    </edge>
    <edge source="PDF_03_2016_Result_8188781800364835129" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Modification of Peg 11/Rtl expression causes late-foetal and/or neonatal lethality in mouse and is essential for the maintenance of foetal capillaries at the foeto-maternal interface during the late-foetal stage.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-4666806675382766829" target="Gene_LDOCI/SIRH7">
      <data key="d8">MENTIONS</data>
      <data key="d9">Knock-out mice for LdocI/Sirh7 show abnormal placental cell differentiation and maturation, with an overproduction of placental progesterone and placental lactogen I from trophoblast giant cells.</data>
    </edge>
    <edge source="PDF_03_2016_Result_7814833608294222903" target="Gene_ZCCHC16/MART4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Disruption of the Zcchc16/Mart4 gene in the mouse causes abnormal behaviours related to cognition.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-4847374812115247732" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Peg10 is overexpressed in human hepatocellular carcinoma and other types of tumours and might promote cancer formation through the suppression of apoptosis and the stimulation of cell proliferation.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-4847374812115247732" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Peg10 is overexpressed in human hepatocellular carcinoma and other types of tumours and might promote cancer formation through the suppression of apoptosis and the stimulation of cell proliferation.</data>
    </edge>
    <edge source="PDF_03_2016_Result_6382256618424890930" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Overexpression of Peg11/Rtll in the liver of adult mice results in highly penetrant tumour formation, suggesting a role as a driver of hepatocarcinogenesis.</data>
    </edge>
    <edge source="PDF_03_2016_Result_4354168392301783316" target="Gene_LDOCI/SIRH7">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ldocl, considered as a tumour suppressor down-regulated in human pancreatic cancer cell lines, inhibits nuclear factor-KB activation and induces apoptosis.</data>
    </edge>
    <edge source="PDF_03_2016_Result_4354168392301783316" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ldocl, considered as a tumour suppressor down-regulated in human pancreatic cancer cell lines, inhibits nuclear factor-KB activation and induces apoptosis.</data>
    </edge>
    <edge source="PDF_03_2016_Result_2318753918519824998" target="Gene_PNMA4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
    </edge>
    <edge source="PDF_03_2016_Result_2318753918519824998" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
    </edge>
    <edge source="PDF_03_2016_Result_2318753918519824998" target="Protein_BCL-2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
    </edge>
    <edge source="PDF_03_2016_Result_2318753918519824998" target="Protein_BCL-XL">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
    </edge>
    <edge source="PDF_03_2016_Result_2318753918519824998" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma4 is a pro-apoptotic protein that can bind the pro-apoptotic Bax protein and the pro-survival Bcl-2 and Bcl-X(L) proteins.</data>
    </edge>
    <edge source="PDF_03_2016_Result_4563320361831730202" target="Gene_PNMA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnmal is a pro-apoptotic protein in neurons, and its overexpression may contribute to neurodegenerative disorders.</data>
    </edge>
    <edge source="PDF_03_2016_Result_4563320361831730202" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnmal is a pro-apoptotic protein in neurons, and its overexpression may contribute to neurodegenerative disorders.</data>
    </edge>
    <edge source="PDF_03_2016_Result_4969557758143124656" target="Gene_PNMA10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Pnma10/SIZNI contributes to Bone Morphogenetic Protein (BMP)-dependent cholinergic-neuron-specific gene expression.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-8730759386501864041" target="Process_APOPTOSIS">
      <data key="d8">MENTIONS</data>
      <data key="d9">NRIF is a mediator of neuronal apoptosis, ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation, and Mzfl is involved in the aetiology of major solid tumours.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-8730759386501864041" target="Protein_TP53">
      <data key="d8">MENTIONS</data>
      <data key="d9">NRIF is a mediator of neuronal apoptosis, ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation, and Mzfl is involved in the aetiology of major solid tumours.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-8730759386501864041" target="Gene_ZNF307">
      <data key="d8">MENTIONS</data>
      <data key="d9">NRIF is a mediator of neuronal apoptosis, ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation, and Mzfl is involved in the aetiology of major solid tumours.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-8730759386501864041" target="Gene_MZFI">
      <data key="d8">MENTIONS</data>
      <data key="d9">NRIF is a mediator of neuronal apoptosis, ZNF307 suppresses the p53-p21 pathway possibly through p53 degradation, and Mzfl is involved in the aetiology of major solid tumours.</data>
    </edge>
    <edge source="PDF_03_2016_Result_1684840525726849843" target="Gene_FV1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Fv1 protects against infection by the murine leukaemia virus and other types of retroviruses by blocking infection through interaction with the capsid protein of the restricted murine leukaemia virus.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-6800160112503435970" target="Gene_ENJS56A1">
      <data key="d8">MENTIONS</data>
      <data key="d9">enJS56A1 and enJSRV-20 can block the replication of related exogenous retroviruses in sheep.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-6800160112503435970" target="Gene_ENJSRV-20">
      <data key="d8">MENTIONS</data>
      <data key="d9">enJS56A1 and enJSRV-20 can block the replication of related exogenous retroviruses in sheep.</data>
    </edge>
    <edge source="PDF_03_2016_Result_7772321383417943399" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Arc is required for learning and memory in the mammalian brain.</data>
    </edge>
    <edge source="PDF_03_2016_Result_503518524870890840" target="Gene_ENS-1/ERNI">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor in chicken.</data>
    </edge>
    <edge source="PDF_03_2016_Result_503518524870890840" target="Protein_SOX2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Ens-1/Erni is involved in the timing of neural plate emergence during embryonic development through the control of the expression of the Sox2 transcription factor in chicken.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-5773482404300397553" target="Gene_GIN-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Gin-2 is present in cartilaginous and ray-finned fish, amphibians, birds and reptiles, suggesting a molecular domestication event approximately 500 MYA, while Gin-1 is more recent and has been formed independently of Gin-2 in a common ancestor of birds/reptiles and mammals.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-5773482404300397553" target="Gene_GIN-2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Gin-2 is present in cartilaginous and ray-finned fish, amphibians, birds and reptiles, suggesting a molecular domestication event approximately 500 MYA, while Gin-1 is more recent and has been formed independently of Gin-2 in a common ancestor of birds/reptiles and mammals.</data>
    </edge>
    <edge source="PDF_03_2016_Result_7673383833239711187" target="Gene_CGINI">
      <data key="d8">MENTIONS</data>
      <data key="d9">CGINI integrase-like domain has been inactivated by mutations but might have retained the three-dimensional folding observed in retroviral integrases, with a proposed role in the resistance to retroviruses through regulation of viral protein ubiquitination.</data>
    </edge>
    <edge source="PDF_03_2016_Result_6686826447617577678" target="Gene_SASPASE">
      <data key="d8">MENTIONS</data>
      <data key="d9">SASPase is involved in wrinkle formation and is necessary for the maintenance of the texture and hydration of the stratum corneum in mouse.</data>
    </edge>
    <edge source="PDF_03_2016_Result_-6836807137793278398" target="Gene_NIXI">
      <data key="d8">MENTIONS</data>
      <data key="d9">NIXI binds ligand-activated/constitutively active nuclear receptors and down-regulates transcription in specific neurons of the central nervous system in the mouse.</data>
    </edge>
    <edge source="PDF_03_2016_Result_498231358140566558" target="Gene_SYNCYTIN">
      <data key="d8">MENTIONS</data>
      <data key="d9">Syncytins are involved in the formation of the placenta by promoting the fusion of trophoblast cells.</data>
    </edge>
    <edge source="PDF_03_2016_Result_4642051770203850366" target="Gene_SYNCYTIN-I">
      <data key="d8">MENTIONS</data>
      <data key="d9">Syncytin-I might also be involved in osteoclast fusion and bone resorption and may also regulate neuro-inflammation in multiple sclerosis.</data>
    </edge>
    <edge source="PDF_03_2016_Result_2937187592715934021" target="Gene_SYNCYTIN-A">
      <data key="d8">MENTIONS</data>
      <data key="d9">Syncytin-A knock-out mouse embryos die in utero between 11.5 and 13.5 days of gestation, demonstrating the critical function of this gene in development.</data>
    </edge>
    <edge source="PDF_03_2016_Result_1928585347851698732" target="Gene_FV1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Fv-4 controls the susceptibility to infection by ecotropic murine leukaemia virus, with expression of the Env protein conferring resistance to virus infection.</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Hypothesis_-8250621175794110137">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Method_-7150736554121306358">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Method_-9124649043959586590">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Method_5349930148425524960">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Method_-1751801214430949228">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-7948630771760546879">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_2707318849210144789">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-7812538130216445846">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_4622611134237590890">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_5465308162423806431">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_7175811470587859729">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-3879734245279788128">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-5460684808047439665">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-8768105610583255133">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_6588235921724353107">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_7471956634593402423">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-8578088350903968672">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_4191206903359502720">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-6072086534126386161">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-5174452707633006292">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_1842399764617129692">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-5473730651300802820">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-3071525508488539027">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_4143400663467412926">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-4329918700508903297">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-4116608036523800360">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-5206290373688159206">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_-8212961012354758019">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Result_9085200772706722116">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Conclusion_-6337803684018119646">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024" target="PDF_05_2024_Conclusion_565513982273108119">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_05_2024_Result_2707318849210144789" target="Gene_RTL10">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the SIRH/RTL family, we find diverse amino-terminal domains, widespread loss of protein-coding capacity in RTL10 despite its retention in several mammalian lineages, and differential utilization of an ancient programmed ribosomal frameshift in RTL3 between the domesticated CA and protease domains.</data>
    </edge>
    <edge source="PDF_05_2024_Result_2707318849210144789" target="Gene_RTL3">
      <data key="d8">MENTIONS</data>
      <data key="d9">In the SIRH/RTL family, we find diverse amino-terminal domains, widespread loss of protein-coding capacity in RTL10 despite its retention in several mammalian lineages, and differential utilization of an ancient programmed ribosomal frameshift in RTL3 between the domesticated CA and protease domains.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-7812538130216445846" target="Gene_PNMA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our analyses also reveal that most members of the PNMA family in mammalian genomes encode a conserved putative amino-terminal RNA-binding domain (RBD) both adjoining and independent from domesticated CA domains.</data>
    </edge>
    <edge source="PDF_05_2024_Result_4622611134237590890" target="Gene_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our analyses lead to a significant correction of previous annotations of the essential CCDC8 gene. We show that this putative RBD is also present in several extant Metaviridae, revealing a novel protein domain configuration in retrotransposons.</data>
    </edge>
    <edge source="PDF_05_2024_Result_7175811470587859729" target="Gene_RTL10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other genes have undergone lineage-specific gene duplication, pseudogenization, or loss, implying lineage-specific retention or loss of functions. Most striking among these is the RTL10 gene, whose protein-coding capacity has only been retained in a subset of mammalian lineages.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-5460684808047439665" target="Gene_RTL3">
      <data key="d8">MENTIONS</data>
      <data key="d9">We find that the RTL3 domesticated genes encode either a CA-protease (PR) or separately retained CA and PR genes in different mammalian lineages.</data>
    </edge>
    <edge source="PDF_05_2024_Result_6588235921724353107" target="Gene_PNMA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among these divergent NTDs, we identify a novel, putative RNA-binding domain (RBD) encoded by the PNMA family, which has undergone dramatic expansion in mammalian genomes and can be retained either with or without an associated CA domain.</data>
    </edge>
    <edge source="PDF_05_2024_Result_1842399764617129692" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 is slightly older (at least ~160 My), with additional marsupial paralogs that have been previously described, whereas ARC is much older (at least ~350 My), with orthologs found across all tetrapods including birds, reptiles, and amphibians.</data>
    </edge>
    <edge source="PDF_05_2024_Result_1842399764617129692" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">PEG10 is slightly older (at least ~160 My), with additional marsupial paralogs that have been previously described, whereas ARC is much older (at least ~350 My), with orthologs found across all tetrapods including birds, reptiles, and amphibians.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-5473730651300802820" target="Gene_PNMA6E/F">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that four orthologous groups in our trees (PNMA6E/F, ZCCHC12/18, PNMA6A/B, and RTL8A/B/C) contain more than one human gene (with orthologs present in other species), indicating that more recent lineage-specific duplication events continue to shape some branches of the gene family.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-5473730651300802820" target="Gene_ZCCHC12">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that four orthologous groups in our trees (PNMA6E/F, ZCCHC12/18, PNMA6A/B, and RTL8A/B/C) contain more than one human gene (with orthologs present in other species), indicating that more recent lineage-specific duplication events continue to shape some branches of the gene family.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-5473730651300802820" target="Gene_PNMA6A/B">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that four orthologous groups in our trees (PNMA6E/F, ZCCHC12/18, PNMA6A/B, and RTL8A/B/C) contain more than one human gene (with orthologs present in other species), indicating that more recent lineage-specific duplication events continue to shape some branches of the gene family.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-5473730651300802820" target="Gene_RTL8">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found that four orthologous groups in our trees (PNMA6E/F, ZCCHC12/18, PNMA6A/B, and RTL8A/B/C) contain more than one human gene (with orthologs present in other species), indicating that more recent lineage-specific duplication events continue to shape some branches of the gene family.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_RTL1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_PEG10">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_PNMA6E/F">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_RTL6">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-3071525508488539027" target="Gene_RTL8">
      <data key="d8">MENTIONS</data>
      <data key="d9">Of these 19 clades, eight are universally retained as at least single intact genes across all placental mammals queried, suggesting they confer an important biological function common to all mammals (ARC, RTL1, PEG10, RTL9, PNMA2 and PNMA6E/F, RTL6 and RTL8).</data>
    </edge>
    <edge source="PDF_05_2024_Result_-4329918700508903297" target="Gene_RTL10">
      <data key="d8">MENTIONS</data>
      <data key="d9">For example, RTL10 was present in the common ancestor of placental mammals but is retained as an intact ORF in only the three out of 18 mammalian genomes we surveyed.</data>
    </edge>
    <edge source="PDF_05_2024_Result_-4116608036523800360" target="Gene_ARC">
      <data key="d8">MENTIONS</data>
      <data key="d9">We find that most Metaviridae-origin CA genes evolve under overall purifying selection, with ARC showing the strongest purifying selection (dN/dS = 0.03). RTL6 also shows strong purifying selection (dN/dS = 0.04), despite its involvement in immune functions</data>
    </edge>
    <edge source="PDF_05_2024_Result_-4116608036523800360" target="Gene_RTL6">
      <data key="d8">MENTIONS</data>
      <data key="d9">We find that most Metaviridae-origin CA genes evolve under overall purifying selection, with ARC showing the strongest purifying selection (dN/dS = 0.03). RTL6 also shows strong purifying selection (dN/dS = 0.04), despite its involvement in immune functions</data>
    </edge>
    <edge source="PDF_05_2024_Result_-5206290373688159206" target="Gene_RTL10">
      <data key="d8">MENTIONS</data>
      <data key="d9">In contrast, for RTL10, we were barely able to rule out the null hypothesis of neutral evolution (dN/dS = 0.72, close to the neutral ratio of 1) using our initial sampling (n = 3 intact primate genes).</data>
    </edge>
    <edge source="PDF_05_2024_Result_9085200772706722116" target="Gene_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our findings of positive selection are intriguing given previous studies that implicate three of the positively selected genes (CCDC8, RTL5, RTL9) in immune-related functions</data>
    </edge>
    <edge source="PDF_05_2024_Result_9085200772706722116" target="Gene_RTL5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our findings of positive selection are intriguing given previous studies that implicate three of the positively selected genes (CCDC8, RTL5, RTL9) in immune-related functions</data>
    </edge>
    <edge source="PDF_05_2024_Result_9085200772706722116" target="Gene_RTL9">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our findings of positive selection are intriguing given previous studies that implicate three of the positively selected genes (CCDC8, RTL5, RTL9) in immune-related functions</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Hypothesis_-217224069592526071">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Method_9082614510201131913">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Method_3810455608429950939">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-8077364468544576836">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-2538667445842039420">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-2111775495626340592">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Conclusion_4234703690517401030">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_1936239000753188640">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_9153092349707605486">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-5298048616412677613">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-4740182779277302709">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_2389533462319179189">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_1088363242006174154">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-3050406182926360430">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-1523441685890294439">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_3427928079360674293">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_5321336177742059226">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-4991677486666615413">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_6827959127765461573">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-148982913318525410">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-246187985418947255">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020" target="PDF_28_2020_Result_-2575054046163591484">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_28_2020_Hypothesis_-217224069592526071" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We hypothesize that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
    </edge>
    <edge source="PDF_28_2020_Hypothesis_-217224069592526071" target="Disease_METABOLIC DISEASES">
      <data key="d8">MENTIONS</data>
      <data key="d9">We hypothesize that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men.</data>
    </edge>
    <edge source="PDF_28_2020_Method_3810455608429950939" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We identified genetic determinants of testosterone levels and related sex hormone traits in 425,097 UK Biobank study participants.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-8077364468544576836" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">The genetic determinants of testosterone levels are substantially different between sexes.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2538667445842039420" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2538667445842039420" target="Disease_TYPE 2 DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2538667445842039420" target="Disease_POLYCYSTIC OVARY SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">A genetically determined 1-standard deviation higher testosterone increases the risks of Type 2 diabetes (T2D) and polycystic ovary syndrome in women, but reduces T2D risk in men.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2111775495626340592" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher testosterone has adverse effects on breast and endometrial cancers in women, and prostate cancer in men.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2111775495626340592" target="Disease_BREAST CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher testosterone has adverse effects on breast and endometrial cancers in women, and prostate cancer in men.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2111775495626340592" target="Disease_ENDOMETRIAL CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher testosterone has adverse effects on breast and endometrial cancers in women, and prostate cancer in men.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2111775495626340592" target="Disease_PROSTATE CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">Higher testosterone has adverse effects on breast and endometrial cancers in women, and prostate cancer in men.</data>
    </edge>
    <edge source="PDF_28_2020_Conclusion_4234703690517401030" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Our findings provide insights into the disease impacts of testosterone and highlight the importance of sex-specific genetic analyses.</data>
    </edge>
    <edge source="PDF_28_2020_Result_1936239000753188640" target="Protein_SHBG">
      <data key="d8">MENTIONS</data>
      <data key="d9">Assessment of our SHBG-associated loci in the published meta-analysis demonstrated 236/278 (85%, binomial P=6.1x10-34) of the captured male SHBG signals had consistent direction of effect (77 with P&lt;0.05), compared to 241/283 in women (85%, binomial P=4.2x10-35, 60 at P&lt;0.05).</data>
    </edge>
    <edge source="PDF_28_2020_Result_9153092349707605486" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Notably, several variants had genome-wide significant but directionally-opposing effects on testosterone in men and women, including the missense variants: rs56196860 in FKBP4 which encodes a regulator of androgen receptor transactivation activity; and rs28929474 in SERPINA 1 which encodes one of a family of proteins which are reported to regulate steroidogenesis in testicular Leydig cells.</data>
    </edge>
    <edge source="PDF_28_2020_Result_9153092349707605486" target="Gene_FKBP4">
      <data key="d8">MENTIONS</data>
      <data key="d9">Notably, several variants had genome-wide significant but directionally-opposing effects on testosterone in men and women, including the missense variants: rs56196860 in FKBP4 which encodes a regulator of androgen receptor transactivation activity; and rs28929474 in SERPINA 1 which encodes one of a family of proteins which are reported to regulate steroidogenesis in testicular Leydig cells.</data>
    </edge>
    <edge source="PDF_28_2020_Result_9153092349707605486" target="Gene_SERPINA 1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Notably, several variants had genome-wide significant but directionally-opposing effects on testosterone in men and women, including the missense variants: rs56196860 in FKBP4 which encodes a regulator of androgen receptor transactivation activity; and rs28929474 in SERPINA 1 which encodes one of a family of proteins which are reported to regulate steroidogenesis in testicular Leydig cells.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Gene_CYP3A7">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Gene_CYP2D6">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Gene_CYP2C8">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Gene_CYP2C9">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Gene_CYP11B2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-5298048616412677613" target="Gene_POR">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among many signals with apparent female-specific effects on testosterone were five signals in/near to genes encoding enzymes in the cytochrome P450 family with reported roles in testosterone hydroxylation (CYP3A7-rs45446698, CYP2D6-rs5751229, CYP2C8|CYP2C9-rs11572082, CYP11B2-rs6471583 and POR-rs17853284).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Disease_POLYCYSTIC OVARY SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_FSHB">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_THADA">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_CYP17A1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_CYB5A">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_LHB">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_NR3C1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4740182779277302709" target="Gene_PRLR">
      <data key="d8">MENTIONS</data>
      <data key="d9">Other signals with female-specific effects on testosterone included: reported PCOS susceptibility loci at FSHB (rs12294104) and THADA (rs58839393); CYP17A1 (rs11441374) encoding 17,20-lyase, the decisive step in androgen synthesis, and its critical cofactor CYB5A-rs17089026/ rs79384925); and also near genes encoding luteinizing hormone subunit beta (LHB- rs78248023) and hormone receptors for glucocorticoids (NR3C1-rs34632394) and prolactin (PRLR-rs112694713).</data>
    </edge>
    <edge source="PDF_28_2020_Result_2389533462319179189" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">In contrast to testosterone traits, the genetic architecture of SHBG levels was highly concordant between men and women (rg 0.84 [0.81-0.87], P&lt;1x10-100); 315 (88%) of the 359 genome-wide significant variants in women were also at least nominally associated (P&lt;0.05) with SHBG in men (Table S4).</data>
    </edge>
    <edge source="PDF_28_2020_Result_2389533462319179189" target="Protein_SHBG">
      <data key="d8">MENTIONS</data>
      <data key="d9">In contrast to testosterone traits, the genetic architecture of SHBG levels was highly concordant between men and women (rg 0.84 [0.81-0.87], P&lt;1x10-100); 315 (88%) of the 359 genome-wide significant variants in women were also at least nominally associated (P&lt;0.05) with SHBG in men (Table S4).</data>
    </edge>
    <edge source="PDF_28_2020_Result_1088363242006174154" target="Protein_SHBG">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among men, we found partially overlapping genetic determinants between the different sex hormone traits. This was reflected by positive genetic correlations between all four sex hormone measures (Table 1, rg 0.19-0.73), with the exception of a weak negative correlation between SHBG and bioavailable testosterone (rg -0.048 (SE 0.024), P=0.04).</data>
    </edge>
    <edge source="PDF_28_2020_Result_1088363242006174154" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Among men, we found partially overlapping genetic determinants between the different sex hormone traits. This was reflected by positive genetic correlations between all four sex hormone measures (Table 1, rg 0.19-0.73), with the exception of a weak negative correlation between SHBG and bioavailable testosterone (rg -0.048 (SE 0.024), P=0.04).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-3050406182926360430" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">These clusters helped inform genetic causal inference analyses by showing primary metabolic effects of testosterone that were beneficial in men (lower fasting glucose and lower T2D risk) but harmful in women (higher PCOS risk).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-3050406182926360430" target="Disease_TYPE 2 DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">These clusters helped inform genetic causal inference analyses by showing primary metabolic effects of testosterone that were beneficial in men (lower fasting glucose and lower T2D risk) but harmful in women (higher PCOS risk).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-3050406182926360430" target="Disease_POLYCYSTIC OVARY SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">These clusters helped inform genetic causal inference analyses by showing primary metabolic effects of testosterone that were beneficial in men (lower fasting glucose and lower T2D risk) but harmful in women (higher PCOS risk).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-1523441685890294439" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Using these genetic instruments, in men and women separately, we could infer causal positive effects of testosterone levels on lean body mass and number of lifetime sexual partners.</data>
    </edge>
    <edge source="PDF_28_2020_Result_3427928079360674293" target="Disease_TYPE 2 DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">For T2D and related traits, the evidence of a protective effect of testosterone was most consistent when using the cluster-specific genetic instrument representing a primary (total and bioavailable) testosterone-increasing effect independent of SHBG.</data>
    </edge>
    <edge source="PDF_28_2020_Result_3427928079360674293" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">For T2D and related traits, the evidence of a protective effect of testosterone was most consistent when using the cluster-specific genetic instrument representing a primary (total and bioavailable) testosterone-increasing effect independent of SHBG.</data>
    </edge>
    <edge source="PDF_28_2020_Result_3427928079360674293" target="Protein_SHBG">
      <data key="d8">MENTIONS</data>
      <data key="d9">For T2D and related traits, the evidence of a protective effect of testosterone was most consistent when using the cluster-specific genetic instrument representing a primary (total and bioavailable) testosterone-increasing effect independent of SHBG.</data>
    </edge>
    <edge source="PDF_28_2020_Result_5321336177742059226" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Exposure to higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose: each 1-SD higher testosterone level (approximately 3.7 nmol/L) was associated with a 15% lower T2D risk in men (total testosterone odds ratio (OR): 0.85; 95% CI: 0.77, 0.95; cluster-specific testosterone OR: 0.86; 95% CI 0.76,0.98).</data>
    </edge>
    <edge source="PDF_28_2020_Result_5321336177742059226" target="Protein_SHBG">
      <data key="d8">MENTIONS</data>
      <data key="d9">Exposure to higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose: each 1-SD higher testosterone level (approximately 3.7 nmol/L) was associated with a 15% lower T2D risk in men (total testosterone odds ratio (OR): 0.85; 95% CI: 0.77, 0.95; cluster-specific testosterone OR: 0.86; 95% CI 0.76,0.98).</data>
    </edge>
    <edge source="PDF_28_2020_Result_5321336177742059226" target="Disease_TYPE 2 DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">Exposure to higher testosterone, independent of SHBG, conferred lower T2D risk and lower fasting glucose: each 1-SD higher testosterone level (approximately 3.7 nmol/L) was associated with a 15% lower T2D risk in men (total testosterone odds ratio (OR): 0.85; 95% CI: 0.77, 0.95; cluster-specific testosterone OR: 0.86; 95% CI 0.76,0.98).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4991677486666615413" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">MR analyses indicated that testosterone increases prostate cancer risk in men: each 1-SD higher bioavailable testosterone level increased prostate cancer risk by 23% (OR: 1.23; 95%CI 1.13-1.33), with consistent findings across all testosterone genetic instruments (unfiltered, Steiger-filtered and cluster-filtered).</data>
    </edge>
    <edge source="PDF_28_2020_Result_-4991677486666615413" target="Disease_PROSTATE CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">MR analyses indicated that testosterone increases prostate cancer risk in men: each 1-SD higher bioavailable testosterone level increased prostate cancer risk by 23% (OR: 1.23; 95%CI 1.13-1.33), with consistent findings across all testosterone genetic instruments (unfiltered, Steiger-filtered and cluster-filtered).</data>
    </edge>
    <edge source="PDF_28_2020_Result_6827959127765461573" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found consistent evidence supporting a causal effect of testosterone on higher PCOS risk in women. These effects were most evident with bioavailable testosterone, with positive findings across all MR models and all instruments (unfiltered, Steiger-filtered and cluster- filtered). These effects equated to an odds ratio of 1.51 (95%CI 1.33-1.72) per 1-SD higher bioavailable testosterone.</data>
    </edge>
    <edge source="PDF_28_2020_Result_6827959127765461573" target="Disease_POLYCYSTIC OVARY SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found consistent evidence supporting a causal effect of testosterone on higher PCOS risk in women. These effects were most evident with bioavailable testosterone, with positive findings across all MR models and all instruments (unfiltered, Steiger-filtered and cluster- filtered). These effects equated to an odds ratio of 1.51 (95%CI 1.33-1.72) per 1-SD higher bioavailable testosterone.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-148982913318525410" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">MR analyses also showed a causal effect of bioavailable testosterone on higher T2D risk and higher fasting insulin in women (using unfiltered and Steiger-filtered instruments). Risk of T2D was increased by 37% (OR: 1.37; 95% CI 1.22, 1.53) per 1-SD higher bioavailable testosterone.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-148982913318525410" target="Disease_TYPE 2 DIABETES">
      <data key="d8">MENTIONS</data>
      <data key="d9">MR analyses also showed a causal effect of bioavailable testosterone on higher T2D risk and higher fasting insulin in women (using unfiltered and Steiger-filtered instruments). Risk of T2D was increased by 37% (OR: 1.37; 95% CI 1.22, 1.53) per 1-SD higher bioavailable testosterone.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-246187985418947255" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found evidence that testosterone increased the risk of estrogen receptor (ER)+ but not ER-breast cancer, with consistent findings across all MR models and instruments.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-246187985418947255" target="Disease_BREAST CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">We found evidence that testosterone increased the risk of estrogen receptor (ER)+ but not ER-breast cancer, with consistent findings across all MR models and instruments.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2575054046163591484" target="Compound_TESTOSTERONE">
      <data key="d8">MENTIONS</data>
      <data key="d9">Furthermore, testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer, again with consistent findings across sensitivity models.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2575054046163591484" target="Disease_ENDOMETRIAL CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">Furthermore, testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer, again with consistent findings across sensitivity models.</data>
    </edge>
    <edge source="PDF_28_2020_Result_-2575054046163591484" target="Disease_OVARIAN CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">Furthermore, testosterone increased the risk of endometrial cancer but reduced the risk of ovarian cancer, again with consistent findings across sensitivity models.</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_6967398282304042958">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_2917739563603746068">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_430883512617757375">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_3650887773818418760">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_796343488752759396">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_7666105977062708496">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-7658845461493436191">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_8573876462104716775">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-903663589177214580">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_4162666203042980428">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-4457804855602327466">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-603793349120865973">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-124952066393809203">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-9052016064248680024">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_2619999751612699767">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-2751770189889020198">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-183868857310836864">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_7617531455839023636">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_8038901095270458073">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-438750193021511875">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-8915771799138376165">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_596475561888453619">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_7788417139704865264">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-7410083995776227336">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-4560048891170104957">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_5009335901464109085">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_3323142523373010295">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-1751590031790914324">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-8310376796190221931">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-4275182837630616509">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_3231423044467125708">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_6830077210168047751">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-8392931956633663813">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-5588286335462859396">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_7535371967778245814">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_3903858293143824201">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_6409500103081842803">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_-2911187999974191348">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_6676597599829207706">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_8682849258717922793">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_417535115365772183">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Result_3470336897953622803">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Hypothesis_-5432545647274465642">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u" target="PDF_07_2018_u_Method_-1891167484164689156">
      <data key="d8">CONTAINS</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6967398282304042958" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share high protein sequence homology with the highest sequence homology of 84% between PNMA7A and PNMA7B.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6967398282304042958" target="Protein_PNMA7B">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share high protein sequence homology with the highest sequence homology of 84% between PNMA7A and PNMA7B.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_2917739563603746068" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">The lowest protein sequence homology of 9.5% is between PNMA7A and CCDC8.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_2917739563603746068" target="Protein_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">The lowest protein sequence homology of 9.5% is between PNMA7A and CCDC8.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_430883512617757375" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share high sequence homology at the N-terminal conserved domain (NCD), except PNMA7A, and PNMA7B.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_430883512617757375" target="Protein_PNMA7B">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share high sequence homology at the N-terminal conserved domain (NCD), except PNMA7A, and PNMA7B.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3650887773818418760" target="Protein_PNMA8A">
      <data key="d8">MENTIONS</data>
      <data key="d9">The other conserved domain of the PNMA family members is the central conserved domain (CCD), except PNMA8A-C, which show significant sequence divergence within this region.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_796343488752759396" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Situated between NCD and CCD domains are unique protein sequence or domain (UPD) found in some members of PNMA including the BH3-like (BH3-L) domain of MOAP-1 and PNMA1.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_796343488752759396" target="Protein_PNMA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Situated between NCD and CCD domains are unique protein sequence or domain (UPD) found in some members of PNMA including the BH3-like (BH3-L) domain of MOAP-1 and PNMA1.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7666105977062708496" target="Protein_PNMA8B">
      <data key="d8">MENTIONS</data>
      <data key="d9">a region rich in Lysine and Arginine basic residues, and designated as KRs is found in the protein sequences of all the members of PNMA family, except PNMA8B, and PNMA8C.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7666105977062708496" target="Protein_PNMA8C">
      <data key="d8">MENTIONS</data>
      <data key="d9">a region rich in Lysine and Arginine basic residues, and designated as KRs is found in the protein sequences of all the members of PNMA family, except PNMA8B, and PNMA8C.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-7658845461493436191" target="Protein_PNMA6F">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share sequence homology at a poly-glutamic acid rich region (PolyE) near the C-terminus, except PNMA6F, 8A, and 8C.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-7658845461493436191" target="Protein_PNMA8A">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share sequence homology at a poly-glutamic acid rich region (PolyE) near the C-terminus, except PNMA6F, 8A, and 8C.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-7658845461493436191" target="Protein_PNMA8C">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA family members share sequence homology at a poly-glutamic acid rich region (PolyE) near the C-terminus, except PNMA6F, 8A, and 8C.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8573876462104716775" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">Nuclear targeting signal of PNMA5 was identified in the VCS region of PNMA5, PNMA7A and PNMA7B</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8573876462104716775" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">Nuclear targeting signal of PNMA5 was identified in the VCS region of PNMA5, PNMA7A and PNMA7B</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8573876462104716775" target="Protein_PNMA7B">
      <data key="d8">MENTIONS</data>
      <data key="d9">Nuclear targeting signal of PNMA5 was identified in the VCS region of PNMA5, PNMA7A and PNMA7B</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_4162666203042980428" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_4162666203042980428" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported to mediate apoptotic signalling by interacting with Bax, a pro-apoptotic member of Bcl-2 family</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4457804855602327466" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4457804855602327466" target="Protein_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4457804855602327466" target="Protein_TNF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was shown to interact with RASSF1A tumor suppressor through TNF receptor mediated signalling upon activation of the TNF receptor by TNF ligand</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-603793349120865973" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-603793349120865973" target="Protein_SMAD1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-603793349120865973" target="Protein_BMP">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA7A was reported to function as transcriptional co-activator and participate in Bone Morphogenic Protein (BMP) signalling by interacting with Smad1 and CBP</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-124952066393809203" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA7A was identified as transcriptional co-activator that interacts with c-Jun and activates AP-1 and CREB signalling</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-124952066393809203" target="Protein_C-JUN">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA7A was identified as transcriptional co-activator that interacts with c-Jun and activates AP-1 and CREB signalling</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-124952066393809203" target="Protein_CREB">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA7A was identified as transcriptional co-activator that interacts with c-Jun and activates AP-1 and CREB signalling</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-9052016064248680024" target="Gene_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">mutations of PNMA7A were found to be associated with human mental retardation</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-9052016064248680024" target="Disease_MENTAL RETARDATION">
      <data key="d8">MENTIONS</data>
      <data key="d9">mutations of PNMA7A were found to be associated with human mental retardation</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_2619999751612699767" target="Protein_PNMA7A">
      <data key="d8">MENTIONS</data>
      <data key="d9">recent studies showed that PNMA7A functions as an oncogene and the expression is elevated in thyroid cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_2619999751612699767" target="Disease_THYROID CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">recent studies showed that PNMA7A functions as an oncogene and the expression is elevated in thyroid cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-2751770189889020198" target="Gene_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-2751770189889020198" target="Disease_3-M SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">Mutations of CCDC8 gene were associated with post-natal growth restriction, one of the well described features of 3M-syndrome</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-183868857310836864" target="Protein_OBSL-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">OBSL-1 was found to be the common protein interacting partner of both CCDC8 and CUL7</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-183868857310836864" target="Protein_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">OBSL-1 was found to be the common protein interacting partner of both CCDC8 and CUL7</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-183868857310836864" target="Protein_CUL7">
      <data key="d8">MENTIONS</data>
      <data key="d9">OBSL-1 was found to be the common protein interacting partner of both CCDC8 and CUL7</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7617531455839023636" target="Disease_3-M SYNDROME">
      <data key="d8">MENTIONS</data>
      <data key="d9">patients with 3-M syndrome were found to exhibit growth hormone deficiency or disordered growth factor signalling</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8038901095270458073" target="Protein_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">CCDC8 protein level is relative low in tumour cells, and over-expression of CCDC8 in cancer cells inhibits invasiveness and metastasis of cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8038901095270458073" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">CCDC8 protein level is relative low in tumour cells, and over-expression of CCDC8 in cancer cells inhibits invasiveness and metastasis of cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-438750193021511875" target="Protein_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A is a tumor suppressor and its protein expression is frequently silenced in many cancer cells through hyper-methylation of its gene promoter</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-438750193021511875" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">RASSF1A is a tumor suppressor and its protein expression is frequently silenced in many cancer cells through hyper-methylation of its gene promoter</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-8915771799138376165" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-8915771799138376165" target="Protein_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 interacts with poly-glutamic acid residues of RASSF1A</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_596475561888453619" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was shown to interact with RASSF1A, and TNF-R through its RASSF1A binding domain within the KRs region and poly-glutamic acid rich residues (polyE) of its C-terminus, respectively.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_596475561888453619" target="Protein_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was shown to interact with RASSF1A, and TNF-R through its RASSF1A binding domain within the KRs region and poly-glutamic acid rich residues (polyE) of its C-terminus, respectively.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_596475561888453619" target="Protein_TNF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was shown to interact with RASSF1A, and TNF-R through its RASSF1A binding domain within the KRs region and poly-glutamic acid rich residues (polyE) of its C-terminus, respectively.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7788417139704865264" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported to be present in an inactive conformation through intramolecular interaction, and by interacting with RASSF1A, MOAP-1 is unfolded with its exposed BH3-like domain to interact and promote Bax activation, leading to transmigration of activated Bax to the mitochondria</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7788417139704865264" target="Protein_RASSF">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported to be present in an inactive conformation through intramolecular interaction, and by interacting with RASSF1A, MOAP-1 is unfolded with its exposed BH3-like domain to interact and promote Bax activation, leading to transmigration of activated Bax to the mitochondria</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7788417139704865264" target="Protein_BAX">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported to be present in an inactive conformation through intramolecular interaction, and by interacting with RASSF1A, MOAP-1 is unfolded with its exposed BH3-like domain to interact and promote Bax activation, leading to transmigration of activated Bax to the mitochondria</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-7410083995776227336" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported as MTCH2 interacting protein and plays an important role in Fas receptor mediated apoptosis signalling by promoting recruitment of tBid to the mitochondria during apoptosis</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-7410083995776227336" target="Protein_MTCH2">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported as MTCH2 interacting protein and plays an important role in Fas receptor mediated apoptosis signalling by promoting recruitment of tBid to the mitochondria during apoptosis</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-7410083995776227336" target="Protein_TBID">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 was reported as MTCH2 interacting protein and plays an important role in Fas receptor mediated apoptosis signalling by promoting recruitment of tBid to the mitochondria during apoptosis</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4560048891170104957" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4560048891170104957" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interaction with PNMA2 leads to inhibition of pro-apoptotic function of MOAP-1.</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_5009335901464109085" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_5009335901464109085" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">interaction with PNMA5 enhances pro-apoptotic function of MOAP-1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3323142523373010295" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3323142523373010295" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2, an onconeuronal antigen, was reported to be aberrantly expressed in a number of tumors, and its over-expression is likely to be closely associated with tumorigenesis</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-1751590031790914324" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">over-expressed PNMA2 failed to promote apoptotic signalling in transfected MCF-7 cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-8310376796190221931" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 was shown to interact with both PNMA1 and MOAP-1 in co-immunoprecipitation studies, as well as functionally antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-8310376796190221931" target="Protein_PNMA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 was shown to interact with both PNMA1 and MOAP-1 in co-immunoprecipitation studies, as well as functionally antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-8310376796190221931" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">PNMA2 was shown to interact with both PNMA1 and MOAP-1 in co-immunoprecipitation studies, as well as functionally antagonized the pro-apoptotic function of both MOAP-1 and PNMA1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4275182837630616509" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">transient co-expression of MOAP-1 and PNMA5 synergistically enhanced apoptotic signalling in transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4275182837630616509" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">transient co-expression of MOAP-1 and PNMA5 synergistically enhanced apoptotic signalling in transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-4275182837630616509" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">transient co-expression of MOAP-1 and PNMA5 synergistically enhanced apoptotic signalling in transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3231423044467125708" target="Protein_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">over-expressed CCDC8 inhibited invasiveness of A549 cells while CCDC8 knock-downed cells promoted invasiveness of the cancer cells in cell migration assay</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3231423044467125708" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">over-expressed CCDC8 inhibited invasiveness of A549 cells while CCDC8 knock-downed cells promoted invasiveness of the cancer cells in cell migration assay</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6830077210168047751" target="Protein_ZCCHC12">
      <data key="d8">MENTIONS</data>
      <data key="d9">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6830077210168047751" target="Disease_THYROID CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">ZCCHC12 was found over-expressed in papillary thyroid tumours and ZCCHC12 knocked downed thyroid cancer cell lines exhibited reduced number of colonies formed in the colony formation assay</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-8392931956633663813" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 has a short half-life of 25 min and the stability of the protein is regulated through ubiquitin proteasome pathway in which degradation of MOAP-1 occurred at G1, and S-G2 phases of cell cycle by the APC/CCdh1 and the UBR5 ubiquitin ligases, respectively</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-5588286335462859396" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Trim39 ubiquitin ligase interacts with MOAP-1 and promotes stability of MOAP-1 by inhibiting the activity of APC/CCdh1-mediated ubiquitination and degradation</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7535371967778245814" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 protein level was enhanced or stabilized in the cancer cells when treated with chemo-drugs or apoptosis stimuli</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_7535371967778245814" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">MOAP-1 protein level was enhanced or stabilized in the cancer cells when treated with chemo-drugs or apoptosis stimuli</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3903858293143824201" target="Gene_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">miRNA-1228 negatively regulates MOAP-1 expression by binding to the miRNA target sequence of the MOAP-1 mRNA, and down-regulation of miRNA-1228 was shown to promote MOAP-1 stabilization</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6409500103081842803" target="Gene_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">miR-25 has been reported to promote cell proliferation by promoting down-regulation of MOAP-1 expression in lung cancer</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6409500103081842803" target="Disease_LUNG CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">miR-25 has been reported to promote cell proliferation by promoting down-regulation of MOAP-1 expression in lung cancer</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_-2911187999974191348" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">pro-apoptotic activity of MOAP-1 was reported to be regulated by members of PNMA family</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6676597599829207706" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-expression of MOAP-1 with PNMA2 resulted in inhibition of pro-apoptotic activity of MOAP-1 in transiently transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6676597599829207706" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-expression of MOAP-1 with PNMA2 resulted in inhibition of pro-apoptotic activity of MOAP-1 in transiently transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_6676597599829207706" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">Co-expression of MOAP-1 with PNMA2 resulted in inhibition of pro-apoptotic activity of MOAP-1 in transiently transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8682849258717922793" target="Protein_PNMA2">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interestingly, PNMA2 has been shown to antagonize both pro-apoptotic activities of MOAP-1 and PNMA1 through heterodimeric interaction with MOAP-1 and PNMA1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8682849258717922793" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interestingly, PNMA2 has been shown to antagonize both pro-apoptotic activities of MOAP-1 and PNMA1 through heterodimeric interaction with MOAP-1 and PNMA1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_8682849258717922793" target="Protein_PNMA1">
      <data key="d8">MENTIONS</data>
      <data key="d9">Interestingly, PNMA2 has been shown to antagonize both pro-apoptotic activities of MOAP-1 and PNMA1 through heterodimeric interaction with MOAP-1 and PNMA1</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_417535115365772183" target="Protein_MOAP-1">
      <data key="d8">MENTIONS</data>
      <data key="d9">co-expression of MOAP-1 with PNMA5 significantly enhanced pro-apoptotic activity of MOAP-1 in transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_417535115365772183" target="Protein_PNMA5">
      <data key="d8">MENTIONS</data>
      <data key="d9">co-expression of MOAP-1 with PNMA5 significantly enhanced pro-apoptotic activity of MOAP-1 in transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_417535115365772183" target="Disease_CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">co-expression of MOAP-1 with PNMA5 significantly enhanced pro-apoptotic activity of MOAP-1 in transfected cancer cells</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3470336897953622803" target="Gene_CCDC8">
      <data key="d8">MENTIONS</data>
      <data key="d9">CCDC8 was found to be hyper-methylated or epigenetically silenced in breast tumors that showed metastasis potential</data>
    </edge>
    <edge source="PDF_07_2018_u_Result_3470336897953622803" target="Disease_BREAST CANCER">
      <data key="d8">MENTIONS</data>
      <data key="d9">CCDC8 was found to be hyper-methylated or epigenetically silenced in breast tumors that showed metastasis potential</data>
    </edge>
    <edge source="PDF_07_2018_u_Hypothesis_-5432545647274465642" target="Gene_PNMA">
      <data key="d8">MENTIONS</data>
      <data key="d9">the expression of PNMA family members may be regulated through other cellular mechanisms</data>
    </edge>
  </graph>
</graphml>
